<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1811246235
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        QUREX XL 1000 mg film-coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        7
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        53.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Qurex<sup>&reg;</sup></strong> <strong>XL</strong> is a fluoroquinolone antibacterial indicated in adults (&ge;18 years of age) with infections caused by designated, susceptible bacteria:</p><p>Complicated Urinary tract infections, and acute uncomplicated pyelonephritis.</p><p><u>Usage </u></p><p>To reduce the development of drug-resistant bacteria and maintain the effectiveness of ciprofloxacin and other antibacterial drugs, <strong>Qurex<sup>&reg;</sup></strong> <strong>XL</strong> should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Qurex<sup>&reg;</sup> XL</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to the active substance, to other quinolone drugs or to any of the other ingredients of this medicine (listed in Section 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking tizanidine.</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor before taking<strong> Qurex<sup>&reg;</sup> XL</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever had kidney problems because your treatment may need to be adjusted.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you suffer from epilepsy or other neurological conditions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a history of tendon problems during previous treatment with antibiotics such as <strong>Qurex<sup>&reg;</sup> XL</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are diabetic because you may experience a risk of hypoglycaemia with ciprofloxacin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have myasthenia gravis (a type of muscle weakness) because symptoms can be</p><p>exacerbated.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have heart problems. Caution should be taken when using Ciprofloxacin, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium&nbsp; in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or a member of your family is known to have a deficiency in glucose-6-phosphate dehydrogenase (G6PD), since you may experience a risk of anaemia with ciprofloxacin.</p><p>&nbsp;</p><p><strong>It is not known if Qurex<sup>&reg;</sup> XL is safe and effective in children under 18 y</strong><strong>ears of age.</strong></p><p><strong>&nbsp;</strong></p><p><strong>While taking Qurex<sup>&reg;</sup> XL</strong></p><p>Tell your doctor immediately, if any of the following occurs <strong>while taking Qurex<sup>&reg;</sup> XL</strong>. Your doctor will decide whether treatment with <strong>Qurex<sup>&reg;</sup> XL</strong> needs to be stopped.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe, sudden allergic reaction<strong> </strong>(an anaphylactic reaction/shock, angio-oedema). Even with the first dose, there is a small chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, sick or faint, or experiencing dizziness when standing up. If this happens, stop taking <strong>Qurex<sup>&reg;</sup> XL</strong> and contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain and swelling in the joints and tendinitis<strong> </strong>may occur occasionally, particularly if you are elderly and are also being treated with corticosteroids. Inflammation and ruptures of tendons may occur even within the first 48 hours of treatment or up to several months after discontinuation of <strong>Qurex<sup>&reg;</sup> XL</strong> therapy. At the first sign of any pain or inflammation stop taking <strong>Qurex<sup>&reg;</sup> XL</strong>, contact your doctor and rest the painful area. Avoid any unnecessary exercise, as this might increase the risk of a tendon rupture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from epilepsy or other neurological conditions<strong> </strong>such as cerebral ischemia or stroke, you may experience side effects associated with the central nervous system. If seizure happens, stop taking <strong>Qurex<sup>&reg;</sup> XL</strong> and contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You may experience symptoms of neuropathy such as pain, burning, tingling, numbness and/or muscle weakness. If this happens, stop taking <strong>Qurex<sup>&reg;</sup> XL</strong> and contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You may experience psychiatric reactions the first time you take <strong>Qurex<sup>&reg;</sup> XL</strong>. If you suffer from depression or psychosis, your symptoms may become worse under treatment with <strong>Qurex<sup>&reg;</sup> XL</strong>. In rare cases, depression or psychosis can progress to thoughts of suicide, suicide attempts, or completed suicide. If this happens, contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypoglycemia has been reported most often in diabetic patients, predominantly in elderly population. If this happens, contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea<strong> </strong>may develop while you are taking antibiotics, including <strong>Qurex<sup>&reg;</sup> XL</strong>, or even several weeks after you have stopped taking them. If it becomes severe or persistent or you notice that your stool contains blood or mucus, stop taking <strong>Qurex<sup>&reg;</sup> XL</strong> and contact your doctor immediately, as this can be life-threatening. Do not take medicines that stop or slow down bowel movements.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your eyesight becomes impaired<strong> </strong>or if your eyes seem to be otherwise affected, consult an eye specialist immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your skin becomes more sensitive to<strong> </strong>sunlight or ultraviolet (UV) light when taking <strong>Qurex<sup>&reg;</sup> XL</strong>. Avoid exposure to strong sunlight, or artificial UV light such as sunbeds.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tell the doctor or laboratory staff that you are taking <strong>Qurex<sup>&reg;</sup> XL</strong> if you have to provide a blood or urine sample.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from kidney problems, tell the doctor because your dose may need to be adjusted.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciprofloxacin may cause liver damage. If you notice any symptoms such as loss of appetite, jaundice (yellowing of the skin), dark urine, itching, or tenderness of the stomach, contact your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciprofloxacin may cause a reduction in the number of white blood cells and your resistance to infection may be decreased. If you experience an infection with symptoms such as fever and serious deterioration of your general condition, or fever with local infection symptoms such as sore throat/pharynx/mouth or urinary problems you should see your doctor immediately. A blood test will be taken to check possible reduction of white blood cells (agranulocytosis). It is important to inform your doctor about your medicine.</p><p>&nbsp;</p><p><strong>Taking other medicines, herbal or dietary supplements</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Do not take<strong> Qurex<sup>&reg;</sup> XL </strong>together with tizanidine, because this may cause side effects such as low blood pressure and sleepiness.</p><p>The following medicines are known to interact with ciprofloxacin in your body. Taking <strong>Qurex<sup>&reg;</sup> XL</strong> together with these medicines can influence the therapeutic effect of those medicines. It can also increase the probability of experiencing side effects.</p><p><strong>Tell your doctor if you are taking</strong>:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin K antagonists (e.g. warfarin, acenocoumarol, phenprocoumon or fluindione) or other oral anti-coagulants (to thin the blood)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; probenecid (for gout)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; methotrexate (for certain types of cancer, psoriasis, rheumatoid arthritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; theophylline (for breathing problems)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tizanidine (for muscle spasticity in multiple sclerosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; olanzapine (an antipsychotic)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; clozapine (an antipsychotic)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ropinirole (for Parkinson&rsquo;s disease)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; phenytoin (for epilepsy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metoclopramide (for nausea and vomiting)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyclosporin (for skin conditions, rheumatoid arthritis and in organ transplantation)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other medicines that can alter your heart rhythm: medicines that belong to the group of antiarrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, some antimicrobials (that belong to the group of macrolides), some antipsychotics</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; zolpidem (for sleep disorders)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; oral antidiabetic drugs such as glyburide, glimepride</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen (used for pain)</p><p>&nbsp;</p><p>Ciprofloxacin may increase the levels of the following medicines in your blood:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pentoxifylline (for circulatory disorders)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; caffeine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; duloxetine (for depression, diabetic nerve damage or incontinence)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lidocaine (for heart conditions or anaesthetic use)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sildenafil (e.g. for erectile dysfunction and pulmonary hypertension)</p><p>&nbsp;</p><p>Some medicines <strong>reduce </strong>the effect of Ciprofloxacin<strong>. </strong>Tell your doctor if you take or wish to take:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antacids</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; omeprazole</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mineral supplements</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sucralfate</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a polymeric phosphate binder (e.g. sevelamer or lanthanum carbonate)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines or supplements containing calcium, magnesium, aluminium or iron</p><p>If these preparations are essential, take <strong>Qurex<sup>&reg;</sup> XL</strong> about at least two hours before or six hours after them.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding </strong></p><p>Since there are no adequate data in pregnant women.<strong> Qurex<sup>&reg;</sup> XL</strong> should not be used during pregnancy unless the potential benefit justifies the potential risk to both fetus and mother.</p><p>Ciprofloxacin is excreted in human milk. The amount of ciprofloxacin absorbed by the nursing infant is unknown. There is a potential risk of serious adverse reactions (including articular damage) in infants nursing from mothers taking ciprofloxacin.</p><p>&nbsp;</p><p>Ask your doctor, health care provider or pharmacist for advice before taking any medicine if you are pregnant or breastfeeding.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p><strong>Qurex<sup>&reg;</sup> XL</strong> can make you feel dizzy and lightheaded. Do not<strong> </strong>drive, operate machinery, or do other activities that require mental alertness or coordination until you know how this medicine affects you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Qurex<sup>&reg;</sup> XL</strong> exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Qurex<sup>&reg;</sup> XL</strong> and ciprofloxacin immediate-release tablets are not interchangeable.</p><p><strong>Qurex<sup>&reg; </sup>XL</strong> should be administered orally once daily.</p><p>Complicated urinary tract infection and acute uncomplicated pyelonephritis<strong>:</strong> 1000 mg orally every 24 hours for 7&ndash;14 days.</p><p>Take whole. Do not split, crush, or chew tablets.</p><p><strong>Qurex<sup>&reg;</sup> XL </strong>may be taken with or without food.</p><p>Drink fluids liberally while taking<strong> Qurex<sup>&reg;</sup> XL </strong>to avoid formation of a highly concentrated urine and crystal formation in the urine.</p><p>Concomitant administration of <strong>Qurex<sup>&reg;</sup> XL</strong> with dairy products (like milk or yogurt) or with calcium-fortified products alone should be avoided since decreased absorption is possible. A 2-hour window between substantial calcium intake (greater than 800 mg) and dosing with <strong>Qurex<sup>&reg;</sup> XL</strong> is recommended.</p><p>&nbsp;</p><p><strong>If you take more Qurex<sup>&reg;</sup> XL than you should </strong></p><p>In case of overdose, contact a health care practitioner or hospital emergency department immediately.<strong> </strong></p><p>&nbsp;</p><p><strong>If you forget to take Qurex<sup>&reg;</sup> XL</strong></p><p>If you forget to take it at the usual time, you may take your dose later in the day. Do not take more than one dose of <strong>Qurex<sup>&reg; </sup>XL</strong> per day, even if you missed a dose.</p><p>If you have any further questions about the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you stop taking Qurex<sup>&reg; </sup>XL</strong></p><p>&nbsp;It is important that you finish the course of treatment even if you begin to feel better after a few days. If you stop taking this medicine too soon, your infection may not be completely cured and the symptoms of the infection may return or get worse. You might also develop resistance to the antibiotic. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine<sup> </sup>can cause side effects, although not everybody gets them.</p><p>The most common adverse reactions are nausea, headache, dizziness, diarrhea, vomiting, and vaginal fungal superinfections.</p><p><strong>Medically important adverse reactions that may occur rarely in ciprofloxacin treated patients:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Body as a Whole </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling unwell</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiovascular </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slow heart rate</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Migraine</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fainting</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central Nervous System </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal dreams</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Convulsive seizures (including status epilepticus)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depersonalization (persistent or recurrent episodes of feeling detached from one&rsquo;s surroundings or body).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression causes feeling of sadness and /or a loss of interest in activities once enjoyed</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased muscle tone</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disturbed coordination</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleeping problems</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleepiness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry mouth</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wind</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thirst</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary Disorders </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver function tests abnormal</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prothrombin decrease</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolic </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperglycemia (increased blood sugar)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypoglycemia (decreased blood sugar)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decreased appetite</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin/Hypersensitivity </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry skin</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maculopapular rash (flat or raised red bump on the skin) / sensitivity to light</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin disorder</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hives</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vesiculobullous rash (blisters or ulcers in the mouth, throat, nose, eyes and other mucous membranes&nbsp;</p></td></tr></tbody></table><p>The frequency of the following adverse reactions reported with ciprofloxacin is unknown:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiovascular </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qt prolongation (seen on ECG, electrical recording of the heart)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Torsade de pointes (type of ventricular tachycardia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the wall of the blood vessels and abnormal heart rhythm in ventricles.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central Nervous System </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased muscle tone</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Worsening of myasthenia gravis (a type of muscle weakness)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peripheral neuropathy</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Polyneuropathy (affecting extremities in roughly the same areas on both sides of the body(</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Twitching (Involuntary contractions of groups of muscle fibers)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye Disorders </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nystagmus (involuntary eye movement leading to eyesight problems(</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pseudomembranous colitis (swelling or inflammation of the large intestine (colon) due to an overgrowth of <em>Clostridium difficile</em> (C difficile) bacteria. This infection is a common cause of diarrhea after antibiotic use)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hemic/Lymphatic </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancytopenia (a drop in the number of red and white blood cells and platelets, which may be fatal)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methemoglobinemia (elevated levels of methemoglobin in the blood. Methemoglobin is a form of hemoglobin that contains the ferric [Fe3+] form of iron)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatic failure (liver failure which may cause death)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections and Infestations </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fungal superinfections in the mouth, gut or vagina</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prothrombin time prolongation or decrease (increased or decreased in time for blood clotting)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in blood cholesterol levels</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in blood potassium levels</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskeletal </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myoclonus (twitches or jerks usually caused by sudden muscle contractions)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the tendons</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rupture of the tendons</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agitation</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disturbed state of mind characterized by restlessness, illusions, and incoherence</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Psychosis (toxic)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin/Hypersensitivity </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AGEP (Acute Generalised Exanthematous Pustulosis): drug reaction characterized by a sudden skin eruption after administration of the drug</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reaction called serum sickness-like reaction</p></td></tr><tr><td style="vertical-align:top"><p><strong>Special Senses </strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disorder of sense of smell</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal increase or decrease in sensitivity to stimuli of the senses</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taste loss</p></td></tr></tbody></table><p>&nbsp;</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use <strong>Qurex</strong><sup>&reg;</sup> <strong>XL</strong> after the expiry date, which is stated on the carton. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of any medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Qurex<sup>&reg;</sup> XL contains </strong></p><p><strong>Qurex<sup>&reg;</sup></strong> <strong>XL 1000</strong> <strong>Tablets:</strong> Each film coated tablet contains 1000 mg ciprofloxacin (as ciprofloxacin hydrochloride and ciprofloxacin).</p><p><strong>Inactive Ingredients: </strong>Crospovidone<strong>,</strong> magnesium stearate, colloidal anhydrous silica, succinic acid, hypromellose, titanium dioxide and macrogol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Qurex® XL looks like and contents of the pack
Qurex® XL tablets are white oval-shaped film coated tablets coded (Cip XL 1000) in one side, plain in other side.
Qurex® XL is available in packs of 7 tablets (one blister of 7).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co. Ltd.</p><p>Prince Hashem Bin Al-Hussein Street.</p><p>Na&#39;ur - Amman - Jordan.</p><p>Tel. (+962 6) 57 27 132</p><p>Fax. (+962 6) 57 27 776</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>كيوركس إكس إل </strong>هو مضاد بكتيري من فئة الفلوروكوينولونات، يستخدم في البالغين ( &ge; 18 سنة) المصابين بعدوى ناتجة عن بكتيريا حساسة محددة:</p><p>عدوى المسالك البولية المعقدة والتهاب حوض الكلية غير المعقد.</p><p><u>الاستخدام:</u></p><p>لتقليل تطور البكتيريا المقاومة للادوية والابقاء على فعالية سيبروفلوكساسين والادوية المضادة للبكتيريا الاخرى، يجب استخدام <strong>كيوركس إكس إل</strong> فقط لعلاج العدوى التي من المؤكد انها ناتجة عن البكتيريا او حساسة لها بشكل كبير.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>موانع</strong><strong> </strong><strong>استعمال كيوركس إكس إل </strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>في حال كنت تعاني من حساسية للمادة الفعالة، أو أدوية الكوينولون الأخرى أو أي من المكونات الأخرى في هذا الدواء (المذكورة في القسم 6).</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>في حال كنت تتناول تيزانيدين.</p><p>&nbsp;</p><p><strong>المحاذير و الاحتياطات</strong><strong> </strong></p><p>تحدث مع طبيبك قبل تناول <strong>كيوركس إكس إل</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان لديك في أي وقت مضى مشاكل في الكلى وذلك لأن العلاج الخاص بك قد يحتاج إلى تعديل.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كنت تعاني من الصرع أو من حالات عصبية أخرى.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان لديك تاريخ من مشاكل في الوتر أثناء العلاج السابق بالمضادات الحيوية مثل <strong>كيوركس إكس إل</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كنت مصاباً بالسكري وذلك لأنك قد تواجه خطر نقص سكر الدم مع سيبروفلوكساسين.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان لديك الوهن العضلي الوبيل (نوع من ضعف العضلات) وذلك لأن الأعراض قد تتفاقم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان لديك مشاكل في القلب. ينبغي توخي الحذر عند استخدام سيبروفلوكساسين، إذا كنت قد ولدت مع أو لديك تاريخ من إستطالة فترة QT (التي تظهر في تخطيط القلب، والتسجيل الكهربائي للقلب)، ولديك عدم توازن في أملاح الدم (وخاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم)، ولديك بطء شديد في نظم القلب (يدعى &quot;ببطء القلب&quot;)، ولديك ضعف في القلب (قصور القلب)، ولديك تاريخ من النوبات القلبية (احتشاء عضلة القلب)، وكنت أنثى أو من كبار السن أو كنت تتناول أدوية أخرى والتي تؤدي إلى تغيرات غير طبيعية في تخطيط القلب.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان من المعروف انك أو أحد أفراد عائلتك لديك نقص في أنزيم الجلوكوز 6 فوسفات نازعة الهيدروجين(G6PD)، وذلك لأنك قد تواجه خطر فقر الدم مع سيبروفلوكساسين.</p><p><strong>&nbsp;</strong></p><p><strong>من غير المعروف اذا كان </strong><strong>كيوركس إكس إل آمن وفعال في الاطفال دون سن 18 سنة. </strong></p><p><strong>&nbsp;</strong></p><p><strong>أثناء تناول </strong><strong>كيوركس إكس إل</strong></p><p>أخبر طبيبك فوراً، إذا حدث أي مما يلي أثناء تناول <strong>كيوركس إكس إل</strong>. سيقرر طبيبك ما إذا كان العلاج <strong>بكيوركس إكس إل</strong> يحتاج إلى توقف.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل تحسسي مفاجئ، وشديد (رد فعل / صدمة تحسسية مفرطة، وذمة وعائية). حتى مع الجرعة الأولى، هناك فرصة صغيرة لتعرضك إلى رد فعل تحسسي شديد مع الأعراض التالية: ضيق في الصدر، دوار، غثيان أو إغماء، أو تعاني من الدوار عند الوقوف. إذا حدث ذلك، توقف عن تناول <strong>كيوركس إكس إل</strong> وتواصل مع طبيبك فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يحدث ألم و تورم في المفاصل والتهاب الأوتار أحياناً، خاصة إذا كنت من كبار السن ويتم علاجك أيضاً بالكورتيكوستيرويدات. من الممكن أن يحدث التهاب وتمزق في الأوتار حتى خلال ال 48 ساعة الأولى من العلاج أو حتى عدة أشهر بعد التوقف عن علاج <strong>كيوركس إكس إل</strong>. عند أول علامة من أي ألم أو التهاب توقف عن تناول <strong>كيوركس إكس إل</strong>، اتصل بطبيبك وقم بإراحة المنطقة المؤلمة. تجنب أي ممارسة لا لزوم لها، لأن ذلك قد يزيد من خطر تمزق الوتر.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الصرع أو غيره من الحالات العصبية مثل نقص التروية الدماغية أو السكتة الدماغية، قد تواجه آثار جانبية مرتبطة بالجهاز العصبي المركزي. في حال حدوث نوبات، توقف عن تناول <strong>كيوركس إكس إل</strong> واتصل بطبيبك فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تواجه أعراض الاعتلال العصبي مثل ألم، لذع، وخز، خدران و/أو ضعف العضلات. إذا حدث ذلك، توقف عن تناول <strong>كيوركس إكس إل</strong> واتصل بطبيبك فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تواجه ردود فعل نفسية في المرة الأولى التي تستعمل فيها <strong>كيوركس إكس إل</strong>. إذا كنت تعاني من الاكتئاب أو الذهان، الأعراض الخاصة بك قد تصبح أسوأ تحت العلاج <strong>بكيوركس إكس إل</strong>. في حالات نادرة، يمكن للاكتئاب أو الذهان أن يتطور إلى التفكير بالانتحار أو محاولات للانتحار أو القيام بالانتحار. إذا حدث ذلك، اتصل بطبيبك فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن نقص في سكر الدم في معظم الأحيان لدى مرضى السكري، ومعظمهم من الفئة المسنة. إذا حدث ذلك، اتصل بطبيبك فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يتطور الإسهال أثناء تناولك للمضادات الحيوية، بما في ذلك <strong>كيوركس إكس إل</strong>، أو حتى بعد عدة أسابيع من توقفك عن تناولها. إذا أصبح شديداً أو مستمراً أو لاحظت أن البراز يحتوي على دم أو مخاط، توقف عن تناول <strong>كيوركس إكس إل</strong> واتصل بطبيبك فوراً، لأن ذلك قد يكون مهدد للحياة. لا تتناول الأدوية التي توقف أو تبطئ حركات الأمعاء.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال أصبح هناك اختلال في النظر أو إذا بدا أن عينيك تتأثر بطريقة أخرى، استشر أخصائي العيون فوراً.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ستصبح بشرتك أكثر حساسية لأشعة الشمس أو الأشعة فوق البنفسجية (UV) عند تناول <strong>كيوركس إكس إل</strong>. تجنب التعرض لأشعة الشمس القوية، أو ضوء الأشعة فوق البنفسجية الاصطناعية مثل الاسرة الشمسية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اخبر الطبيب أو موظفي المختبر بأنك تتناول <strong>كيوركس إكس إل</strong> إذا كان عليك تقديم عينة دم أو بول.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى، اخبر الطبيب لأن جرعتك قد تحتاج إلى تعديل.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يسبب سيبروفلوكساسين تلف في الكبد. إذا لاحظت أي أعراض مثل فقدان الشهية، اليرقان (اصفرار الجلد)، البول الداكن، حكة او ألم في المعدة عند اللمس أو الضغط، اتصل بطبيبك على الفور.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي سيبروفلوكساسين إلى انخفاض في عدد خلايا الدم البيضاء وقد تنخفض مقاومتك للعدوى. إذا كنت تعاني من عدوى مع أعراض مثل حمى وتدهور خطير في حالتك العامة، أو حمى مع أعراض عدوى موضعية مثل التهاب الحلق / البلعوم / الفم أو مشاكل في البول يجب أن تراجع الطبيب على الفور. سيتم إجراء فحص الدم للتحقق من إحتمالية إنخفاص خلايا الدم البيضاء (ندرة المحببات). من المهم إبلاغ طبيبك عن الداوء.</p><p>&nbsp;</p><p><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أخذ</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>غذائية</strong></p><p>اخبر طبيبك أو الصيدلي اذا كنت تتناول، أو تناولت مؤخراً أو قد تتناول أي أدوية أخرى.</p><p>لا تتناول <strong>كيوركس إكس إل</strong> بالتزامن مع تيزانيدين، لأن هذا قد يسبب آثار جانبية مثل انخفاض ضغط الدم والنعاس.</p><p>من المعروف أن الأدوية التالية تتفاعل مع سيبروفلوكساسين في الجسم. تناول <strong>كيوركس إكس إل</strong> مع هذه الأدوية يمكن أن يؤثر على التأثير العلاجي لتلك الأدوية. ويمكن أيضا أن يزيد من احتمال التعرض للآثار الجانبية.</p><p><strong>اخبر طبيبك في حال كنت تتناول:</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>مضادات فيتامين ك (مثل الوارفارين، أسينوكومارول، فينبروكومون أو فلوينديون) أو غيرها من مضادات التخثرالتي تؤخذ عن طريق الفم (لترقق الدم)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>بروبينيسيد (للنقرس)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ميثوتريكسيت (لأنواع معينة من السرطان، الصدفية، التهاب المفاصل الروماتويدي)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ثيوفيلين (لمشاكل التنفس)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تيزانيدين (للتشنج العضلي في التصلب المتعدد)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>أولانزابين (مضاد للذهان)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>كلوزابين (مضاد للذهان)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>روبرينيول (لمرض باركنسون)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الفينيتوين (للصرع)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ميتوكلوبراميد (للغثيان والقيء)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>سيكلوسبورين (للحالات الجلدية، والتهاب المفاصل الروماتويدي وزرع الأعضاء)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الأدوية الأخرى التي يمكن أن تغير نظم القلب: الأدوية التي تنتمي إلى مجموعة مضادات اضطراب نظم القلب (مثل: الكينيدين والهيدروكينيدين وديسوبيراميد وأميودارون وسوتالول ودوفتيليد وإيبوتيليد)، ومضادات الاكتئاب ثلاثية الحلقات، وبعض مضادات الميكروبات (التي تنتمي إلى مجموعة الماكروليدات)، و بعض مضادات الذهان</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>زولبيديم (لاضطرابات النوم)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية الخافضة لسكر الدم التي تؤخذ عن طريق الفم مثل جليبيريد، جليميبرايد</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية المضادة للالتهاب غير الستيرويدية مثل ايبوبروفين ونابروكسين (لعلاج الالم)</p><p><strong>&nbsp;</strong></p><p>قد يزيد سيبروفلوكساسين من مستويات الأدوية التالية في الدم:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بنتوكسيفيلين (اضطرابات الدورة الدموية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكافيين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دولوكستين (للاكتئاب، ولتلف العصب بسبب مرض السكري أو سلس البول)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليدوكائين ( لحالات القلب أو لاستعماله للتخدير)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيلدينافيل (على سبيل المثال لضعف الانتصاب وارتفاع الضغط الرئوي)</p><p>&nbsp;</p><p>بعض الأدوية تقلل من تأثير سيبروفلوكساسين. اخبر طبيبك إذا كنت تتناول أو ترغب في تناول:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الحموضة</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أوميبرازول</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكملات المعدنية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوكرالفات</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رابط الفوسفات المبلمر (على سبيل المثال سيفلامر أو كربونات اللانثانوم)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية أو مكملات تحتوي على الكالسيوم، أو المغنيسيوم، أو الألومنيوم، أو الحديد</p><p>إذا كان تناول هذه المستحضرات ضرورياً، تناول <strong>كيوركس إكس إل</strong> على الاقل قبل حوالي ساعتين من تناول هذه المستحضرات أو بعد ست ساعات من تناولها.</p><p>&nbsp;</p><p><strong>الحمل</strong><strong> </strong><strong>والرضاعة </strong></p><p>لا يوصى بإستخدام <strong>كيوركس إكس إل</strong> أثناء فترة الحمل بسبب عدم وجود معلومات كافية في النساء الحوامل الا في حال كانت الفائدة المرجوة تفوق الخطر المحتمل على الجنين والام.</p><p>يتم افراز سيبروفلوكساسين في حليب الام. ان كمية سبروفلوكساسين التي يتم امتصاصها&nbsp; من قبل الطفل الرضيع غير معروفة. هناك خطر محتمل لحدوث ردود فعل جانبية خطيرة (تشمل ضرر مفصلي) في الرضع من قبل الامهات اللاتي تناولن سيبروفلوكساسين.</p><p>اذا كنتِ حاملا او مرضعة او تخططين للانجاب؛ استشيري طبيبك او الصيدلي قبل تناول هذا الدواء.</p><p>&nbsp;</p><p><strong>تأثير سافير إكس إل على القيادة وإستخدام الآلات</strong></p><p>قد يسبب <strong>كيوركس إكس إل</strong> الدوار والدوخة. لا تقم بالقيادة، تشغيل الآلات او القيام بنشاطات اخرى تتطلب تيقظ عقلي او توازن حتى تعرف تأثير هذا الدواء عليك.&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول <strong>كيوركس </strong><strong>إكس إل</strong> تماما كما اخبرك الطبيب. إستشر طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p>لا يمكن استبدال <strong>كيوركس </strong><strong>إكس إل</strong> بأقراص سيبروفلوكساسين فورية الإنطلاق.</p><p>يجب تناول <strong>كيوركس </strong><strong>إكس إل </strong>عن طريق الفم مرة واحدة يوميا.<strong> </strong></p><p>إلتهابات المسالك البولية المعقدة والتهاب حوض الكلية غير المعقد الحاد: قرص واحد (1000 ملغم) عن طريق الفم كل 24 ساعة لمدة 7 &ndash; 14 يوم.</p><p>قم ببلع القرص<strong> </strong>كاملا. لا تقم بتجزئة، طحن او مضغ الاقراص.</p><p>من الممكن تناول <strong>كيوركس إكس إل </strong>&nbsp;مع الطعام أو بدونه.</p><p>اشرب الكثير من السوائل اثناء تناول <strong>كيوركس </strong><strong>إكس إل</strong> لتجنب تشكل البول مرتفع التركيز وتشكل الحصى في البول.</p><p>تجنب تناول <strong>كيوركس </strong><strong>إكس إل</strong> بالتزامن مع منتجات الألبان (مثل الحليب أو اللبن الرائب) أو المنتجات المدعمة بالكالسيوم لوحده لأن امتصاص سيبروفلوكساسين من المحتمل ان يقل. يوصى بإبقاء فترة ساعتين بين تناول جرعة كالسيوم كبيرة (اكبر من 800 ملغم) وجرعة<strong> </strong><strong>كيوركس </strong><strong>إكس إل.</strong></p><p>&nbsp;</p><p><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كيوركس إكس إل </strong><strong>&nbsp;</strong></p><p>إذا تناولت جرعة زائدة، اتصل بمقدم الرعاية الصحية او قم بزيارة قسم الطوارئ على الفور.</p><p>&nbsp;</p><p><strong>نسيان</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>كيوركس إكس إل </strong><strong>&nbsp;</strong></p><p>في حال نسيت تناول الجرعة في وقتها الإعتيادي، قم بتناولها في وقت لاحق من اليوم. لا تتناول أكثر من جرعة واحدة من <strong>كيوركس </strong><strong>إكس إل</strong> يوميا، حتى لو فاتتك جرعة.</p><p>إذا كان لديك إستفسارات أخرى حول استخدام هذا العلاج إستشر طبيبك أو الصيدلي.</p><p>&nbsp;</p><p><strong>التوقف عن تناول جرعة</strong><strong> </strong><strong>كيوركس إكس إل</strong></p><p>من المهم أن تنتهي من العلاج حتى لو بدأت تشعر بأنك أفضل بعد بضعة أيام. إذا توقفت عن تناول هذا الدواء في وقت مبكر جداً، قد لا يتم علاج العدوى تماماً ومن الممكن أن تعود أعراض العدوى أو تزداد سوءاً. من المحتمل أيضاً أن يحدث لديك مقاومة للمضادات الحيوية. إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن الادوية الأخرى، قد يسبب هذا الدواء اعراضا جانبية الا ان هذه الاعراض قد لا تظهر عند جميع المرضى.</p><p>الاعراض الجانبية الاكثر شيوعا هي غثيان، صداع، دوار، إسهال، تقيؤ وعدوى الفطريات المهبلية الإضافية.</p><p><strong>الاعراض الجانبية المهمة طبيا والتي قد تحدث</strong><strong> </strong><strong>بشكل نادر في المرضى الذين تعالجوا بسيبروفلوكساسين:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>التصنيف العضوي الجهازي</strong></p></td><td style="vertical-align:top"><p><strong>الاعراض الجانبية</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>الجسم بشكل عام</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتوعك</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعب</p></td></tr><tr><td style="vertical-align:top"><p><strong>القلب والاوعية الدموية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بطء في معدل ضربات القلب</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع نصفي</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوعي</p></td></tr><tr><td style="vertical-align:top"><p><strong>الجهاز العصبي المركزي</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أحلام مضطربة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات تشنجية (تشمل الحالة الصرعية)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب تبدد الشخصية &nbsp;( نوبات دائمة او متجددة يشعر الشخص انه منفصل عن محيطه او جسده)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكتئاب يسبب حزن و/اوفقدان الاهتمام بالانشطة التي سبق واستمتعت بها</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة توتر العضلة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان التوازن</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النوم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتعاش</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p></td></tr><tr><td style="vertical-align:top"><p><strong>المعدة والامعاء</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساك</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريح</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عطش</p></td></tr><tr><td style="vertical-align:top"><p><strong>اضطرابات كبدية صفراوية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلال في نتائج وظائف الكبد</p></td></tr><tr><td style="vertical-align:top"><p><strong>الفحوصات</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في مستوى البروثرومبين</p></td></tr><tr><td style="vertical-align:top"><p><strong>الايض</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع غلوكوز الدم (ارتفاع السكر في الدم)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض غلوكوز الدم (انخفاص السكر في الدم)</p></td></tr><tr><td style="vertical-align:top"><p><strong>اضطرابات نفسية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>الجلد / فرط الحساسية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الجلد</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح بقعي حطاطي: (نتوءات حمراء مسطحة أو بارزة تظهر على الجلد) / حساسية للضوء</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضراب في الجلد</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شرى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح حويصلي بقاعي (بثور أو تقرحات في الفم، والحلق، والأنف، والعينين، والأغشية المخاطية الأخرى مثل الأعضاء التناسلية التي قد تتطور إلى بثور واسعة النطاق أو تقشر الجلد)</p></td></tr><tr><td style="vertical-align:top"><p><strong>حواس خاصة</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ازدواج الرؤية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في التذوق&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>بولي تناسلي</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الدورة الشهرية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دم في البول</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلال في وظائف الكلى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب في المهبل</p></td></tr></tbody></table><p>&nbsp;</p><p>معدل التكرار للأعراض الجانبية التالية التي تم رصدها مع سيبروفلوكساسين غير معروف:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>التصنيف العضوي الجهازي</strong></p></td><td style="vertical-align:top"><p><strong>الاعراض الجانبية</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>القلب والاوعية الدموية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استطالة فترة QT (التي تظهر في تخطيط القلب، والتسجيل الكهربائي للقلب)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورساد دي بوانت &nbsp;(نوع من تسارع نظم القلب البطيني)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب جدار الأوعية الدموية واضطراب نظم القلب في البطينين</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجهاز العصبي المركزي</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة توتر العضلة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف في العضلات</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم الوهن العضلي الوبيل (نوع من ضعف العضلات)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اعتلال عصبي طرفي</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اعتلال عصبي متعدد ( يؤثر على الأطراف في نفس المناطق تقريباً على جانبي الجسم).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز ( انقباضات لا ارادية في مجموعة من الالياف العضلية)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اضطرابات العين</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رأرأة (حركة لاإرادية في العين تؤدي إلى مشاكل في البصر)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المعدة والامعاء</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب القولون الغشائي الكاذب (تورم أو التهاب الأمعاء الغليظة (القولون) بسبب فرط نمو بكتيريا كلوستريديوم ديفيسيل (C difficile). هذه العدوى هي سبب شائع للإسهال بعد استخدام المضاد الحيوي)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الدم / الجهاز الليمفاوي</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلة الكريات الشاملة (انخفاض في عدد خلايا الدم الحمراء والبيضاء والصفائح الدموية والتي قد تكون مميتة)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميتهيموغلوبينية الدم (مستويات مرتفعة من ميتهيموغلوبين في الدم. ميتهيموغلوبين هو شكل من أشكال الهيموجلوبين الذي يحتوي على الحديد [Fe3+] &nbsp;بشكل حديد ثلاثي التكافؤ)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كبدية صفراوية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل كبدي (يشمل حالات قد تؤدي الى الوفاة)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>العدوى والاصابات</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الفطريات الإضافية في الفم، الأمعاء أو المهبل</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الاصابات</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقصان أو زيادة زمن البروثرومبين (زيادة أو نقصان في الوقت المناسب لتجلط الدم)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في مستويات الكوليسترول في الدم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في مستويات البوتاسيوم في الدم</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجهاز العضلي العظمي</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في العضلات</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رمع عضلي (ارتعاش العضلة أو اهتزازات عادة ما تكون نتيجة تقلصات &nbsp;مفاجئة في العضلات)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوتار</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تمزق الأوتار</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اضطرابات نفسية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيج</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتباك</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة اضطراب في العقل تتميز بأرق، وأوهام، وعدم ترابط</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ذهان (سام)</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجلد / فرط الحساسية</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البثار الطفحي المعمم الحاد )رد فعل من الدواء يتميز بظهور طفح بشكل مفاجئ على الجلد بعد تناول الدواء).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل تحسسي يدعى شبيه المرض المصلي</p></td></tr><tr><td style="vertical-align:top"><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>حواس خاصة</strong></p></td><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في حاسة الشم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة غير طبيعية في الحساسية لمؤثرات الحواس</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقصان غير طبيعي في الحساسية لمؤثرات الحواس</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان التذوق</p></td></tr></tbody></table><p>&nbsp;</p><p>اذا حدثت لك أي من هذه الأعراض الجانبية، اخبر طبيبك او الصيدلي. هذا يشمل اي اعراض جانبية محتملة لم يتم ذكرها في هذه النشرة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي الأطفال ونظرهم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم <strong>كيوركس إكس إل </strong>&nbsp;بعد تاريخ الإنتهاء المذكور على العبوة. يدل تاريخ الإنتهاء على اخر يوم من الشهر المذكور.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ على درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية في المياه العادمة أو النفايات المنزلية. اسأل الصيدلي حول الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ماهي</strong><strong> </strong><strong>محتويا</strong><strong>ت كيوركس </strong><strong>إكس إل </strong><strong>&nbsp;</strong></p><p><strong>أقراص كيوركس إكس إل 1000</strong>: يحتوي كل قرص مغلف على 1000 ملغم سيبروفلوكساسين (على هيئة سيبروفلوكساسين هيدروكلورايد وسيبروفلوكساسين).</p><p><strong>المواد غير الفعالة الأخرى</strong>: كروس بوفيدون، ستيارات الماغنيسيوم، سيليكا غروية لامائية، حمض السكسينيك، هيبروميلوز، ثاني أكسيد التيتانيوم وماكروغول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما</strong><strong> </strong><strong>هو</strong><strong> </strong><strong>الشكل</strong><strong> </strong><strong>الصيدلاني</strong><strong> لكيوركس </strong><strong>إكس إل&nbsp; ووصفه</strong><strong> </strong><strong>وحجم</strong><strong> </strong><strong>عبوته </strong></p><p>أقراص <strong>كيوركس إكس إل</strong> هي أقراص مغلفة بيضاء اللون بيضاوية الشكل مرمزة بالرمز (Cip XL 1000) على جهة واحدة، فارغة على الجهة الاخرى.</p><p>تتوفر أقراص <strong>كيوركس إكس إل</strong> في عبوات من 7 أقراص (شريط واحد يحتوي على 7 أقراص).</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة دار الدواء للتنمية والاستثمار المساهمة المحدودة</p><p>شارع الأمير هاشم بن الحسين.</p><p>ناعور &ndash; عمان &ndash; الأردن.</p><p>هاتف. 132 27 57 (6 962 +)</p><p>فاكس.776 27 57 (6 962 +)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Qurex® XL 1000 mg film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains 1000 mg ciprofloxacin (as ciprofloxacin hydrochloride and ciprofloxacin).
For a full list of excipients see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets.
Qurex® XL tablets are white oval-shaped film coated tablets coded (Cip XL 1000) in one side, plain in other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Qurex&reg; XL is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the conditions and patient populations listed below.<br />Complicated Urinary Tract Infections, and Acute Uncomplicated Pyelonephritis<br />Qurex&reg; XL is indicated for the treatment of complicated urinary tract infections (cUTI) caused by:<br />Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Proteus mirabilis, or Pseudomonas aeruginosa and acute uncomplicated pyelonephritis (AUP) caused by Escherichia coli.<br />Limitations of Use<br />&bull; The safety and efficacy of ciprofloxacin in treating infections other than urinary tract infections has not been demonstrated.<br />&bull; Qurex&reg; XL is not indicated for pediatric patients.<br />Usage<br />To reduce the development of drug-resistant bacteria and maintain the effectiveness of ciprofloxacin and other antibacterial drugs, Qurex&reg; XL should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.<br />Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to ciprofloxacin. Therapy with ciprofloxacin may be initiated before results of these tests are known; once results become available appropriate therapy should be continued.<br />As with other drugs, some isolates of Pseudomonas aeruginosa may develop resistance fairly rapidly during treatment with ciprofloxacin. Culture and susceptibility testing performed periodically during therapy will provide information not only on the therapeutic effect of the antimicrobial agent but also on the possible emergence of bacterial resistance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage<br />Qurex&reg; XL and ciprofloxacin immediate-release tablets are not interchangeable.<br />Qurex&reg; XL should be administered orally once daily.</p><table border="1" cellspacing="0" cellpadding="0" style="width:589px"><tbody><tr><td style="vertical-align:top"><p><strong>Dosage Guidelines Indication </strong></p></td><td style="vertical-align:top"><p><strong>Dose </strong></p></td><td style="vertical-align:top"><p><strong>Frequency </strong></p></td><td style="vertical-align:top"><p><strong>Usual Duration </strong></p></td></tr><tr><td style="vertical-align:top"><p>Complicated Urinary Tract Infection and Acute Uncomplicated Pyelonephritis</p></td><td style="vertical-align:top"><p>1000 mg</p></td><td style="vertical-align:top"><p>every 24 hours</p></td><td style="vertical-align:top"><p>7&ndash;14 Days</p></td></tr></tbody></table><p>Patients whose therapy is started with ciprofloxacin IV for UTIs may be switched to ciprofloxacin extended release tablets when clinically indicated at the discretion of the physician.<br />Administration<br />Qurex&reg; XL tablets should be taken whole and not split, crushed, or chewed.<br />Qurex&reg; XL should be administered at least 2 hours before or 6 hours after antacids containing magnesium or aluminum, polymeric phosphate binders (for example, sevelamer, lanthanum carbonate), as well as sucralfate, Videx&reg; (didanosine) chewable/buffered tablets or pediatric powder, other highly buffered drugs, metal cations such as iron, and multivitamin preparations with zinc.<br />Concomitant administration of Qurex&reg; XL with dairy products (like milk or yogurt) or with calcium-fortified products alone should be avoided since decreased absorption is possible. A 2-hour window between substantial calcium intake (greater than 800 mg) and dosing with Qurex&reg; XL is recommended<br />Adequate hydration of patients receiving Qurex&reg; XL should be maintained to prevent the formation of highly concentrated urine. Crystalluria has been reported with quinolones.<br />Impaired Renal Function<br />&bull; In patients with cUTI and acute uncomplicated pyelonephritis with a creatinine clearance of &le; 30 mL/min, the dose of ciprofloxacin should be reduced from 1000 mg to 500 mg daily. The use of Ciprofloxacin 1000 mg tablets is not recommended in this patient population.<br />&bull; For patients on hemodialysis or peritoneal dialysis, administer ciprofloxacin after the dialysis procedure is completed (maximum dose should be Ciprofloxacin 500 mg extended release every 24 hours). The use of Ciprofloxacin 1000 mg is not recommended in this patient population.<br />&bull; For patients on continuous ambulatory peritoneal dialysis (CAPD), the maximum dose should be 500 mg every 24 hours.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity
Qurex® XL is contraindicated in persons with a history of hypersensitivity to ciprofloxacin, any member of the quinolone class of antibacterials, or any of the product components.
Tizanidine
Concomitant administration with tizanidine is contraindicated
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><br />Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects<br />Fluoroquinolones, including ciprofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions from different body systems that can occur together in the same patient. Commonly seen adverse reactions include tendinitis, tendon rupture, arthralgia, myalgia, peripheral neuropathy, and central nervous system effects (hallucinations, anxiety, depression, insomnia, severe headaches, and confusion). These reactions can occur within hours to weeks after starting ciprofloxacin. Patients of any age or without pre-existing risk factors have experienced these adverse reactions.<br />Discontinue Qurex&reg; XL immediately at the first signs or symptoms of any serious adverse reaction. In addition, avoid the use of fluoroquinolones, including ciprofloxacin, in patients who have experienced any of these serious adverse reactions associated with fluoroquinolones.<br />Tendinitis and Tendon Rupture<br />Fluoroquinolones, including ciprofloxacin, have been associated with an increased risk of tendinitis and tendon rupture in all ages. This adverse reaction most frequently involves the Achilles tendon, and also been reported in the rotator cuff (the shoulder), the hand, the biceps, the thumb, and other tendons. Tendinitis and tendon rupture can occur within hours or days of starting ciprofloxacin, or as long as several months after completion of fluoroquinolone therapy. Tendinitis and tendon rupture can occur bilaterally.<br />The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is further increased in patients over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. Other factors that may independently increase the risk of tendon rupture include strenuous physical activity, renal failure, and previous tendon disorders such as rheumatoid arthritis. Tendinitis and tendon rupture have also occurred in patients taking fluoroquinolones who do not have the above risk factors.<br />Discontinue Qurex&reg; XL immediately if the patient experiences pain, swelling, inflammation or rupture of a tendon. Avoid fluoroquinolones, including ciprofloxacin, in patients who have a history of tendon disorders or have experienced tendinitis or tendon rupture.<br />Peripheral Neuropathy<br />Fluoroquinolones, including ciprofloxacin, have been associated with an increased risk of peripheral neuropathy. Cases of sensory or sensorimotor axonal polyneuropathy affecting small and/or large axons resulting in paresthesias, hypoesthesias, dysesthesias and weakness have been reported in patients receiving fluoroquinolones, including<br />ciprofloxacin. Symptoms may occur soon after initiation of ciprofloxacin and may be irreversible in some patients.<br />Discontinue Qurex&reg; XL immediately if the patient experiences symptoms of peripheral neuropathy including pain, burning, tingling, numbness, and/or weakness, or other alterations in sensations including light touch, pain, temperature, position sense and vibratory sensation and/or motor strength in order to minimize the development of an irreversible condition. Avoid fluoroquinolones, including ciprofloxacin, in patients who have previously experienced peripheral neuropathy.<br />Central Nervous System Effects<br />Fluoroquinolones, including ciprofloxacin, have been associated with an increased risk of central nervous system (CNS) effects, including convulsions, increased intracranial pressure (including pseudotumor cerebri), and toxic psychosis. Ciprofloxacin may also cause central nervous system (CNS) events including: nervousness, agitation, insomnia, anxiety, nightmares, paranoia, dizziness, confusion, tremors, hallucinations, depression, and psychotic reactions that have progressed to suicidal ideations/thoughts and self-injurious behavior such as attempted or completed suicide. These reactions may occur following the first dose. Advise patients receiving ciprofloxacin to inform their healthcare provider immediately if these reactions occur, discontinue the drug, and institute appropriate care. Ciprofloxacin, like other fluoroquinolones, is known to trigger seizures or lower the seizure threshold. As with all fluoroquinolones, use Ciprofloxacin with caution in epileptic patients and patients with known or suspected CNS disorders that may predispose to seizures or lower the seizure threshold (for example, severe cerebral arteriosclerosis, previous history of convulsion, reduced cerebral blood flow, altered brain structure, or stroke), or in the presence of other risk factors that may predispose to seizures or lower the seizure threshold (for example., certain drug therapy, renal dysfunction). Use Ciprofloxacin when the benefits of treatment exceed the risks, since these patients are endangered because of possible undesirable CNS side effects. Cases of status epilepticus have been reported. If seizures occur, discontinue Ciprofloxacin.<br />Exacerbation of Myasthenia Gravis<br />Fluoroquinolones, including Ciprofloxacin, have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Postmarketing serious adverse reactions, including deaths and requirement for ventilatory support, have been associated with fluoroquinolone use in patients with myasthenia gravis. Avoid Ciprofloxacin in patients with known history of myasthenia gravis.<br />Other Serious and Sometimes Fatal Adverse Reactions<br />Other serious and sometimes fatal adverse reactions, some due to hypersensitivity, and some due to uncertain etiology, have been reported in patients receiving therapy with quinolones, including ciprofloxacin. These events may be severe and generally occur following the administration of multiple doses. Clinical manifestations may include one or more of the following:<br />&bull; Fever, rash, or severe dermatologic reactions (for example, toxic epidermal necrolysis, Stevens-Johnson syndrome);<br />&bull; Vasculitis; arthralgia; myalgia; serum sickness;<br />&bull; Allergic pneumonitis;<br />&bull; Interstitial nephritis; acute renal insufficiency or failure;<br />&bull; Hepatitis; jaundice; acute hepatic necrosis or failure;<br />&bull; Anemia, including hemolytic and aplastic; thrombocytopenia, including thrombotic thrombocytopenic purpura; leukopenia; agranulocytosis; pancytopenia; and/or other hematologic abnormalities.<br />Discontinue Qurex&reg; XL immediately at the first appearance of a skin rash, jaundice, or any other sign of hypersensitivity and supportive measures instituted.<br />Hypersensitivity Reactions<br />Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving quinolone therapy, including ciprofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines, and airway management, including intubation, as indicated.<br />Hepatotoxicity<br />Cases of severe hepatotoxicity, including hepatic necrosis, life-threatening hepatic failure, and fatal events, have been reported with ciprofloxacin. Acute liver injury is rapid in onset (range 1&ndash;39 days), and is often associated with hypersensitivity. The pattern of injury can be hepatocellular, cholestatic or mixed. Most patients with fatal outcomes were older than 55 years old. In the event of any signs and symptoms of hepatitis (such as anorexia, jaundice, dark urine, pruritus, or tender abdomen), discontinue treatment immediately.<br />There can be a temporary increase in transaminases, alkaline phosphatase, or cholestatic jaundice, especially in patients with previous liver damage, who are treated with ciprofloxacin.<br />Serious Adverse Reactions with Concomitant Theophylline Use<br />Serious and fatal reactions have been reported in patients receiving concurrent administration of ciprofloxacin and theophylline. These reactions have included cardiac arrest, seizure, status epilepticus, and respiratory failure. Instances of nausea, vomiting, tremor, irritability, or palpitation have also occurred.<br />Although similar serious adverse reactions have been reported in patients receiving theophylline alone, the possibility that these reactions may be potentiated by ciprofloxacin cannot be eliminated. If concomitant use cannot be avoided, monitor serum levels of theophylline and adjust dosage as appropriate.<br />Clostridium difficile-Associated Diarrhea<br />Clostridium difficile (C. difficile)-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including ciprofloxacin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.<br />C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing isolates of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.<br />If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and institute surgical evaluation as clinically indicated.<br />Prolongation of the QT Interval<br />Some fluoroquinolones, including Ciprofloxacin have been associated with prolongation of the QT interval on the electrocardiogram and cases of arrhythmia. Cases of torsade de pointes have been reported during postmarketing surveillance in patients receiving fluoroquinolones, including Ciprofloxacin.<br />Avoid Ciprofloxacin in patients with known prolongation of the QT interval, risk factors for QT prolongation or torsade de pointes (for example, congenital long QT syndrome, uncorrected electrolyte imbalance, such as hypokalemia or hypomagnesemia and cardiac disease, such as heart failure, myocardial infarction, or bradycardia), and patients receiving Class IA antiarrhythmic agents (quinidine, procainamide), or Class III antiarrhythmic agents (amiodarone, sotalol), tricyclic antidepressants, macrolides, and antipsychotics. Elderly patients may also be more susceptible to drug-associated effects on the QT interval.<br />Musculoskeletal Disorders in Pediatric Patients and Arthropathic Effects in Animals<br />An increased incidence of adverse reactions compared to controls, including reactions related to joints and/or surrounding tissues, has been observed.<br />In pre-clinical studies, oral administration of Ciprofloxacin caused lameness in immature dogs. Histopathological examination of the weight-bearing joints of these dogs revealed permanent lesions of the cartilage. Related quinolone-class drugs also produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species.<br />Photosensitivity/Phototoxicity<br />Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions (for example, burning, erythema, exudation, vesicles, blistering, edema) involving areas exposed to light (typically the face, &ldquo;V&rdquo; area of the neck, extensor surfaces of the forearms, dorsa of the hands), can be associated with the use of quinolones including Ciprofloxacin after sun or UV light exposure. Therefore,<br />avoid excessive exposure to these sources of light. Discontinue Ciprofloxacin if phototoxicity occurs.<br />Development of Drug Resistant Bacteria<br />Prescribing Ciprofloxacin in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.<br />Potential Risks with Concomitant Use of Drugs Metabolized by Cytochrome P450 1A2 Enzymes<br />Ciprofloxacin is an inhibitor of the hepatic CYP1A2 enzyme pathway. Co-administration of ciprofloxacin and other drugs primarily metabolized by CYP1A2 (for example, theophylline, methylxanthines, caffeine, tizanidine, ropinirole, clozapine, olanzapine) results in increased plasma concentrations of the co- administered drug and could lead to clinically significant pharmacodynamic adverse reactions of the co-administered drugs.<br />Interference with Timely Diagnosis of Syphilis<br />Ciprofloxacin has not been shown to be effective in the treatment of syphilis. Antimicrobial agents used in high dose for short periods of time to treat gonorrhea may mask or delay the symptoms of incubating syphilis. Perform a serologic test for syphilis in all patients with gonorrhea at the time of diagnosis. Perform follow-up serologic test for syphilis three months after ciprofloxacin treatment.<br />Crystalluria<br />Crystals of ciprofloxacin have been observed rarely in the urine of human subjects but more frequently in the urine of laboratory animals, which is usually alkaline. Crystalluria related to ciprofloxacin has been reported only rarely in humans because human urine is usually acidic. Avoid alkalinity of the urine in patients receiving ciprofloxacin. Hydrate patients well to prevent the formation of highly concentrated urine.<br />Pediatric Use<br />Safety and effectiveness of ciprofloxacin in pediatric patients and adolescents less than 18 years of age have not been established. Ciprofloxacin causes arthropathy in juvenile animals. Ciprofloxacin is not indicated for pediatric patients.<br />Geriatric Use<br />Geriatric patients are at increased risk for developing severe tendon disorders including tendon rupture when being treated with a fluoroquinolone such as ciprofloxacin. This risk is further increased in patients receiving concomitant corticosteroid therapy. Tendinitis or tendon rupture can involve the Achilles, hand, shoulder, or other tendon sites and can occur during or after completion of therapy; cases occurring up to several months after fluoroquinolone treatment have been reported. Caution should be used when prescribing ciprofloxacin to elderly patients especially those on corticosteroids. Patients should be informed of this potential side effect and advised to discontinue ciprofloxacin and contact their healthcare provider if any symptoms of tendinitis or tendon rupture occur.<br />In a large, prospective, randomized ciprofloxacin clinical trial in cUTI, 49% (509/1035) of the patients were 65 and over, while 30% (308/1035) were 75 and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals on any drug therapy cannot be ruled out. Ciprofloxacin is known to be substantially excreted by the kidney, and the risk of adverse reactions may be greater in patients with impaired renal function. No alteration of dosage is necessary for patients greater than 65 years of age with normal renal function. However, since some older individuals experience reduced renal function by virtue of their advanced age, care should be taken in dose selection for elderly patients, and renal function monitoring may be useful in these patients.<br />In general, elderly patients may be more susceptible to drug-associated effects on the QT interval. Therefore, precaution should be taken when using ciprofloxacin with concomitant drugs that can result in prolongation of the QT interval (for example, class IA or class III antiarrhythmics) or in patients with risk factors for torsade de pointes.<br />Renal Impairment<br />Ciprofloxacin is eliminated primarily by renal excretion; however, the drug is also metabolized and partially cleared through the biliary system of the liver and through the intestine. These alternate pathways of drug elimination appear to compensate for the reduced renal excretion in patients with renal impairment. No dosage adjustment is required for patients with uncomplicated UTIs receiving 500 mg Ciprofloxacin. Dosing in children (less than 18 years of age) with impaired renal function has not been studied.<br />Hepatic Impairment<br />In preliminary studies in patients with stable chronic liver cirrhosis, no significant changes in ciprofloxacin pharmacokinetics have been observed. The pharmacokinetics of ciprofloxacin in patients with acute hepatic insufficiency, have not been studied.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ciprofloxacin is an inhibitor of human cytochrome P450 1A2 (CYP1A2) mediated metabolism. Co-administration of Ciprofloxacin with other drugs primarily metabolized by CYP1A2 results in increased plasma concentrations of these drugs and could lead to clinically significant adverse events of the co-administered drug.<br />Drugs That are Affected by and Affecting ciprofloxacin</p><table border="1" cellspacing="0" cellpadding="0" style="width:590px"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>Drugs That are Affected by ciprofloxacin</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Drug(s) </strong></p></td><td style="vertical-align:top"><p><strong>Recommendation </strong></p></td><td style="vertical-align:top"><p><strong>Comments </strong></p></td></tr><tr><td style="vertical-align:top"><p>Tizanidine</p></td><td style="vertical-align:top"><p>Contraindicated</p></td><td style="vertical-align:top"><p>Concomitant administration of tizanidine and ciprofloxacin is contraindicated due to the potentiation of hypotensive and sedative effects of tizanidine.</p></td></tr><tr><td style="vertical-align:top"><p>Theophylline</p></td><td style="vertical-align:top"><p>Avoid Use (Plasma Exposure Likely to be Increased and Prolonged)</p></td><td style="vertical-align:top"><p>Concurrent administration of ciprofloxacin with theophylline may result in increased risk of a patient developing central nervous system (CNS) or other adverse reactions. If concomitant use cannot be avoided, monitor serum levels of theophylline and adjust dosage as appropriate.</p></td></tr><tr><td style="vertical-align:top"><p>Drugs Known to Prolong QT Interval</p></td><td style="vertical-align:top"><p>Avoid Use</p></td><td style="vertical-align:top"><p>Ciprofloxacin may further prolong the QT interval in patients receiving drugs known to prolong the QT interval (for example, class IA or III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics).</p></td></tr><tr><td style="vertical-align:top"><p>Zolpidem</p></td><td style="vertical-align:top"><p>Avoid use</p></td><td style="vertical-align:top"><p>Co-administration with ciprofloxacin may increase blood levels of zolpidem, concurrent use is not recommended.</p></td></tr><tr><td style="vertical-align:top"><p>Oral antidiabetic drugs</p></td><td style="vertical-align:top"><p>Use with caution Glucose-lowering effect potentiated</p></td><td style="vertical-align:top"><p>Hypoglycemia sometimes severe has been reported when ciprofloxacin and oral antidiabetic agents, mainly sulfonylureas (for example, glyburide, glimepiride), were co-administered, presumably by intensifying the action of the oral antidiabetic agent. Fatalities have been reported<em>. </em>Monitor blood glucose when ciprofloxacin is co-administered with oral antidiabetic drugs</p></td></tr><tr><td style="vertical-align:top"><p>Phenytoin</p></td><td style="vertical-align:top"><p>Use with caution</p><p>Altered serum levels of phenytoin (increased and decreased)</p></td><td style="vertical-align:top"><p>To avoid the loss of seizure control associated with decreased phenytoin levels and to prevent phenytoin overdose-related adverse reactions upon ciprofloxacin discontinuation in patients receiving both agents, monitor phenytoin therapy, including phenytoin serum concentration during and shortly after co-administration of ciprofloxacin with phenytoin.</p></td></tr><tr><td style="vertical-align:top"><p>Cyclosporine</p></td><td style="vertical-align:top"><p>Use with caution (transient elevations in serum creatinine)</p></td><td style="vertical-align:top"><p>Monitor renal function (in particular serum creatinine) when ciprofloxacin is co-administered with cyclosporine.</p></td></tr><tr><td style="vertical-align:top"><p>Anti-coagulant drugs</p></td><td style="vertical-align:top"><p>Use with caution (Increase in anticoagulant effect)</p></td><td style="vertical-align:top"><p>The risk may vary with the underlying infection, age and general status of the patient so that the contribution of ciprofloxacin to the increase in INR (international normalized ratio) is difficult to assess. Monitor prothrombin time and INR frequently during and shortly after co-administration of ciprofloxacin with an oral anti-coagulant (for example, warfarin).</p></td></tr><tr><td style="vertical-align:top"><p>Methotrexate</p></td><td style="vertical-align:top"><p>Use with caution Inhibition of methotrexate renal tubular transport potentially leading to increased methotrexate plasma levels</p></td><td style="vertical-align:top"><p>Potential increase in the risk of methotrexate associated toxic reactions. Therefore, carefully monitor patients under methotrexate therapy when concomitant ciprofloxacin therapy is indicated.</p></td></tr><tr><td style="vertical-align:top"><p>Ropinirole</p></td><td style="vertical-align:top"><p>Use with caution</p></td><td style="vertical-align:top"><p>Monitoring for ropinirole-related adverse reactions and appropriate dose adjustment of ropinirole is recommended during and shortly after co-administration with ciprofloxacin.</p></td></tr><tr><td style="vertical-align:top"><p>Clozapine</p></td><td style="vertical-align:top"><p>Use with caution</p></td><td style="vertical-align:top"><p>Careful monitoring of clozapine associated adverse reactions and appropriate adjustment of clozapine dosage during and shortly after co-administration with ciprofloxacin are advised.</p></td></tr><tr><td style="vertical-align:top"><p>NSAIDs</p></td><td style="vertical-align:top"><p>Use with caution</p></td><td style="vertical-align:top"><p>Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.</p></td></tr><tr><td style="vertical-align:top"><p>Sildenafil</p></td><td style="vertical-align:top"><p>Use with caution Two-fold increase in exposure</p></td><td style="vertical-align:top"><p>Monitor for sildenafil toxicity</p></td></tr><tr><td style="vertical-align:top"><p>Duloxetine</p></td><td style="vertical-align:top"><p>Avoid Use Five-fold increase in duloxetine exposure</p></td><td style="vertical-align:top"><p>If unavoidable monitor, for duloxetine toxicity</p></td></tr><tr><td style="vertical-align:top"><p>Caffeine/Xanthine Derivatives</p></td><td style="vertical-align:top"><p>Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life</p></td><td style="vertical-align:top"><p>Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products). Monitor for xanthine toxicity and adjust dose as necessary.</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Drug(s) Affecting Pharmacokinetics of ciprofloxacin extended release </strong></p></td></tr><tr><td style="vertical-align:top"><p>Antacids, Sucralfate, Multivitamins and Other Products Containing Multivalent Cations (magnesium/aluminum antacids; polymeric phosphate binders (for example, sevelamer, lanthanum carbonate); sucralfate; Videx&reg; (didanosine) chewable/buffered tablets or pediatric powder; other highly buffered drugs; or products containing calcium, iron, or zinc and dairy products)</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Ciprofloxacin should be taken at least two hours before or six hours after Multivalent cation-containing products administration.</p></td><td style="vertical-align:top"><p>Decrease ciprofloxacin absorption, resulting in lower serum and urine levels considerably lower than desired for concurrent administration of these agents with ciprofloxacin.</p></td></tr><tr><td style="vertical-align:top"><p>Probenecid</p></td><td style="vertical-align:top"><p>Use with caution (interferes with renal tubular secretion of ciprofloxacin and increases ciprofloxacin serum levels)</p></td><td><p>Potentiation of ciprofloxacin toxicity may occur.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Pregnancy Category C<br />There are no adequate and well-controlled studies in pregnant women. Ciprofloxacin should not be used during pregnancy unless the potential benefit justifies the potential risk to both fetus and mother. An expert review of published data on experiences with ciprofloxacin use during pregnancy by TERIS&ndash;the Teratogen Information System concluded that therapeutic doses during pregnancy are unlikely to pose a substantial teratogenic risk (quantity and quality of data=fair), but the data are insufficient to state that there is no risk.<br />A controlled prospective observational study followed 200 women exposed to fluoroquinolones (52.5% exposed to ciprofloxacin and 68% first trimester exposures) during gestation. In utero exposure to fluoroquinolones during embryogenesis was not associated with increased risk of major malformations. The reported rates of major congenital malformations were 2.2% for the fluoroquinolone group and 2.6% for the control group (background incidence of major malformations is 1&ndash;5%). Rates of spontaneous abortions, prematurity and low birth weight did not differ between the groups and there were no clinically significant musculoskeletal dysfunctions up to one year of age in the ciprofloxacin exposed children.<br />Another prospective follow-up study reported on 549 pregnancies with fluoroquinolone exposure (93% first trimester exposures). There were 70 ciprofloxacin exposures, all within the first trimester. The malformation rates among live-born babies exposed to ciprofloxacin and to fluoroquinolones overall were both within background incidence ranges. No specific patterns of congenital abnormalities were found. The study did not reveal any clear adverse reactions due to in utero exposure to ciprofloxacin.<br />No differences in the rates of prematurity, spontaneous abortions, or birth weight were seen in women exposed to ciprofloxacin during pregnancy. However, these small postmarketing epidemiology studies, of which most experience is from short term, first trimester exposure, are insufficient to evaluate the risk for the less common defects or to permit reliable and definitive conclusions regarding the safety of ciprofloxacin in pregnant women and their developing fetuses.<br />Reproduction studies have been performed in rats and mice using oral doses up to 100 mg/kg (0.6 and 0.3 times the maximum daily human dose of 1000 mg based upon body surface area, respectively) and have revealed no evidence of harm to the fetus due to ciprofloxacin. In rabbits, oral ciprofloxacin dose levels of 30 and 100 mg/kg (approximately 0.4-and 1.3-times the highest recommended therapeutic dose based upon body surface area) produced gastrointestinal toxicity resulting in maternal weight loss and an increased incidence of abortion, but no teratogenicity was observed at either dose level. After intravenous administration of doses up to 20 mg/kg (approximately 0.3-times the highest recommended therapeutic dose based upon body surface area), no maternal toxicity was produced in the rabbit, and no embryotoxicity or teratogenicity was observed.<br />Nursing Mothers<br />Ciprofloxacin is excreted in human milk. The amount of ciprofloxacin absorbed by the nursing infant is unknown. Because of the potential risk of serious adverse reactions (including articular damage) in infants nursing from mothers taking Ciprofloxacin, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fluoroquinolones including ciprofloxacin may result in an impairment of the patient&#39;s ability to drive or operate machinery due to CNS reactions. This applies particularly in combination with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical Trials Experience<br />Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.<br />Clinical trials in patients with urinary tract infections enrolled 961 patients treated with 500 mg or 1000 mg ciprofloxacin extended release tablets. The overall incidence, type and distribution of adverse reactions were similar in patients receiving both 500 mg and 1000 mg of ciprofloxacin. The adverse reaction information from clinical studies does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.<br />In the clinical trial of cUTI and acute uncomplicated pyelonephritis (AUP) defined as infections occurring in premenopausal, non-pregnant women with no known urological abnormalities or comorbidities, ciprofloxacin extended release tablets (1000 mg once daily) in 517 patients was compared to ciprofloxacin immediate-release tablets (500 mg twice daily) in 518 patients for 7 to 14 days. Discontinuations due to adverse reactions thought to be drug-related occurred in 3.1% (16/517) of patients in the ciprofloxacin arm<br />and in 2.3% (12/518) of patients in the control arm. The most common reasons for discontinuation in the ciprofloxacin arm were nausea/vomiting (4 patients) and dizziness (3 patients). In the control arm the most common reason for discontinuation was nausea/vomiting (3 patients).<br />In these clinical trials, the following events occurred in &ge; 2% of all ciprofloxacin patients: nausea (4%), headache (3%), dizziness (2%), diarrhea (2%), vomiting (2%) and vaginal moniliasis (2%).<br />Adverse reactions, judged by investigators to be at least possibly drug-related, occurring in greater than or equal to 1% of all ciprofloxacin treated patients were: nausea (3%), diarrhea (2%), headache (1%), dyspepsia (1%), dizziness (1%), and vaginal moniliasis (1%). Vomiting (1%) occurred in the 1000 mg group.<br />Medically important adverse reactions that occurred &lt;1% in ciprofloxacin treated patients:</p><table border="1" cellspacing="0" cellpadding="0" style="width:550px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Body as a Whole </strong></p></td><td style="vertical-align:top"><p>Abdominal pain, Asthenia, Malaise</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiovascular </strong></p></td><td style="vertical-align:top"><p>Bradycardia, Migraine, Syncope</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central Nervous System </strong></p></td><td style="vertical-align:top"><p>Abnormal dreams, Convulsive seizures (including status epilepticus), Depersonalization, Depression (potentially culminating in self-injurious behavior, such as suicidal ideations/thoughts and attempted or completed suicide), Hypertonia, Incoordination, Insomnia, Somnolence, Tremor, Vertigo</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal </strong></p></td><td style="vertical-align:top"><p>Constipation, Dry mouth, Flatulence, Thirst</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary Disorders </strong></p></td><td style="vertical-align:top"><p>Liver function tests abnormal</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations </strong></p></td><td style="vertical-align:top"><p>Prothrombin decrease</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolic </strong></p></td><td style="vertical-align:top"><p>Hyperglycemia, Hypoglycemia</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders </strong></p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin/Hypersensitivity </strong></p></td><td style="vertical-align:top"><p>Dry skin, Maculopapular rash, Photosensitivity/phototoxicity reactions, Pruritus, Rash, Skin disorder, Urticarial, Vesiculobullous rash</p></td></tr><tr><td style="vertical-align:top"><p><strong>Special Senses </strong></p></td><td style="vertical-align:top"><p>Diplopia, Taste perversion</p></td></tr><tr><td style="vertical-align:top"><p><strong>Urogenital </strong></p></td><td style="vertical-align:top"><p>Dysmenorrhea, Hematuria, Kidney function abnormal, Vaginitis</p></td></tr></tbody></table><p>Postmarketing Experience<br />The following adverse reactions have been reported from worldwide marketing experience with fluoroquinolones, including ciprofloxacin. Because these reactions are reported<br />voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p><table border="1" cellspacing="0" cellpadding="0" style="width:595px"><tbody><tr><td style="vertical-align:top"><p><strong>Postmarketing Reports of Adverse Drug Reactions System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiovascular </strong></p></td><td style="vertical-align:top"><p>QT prolongation, Torsade de Pointes, Vasculitis and ventricular arrhythmia</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central Nervous System </strong></p></td><td style="vertical-align:top"><p>Hypertonia, Myasthenia, Exacerbation of myasthenia gravis, Peripheral neuropathy, Polyneuropathy, Twitching.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye Disorders </strong></p></td><td style="vertical-align:top"><p>Nystagmus</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal </strong></p></td><td style="vertical-align:top"><p>Pseudomembranous colitis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hemic/Lymphatic </strong></p></td><td style="vertical-align:top"><p>Pancytopenia (life threatening or fatal outcome), Methemoglobinemia</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary </strong></p></td><td style="vertical-align:top"><p>Hepatic failure (including fatal cases)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections and Infestations </strong></p></td><td style="vertical-align:top"><p>Candidiasis (oral, gastrointestinal, vaginal)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations </strong></p></td><td style="vertical-align:top"><p>Prothrombin time prolongation or decrease Cholesterol elevation (serum) Potassium elevation (serum)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskeletal </strong></p></td><td style="vertical-align:top"><p>Myalgia, Myoclonus, Tendinitis, Tendon rupture</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders </strong></p></td><td style="vertical-align:top"><p>Agitation, Confusion, Delirium, Psychosis (toxic)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin/Hypersensitivity </strong></p></td><td style="vertical-align:top"><p>Acute generalized exanthematous pustulosis (AGEP) Fixed eruption Serum sickness-like reaction</p></td></tr><tr><td style="vertical-align:top"><p><strong>Special Senses </strong></p></td><td style="vertical-align:top"><p>Anosmia, Hyperesthesia, Hypesthesia, Taste loss.</p></td></tr></tbody></table><p>Adverse Laboratory Changes<br />Changes in laboratory parameters while on ciprofloxacin are listed below:<br />Hepatic&ndash;Elevations of ALT (SGPT), AST (SGOT), alkaline phosphatase, LDH, serum bilirubin. Hematologic&ndash;Eosinophilia, leukopenia, decreased blood platelets, elevated blood platelets, pancytopenia. Renal&ndash;Elevations of serum creatinine, BUN, crystalluria, cylindruria, and hematuria have been reported. Other changes occurring were: elevation of serum gammaglutamyl transferase, elevation of serum amylase, reduction in blood glucose, elevated uric acid, decrease in hemoglobin, anemia, bleeding diathesis, increase in blood monocytes, and leukocytosis.<br />To report any side effects in KSA:<br />o National Pharmacovigilance and Drug Safety Centre (NPC)<br />&minus; Fax: + 966 112057662<br />&minus; Call NPC at + 966 112038222, Exts: 2317-2356-2353-2354-2334-2340<br />&minus; Toll free phone: 8002490000<br />&minus; E-mail: npc.drug@sfda.gov.sa<br />&minus; Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of acute overdosage, reversible renal toxicity has been reported in some cases. Empty the stomach by inducing vomiting or by gastric lavage. Observe the patient carefully and give supportive treatment, including monitoring of renal function, urinary pH and acidify, if required, to prevent crystalluria and administration of magnesium, aluminum or calcium containing antacids, which can reduce the absorption of ciprofloxacin. Adequate hydration must be maintained. Only a small amount of ciprofloxacin (less than 10%) is removed from the body after hemodialysis or peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mechanism of Action<br />Ciprofloxacin is a member of the fluoroquinolone class of antibacterial agents, ATC code: J01MA02.<br />Qurex&reg; XL (ciprofloxacin hydrochloride and ciprofloxacin extended release tablets) contain ciprofloxacin, a synthetic broad-spectrum antimicrobial agent for oral administration.<br />Qurex&reg; XL tablets consist of an immediate release layer and an erosion matrix type controlled-release layer. The tablets contain a combination of two types of ciprofloxacin drug substance, ciprofloxacin hydrochloride and ciprofloxacin (base).<br />Microbiology<br />Mechanism of Action<br />The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV (both Type II topoisomerases), which are required for bacterial DNA replication, transcription, repair, and recombination.<br />Mechanism of Resistance<br />The mechanism of action of fluoroquinolones, including ciprofloxacin, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, microorganisms resistant to these classes of drugs may be susceptible to ciprofloxacin. Resistance to fluoroquinolones occurs primarily by either mutations in the DNA gyrases, decreased outer membrane permeability, or drug efflux. In<br />vitro resistance to ciprofloxacin develops slowly by multiple step mutations. Resistance to ciprofloxacin due to spontaneous mutations occurs at a general frequency of between<br />&lt; 10-9 to 1x10-6 .<br />Cross Resistance<br />There is no known cross-resistance between ciprofloxacin and other classes of antimicrobials.<br />Ciprofloxacin has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections ciprofloxacin.<br />Gram-positive bacteria<br />Enterococcus faecalis Staphylococcus saprophyticus<br />Gram-negative bacteria<br />Escherichia coli<br />Klebsiella pneumoniae<br />Proteus mirabilis<br />Pseudomonas aeruginosa<br />The following in vitro data are available, but their clinical significance is unknown. At least 90 percent of the following bacteria exhibit an in vitro minimum inhibitory concentration (MIC) less than or equal to the susceptible breakpoint for ciprofloxacin (&lt;1 mcg/mL). However, the efficacy of ciprofloxacin in treating clinical infections due to these bacteria has not been established in adequate and well-controlled clinical trials.<br />Gram-negative bacteria<br />Citrobacter koseri<br />Citrobacter freundii<br />Edwardsiella tarda<br />Enterobacter aerogenes<br />Enterobacter cloacae<br />Klebsiella oxytoca<br />Morganella morganii<br />Proteus vulgaris<br />Providencia rettgeri<br />Providencia stuartii<br />Serratia marcescens<br />Susceptibility Test Methods<br />When available, the clinical microbiology laboratory should provide the results of in vitro susceptibility test results for antimicrobial drug products used in resident hospitals to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens. These reports should aid the physician in selecting an antibacterial drug product for treatment.<br />Dilution Techniques<br />Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized test method (broth and/or agar).1,3 The MIC values should be interpreted according to criteria provided in the following table.<br />Diffusion Techniques<br />Quantitative methods that require measurement of zone diameters can also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. The zone size provides an estimate of the susceptibility of bacteria to antimicrobial compounds. The zone size should be determined using a standardized test method.2,3 This procedure uses paper disks impregnated with 5 mcg ciprofloxacin to test the susceptibility of bacteria to ciprofloxacin. The disc diffusion interpretive criteria are provided in the following table:</p><table border="1" cellspacing="0" cellpadding="0" style="width:559px"><tbody><tr><td rowspan="2" style="vertical-align:bottom"><p><strong>Susceptibility Test Interpretive Criteria for Ciprofloxacin Bacteria </strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>MIC (mcg/mL) </strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Zone Diameter (mm) </strong></p></td></tr><tr><td><p><strong>S </strong></p></td><td><p><strong>I </strong></p></td><td><p><strong>R </strong></p></td><td><p><strong>S </strong></p></td><td><p><strong>I </strong></p></td><td><p><strong>R </strong></p></td></tr><tr><td><p><em>Enterobacteriaceae </em></p></td><td><p>&le;1</p></td><td><p>2</p></td><td><p>&ge;4</p></td><td><p>&ge;21</p></td><td><p>16&ndash;20</p></td><td><p>&le;15</p></td></tr><tr><td><p><em>Enterococcus faecalis </em></p></td><td><p>&le;1</p></td><td><p>2</p></td><td><p>&ge;4</p></td><td><p>&ge;21</p></td><td><p>16&ndash;20</p></td><td><p>&le;15</p></td></tr><tr><td><p><em>Pseudomonas aeruginosa </em></p></td><td><p>&le;1</p></td><td><p>2</p></td><td><p>&ge;4</p></td><td><p>&ge;21</p></td><td><p>16&ndash;20</p></td><td><p>&le;15</p></td></tr><tr><td><p><em>Staphylococcus saprophyticus </em></p></td><td><p>&le;1</p></td><td><p>2</p></td><td><p>&ge;4</p></td><td><p>&ge;21</p></td><td><p>16&ndash;20</p></td><td><p>&le;15</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>S=Susceptible, I=Intermediate,</p><p>R=Resistant.</p></td><td colspan="5"><p>&nbsp;</p></td></tr></tbody></table><p>A report of &ldquo;Susceptible&rdquo; indicates that the antimicrobial is likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations at the site of infection necessary to inhibit growth of the pathogen. A report of &ldquo;Intermediate&rdquo; indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone that prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of &ldquo;Resistant&rdquo; indicates that the antimicrobial is not likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations usually achievable at the infection site; other therapy should be selected.<br />Quality Control<br />Standardized susceptibility test procedures require the use of laboratory controls to monitor the accuracy and precision of supplies and reagents used in the assay, and the techniques of the individuals performing the test.1, 2 Standard ciprofloxacin powder should provide the following range of MIC values noted in following table. For the diffusion technique using the ciprofloxacin 5 mcg disk the criteria in the following table should be achieved.<br />Acceptable Quality Control Ranges for Ciprofloxacin&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Bacteria </strong></p></td><td style="vertical-align:top"><p><strong>MIC range (mcg/mL) </strong></p></td><td style="vertical-align:top"><p><strong>Zone Diameter (mm) </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecalis </em>ATCC 29212</p></td><td style="vertical-align:top"><p>0.25&ndash;2</p></td><td><p>-</p></td></tr><tr><td style="vertical-align:top"><p><em>Escherichia coli </em>ATCC 25922</p></td><td style="vertical-align:top"><p>0.004&ndash;0.015</p></td><td style="vertical-align:top"><p>30&ndash;40</p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas aeruginosa </em>ATCC 27853</p></td><td style="vertical-align:top"><p>0.25&ndash;1</p></td><td style="vertical-align:top"><p>25&ndash;33</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus </em>ATCC 29213</p></td><td style="vertical-align:top"><p>0.12&ndash;0.5</p></td><td style="vertical-align:top"><p>-</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus </em>ATCC 25923</p></td><td><p>-</p></td><td style="vertical-align:top"><p>22&ndash;30</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Ciprofloxacin extended release tablets are formulated to release drug at a slower rate compared to immediate-release tablets. Approximately 35% of the dose is contained within an immediate-release component, while the remaining 65% is contained in a slow-release matrix.<br />Maximum plasma ciprofloxacin concentrations are attained between 1 and 4 hours after dosing with Ciprofloxacin extended release tablets. In comparison to the 250 mg and 500 mg ciprofloxacin immediate-release twice a day (BID) treatment, the Cmax of Ciprofloxacin extended release tablets 500 mg and 1000 mg once daily are higher than the corresponding BID doses, while the AUCs over 24 hours are equivalent.<br />The following table compares the pharmacokinetic parameters obtained at steady state for these four treatment regimens (500 mg once a day (QD) Ciprofloxacin extended release tablets versus 250 mg BID ciprofloxacin immediate-release tablets and 1000 mg QD Ciprofloxacin extended release tablets versus 500 mg BID ciprofloxacin immediate-release).<br />Ciprofloxacin Pharmacokinetics (Mean &plusmn; SD) Following Ciprofloxacin and Ciprofloxacin extended release Administration</p><table border="1" cellspacing="0" cellpadding="0" style="width:589px"><tbody><tr><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>Cmax (mg/L)</p></td><td colspan="2" style="vertical-align:top"><p>AUC0&ndash;24h (mg&bull;h/L)</p></td><td colspan="2" style="vertical-align:top"><p>T1/2 (hr)</p></td><td colspan="2" style="vertical-align:top"><p>Tmax (hr) 1</p></td></tr><tr><td style="vertical-align:top"><p>Ciprofloxacin extended release 500 mg QD Ciprofloxacin 250 mg BID</p></td><td colspan="2" style="vertical-align:top"><p>1.59 &plusmn; 0.43 1.14 &plusmn; 0.23</p></td><td colspan="2" style="vertical-align:top"><p>7.97 &plusmn; 1.87 8.25 &plusmn; 2.15</p></td><td colspan="2" style="vertical-align:top"><p>6.6 &plusmn; 1.4 4.8 &plusmn; 0.6</p></td><td colspan="2" style="vertical-align:top"><p>1.5 (1 &ndash; 2.5) 1 (0.5 &ndash; 2.5)</p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Ciprofloxacin extended release 1000 mg QD Ciprofloxacin 500 mg BID</p></td><td colspan="2" style="vertical-align:top"><p>3.11 &plusmn; 1.08 2.06 &plusmn; 0.41</p></td><td colspan="2" style="vertical-align:top"><p>16.83 &plusmn; 5.65 17.04 &plusmn; 4.79</p></td><td colspan="2" style="vertical-align:top"><p>6.31 &plusmn; 0.72 5.66 &plusmn; 0.89</p></td><td colspan="2" style="vertical-align:top"><p>2 (1 &ndash; 4) 2 (0.5 &ndash; 3.5)</p></td><td><p>&nbsp;</p></td></tr></tbody></table><p>Results of the pharmacokinetic studies demonstrate that Ciprofloxacin extended release may be administered with or without food (for example, high-fat and low-fat meals or under fasted conditions).<br />Distribution<br />The volume of distribution calculated for intravenous ciprofloxacin is approximately 2.1&ndash;2.7 L/kg. Studies with the oral and intravenous forms of ciprofloxacin have demonstrated penetration of ciprofloxacin into a variety of tissues. The binding of ciprofloxacin to serum proteins is 20% to 40%, which is not likely to be high enough to cause significant protein binding interactions with other drugs. Following administration of a single dose of Ciprofloxacin extended release, ciprofloxacin concentrations in urine collected up to 4 hours after dosing averaged over 300 mg/L for both the 500 mg and 1000 mg tablets; in urine excreted from 12 to 24 hours after dosing, ciprofloxacin concentration averaged 27 mg/L for the 500 mg tablet, and 58 mg/L for the 1000 mg tablet.<br />Metabolism<br />Four metabolites of ciprofloxacin were identified in human urine. The metabolites have antimicrobial activity, but are less active than unchanged ciprofloxacin. The primary metabolites are oxociprofloxacin (M3) and sulfociprofloxacin (M2), each accounting for roughly 3% to 8% of the total dose. Other minor metabolites are desethylene ciprofloxacin (M1), and formylciprofloxacin (M4). The relative proportion of drug and metabolite in serum corresponds to the composition found in urine. Excretion of these metabolites was essentially complete by 24 hours after dosing. Ciprofloxacin is an inhibitor of CYP1A2 mediated metabolism. Co-administration of ciprofloxacin with other drugs primarily metabolized by CYP1A2 results in increased plasma concentrations of these drugs and could lead to clinically significant adverse events of the co-administered drug.<br />Elimination<br />The elimination kinetics of ciprofloxacin are similar for the immediate-release and the extended release tablet. In studies comparing the ciprofloxacin extended release and immediate-release ciprofloxacin, approximately 35% of an orally administered dose was excreted in the urine as unchanged drug for both formulations. The urinary excretion of ciprofloxacin is virtually complete within 24 hours after dosing. The renal clearance of ciprofloxacin, which is approximately 300 mL/minute, exceeds the normal glomerular filtration rate of 120 mL/minute. Thus, active tubular secretion would seem to play a significant role in its elimination. Co-administration of probenecid with immediate-release ciprofloxacin results in about a 50% reduction in the ciprofloxacin renal clearance and a 50% increase in its concentration in the systemic circulation. Although bile concentrations of ciprofloxacin are several fold higher than serum concentrations after oral dosing with the immediate-release tablet, only a small amount of the dose administered is recovered from the bile as unchanged drug. An additional 1 to 2% of the dose is recovered from the bile in the form of metabolites. Approximately 20 to 35% of an oral dose of immediate-<br />release ciprofloxacin is recovered from the feces within 5 days after dosing. This may arise from either biliary clearance or transintestinal elimination.<br />Specific Populations<br />Elderly<br />Pharmacokinetic studies of the immediate-release oral tablet (single dose) and intravenous (single and multiple dose) forms of ciprofloxacin indicate that plasma concentrations of ciprofloxacin are higher in elderly subjects (&gt; 65 years) as compared to young adults. Cmax is increased16 to 40%, and mean AUC is increased approximately 30%, which can be at least partially attributed to decreased renal clearance in the elderly. Elimination half-life is only slightly (~20%) prolonged in the elderly. These differences are not considered clinically significant.<br />Renal Impairment<br />In patients with reduced renal function, the half-life of ciprofloxacin is slightly prolonged. No dose adjustment is required for patients with uncomplicated UTIs receiving 500 mg ciprofloxacin extended release tablets. For cUTI and AUP, where 1000 mg is the appropriate dose, the dosage of ciprofloxacin extended release tablets should be reduced to ciprofloxacin extended release tablets 500 mg q24h in patients with creatinine clearance equal to or below 30 mL/min.<br />Hepatic Impairment<br />In preliminary studies in patients with stable chronic cirrhosis, no significant changes in ciprofloxacin pharmacokinetics have been observed. The kinetics of ciprofloxacin in patients with acute hepatic insufficiency, however, have not been fully elucidated.<br />Drug-Drug Interactions<br />Antacids<br />Concurrent administration of antacids containing magnesium hydroxide or aluminum hydroxide may reduce the bioavailability of ciprofloxacin by as much as 90%.<br />Histamine H2-receptor antagonists<br />Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of ciprofloxacin.<br />Metronidazole<br />The serum concentrations of ciprofloxacin and metronidazole were not altered when these two drugs were given concomitantly.<br />Tizanidine<br />In a pharmacokinetic study, systemic exposure of tizanidine (4 mg single dose) was significantly increased (Cmax 7-fold, AUC 10-fold) when the drug was given concomitantly with ciprofloxacin (500 mg twice a day for 3 days). Concomitant administration of tizanidine and ciprofloxacin extended release is contraindicated due to the potentiation of hypotensive and sedative effects of tizanidine.<br />Ropinirole<br />In a study conducted in 12 patients with Parkinson&rsquo;s disease who were administered 6 mg ropinirole once daily with 500 mg ciprofloxacin twice-daily, the mean Cmax and mean AUC of ropinirole were increased by 60% and 84%, respectively. Monitoring for ropinirole-related adverse reactions and appropriate dose adjustment of ropinirole is recommended during and shortly after co-administration with ciprofloxacin extended release.<br />Clozapine<br />Following concomitant administration of 250 mg ciprofloxacin with 304 mg clozapine for 7 days, serum concentrations of clozapine and N-desmethyl-clozapine were increased by 29% and 31%, respectively. Careful monitoring of clozapine associated adverse reactions and appropriate adjustment of clozapine dosage during and shortly after co-administration with ciprofloxacin extended release are advised.<br />Sildenafil<br />Following concomitant administration of a single oral dose of 50 mg sildenafil with 500 mg ciprofloxacin to healthy subjects, the mean Cmax and mean AUC of sildenafil were both increased approximately two-fold. Use sildenafil with caution when co-administered with ciprofloxacin extended release due to the expected two-fold increase in the exposure of sildenafil upon co-administration of ciprofloxacin.<br />Duloxetine<br />In clinical studies, it was demonstrated that concomitant use of duloxetine with strong inhibitors of the CYP450 1A2 isozyme such as fluvoxamine, may result in a 5-fold increase in mean AUC and a 2.5-fold increase in mean Cmax of duloxetine.<br />Lidocaine<br />In a study conducted in 9 healthy volunteers, concomitant use of 1.5 mg/kg IV lidocaine with 500 mg ciprofloxacin twice daily resulted in an increase of lidocaine Cmax and AUC by 12% and 26%, respectively. Although lidocaine treatment was well tolerated at this elevated exposure, a possible interaction with ciprofloxacin extended release and an increase in adverse reactions related to lidocaine may occur upon concomitant administration.<br />Metoclopramide<br />Metoclopramide significantly accelerates the absorption of oral ciprofloxacin resulting in a shorter time to reach maximum plasma concentrations. No significant effect was observed on the bioavailability of ciprofloxacin.<br />Omeprazole<br />When ciprofloxacin extended release was administered as a single 1000 mg dose concomitantly with omeprazole (40 mg once daily for three days) to 18 healthy volunteers, the mean AUC and Cmax of ciprofloxacin were reduced by 20% and 23%, respectively. The clinical significance of this interaction has not been determined.<br />&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazards for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential, or toxicity to reproduction. Like a number of other quinolones, ciprofloxacin is phototoxic in animals at clinically relevant exposure levels. Data on photomutagenicity/photocarcinogenicity show a weak photomutagenic or phototumorigenic effect of ciprofloxacin in-vitro and in animal experiments. This effect was comparable to that of other gyrase inhibitors.<br />Articular tolerability: As reported for other gyrase inhibitors, ciprofloxacin causes damage to the large weight-bearing joints in immature animals. The extent of the cartilage damage varies according to age, species and dose; the damage can be reduced by taking the weight off the joints. Studies with mature animals (rat, dog) revealed no evidence of cartilage lesions. In a study in young beagle dogs, ciprofloxacin caused severe articular changes at therapeutic doses after two weeks of treatment, which were still observed after 5 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Inactive ingredients: Crospovidone, magnesium stearate, colloidal anhydrous silica, succinic acid, hypromellose, titanium dioxide and macrogol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0" style="width:389px"><tbody><tr><td><p><strong>Immediate packaging</strong></p></td><td><p><strong>Outer packaging</strong></p></td></tr><tr><td style="vertical-align:top"><table border="0" cellspacing="0" cellpadding="0" style="width:421px"><tbody><tr><td style="vertical-align:top"><p>PVC/PVDC</p><p>Aluminum foil</p></td></tr></tbody></table><p>&nbsp;</p></td><td style="vertical-align:top"><p>Carton</p><p>Leaflet</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
Prince Hashem Bin Al-Hussein Street.
Na'ur - Amman - Jordan.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                22/01/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,iVBORw0KGgoAAAANSUhEUgAABAAAAAQACAYAAAB/HSuDAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyZpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8&#x2B;IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDcuMC1jMDAwIDc5LmRhYmFjYmIsIDIwMjEvMDQvMTQtMDA6Mzk6NDQgICAgICAgICI&#x2B;IDxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI&#x2B;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&#x2B;IDwvcmRmOlJERj4gPC94OnhtcG1ldGE&#x2B;IDw/eHBhY2tldCBlbmQ9InIiPz7UjGOoAALHwklEQVR42uzdCVxU9f7/8Q8zwLAjgoIsiuKOioIoIrjgmvp3yy210jbNtMWu1xazupW3Mrvdlqtltnnbblm/tEXNFkuvtpjapuZSaua&#x2B;BaIgzPzPOYV3PJ4zC4tsr&#x2B;d9cGdghgHhNJz3e76Lj8PhEAAAAAAAULNZ&#x2B;BEAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAAoAAAAAAABAAQAAAAAAACgAAAAAAAAABQAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAKAAAAAAAAAAFAAAAAAAAoAAAAAAAAAAUAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAAAUAAAAAAACgAAAAAAAAABQAAAAAAACAAgAAAAAAAFAAAAAAAAAACgAAAAAAAEABAAAAAAAAKAAAAAAAAKAAAAAAAAAAFAAAAAAAAIACAAAAAAAAUAAAAAAAAAAKAAAAAAAAQAEAAAAAAAAoAAAAAAAAAAUAAAAAAACgAAAAAAAAgAIAAAAAAABQAAAAAAAAAAoAAAAAAABAAQAAAAAAAC4S35r&#x2B;D/Tx8eG3DAAAAADwiMPhqLH/NkYAAAAAAABQC1AAAAAAAABAAQAAAAAAAGoCX34EAAAAKIWLsdCSgx8zAFAAAAAAoHqH&#x2B;/L6PigJAIACAAAAANUo7Jfn908pAAAUAAAAAAT&#x2B;WvZvpAwAAAoAAAAAQn8VeTwzjnL8XikCAFAA8CMAAAAg9JfiMSq6BHC4&#x2B;BqOMvxbKAIAUAAAAACgVgd/Hy8eq7KmEThMvr6jFP9OigAAFAAAAACotaHfp5SPWx6FgKMUj2lUCDi8/J4pAgBQAAAAAKDWhX6fUn5eab8vhweB3OHhYztKGewpAgBQAAAAAKBGhv7SBHkfL78HT1&#x2B;99/EgkPvowrknhYD&#x2B;sR1efM8UAQAoAAAAAFBtQ78nId7Hi7BfmkLBKKSbve8w&#x2B;RoOXSHgbRlAEQCAAgAAAACE/jLcpzTft4&#x2B;LAG/0ir9D9z14UgY4XFynCABAAQAAAIBaHfq9vb0s37tZ2DcL4t6WARQBAEABAAAAUK2Df3mG/tLe5unXdhf&#x2B;jYK5iPtX9p1LAX0ZIBQBAEABAAAAQOg//2MVVQZ4WgCISej3MQnp&#x2B;kLAaGSAflQARQAAUAAAAABU6dDvKuhXROjXf7y0RYC3HC5CvsOgEHA11F8/KkAoAgCAAgAAAKA2h34fF59vdF9v1wooj&#x2B;AvcuEr/EalgPP7PhQBAEABAAAAUBtCv1lo93ER9n1K8bnuSoeyhn&#x2B;z0O9uaL/DJOyLF0WA/jG8&#x2B;f1RBACgAAAAACD0u/08Hw9ucxf6RVy/qu9J6Pe0GPDk&#x2B;yrv8O/qfbNw73Dx8zcqAkRXCHgT7CkCAFAAAAAAEPq9Dv1mIb6sod&#x2B;T0QA&#x2B;bu4nLoK/u5&#x2B;NJwWAoxTvUwQAAAUAAABApQb/8l7B39XHPQ35ngR&#x2B;T6cHmH2vFVEA2N2Ef&#x2B;fb7G6KAIfJ91veRQAlAAAKAAAAAEK/x6FfxLOh&#x2B;&#x2B;IiyHsT&#x2B;su6PoA3JYC7AsCuC&#x2B;AON&#x2B;G/5P5WD4oAowUEy7sIYDQAAAoAAACAGhb6XQX9igr97oJ8yfsWk9sspSwLyhL&#x2B;xSD8uxri72NSBphdF93HKQIAgAIAAACgRod&#x2B;szBv8aAcKO2aAO5&#x2B;jg6TEsDTAsDouj7Y&#x2B;5iEf4oAALX7j5zDUbOfd3x8fPgtAwCA6hz6RbxbqM&#x2B;T0G8ppzLA1b/FXQHg6bx//ZvdKfSb3W72Oa6uuyohRIxHK7j7N3mKIgCoQmpyRqYAAAAAhP7Sf15lbNvn7n1Xgd7iogBwF/jNphB48m81Crzuhv7bDa67C/t2N0UBRQCAWl0AMAWgEg6ioqIiOXv2rOTl5WkFhd1uF19f33P3US&#x2B;tVqv2cfV29e3UqVMSGhqqfUy93WKxaJclBYd6WfJx9U29n6q4uFh7bKMD2WazSWFhofb9&#x2B;Pv7a7eXPIbz/dVL9Xb1fupbyeOVfI/amYPT11QFBgZKfn7&#x2B;ucdSv7&#x2B;S77nk&#x2B;y75Ws4/A/X7UR&#x2B;35N9Vcp&#x2B;Sn4V6W8m/S/1Yyefry56Sz1HvX/I1S75uyZvzz9f5e3J&#x2B;LOf7AACqeeIv/ZN5Vdq2z9M5/u6um4V&#x2B;i5vA7800AO3jERER1uuvv77R8OHDs1q1atXvyJEj3z/77LOv33fffTvdBG6LyXXnQG80bF9/XZyKAP3UAOfFAu1O/5ayTA1wNWXBo2PNUdNfoash5/bOTynqual63qmeK5ecy6r3OXPmjHZerPr999&#x2B;18&#x2B;&#x2B;S83M1C6jn2Or76sfVz1PP&#x2B;dWcoJ7LBgUFSUFBgXa78/ms89dXHyMsLEw7hy45b1Y/X80N6tcroX4d9T7q7epjnvuPQjnXVe&#x2B;v/LcpW7Zs0W5X/w2NGjWS3bt3a9&#x2B;Ten/136A&#x2B;vnpdvVQ/pyQ/qNfVz0lMTNQ&#x2B;p&#x2B;T7LPl5lJx3q&#x2B;&#x2B;r942PjxfleUD7Wrm5uefyTd&#x2B;&#x2B;fTmwKAAAAAAqJfhX5rZ9&#x2B;vtYPAz9Pm5CvaWUt3u7KKAEBARYb7311sZDhgzJbNy4cfvIyMiOyq9B&#x2B;zoNGzZsMnv27O5Tp0798cEHH3z8H//4xx5xPeRfH/wtuuvOtxkVAK6KAOePWZyul6UI8PHgukfHLEUAAAoAAACA6hH6RSp22z5P3yxefKy0RYB2OXz48HrTp0/vlZSU1D46OloN/Ybnmr6&#x2B;vuH169fv8uCDDza/6qqrls&#x2B;ZM&#x2B;ftV1999aCb8G80CkAf/C0GH6MIAAAKAAAAQOivlNAv4v08/tKEfn2YN/uYu2LA5dSA/v37R1577bUdunTpkqOE&#x2B;rZWqzXI0x&#x2B;&#x2B;v79/ZJs2bcYtWrSo93333ffNa6&#x2B;9tnTWrFk/ivHcf7uuDDC6dBX8S1MEmAV/syJAdCWAUAQAoAAAAACovNDvKuhXxW37zMqBsoZ&#x2B;/W2ejhSQJk2aBM6ZM6dr&#x2B;/btU5TrWX5&#x2B;fqFl&#x2B;T0GBgZGJyUlXXLbbbf1yMnJeWXhwoWfPv/887/K/&#x2B;bmO7y8tHtZBDiHeH34d3hRBOiPGwdFAAAKAAAAgJob&#x2B;kUuzrZ97sK6J6/0e1IMaB8LCwuz3nXXXW0GDBjQo1GjRh2Cg4MblPfv1mq1Bnbp0uXqDh06DJk6deqqBQsWrFi4cOFeD8K&#x2B;8ygAHzl/RECxh0WA3eR9d0WAXff7pAgAQAEAAABQyaHfXfCvjG37PF3N39tX/V29wm9xUQSc93Wio6Nt06ZNazFy5Mh&#x2B;MTExLUJDQ2OVX4W1on/fAQEBUampqWOeeuqp/6dYOG/evP&#x2B;uXr36uIvQ764QMCsC7C6KgBLuigDnHQSkDEWAw8XnUgQAoAAAAACE/nIK/foQX5Gh3zmUuwr95TGX35Owf95lVFSU/7XXXttYCd4Zbdq06RYcHBxjsVislXEM&#x2B;Pn5BQ8aNOjGnj17jvjyyy&#x2B;X33TTTe9///33eQaBvyTgW1x8zKgIcL6/WSHgSRGgXy/A3fFpVASIrhAQigAAFAAAAIDgX7bQL1Ix2/Z58n5Zt&#x2B;1zVQR4HfadL6&#x2B;77rqGY8eOzWzVqlVa/fr1k6vQ8WAJCQmJz8nJufrLL78c9tZbbz2jfK9r8vPzi1yEf7tB6Le4CPpGowD09/OkCDCbJkARAIACAAAAoAqFfn34NwvxIuW/bZ8nQ/3dze/36jIoKMg3OTk55N57781p06ZNamxsbDur1epflQ&#x2B;TwMDAyMsuu2xGnz59hqxdu3bV&#x2B;PHjV/5ZBBiFf3dFgPNtFnG9cGB5FgEOg2OMIgAABQAAACD0V4HQL1I1tu3zeO7&#x2B;n&#x2B;9b9LcrAd&#x2B;qhOe6o0aNap2Tk9MzLi4uxdfXN7A6HTcWi8W3fv36rYcNG9Z6165dOWvWrPl48uTJq44cOVLoFPI9KQKMpgB4WwQ4vHjTh32HyTFbrkUAJQAACgAAAFCdQr&#x2B;roF/Z2/Z5MqS/LKHfLOyLePZKv/aWlZVVZ9KkSR0yMzO7NGrUKN1qtdpqwvEUHR3d5tJLL22TkZHRdf369Wtmzpy5eufOnaf/DOolRYBRKeBjEPyd1wbwZMcAV7sF2A3CvrsiQD/CoFyKAEYDAKAAAAAAhP7K3bbPk/n93ob9Cy4XLlyYlZ6e3rZly5bdbDZbeE09xuLi4tIuvfTStG7duvVbtGjRS4899tiPBw8eLHAqAnzE9RQBV&#x2B;sFlKYIMLvdhyIAAAUAAAAg9BuHnIrYtq&#x2B;yQn9Zt&#x2B;1zexkdHe0/ZcqUFkOGDMlOSkpKCw4OblCG30W1U69evZa33XbbA6NGjVr3xhtvvPfUU0/9uHfv3jNy/ogAT4oAT6cEGC0a6DApAqwUAQAoAAAAAKG/4kO/SMVv22dWAJRm2z53UwDOXQ8KCrJOnTq1Wb9&#x2B;/dqlpaXlhIWFxSu/CmttPhSbNGmSOXPmzC6XX375t3fdddeCF198cW9xcbHFgyLAm0UC7boArg/8DpPwTxEAgAIAAAAQ&#x2B;k1uMwvxFR36Xc3xd1UAVPi2fepifjfddFPTgQMHtk9OTu5Ur169FurieByR5x8XsbGxKfPnz5/7l7/8Zf0jjzyy5I033tiXm5t71qQIcA7/ZkWAc9B3XjfArgvdZlMArE7FgfN1igAAFAAAAKBGBf/K2rbP1ZD/i71tX5m27xs7dmzs1VdfndWqVasO0dHRrZXQ78fR6Jq/v3&#x2B;I8vPq/fTTT2feeeed3/zlL395/u23394vF64L4Bz&#x2B;jdYDMFsbwGiKgIhn2whanK6XRxGgD/8UAQAoAAAAQI0O/SKVt22fJ4v6efVKf05OTt2JEye2z87O7q6Gfj8/vyCOxlKc9Pr6BjVp0iRr8eLFzbdu3bpuyZIln/3973/fIq5HAei3DTRaJFC/laDRVADn0F&#x2B;RRYCPB9cpAgAKAAAAgHIL/a6CPtv2ebBtX8uWLYNmz56dmZaW1j4pKSnTarUGcDSWj&#x2B;Dg4PrKz3VISkpKv8svv/zzZ5999t1HH310u7geBeAj7ncL0G8laHTpSRFgFvzNigA9igAAFAAAAKDGhH6RilvB31X4r9Bt&#x2B;5TQH3zXXXdlKMG0TaNGjTqEhIREczRW4Emwr29Aq1at&#x2B;syZM6dT//7933rxxRfXvfbaa/uKFQZFgDe7BXiya4DIhTsFOBcBDi&#x2B;KADEpAYQiAAAFAAAAqKjQbxboPQn97gJ&#x2B;RYZ&#x2B;VwWAJ8P6Sz3MPzQ01HfWrFltBw4c2C0xMTE1ODi4nsnPDhXEZrOF9&#x2B;nTZ2K3bt2GTZ48efkzzzzzyeLFi/fKhSMCPNk&#x2B;0N2UAFe7BfjIhaMASlsEGN2PIgAABQAAAIT&#x2B;cgv9nhQCVXHbvrLM7y/Vtn2zZ89um5WV1bZDhw59AwIC6rCCf5UoAuoov5MxqampvQYPHvzqggULvvroo4&#x2B;OyoXTAeziWRngyZQAfRFgVAyYFQF2XYj3KWMR4PDmeYMiAKAAAAAAhH5xEeIrOvRfrG37vF3cT7s&#x2B;efLkxDFjxmQkJyd3joyMbF6G3wUqUFBQUL0RI0bc2K9fv1/XrFnzwZw5cz5VLo&#x2B;L6&#x2B;kARtsG6tcL0Ad/oykDRosGmhUB&#x2B;oUD3f3366oI8Go0AEUAQAEAAABqXvAv7xX8XX28qmzbZxb6vR7ib7PZrJdcckn9CRMmdMzMzMyJiIhI9PX1Dawpx5Sa&#x2B;woKCqSwsFB7U6fO169fX/7Igw6xWKzV&#x2B;t8XGhoar/z&#x2B;rs3Ozh74/PPPP/vEE098u3379nwxHgVgtFWg0baBzkWA0SgAV4sGuioCjKYFeFMEiK4QoAgAKAAAAACh3&#x2B;vQrw/1RqFfpIZs26dejhkzpsGoUaNSlODYNzw8PMHPzy&#x2B;4uh9Lu3btkiNHjsixY0dl06bNcurUKS2Tnj59Wvz9bXL27Fkl8PuIzRag3VavXj2tCGjQIFaio6MlPb2jBAQESkhISLX7tyvfc&#x2B;zUqVPvHD9&#x2B;/O5Nmzatuf7665dt27btlEER4GoLQaNFAi1ivnWgfmSAJ0WAgyIAAAUAAACEfm&#x2B;Df23ats9V6HdXBlhL3u/Vq1fdq6&#x2B;&#x2B;ukMXRUJCQprVarVV92NJDfJLl74jX3yxXvbt&#x2B;017db9p02aSmZkpfn5&#x2B;0rp1ay3kh4WFaUXAmTNnJCgoUIqKimXnzp2Sl3dK&#x2B;by98uOPP8jnn68Wq9VX4uLiJTs7S1q0aKmuwl&#x2B;d/ruyRkRENOnZs2eTNWvWdFm5cuWyW2655fNDhw4VOBUBrrYQ1BcBdg&#x2B;KAKORAeJhAWBWBLjaOrDcigBKAIACAAAAEPo9Df3VYts&#x2B;JegHzJ49O71r167pTZo06Wiz2SJqyjH14osvyuLFLymBP0n69esvPXr0FCUAm94/ODhYeyvRvn37c9fVqQHr16&#x2B;X1157VVasWCEHDx6QmTNvq1YFgLOoqKhml1122U09evTo/cUXX3x6yy23fLp79&#x2B;7TYjwdwEeMtw00WiTQk4UCXS0S6Hy7ux0E9F&#x2B;zXIsARgMAFAAAAKBmhX53AV&#x2B;kBm7bFxsba7vqqquajho1qlfjxo3bh4SENKhJx1V&#x2B;fr7cddcsWb36U3noobnSq1evUj2OGvq//PJLWbt2rezatVNdWE969&#x2B;4tDzwwR6xWqyxbtlQ&#x2B;/fRTadKkiVx//fXK7cHV7b8/q3IstBs2bFjbTp06ZS1duvTdW2655cuCgoJiMR4F4Gq3AKNpAqUpAsxu96EIAEABAABA7Qz97oJ/Tdu2z9NX&#x2B;C/Yrs859N94442tMjIyWqWmpuaooV8NgDXt&#x2B;FKH8I8cealynFmU8P61WCwWrx/jwIH9smTJW/Ldd99qoT89vZNceumlEhPTQDZu3CB/&#x2B;9u9sm3bNklISJB27VLkgw/el48&#x2B;WiWvvfa6hIWFV8v/LOPi4lInT57cIScn57PPP/987fTp09fn5uaeFeNRABVRBNgNAn3J7VaKAAAUAAAAEPrFRfCvrG373F23SOkW9SvVtn2zZs1q3bNnz&#x2B;T09PQ&#x2B;SuiPq&#x2B;nb9r377lJ5//3lsmXLFq/D/4kTJ&#x2B;TWW2&#x2B;RdevWy1/&#x2B;MkNmzPirtvjfDz/8IEuWvCmrV6/Wpgj06tVbpk27URo2bKge29K/f3&#x2B;56qqJ8uCDD8mcOXOq9X&#x2B;nLVq06K6&#x2B;KcfM508//fTbc&#x2B;fO3SbnTwewi2dFgLu1AcRFIUARAIACAACAWhL8q9K2fRYPQ39ptu0r7aJ&#x2B;bi/Hjx8fN3HixMw2bdp0Vud6K0HYr7Ycc2vW/Fc6d&#x2B;4kiYmJbu&#x2B;r7giwcuVK2b//N5kwYaJERkbKtddeJ3XrRmqh/&#x2B;efd2m7BQQGBkhKSoo88sg8adKksfj5&#x2B;Z/3OOrXuv/&#x2B;&#x2B;5XPvVamTJki8fHx1f7nmJSUlD1nzpy0G2644bt///vf//fYY4/9qPy8Ck2KALNtA50LAaMRAHanwC&#x2B;6IO9cBJSEf/uf93G&#x2B;ThEAUAAAAIBaHvr1od4sxIt4Po&#x2B;/tCv4l2Z&#x2B;v9eXY8eOjR0wYECLXr169a9bt25jf3//kNp4/CUkxMvSpYe0qQABAQEX3K6uD6DO6X/vvXfl5MmT2kJ/6kiBMWNGSe/efWXChCu1dQM&#x2B;/fRj&#x2B;eyzz5TrD0rr1sluv25ycrLk5eVpj19jTrB9fYMaNWrU&#x2B;fbbb0&#x2B;dOHHiDw8&#x2B;&#x2B;OCiJ554YqdcuC6AxcMiQD8SQL&#x2B;AoNHIALNtBC1O18ujCNCHf4oAgAIAAABU89AvUr237Ttvfr8SOoP/&#x2B;te/dszKyspUt&#x2B;3z8/MLqu3H4qhRo&#x2B;WOO26Xt99eIhMnXq197NixY7Jx40ZZunSpnDhxXBu6P2bMGC3Yq6FdLQROncqXF198QTIyOkt0dIzk5PTS3jz13HPPSaNGDbW3mkYdQRIbG9t&#x2B;7ty590&#x2B;aNGn9M888897jjz&#x2B;&#x2B;Qy5cF8DVFoIWMV8bwGiKgN0g9FdkEeDjwXWKAIACAAAAQn8Zgn9V37bPbJG/sgz1L8tK/tb09PSwm2&#x2B;&#x2B;uWNnRXR0dLOQkJBok59draQOv1&#x2B;16iOZPn26Elyt8ttv&#x2B;7UF&#x2B;&#x2B;LjY2XcuHFK6G8tRUVnZfny5fLCCy/K7t2/SIsWLeTRR/&#x2B;hDfMPDAz06uupWW/Romfl3nvvkbfffkdstoAa&#x2B;7O12WzhycnJ/ebOndv1xhtv3Dhr1qzFr7322q/iejqAvggwWiTQaCSA0ZoBFAEAKAAAACD01&#x2B;xt&#x2B;9q1axcyatSopsOHD&#x2B;&#x2B;VkJDQRgn9MRyNpseoZGd3kyeeeFLeeutN6dgxXa6&#x2B;&#x2B;mot2K9atUpef/112b79J20F/549e8rQoUPVYFuqr3Xw4AFtVMGTTz4p8&#x2B;c/oz1ebaBOL1HXCHj22WdbTp48ecVzzz235qWXXtoj7kcBeLJbQHkUAWbB36wIEF0JIBQBAAUAAACE/tKHfnfBv7Zu22d6GRQUZJ09e3ZbJVSmJScnZwcHB0dzNHouIyNDe1O9/PLLsmDBfMnN/V3Gj79cGx0QFxdXqsc9deqUrFu3TtauXSNff/21NG3aVN5//4NSP151phyT9bp37z6&#x2B;U6dOAydNmrTy0UcfXblkyZL9JkWAu90C3E0JMNtFwPlzLLpw72kRoH&#x2B;ucVAEABQAAAAQ&#x2B;ss39JuF&#x2B;KoQ&#x2B;itt275rr7220VVXXdVdCZYdIiMjm9f0bftcKSoqkuPHj6uvOEt4eLiWtdS5&#x2B;l988YUoQVP5WJj2in&#x2B;rVq3kkksGaKv4GxkwYIAkJTWRFStWaIsDzp//lMTGxkmDBnHK57bQhu2rCwaGhYWK3e7QhvWrX1sN&#x2B;4cPH5bTp/O1BQO///572bp1m1gsPtp0gQULnq6VwV8vMDAwIjMzc3Tbtm2zhw4d&#x2B;spbb73149tvv33AoAjwdAtBixgvGuhq20CzbQTNigC77nmAIgCgAAAAgOBfwaHf6P7ebNvnfB&#x2B;LlH1hv0rZtk8N/ZdffnlXJch2jIiISLRarQG1/VhUM9Jbby2Rhx56SAvmN9wwVUaMGCmffbZa7r77bunYsaO2gr96n3/961/SuPE8ueqqq&#x2B;TKKydKaGjoeY&#x2B;l/EwlI6OL9lZYWCj79u2TzZs3y&#x2B;&#x2B;/n5T3339PKxXU/HbmTKHY7X&#x2B;MQPf19VXuWyR160Yot&#x2B;dJ/foxkp6eLsOHD5cmTZK0nQNwPuXnHjt&#x2B;/Pi/jBw58veNGzcunzFjxjtr1qw5Lq5HAbjaLcBsbQD96AGzRQNdFQHOWwlKGYoAh4vPpQgAKAAAACD0S9Xatk//qv9F2bZv0qRJjfr37986Ozt7QHh4eKwSOAM5Gs87LmXIkKHSuXNnuf/&#x2B;&#x2B;5VgP0Hefvv/ZNq0qbJixUo5ceKEvPnmG9oq/snJrbX7RUdHi5&#x2B;fn8vHVUcTNG7cWHs7lxTtdiX8n5biYrtYrdZz9zt9&#x2B;vQFZQLcs9lsYRkZGSOXL1/ec9WqVf&#x2B;ZPn36J7t27coX41EA7rYQNFobwGIQ/l2tFWBWBOjXC3D3nGdUBIiuEBCKAIACAAAAQn/FreBvKUXoL89t&#x2B;8zua9Xfr0&#x2B;fPpETJ07skKmIi4tLqe2hXx1i/&#x2B;uvv0rz5s1Ff0iqQ/BnzZol27ZtlXvvvVduueUWueuuu2TQoIGi/BzlmmuuVeegy/jx46Vnz15a&#x2B;C8t9dX8oKDgCz5O&#x2B;C/b04y6RsCQIUNu6NGjx&#x2B;BNmzZ9OmrUqLcOHTpUYFAEuNo5wDns64O&#x2B;0XQA/f08KQLMpglQBAAUAAAA1KrQ7yroV/a2fe6G9OtDvbehv1y27WvZsmXQjTfe2O6SSy7prYTUFoGBgZG1&#x2B;ThU5/Tv3btXe9X&#x2B;ySefkMcee0y6ds2WadNukKys7HOvwKuXvXr1kqNHj8jw4cOke/fusmDBAtm5c4fs2LFT2rVLUW7vzX/Y1UB4eHiC8vu7/Pvvv&#x2B;&#x2B;4YsWKd6&#x2B;55prPCgoKip2KAG&#x2B;2DTRaK8DV&#x2B;gDlVQQ4DJ6jyr0IoAQAKAAAAKjJoV&#x2B;kBm7bl5GREZ6dnR07ceLESxISEtqybd8fCgoKZd68ubJw4bOSk5MjU6ZMkbS0NOX9hTJixAgZOnSIjB07Tnr2zNFGBPTv3197u&#x2B;&#x2B;&#x2B;&#x2B;2T27NnanPxXXnlFMjIy&#x2B;WFWQ/Xq1Ws1bty4lsrvvt&#x2B;XX365Wrm&#x2B;Mj8/v0iMpwOYFQFGawN4WwTow75dLtwe0JutA6W8igBGAwCeYRUWAACcTiBLlCL0&#x2B;4jrufb6&#x2B;xq9Qi7iejV8i1y4&#x2B;r1Vd5vR&#x2B;85v&#x2B;o8b3cfX5H1f3cd8DW4r&#x2B;Zifp5dJSUkh999/f/vNmzdP&#x2B;fjjj596&#x2B;OGHH23VqlUfwv//2Gz&#x2B;cscds&#x2B;S9996XgwcPaIF/7dq1MnPm7bJ06VI5fPiITJhwpdx1151y4MD&#x2B;c5/XtGmStG7dUrp378YPsQY8P8XGxrYbOnTotB9&#x2B;&#x2B;GHWI4880tFms/np/jv0&#x2B;/PNavDfp9F1T98sBs8hzs83&#x2B;ucoi8nzl9HznKtRTK52O3H5PM4RAxhjBAAAoNafVJf2U1287&#x2B;62qrRtn9mr/hWxbd&#x2B;560pwsUyfPr354MGDu7Rs2bJTnTp1Ejkaz1dYWCBbtmwVPz9fJdQfkKysbtoK/itXrtIW8bvxxqnaVIDBg4fI008vlB07tktubq7UqRNx7jFGjhwl3bp1Z8u9GiYxMbHzzTffnDp06ND1n3/&#x2B;&#x2B;X//&#x2B;c9/bti0aVOunD8KwJNtA43WC3C3daDRtoFmtxsN99ePCNBPNWBEAEABAABAlQj&#x2B;VWHbvvKY418p2/ZZFUrgj77lllt6NW/ePKV&#x2B;/frJvFJnTN1iTx2&#x2B;r66wry70p77Cn59/Wnvl/5dffpE9e/ZIZmZXSU5Olk6dOktoaIh07dr1whM9X1/Cfw2l/Oekjp7JbtKkSdYll1yydd68eQvnzp27Tc6fDmAXz4oAT9cGMFo00GFSBFgpAgAKAAAAanvo14d/sxAvUnHb9pVlfr/Xl2PGjGkwYsSIlKysrJzIyMgmSigN4mj8nzNnzsiGDRtk&#x2B;/afpG3bdhIfHy9t2rSRu&#x2B;&#x2B;&#x2B;R9tyb&#x2B;vWrbJ69SeyePFiefHFF2TAgIEyefJkbS2AkBBW2&#x2B;d5zccnOjq61Zw5cx6YMmXK5ldfffWd&#x2B;fPnb927d&#x2B;8ZD4oAbxYJtBuEbqPRAPrwTxEAUAAAAEDol&#x2B;q5bZ/&#x2B;cyxGt48ePTpm&#x2B;PDhbVMVjRo1Svfz86v1of&#x2B;TTz6VFSuWy7hxY7Wgr3r55cUyf/4CbWi/WgR8/fXX8tlnn2nh/rbbbtfm8y9c&#x2B;IxERUUp4f8lSUvrWKZt&#x2B;1CDT&#x2B;p9fQMTExMzbrvttvRx48Z9c8899yx6/vnn94r5iAD9FoJGRYBzAaBfQFC/yr/RFACrU3HgfL2sRYA&#x2B;/FMEABQAAABCf5mCf3Xatq&#x2B;sod9dyPdkbr&#x2B;lbdu2IUr46NRZ0bBhww5K6A/haPyfo0cPy3//u1b&#x2B;/e&#x2B;X5LrrJmsr&#x2B;Z88&#x2B;bts2vSNdOrUSXtV/9ixY7J69Wot9L/77rvyr3/Nl9dff10CAgLPbfMHuHn&#x2B;syr//aXPnz&#x2B;/xc0337xm0aJFyx9//PEdcuG6AGY7BxiVAvqRAEZTAjzZRtDidL0sRYCPB9cpAgAKAAAAob/SQr9IxW3b5yr8u5vf723Yv2DbvqFDhyaNGDGif3R0dDNW7jdWUFAgjRsnKeH/Zfn222/llltuksWLX9RW8V&#x2B;06HltmP9jjz0mfn5W6dOnj3I895VHH/2HbNq08c/3WSoB3rHZbGHt2rUbMHfu3Oybbrpp89VXX/30p59&#x2B;elRcjwIw20LQuQhwHilgVgQ4h36KAIACAACAKhP63QV/V6HfXcCvyNDvqgBwFfxLHfZLLpWg73/99dc3HzRoUGaLFi26EPpd&#x2B;&#x2B;2332TixAnyzTcb5JlnntVe7X/44Ufkp5&#x2B;2ydNPz9fef/TRx9TApt2/uLhY3njjTVm8&#x2B;CUZOXI04R9l4u/vH6ouFLhs2bKm33333Wfz5s1bsWTJkv3iehSAj7jfLcBoSoD&#x2B;0pMiwCz4mxUBoisBhCIAoAAAABD6KyP0i1SvbfvcTQE4dz0oKMg6fvz4hpMmTerTsGHDNpGRkU1Zwd9z27ZtVYJ9kbzyyr9l7twHJT6&#x2B;oUyefL3ceuut8vvvuefCv0od6j9mzGh&#x2B;aChXalHXpUuXUS&#x2B;99FLOnXfeue6xxx57T7m&#x2B;x6QI8Ga3AE92DRBdiNeHf4cXRYD&#x2B;udhBEQBQAAAACP3ehn6zEF/Rod/VHH9XBUCFb9sXFRXlP3DgwAZTpkzplZiY2EZ5v6nFYvHniPROTEyM3HPPvfLuu8skObmNTJt2o3TunHEu9NetW5cfEi6aoKCgqA4dOvy/Z555ptu4cePefP31179&#x2B;7rnndhsUAZ5sH&#x2B;huSoAnawU4PCgC7LrnTIoAgAIAAEDwL3PoN7u/pwv3iVSNbfvKtH3fhAkT4keNGtVRka2E/hbKr8HC0Vh6FotFJkyYKOPHX66u1M4PBFWCzWYL79u379XZ2dlDJ06cuPKvf/3rsnXr1p2QC6cD2MWzMsCTKQGlLQKcdxCQMhQBDhefSxEACgAAAAj9pqFfpPK27fNkUT&#x2B;vLjMzM8PvuOOObsnJySkJCQmpVqs1gKOxnE&#x2B;6CP&#x2B;oggIDAyOzsrIuW7VqVZ&#x2B;33377xcWLF29esWLFEXE9HcBo20D9egH64G80ZcBo0UCzIkC/XoC7vwlGRYDoCgGhCAAFAAAA1SP0uwr6bNtnfmkteb9Ro0YBd955Z2rv3r17xsbGJttstjocjUDtpE4NGDdu3PQhQ4YcXL169TtXXXXV8kOHDhXIhaMAzLYK1C8SqJ8SYDQKQH8/T4oAs2kCF7UIsNvtFAGgAAAAoAaFfpEauG1fZmZmnfHjx7caMGBA33r16jULDAysy2J&#x2B;AEqey9TFApXnh&#x2B;u2bt3ab/HixS/cfffdm06cOFHoVASYhX&#x2B;j3QL0UwRcrRNQnkWAw&#x2B;RvQrkVARaLxYfRAKAAAACgaod&#x2B;o/B&#x2B;sUK/qwLAk2H9pR7mn5iYGHDjjTe2ycnJyWjWrFlGUFBQXZOfHQBoz9URERGJU6dOnXXZZZdtV2waMWLEG/v37z9jUgTotxB0vm4pYxGgD/vOt7vbQUA/&#x2B;qBciwCmBYACAACAign97oJ/ddi2z5v5/e5e4Tfdrk&#x2B;ctu276aabmo0aNapHYmJiSp06dRI5GgF4w2Kx&#x2B;NarV6&#x2B;V&#x2B;rZ58&#x2B;b2//nPf9647777vjl48GCBU6g320LQR1wvEujJQoFGiwT6UAQAFAAAgNoX&#x2B;s1CfEWH/ou1bZ&#x2B;3i/tZoqKi/LKzs6NuvfXW3i1atEiNjIxspvwqrByRAMpKLQFuuOGG2UOHDv3mq6&#x2B;&#x2B;&#x2B;u&#x2B;111774ZEjRwrFeBSAq90C9NMEyrMI0JcClVIEsD4AKAAAAAT/ign9Rvd39fGybNvnycJ&#x2B;nm7bZxb6vR7iHxER4T948OAGw4YNa5eRkdFdPUm3WCyEfgAVIi4uLlV9U2Q89NBDL77yyit7/lwjwGgUgKsiwNMpAUaLBjpMigBrVSgC1PUBKAJAAQAAIPRXXOjXh3qj0O&#x2B;qCPDx4rYqsW3f6NGjY6644opOKSkpnZWT8Q4ciQAupoYNG3Z84oknUmbMmPH1a6&#x2B;9tuyhhx76QVcEmIV/bxYJtBuEbqPRAPrwb3X63EovApgaAAoAAEBtDP2ugn5N37bPVeh3Vwact23fP/7xjx5t27ZNSUxM7OTr6xvI0QigsigB1095Lupy2223dRk5cuTaq666av7atWtPFBcXW0yKALNtA52LAOcCQL9ugH6Vf6MpACXhv&#x2B;R5uLyKAH3493pqwMmTJykCQAEAACD0V1Lorxbb9ilhP/S6665r3a9fvx7x8fFtAwMDIzkaAVQ1SUlJXVeuXNlm586dXy5YsGDpE088sVMunA7gbttAs7UBjKYI2MWzbQTLqwjw8eC6S&#x2B;Hh4dp9T506RREACgAAAKHf5D61bts&#x2B;dTG/GTNmtOnZs2da69atuwUHB9fjaARQ1dlstnDlOavPo48&#x2B;mjV9&#x2B;vRNd99994svvfTSHnE9CsBsC0HnIsBoJIC&#x2B;CHAO/VW6CFCe07X7Hj16lCIAFAAAgBoR&#x2B;t0F/9q2bZ/&#x2B;cwxvf/jhhzuoob9p06ap4eHhCazgD6BaBgxf30B1asDChQvbTp069cOlS5euvf/&#x2B;&#x2B;38U16MA9NsGmu0WYFYE&#x2B;HhRBJgFf7MiQHQlgJRHERAZGand98SJExQBoAAAANS40G8W4is69JsFfU8KAG8W9SvVtn3jxo1rNH78&#x2B;B7KyXI75WSwaRl&#x2B;FwBQpfj7&#x2B;4ekp6cPS01NHTR48OBls2fPXrp8&#x2B;fJDJkWAu90C3E0JMCoCHLrPsejCvadFgP5vlaM8i4A6depo9y0sLKQIAAUAAKDKBf/K3LZPfx&#x2B;Lh6G/NNv2lXZRP5eXQUFBvkOGDGlwxRVXpKelpXVTQn8ztu0DUJNZrVa/9PT04W&#x2B;&#x2B;&#x2B;WbW2rVrl7388stfOU0NMFsw0NUWgha5cLSAq&#x2B;0Djd53VwTYdX9TKrwI8Pf31&#x2B;576NAhigBQAAAAalToF/Fs4T6Rit&#x2B;2rzTz&#x2B;726VE5&#x2B;rd26daszc&#x2B;bMHq1bt26v7qFN6AdQ2wQHB9fv27fv1T169Bg1bty4/0yYMOG9/fv3n5ELpwN4UwQYTQnQjx4wWyvAVRHgvJWglKEIcLj4XEP169fXHiM/P58iABQAAICLFvpdBX227TMZ1u/8fmpqauiUKVPa5&#x2B;TkdIuNjW1rs9nCOBoB1Hb&#x2B;/v6hahGwZcuWfsuXL39z8eLFm957771D4no6gLvdApyLAItB&#x2B;He1VoBZEaBfL8Dd30ujIkB0hYB4WgQEBQVp9z9y5AhFACgAAAC1LvS7exPxfgE/KUPYN7q0tm/fPmTq1KnqYn7Z8fHx7dQTXZOfHQDUauHh4fGjR4&#x2B;&#x2B;eeDAgQfefffdVy&#x2B;77LKPxHg6gFn41xcB&#x2B;qBvNB1Afz9PigCzaQIXpQiIiopiagAoAAAA1TL0i9TQbfsefvjhLqmpqW1atmzZXQ39LOYHAJ4JCQmJGTNmzC29evUasGbNmlUzZ878ZPv27flORYA32wYarRXgan2A8ioCHCZ/M8utCFCnBhw8eJASABQAAEDoL3Podxf8a&#x2B;u2faaXNpvNMmPGjFbDhg3LSkpKSlO37eNoBIDSq1evXgvlObV5z549/9&#x2B;6detWjB079r0TJ04UelkEGC0S6G0RoA/7zre720FAP/qgXIuA6Oho7b4HDhygCAAFAAAQ&#x2B;ss19JuF&#x2B;KoQ&#x2B;itl276goCDrxIkTE0eMGJHeoUOHnNDQ0GiLxeLPEQkA5fcnrk6dOg0vueSSazZt2tRu&#x2B;fLlHz7wwAMb9u7de0aMpwD4yIXbBpotEujJjgFGuwX4VLUiICYmRrvvzp07KQJAAQAABP9yC/1G9y/ttn0WKfvCfpWybd&#x2B;UKVOSMjIykrKzs3tHRUU1V0I/fz8BoIL/5DVq1Kjzdddd13HIkCFbP/roo/evvPLK1cXFxWajAFztFqCfJuBpEWA3CPRGRYFPZRUBSUlJ2n337dtHEQAKAAAg9Jdb6BepvG379K/6V/i2ferliBEjYq655prMtm3bpjdo0KAdc/oBVHcOJSKu3btfbH5WOXG6UPvYwfx8uSSpkUQG2qrq30BrTExM8tixY1ulKpYsWfLh3//&#x2B;9x/y8/OLxHgUgKsiwNMpAUaFgFkRYK0KRUBcXJx2399&#x2B;&#x2B;40iABQAAEDor9QV/C2lCP3luW2f2X2tzu/bbDZrcnJyyKxZs7oq55idlZOptr6&#x2B;vkEcjQBqzt8WkXe2/yK7TuZKUVGxWC0WsStxMS4sRHo2jK3qfxctrVq16nXHHXd0Hz9&#x2B;/FevvvrqUuX6t3L&#x2B;dACz8O/NIoF2g9BtVATow3&#x2B;VKAJiY2O1&#x2B;x47dowiABQAAFADQ7&#x2B;roF/Z2/Z5MqS/LKG/3LbtmzhxYutBgwb1io&#x2B;PT/H39w/jaARQU2UrQX/bxh&#x2B;kbmCgFNvtWlr9fM9&#x2B;6RbfQKyWqj/QSZ2ClZiY2OX222/v0qNHjzdfeOGFjxctWrRHNzXAky0EnYsA5wJAv26AfpV/oykAVqfiwPl6WYsAffj3uAioW7eudt9ffvmFIgAUAABA6Pc49ItU3W37Sr2Sf7t27UJuvvnm1DZt2jRPTk7uERQUFMnRCKA2SI2JkpjgIDlecFYCfK3i43DI9qMnZPWe3yQnMa5a/Vu6dOkyIi0trd&#x2B;dd9655fHHH39l3rx5P8mF0wHM1gwwKgX0IwHMpgK420bQ4nS9LEWAjwfXXUpMTGRqACgAAKAGhH53wb&#x2B;02/aVZ&#x2B;ivUtv2qZfKCWK6csKY0rp16&#x2B;6EfgC1UWxIkPRukiDPb94qAdYA7WMFxXZZ&#x2B;tMv1a4AUPn7&#x2B;4c2bNiw08MPP9zhyiuv/Oiuu&#x2B;76z7vvvnuwWCHmowDMthB0LgKMRgLoiwDn0F&#x2B;li4CSqQF79uyhCKAAAADUsNCvD/PuQr9IxW/bZ/aqf0Vs23fuemhoqO&#x2B;kSZOajB49OrtZs2adw8LC4tR5pByRAGori/LnqLcS9D/fu18O5p0Wf6tFfC0&#x2B;si/vlOw&#x2B;mSeNwkPOS5bV5t9lsfi1bdu2/yuvvJL&#x2B;66&#x2B;/fvvggw&#x2B;&#x2B;/vzzz&#x2B;8R16MA9NsGmu0WYFYE&#x2B;HhRBJgFf7MiQK9cioCGDRtq992&#x2B;fTtFAAUAAKCKBP&#x2B;qsG1fec3xv&#x2B;jb9qmL&#x2B;Smhv3Hfvn2TMzMz&#x2B;yqhP8FqtfpzNALAH&#x2B;oGBkjvxAR5&#x2B;Yef/ggEyp&#x2B;qIuVpdMGGHyQuPFhOnikUh8MhoTZ/sVmtUuywS2xIsEQpn1c/OFCilbc6AVVz1wB1dFfz5s17zp8/v8OECRPeu&#x2B;22295ft27dcZMiwN1uAe6mBBgVAQ7d51h04d7TIkBMSgApjyKgWbNm2n23bdtGEUABAACoAaFfH/7NQrxIxW3b5&#x2B;38/jJt39e/f//IKVOmdElLS8uMiYlpbbFYCP0AYCI1JlJe&#x2B;9FHCouLlYDv0EYGfH/4mHy1/5D4&#x2B;1q1CFmkBH&#x2B;L8hTra/URq49F1DUCQ/1tEuBrkR6NYiUrPkYSwkOr5GgBm81Wp1u3buM&#x2B;&#x2B;OCD7K1bt351zz33LFu&#x2B;fPkhgyLALp5tIWiRC0cLuNs20GwbQbMiQF88OAz&#x2B;9jvKswho0aKFdt/i4mKKAAoAAEANDP0ilbdtnyeL&#x2B;nl1OXjw4PqTJk3KSElJ6VS3bt3GgYGBERyNAOBevaBAyUqIkX0nT0mdQJsW9kP9/STI108KiovF32KRvLNn5dTZIuXtrBw&#x2B;dUaOnj4jhUVFyu0OeXPLLlm&#x2B;Y68Mb9lEhrZIrLL/zvDw8IadO3du&#x2B;H//9385r7/&#x2B;&#x2B;rOLFi3a/Nlnnx2TC6cDeFMEuJsSUNoiwKr7HOfQX6FFgNVq1e77448/UgRQAAAAyjH0uwr6tXHbPm8W99PeevbsGTF27NjWffr0yYmJiWmlvsrD0QgAF9KCvNVq&#x2B;MdF3QFgSlqyFClh3s/qemmUwqJiyS0skp9P/i6Pf/WdNmLAX/mUQnux/Pv7bZIeV1/iQoKq9M9C&#x2B;VsRccUVV8y49NJLD61fv/79xx9//NOlS5ceEtfTAdztFmBUBOinEZgtGmhWBOgXDnR3PuGqCHC4KBEMtW7dWnuMkydPUgRQAAAAavm2fa7Cv7v5/WVayT82Njbgb3/7W6eMjIzUZs2aZaqrPnM0AsD5lFwueWeLZNeJk/LfXw/I3t/zJLleXemTGK/N3b/wj42PEv7d/1lTpwREKm&#x2B;nzgZKiL&#x2B;fnDhTIA7lz6Fd&#x2B;YK&#x2B;VouE&#x2B;vlVm59RcHBw/V69ek3o3r376KVLlz47atSolX/uGFDsYfjXFwH6KQFGowBcLRroqghweBjizYoA0RUC4mkREB4ert3/hx9&#x2B;oAigAAAAQn8pQr9ZoPck9LsL&#x2B;BUZ&#x2B;l0VAK6Cf5m37YuIiPCbMmVKs5EjR&#x2B;YkJia2U05GEjgaAcDct4ePysJvtshveXlitVi0ef1bjhyXD3f9Kpe3aSYpMVHaQn6eUtPpwbx8&#x2B;eHwMfl0z37ZdvS4&#x2B;CmPW2R3KLfZJSY4SCa2ayFhNr9q97Py9fUNHDZs2A0HDhzot379&#x2B;o&#x2B;uu&#x2B;66D/fv33/GqQjwZttAo7UCzIoAu5dFgKMyi4Dk5GTt/lu2bKEIoAAAAEK/F6Hfk0Kgpm7b524KwLnrNpvNMm3atKYDBw5MTUtL6xMcHBxtsVisHJEA4F7TiDAZndxUVu7aK98eOiY2q4&#x2B;E&#x2B;P0xp/&#x2B;pb36QhLAQbQvAPo0TtCkAZg7mn5bvDh39I/QfOSHF9mIt9FvV3QKUy3pBAdInMUEuaZqgjQioxn/rLVFRUc0HDRrU7Keffhq2ZMmSlyZMmPCZnL9AoCdFgNEigWZFgNHIAPGwADArAlxtHVguRUCrVq18WB&#x2B;AAgAACP3eh36zEF/Rod/VHH9XBUCFb9unXt5zzz3J3bp1a5Oent43KCgoSt3PmSMSALwTrIT97IQYyYirL5/88pus&#x2B;uVX2XHshLaSf7CfrxzIy5fnN2&#x2B;TD3bulQFJDaV34zgJ8PXVEuDvBYWy4cBh2bD/sGw&#x2B;eFTyCs9qc/3V0H9WCf0JYcHSMrKO8jnx0rxuuLa2QE06BQgJCYm58sorZ2RmZnb56quvvhg3btwnYj4dwEcu3DbQbJFATxYKdLVIoPPt7rYS1H/Nci0CStYH&#x2B;OabbygCKAAAoNYF//Jewd/Vxz0d8l&#x2B;ttu0bO3Zs7BVXXNE5JSUlo379&#x2B;q15pR8Ayoc6TL9vk3jp3jBWPv5ln3y8Z6/8dPR3bTSAn59FjuSfkec2bdG2/IsKCpSjpwtkz8lc2Zd7SkmBDgn09ZWzxXYt9LeLjpK29epKemx95eM1/mnap1mzZtnqW05OTv&#x2B;XX3759ZkzZ24sLi42GwXgarcA/TSB0hYBZrf7VFYRkJqaqt1348aNFAEUAABA6Pci9OtDvVHoF6kh2/ZZFT169Ii4&#x2B;uqrO/Ts2bNvZGRkYz8/vxCORgA4n93ukH15p2Tb0ZPaSvu/KcFcHbKvbt2nviqfVCdUCe5BEhloc/k4Nl&#x2B;LNky/T1K8vLN1l7y/81c5XXRW/K0W7e3HI8elyH5Mu64&#x2B;UafGRGmjCKJDAqWdEvrV8F8LQr&#x2B;hmJiYNjfffHPz3r17f7h69eqv/vnPf363a9eufDEeBVARRYDdINCX3G6tCkVAhw4dtPt&#x2B;8cUXFAEUAABQY0K/q6DPtn3ml9aS97OysuoMHz48SXkb0KBBg2R/f/8wjkYA0IV&#x2B;JdifOF0gH&#x2B;7eJ1/uOyiH8k9LXsFZJbAXn9umr9jukAA/q/haLFI3IECSIkKlU4P60loJ6&#x2B;q8fDPqMP6GdULF39dHzhT98WdES5dKbIuw2eSOrA7agoENw0PFR/mY1fLHfQqL7dpIAPV9S6n/hFZfVqvVPyUlZaDyNmDs2LE75s2bN//xxx/fnp&#x2B;fXyTnrxPgSRHgbm0AcVEIVOkioHPnztp99&#x2B;3bRxFAAQAAhH43oV&#x2B;kBm7bl5GREX7NNdekdOrUqX1SUlK6Oq&#x2B;foxEAjO3PzZcnN3wv&#x2B;/NOacPx1YCvigwOkvjQYMkrKJQCu11OKZfHzhRIkcMux8&#x2B;ckXW/5st/9x2U6KBA6d8kQdIa1NMW&#x2B;lMVKcH9V&#x2B;XxPt3zmzanf/eJXLFZrcrjFGvBPsBqka7xDWRoy8bSODz0vL9Oa/bul6/2H5Y9J/PETwn/EYEB2uKB6jSA2no6ERUV1eyBBx54eMKECWueffbZd55&#x2B;&#x2B;umdubm5Z02KALNtA50LAbMCwK4L3UZFQEn4t5d0FU7XK60IiIuL0&#x2B;67du1aigAKAACoVaHfKLxfrNDvqgDwZFh/qYf5KydHfrfffnu7fv36ZSUmJnZQV/DnaAQA106cKZR/fPWdbD96QgL9rBJm81eCukVGtkyS9g2ipH5QgBbY1RECaiD/6dgJ&#x2B;WzPftl98o&#x2B;t/vyVgK4&#x2B;xr&#x2B;/3y7v79wjg5smiq&#x2B;vRVb9/Kvs&#x2B;T1PCouK/0huyv8VOOzSpn5d6dignrSKipCmdcO1J/CCIrscPJWvfd3okCD5ZPd&#x2B;&#x2B;Vz5Gv7WP7aiL1Y&#x2B;96y9WFJj6p0bHVAbWSwW3xYtWvSYM2dO&#x2B;rRp03685557Fj3//PN75MLpABY3RYCrKQHF4npkgNk2ghan65VaBHTt2lW777p16ygCquJ5ssNRs38vPlVkuJLzz7moqEjOnj0reXl52vdnt9vVvUjP3Ue9tFqt2sfV29W3U6dOSWhoqPYx9XblCUi7LPn3qZclH1ff1PupiouLtcfWfw8qm80mhYWF2vfj7&#x2B;&#x2B;v3V7yGM73Vy/V29X7qW8lj1fyPf75hHjuuiowMFDy8/PPPZb6/ZV8zyXfd8nXcv4ZqN&#x2B;P&#x2B;rgl/66S&#x2B;5T8LKx/rjir/rvUj5V8vv53XfI56v1LvmbJ1y15c/75On9Pzo/lfB/UitDvLvhXh237vJnf7&#x2B;4VftPt&#x2B;pxD/9ixYxteeeWVvZOSklLDw8MbcjQCgOeWbt8ti7/bJoHqeZX8Mcw/Iy5apqa30YbuG8lXQv3WI8dk&#x2B;a69yuUJJZzb/9yiz66tEaAO2/ezWMXP6qOVB3FhwZId30BSYiKlWUT4uccpdtjlP1t2ytq9B&#x2B;Xo6TMS4uerLQrYt0mC2Hytsuv4SamjnC/uP5UvA5s2ktiQIH5hTufIyvl83ubNmz968sknP3jppZf2yIWjABxy/ggBh8F1h9PnOHSP4TC5FLlwRIDzx/TX9TsH6N8Xg9vFi&#x2B;surVmzxlFyXq5moPj4eDly5Ih2vp6bm3su3/Tt27fK/Y5rIkYAACD0V49t&#x2B;9xd93Quf1lX8rcof8At06ZNSxowYEC7jh079lJDPyv4A6jO1MCcW3hWgpQAfOjUae3V9oLiYmkeWUfK8hJAofIYh06d0RbV87NYDO8TFRigDfm3qy84/PmCxMaDh2XjgSPSMaae4V&#x2B;lICWct4qMkH15&#x2B;fLT0ZPaXH6LxUcbEaCe3Nv&#x2B;fMHEX3lqvrNrivLvCNMKAT21bNifd1rbASDIz0&#x2B;OnC6QX07mSfuYKBndKkky4xjIZXL&#x2B;oQVEdSHbtLS0If/617&#x2B;6zZw585s77rjj5XfeeeeAXDgKwPnVff22gUaLBOq3EjS6FKegX5EjAnw8uO5SVlYWUwMoAADgogf/qrRtn8XD0F&#x2B;abftcFQFlWsl/&#x2B;vTpzfr379&#x2B;udevW7Rs0aJCiDoXkaARQE/xeUChzv9ikDaXPKzyrvYoe7OsrD&#x2B;ZkSJSLxfWM5J89K78pwfyXE3my5tf9svf3PGlZt470ahwv7aMjL1hMLyOuvuw43lBe/n67hPj7aav9558tln9&#x2B;9a0k14uUNCWMRwcHaFvzFRY7tO/1o92/yvZjJ5XrZ8VXeTz1&#x2B;1W/rjpXv/jPEZlqQFU/rj6en0lH62&#x2B;1ys0d28qQZolaCaAuNqiWCBm1d66/1yWAKiAgIKJFixa9XnjhhTZff/31ytmzZy9ft27dcZMiwNvdAsqjCDAL/mZFgF65FAElUwN27NhBEUABAADVIvTrQ71ZiBfxfB5/ld22T70cMGBA1NSpU7NSUlLSo6OjW1utVhtHI4Capk6gTZIiwuXDXb9qi96pw&#x2B;lPFhZo8&#x2B;2jgmK8eqwN&#x2B;4/IKz/skL25eeKnPI46lP6L3w4pbwclM76B9GsSL63q1f3fE7lyn3FtmkndAJt8sf&#x2B;g7DyWq239d7bQLmv37pd1vx7QRg/4Kt&#x2B;XmprUgkId6q&#x2B;&#x2B;Yl9kd0hYoL&#x2B;0qBuuDdH/9tAxWblrzx&#x2B;pTHlcdd7&#x2B;6aIil9&#x2B;vOnIgKSJMe4PnnKeNllwPCQmJ7tGjx/ilS5fm/PzzzxsWLly4/LnnnttdrM5dPb8I8GS3AOeg78n2gaIL8frw7/CiCBCTEkDKowho2rSpdt8vv/ySIoACAADKHPpdBf2avm2fq9Dvrgw4t23f4MGD6w8aNKjpADX9R0U1sdlsdTgaAdRkauDvEhctH&#x2B;7a&#x2B;&#x2B;eaRcpJso9VPt97QFv53mz4vpHMhBhJrBOmDeN/b/seOZCXL4H&#x2B;VuXxLPL5nt/kv0qgz0mMk/5JCdJYuZ/Pn19/ULNGcknThrL16En58fBR2XE8Vw7nn9Ze2Vfvc1YJ&#x2B;&#x2B;ocfb9wqzRXPi8iKECbz98oPETqBNi0YuD5zVv/lwTVIepWq8QEV/95&#x2B;&#x2B;oaUeqbErCr0jmK2Txxn7CwsLiUlJS4efPm5fTv3//fTz311NqPP/74qFy4EKCnWwha5MLRAmaXdnG9jaBZEaAvHhwG50uO8iwCOnXqpN33ww8/pAi4mMcuiwBeHCwCyCKAqLWh392biHcL&#x2B;HnyCr&#x2B;3r/xbmzRpEjhjxoz2PXr06NK4ceNOyvMDLwUBqFXyzxbJLav&#x2B;K0fzz0igr3KOo5wSqK/E39o5RVuUrzQO5J2WT3bvk&#x2B;U792hD9wOUAK8&#x2B;6aoL86kr7GclNJBLWzaRekqYtxj8&#x2B;VMX&#x2B;1NX8Vdf&#x2B;3f8eZ6irlNQMse/xL7cUzLvi83azgDq966OEFC/xvVpraVP44Rq/7vZsWOHKCFaevboIWlpaRIXH19lzu&#x2B;dz5edL&#x2B;1OUzGUc/6DGzduXPH4449/umzZsgNuwr9&#x2B;YUD9ooDFcuGigPoFAY2Cv6siwGzhQBHjxQGNCgKjBQK9DZpVJpjW5IxMAUABQAFAAUDodx/6RWrgtn3NmjULGj16dONx48b1b9CgQcvw8PA4k58dANQKL367Td756WdteL3qpBLaO0RHyt&#x2B;6dyrT4&#x2B;4&#x2B;mStr9x6QlT/vleNnCiRIOedR//TlK&#x2B;dVdZXzscz4GBnWsrFEBnq&#x2B;3oC6UKG6cKG63d8HO/do19WRCqcKiyQyKECuT02WtAZR1Tv4b9&#x2B;urWnQokUL&#x2B;fnnn&#x2B;WbDRvkwP790rpNG&#x2B;malSX&#x2B;f/6eKvv83vlc0&#x2B;jjJeeUyrnx4WXLli1&#x2B;6KGH1m/dujXPiyLAaLcAV0WAWSEgpSwCHCbB3lURUKodA6pKEcAuAABQNUO/u&#x2B;Bf27bt8yj0Dxs2rOH48eP7JCQktFFCf4IPDRcAaC5Jaihf7DskJwoKtFfkIwL8ZfOho/Lujt3agnl5BYXanH51qzwl2mlPrPGhIdrHIgJsptv2NQoP1d7U6QQf/bJPWxzwVEGRBPv7yemiYln&#x2B;815Z/9shbRrCZclNtVf53fn&#x2B;8HGZv&#x2B;FH5fKItlChj/I/dVX/3onxcmmrxhJTA7bsy8vNleUrVkiXzEwJDwuTevXra8XJsqVLpWXLltKgQYOqdm5zXnDUv7gUFBRUb&#x2B;TIkTf26dNn6GefffbuvHnz1m3YsOGkQRGgnypgtkigfkqA0XQAV4sGmpUAZgsHmp2XGU0NcA7zHk8L0D0GUwMq4jhlBMDFb5EYAcAIAEJ/hYZ&#x2B;sxBfFUJ/pWzbp/y3brn11ltbDBw4MD05OTlLDf0cjQBg7OUftsvSbT&#x2B;L75/nEOrZTcHZIi2o23wt2pZ9hUXK&#x2B;YFFnZPvr73qrq6ynxgRIolhodKtUaw0DHM9V33L0eOyfOde&#x2B;Xr/YW0LQptVeUz7H1sRZsRGy6TU1hIdHOjyMc4o52Tqln3fKI&#x2B;x8eBRSQgNkq4JDSQ1Jqpan7ds3bpVu1Rf9T9y&#x2B;LB8vWGDfPD&#x2B;&#x2B;zJw0CDtFX/1nLRRYqIW/q3Wyt2B1uiVfk&#x2B;ul5wz5&#x2B;bm/rZ48eKFd99994bTp08XmRQBzq/4G736r58iYDQSwGxkgLsiwGh0QK0YEcAUAAoACgAKAM6ILn7wr8xt&#x2B;/T3qZbb9o0aNarB1KlTezZr1ixFXcFf&#x2B;TVYORoBwLUdx0/KI&#x2B;s2ye&#x2B;FRRLsZ9UCvnp2oG6xl1tQKGfVxfWUP2uFyrnI8TOF2nx77TxHeeZVw3zdQJv2Sr&#x2B;67V/ziHCXX0vdHWDe&#x2B;s3a11D/UqpP3meUx20UFip3Z3eUUJtnQ9zV78HXi4UKq4Ljx4/LV199JT169NDOM0t8u3mzPL1ggbRKTtbOw04p58v9&#x2B;vWT1LS0KvdvcDf/3zn4G5UB2laNxcUFBw4c2LZq1aplt99&#x2B;&#x2B;xe5uf&#x2B;fve&#x2B;Ab6u&#x2B;9v9asmxZsuW9V2zHjreTOHuTQSBksAIptNCUhg7a8rp4r3S80tfX8foK5d/SFii0hUehUAqlYQQKCdl7OomTOHa8916SLVn/3zmWjKLoSvLIsPM7&#x2B;SiSr&#x2B;7Svb977/l&#x2B;zznf09kP1&#x2B;UASkTAgAsyYLhEgHWYL7j4W4kcGCsiwHo1zq0kACQBIAkASQBIG1&#x2B;gH7h22vaNpL5/2O8rVqwI//znP1&#x2B;4aNGiZREREWniutLJ0ShNmjRp3ptF&#x2B;AK1XT3ifYBr9UkPgOrtteJzr7mfYQhF/DuEz0L1/CUtbThU34RTDa3QqFUMxnv7zYgN1ONnS&#x2B;cgROvndntPHijCnqpaBwDvI9ZrxNM3L0aCQT8xjqnw26qrq5GQkDDkG7a3teH111/nGv&#x2B;pBQXoFH5xTU0Nqior2e&#x2B;8/Y47EBYWxv4qva5Vcxfhd/zsbj7ONBkYsDQ0NJzauXPnB1/84hc/Ej6xBa61ANx1DHCVHWAdBREw4ALsXxdEgNQAkCZNmrSJBfqB4af0X&#x2B;m2fe7q/VWOf2/YsCF22bJlaUuXLl2YmJhYqNFoAiDF/KRJkybtEtTQ0N2LPdV1MFsGUBgbyW34nI3q&#x2B;BOCXANvjUOkOkDcailNPzM8BAXREfj2R3sHnWsBcAP9/VDW3omuvj63BMDppjbsr66HWuUzVEjd3d&#x2B;PBQkxiNRrJ8yxLzl/Hr/8xS8wb9483HrbbQgJCYHa1xezZ8/GE48/jt7eXmROmYKkhATk5ORgUnIyQgX4Hye&#x2B;z0Vg0TF4NRxgSVl6UVFRebfffnvetGnT5u7cuXPbz3/&#x2B;8/1VVVVGuNYCcNc20JVegKfWga7aBip976ru3&#x2B;q0nI8CyB&#x2B;tRoDUBxjtmJUZAFfooSMzAGQGgAT98BLoT7S2fZ5E/UbUtm/OnDmGL3zhC9MWLFgwJykpqVBco4FyNEqTJk3apUbCeHsEyKZ2fNQur7mnF2bxvDcI3&#x2B;bG1ESsSE1AlC5g2OulNnulbR3YXlGDfdWNMA1YYKX2e&#x2B;Kl1/jiptQkbMiZrOgX7qtpxPPHilHb1W1r3Wdl4cElyXF4cFoWiw6OV9u6dSv7TmGhodzCb//&#x2B;/Zg/fz77smfOnCExPPZtW1pakJaWhlWrVqGishJq4b8VFRXhQlkZvvTQQ9Drr&#x2B;0MCGfg764EwHF&#x2B;&#x2B;/eOGQCuSgQE&#x2B;D/8z3/&#x2B;843HHnvsiFNGwICXr5FmBCiVBThmBLjKDnD1NzAOMwJkCYAkACQBIAkA6UGNL9APTMC2fYmJif5f&#x2B;9rXcm&#x2B;99dblsbGx2cIxipKjUZo0adLcG6Xv761uwN&#x2B;KS1HW2s4gUysAN03vMPUjNlCHdRmTMCMuCjEehPdomYr2ThyobcLHFbWo7&#x2B;5BL/lRJAxoGYBG5YOVk5OwdvIkxAW5r8DqMfejjjISKutxoK4R4cIvW5ORjLyocMVuAuPFjh8/jkMHDqCltZXb982aORP3ffazg8SJ8PWam5rY5yIdgCmZmeyv7di&#x2B;nf3jwMBApGdkcJaAagx0Derq6nD&#x2B;/HmEhoYiPDwcBoOB/dTL4ed7m&#x2B;7vDPpdEQAOJIH17Nmz/3rjjTc&#x2B;&#x2B;P3vf18s8EO/F0TAcEUCLS6A/nVNBEgCQBIAkgCQBIAE/RO3bZ8nYb&#x2B;r2rYvLS0t4JZbbon73Oc&#x2B;tzI1NXWauA/EQ6b3S5MmTdqwzWS24FhDC/5SdBZVnV18K6XIez9F7W3ifbdPScXchGhu6eeIKkpbO3CovhHH61twprkNPcKPo1R/Ev0L9NNwyQCJ/uVEhmJScNCw942E/3x9qMPA1bm9m0wmFJ8&#x2B;jYioKMTFxnr0e8gfPHHiBEoFsI4SyyQmJTG4Jl/V2To7O7Ft2zZUlJfj/s9&#x2B;lgE&#x2B;GS37t7/9DXeuXw/xfLssv4u28etf/xq5ubmcdaDRaNg/jYuL432mTgNj5ee7ivQ7An&#x2B;7T&#x2B;kq6u&#x2B;8vH1&#x2B;x2nC97VUVlbuf&#x2B;KJJ1585ZVXKuhvBSLAWTPACuXsAFdZAq46BLjrHuD8eTREgDefrwgRIAkASQBIAkASABL0X37Q7wziLyfodwTl7kD/VWnbR5&#x2B;/8Y1vpK9du7YwPz9/YWhoaIp03aVJkybNO2szmliwj6L8roxa7R1vaMbWC9U4VNfI0Xaan1LwKZpPAH5tejKLATb3GHFKAP6ixmZuA0iRfjGbmF&#x2B;FpGADpkWHc8p&#x2B;giFwXDOzlIr/8ssvc6S&#x2B;cMYM9nvIVyXfzDkKT9Ofe/ZZtLa1Ye68eewb9gqfr72jAxox/5w5c7hNn6Pt2bMHv37ySXx240bcuHLlkC/n6CeO1mg/KPNg&#x2B;vTpQ9Oqq6rw/PPP45F//3f2ZRubmnC2uBj/eOstJh2ysrKwePHiUW1fqeWfMwHgKhPAGfi7yhJwnl/4yj1nz5796Iknnnhz69at9Q4ZAZ46B3giAtyVCFgvAxHgTetAQDlj4LKSAJIAkASAJAAkASCB/9iCfuDytO3z5u9rtm3fQw89lHrPPfcsSEhISEtMTJwu2/ZJkyZNmndGavx1XT04UNuIIwLUU93/3TnpKIyJUCQCTMKX2C/mf6&#x2B;kAmVtHVx/TzdjquEnMoA&#x2B;d/WbITwJRAXqofNVs/r/9NgIFESFIzcqbFym6tfX16OxsZEBMEXFXZEBL7zwAv/&#x2B;4OBgRERGwiB80KnTpg1F&#x2B;Cldv7SsDJ&#x2B;&#x2B;9160tbejtLSUo/yGwEBohQ&#x2B;4cNEiru0n5X8C5ZRdQOvd8KlPscjf5bDamhr84dlneX/nzp2LgqlT2X&#x2B;jTAX6zbT9yooKLjtYs3YtZs2ahS88&#x2B;CA&#x2B;v2kTfx4LP18pkq9EFLjTAnCe33le4TN3iPN45rnnnnv5t7/9bTHcZwEotRC0DpMIcAb9StM8Af/hEgFXPBtAEgCSAJAEgCQAJOi/MqDfGfwrgXhg7Nv2eZPqP6Zt&#x2B;8T4VM&#x2B;fPz/kBz/4wbKsrKxpMTEx&#x2B;WLsStAvTZo0acMwAvLPHz2DLecrMOBjhV74ExSl7xK&#x2B;Vp4A6bdmpDBYD9RoXC5/pqUNP9h2gNPvfWwkgNFsgcHfD3dkpXLUf0p4KDRqH4RrtdzqbzzbkSNH8Pprr8EgwP2ixYs5Yu9oBw4cwCsvv4wf/&#x2B;QnaGxoQFNTEw6KaVS3n5GZiWXLlnF9/uniYm7ZVyFANflwkVFRWDh/Pl4T6z537hy&#x2B;&#x2B;93vclZAh3iJ5xv0Oh38LkM7PxIVrBT7sWTJEt6PXTt2sKAgERP33HMPkxjk31EpAhntz4ULF1iYsEPMQ2UJKSmjS7RzRwB4SvNXIgWUSgScCQWTydROGQHPP//8&#x2B;6&#x2B;88ko53GcBeCsSaMHwRAKVtAIcQb277ADg8pUFWEdzTiUBIAkASQBIAkCCftm2zxPod/xe5Wq&#x2B;1atXR27YsCF38eLFN0RHR2dqNBqp4C9NmjRpo/CxCOzvrqzHP0vKUdvZLZ7/KmiFD9ArpoPa&#x2B;hmCsKkgC2lhQWjpNbGYX1OvkTsDUCu&#x2B;LlO/QAlWBv6kCTAzNhJ3ZaUhMyJ0Qh6zHuFXHj12DB9//DEdQKxfv57T9qlGnnzU9997D8EC5JOAXqfwV81i2rTp01FTXc3R/n/7&#x2B;tc/8WvFdwT0iQg4cvgwi/4tX74cCxYuHPLbLsc5t7swtI&#x2B;vvfoq729ERAT7gKdOnuQshwe/8IWLwD35sYcOHUJIcDCPAcpS8PPzG7N9clUGoBTRHy4BYP9OiRgwGo1t4tjvfumll97905/&#x2B;dF6BCBhOt4Dhdg2AF0TAcPQBxjIbwDqS8ykJAEkASAJAEgDXM&#x2B;h3B/Svdts&#x2B;b1L6RwP6lcA&#x2B;4H1NPyv4P/bYY7Nmz549ffLkyfPENRUEadKkSZM2ptYswP3&#x2B;mjp8UFaDkpY2BPlpmACgLAECfKkhBrQI4E&#x2B;if23GPhgtZjGPH/zVKqh9VCgUwH9aTDgWJMZCo1JN&#x2B;OPVL/wuAsQ7du5kX4&#x2B;Ae3Z2Nvs97e3tHCmniDmBaQL&#x2B;FDFfvWbNJSnzbW1taG1pQVh4OJMIrkoLRgusHbUI3n3nHfiK7RQUFLA/fZh&#x2B;w44dWHfrrSxiSP5qeno6/LXaK&#x2B;rrO/qbSrX/7kC&#x2B;0ryuOgQolRIIX7pNHIu/vvjii3s&#x2B;&#x2B;uijhmESAd5oAygJAyplAoykY8BwsgEuCwkgCQBJAEgCQBIAEvRfv237RqzkHxcX5/&#x2B;jH/1o9vz582cmJibmC4co0ke2lJAmTZq0EdmF9i4cq29CQXQ44oP0bgG6WTzP/3TsDD6uqBl8xtu8fxLyC9P6ITXUIEC/GtGBOiQZghDk54tEQyDCA7Tj9vjU1NSwn5aUlOR2PvI/yQe0&#x2B;3dk5LNRBP/DDz&#x2B;ErzgukyZNYlDfIIB/S3MzK/zPnDkTmVlZnFJ/JW3f3r2ora1l8UA7sbB582aO&#x2B;ovnK7rF7&#x2B;kTv/v2229n0H81/XxXAN5dBoAS8FciC5SIA1daAuI8Nx4/fvydv/71rzvffPPNarjWBfCWCLC4IQDclQd40gfwJBroTAYogf8xJwEmMkb2lY8TadImLPl1Lbftu9qgH7hMbftycnL0GzZsSL3zzjtXxMfHZwUFBSXI0ShNmjRpI7emHiN2VdXhjTNl/DlEAHhS3c8OD8X8pBhEagNg0F5c31/f1fvJQ4ZIf&#x2B;HMUxtAull/bWYe8qLCJ9QxahYg/bEf/hDTCwuxadOmS5T7yU6dOsVRclLsp5p8iuynZ2SwGGBCQgKio6MRHxeHN954g9P9qaafhP9ixHRKr7/cRqn8RE4kxMezkKDdcnJzsXXrVuzevRuzZ89mLYLyykqsWLEC93760xcFu66iz3URYHQMZLmax1XQyTlA5kgCOH7vPF1pP/R6feScOXPuz8vLu3nx4sUv/OY3v9l3/vz5bhuY94Fy5wCVi88&#x2B;Du&#x2B;O06xu3h3nAVyXAagUAL4nAO9qm8MC&#x2B;NezSQJAmjQJ&#x2B;q8U6Acuf9s&#x2B;JQJgJG37PJUADH2OiIjQbNy4MfXWW2&#x2B;dk5OTMz84ODhRjkZp0qRJGxujuv59NfXcos/PV8VR/HMt7Tjb3IZ3Sys4aj87Lopb&#x2B;XX396OktQPFza3oNPVzCUB3vxk68V1GeDDWTJ6E3MiJBf77TCa88Oc/I2PKFGzYsMEl&#x2B;CdQeLKoiIXvnnj8cRYAJEV8UvKn9n&#x2B;UgUnEQGJSEj73wAOjVsX3xuyZnPb927ljB9555x1u40dAn7INKAOWNAVIwI/mz8rO5gwEyqQlHQNS9A8LC7vq58A5WuwM1J0JAk/LO2YIeFrW0/p1Ol3U2rVrv7VkyZILe/bsefu5557bdejQoTZcmgXgDP7t4Nri4PtYHAC3I/gecALgju/0nRqXZgY4LufsRzou7&#x2B;P0WYkEcF4WHtZ9/eIFWQJw5W8MsgRAlgBcI8B/NGJ&#x2B;Vwr0X7Nt&#x2B;0jB/6677or7yle&#x2B;siwtLS0/KipqimzbJ02aNGljbyTKZxHP5zMC8Bc3teJQfRNKxGd61pNCP33XZyafgPXs4OujQkiAH6L1OvgJPyA9zIDC2Cikhxom3LEh//C3Tz3FQPjbjzwCjfClusQ0LaX4i&#x2B;/Jt9Lr9XysCER/9NFHCNBq0d7Whl6TCfV1dRxtTxbAf9vHH&#x2B;Phhx9GcnLyFdn3j7ZuxdkzZzAlIwOnTp/m33DTypUIj4jAvz74AAaDgTsQNIoXpfpTvb9a/I79Bw7wdNIvWLp8OSZdof311t93VwZgn&#x2B;7od7pK7Xf87Crt3/63Ky0AJZFA&#x2B;/xGo7Fh3759bzz00EObhd9tUSACxlonwJVewEh1AgD3WgCewK3V23MpCQBJAEgCQBIA1zvoV5rfW&#x2B;E&#x2B;4Npo2zdi0C&#x2B;uQc3ChQtDP//5z8&#x2B;YPXv2YgL9YtxqIU2aNGnSrpj1CF&#x2B;kqKEZ75ZW4lh9M3zFM9&#x2B;ffAzb9yTw9&#x2B;j8aciOCOXvVBNYeoXq9P/0/PPoEOCeAHRubi77X1SzTwJ4FNUnHy5Q&#x2B;JA3rljBwnlUT0/ifjrhqxHIpvIIIgZ279qFf//Od5A5ZcoV2fcasR/HjhxhjYEysT8FU6dyWr/WJtxHvl5DQwOLEcbHx7MfTL4zlS6QCxQbG3tNnQtX7f1cAXfH790p/nsSCLRjAuf1uCMFHOdramo6WVxcvPv73//&#x2B;ezU1Nb1eEAHOGgJWD6SA47vF/tPhWTTQU9cAZzLgspAAkgCQBIAkACQBIEH/8EA/cPXa9nkj6jes99tuuy3qvvvuK5w1a9aimJiYbDG&#x2B;NNIFlyZN2ng2y4AV&#x2B;2vq0dRrwsLEGIRo/cfdbyBl/60XarCtvBrnWzug9R30Ebr6zcgKD8GPFs&#x2B;Cr2rign&#x2B;7P0k&#x2B;FwFl8o0iIyPZnyL/hVrznT93Dlu2bEFTYyO&#x2B;/5//eVG6PC2/f98&#x2B;tLS0QC2WodZ4c&#x2B;fNc7vNohMnUFRUhCVLliDGAwAncoK2Tan6tO7Q8HBuu5eYmOjST37&#x2B;&#x2B;edZiPAzn/kMJk&#x2B;ezNNLSkp4m1MyM5GVlXVNnw8lAsC5G4AS8HdHCLgC9I7zuRIKdCYInNdD48V2nkq2bdv2xk9&#x2B;8pMdnZ2d/V6C/5FkBThnB4ykjeBYkQDXNQEgNQCkSbv2SSzZtu8qtO0jMb8f//jHi7Kzs3NTU1NnC4dKJ0ejNGnSxruRmN6RuiZUd3Sxqn6XAJAfXqjG7LhIrJuSCp3v5a1kYk9/wAqTACR&#x2B;4vHWY2vDN5IHHan435SWiMVJsfi3D3aho68farFOUvQ/0dCCPdV1WJgYO2HPJQHs3/32t1wXv2D&#x2B;fI6Ikx7AyTNncPr0aRSLFx3v/Px8zJwx45JaeQqSzJo9e1gCekEGA9IEONfp9ZRKjurqap4eERHBRIS9qwCRC/94802cO3cODz74IEfxqTRBAE3OSsgvKOA6f0cXxyrGRFlpKfbu2cNEAX1HRICdDBgH/ppXoHEsgKXSttxpBjhOd5zPYDBMXr169TcoyHHw4MHtv/zlL3c3NDQYncC&#x2B;szaAJ9FARz/PVb2/1Wm9djFAFZR1AezkgJLwn5IYoZKPfN1qAcgMgCtkMgNAZgBMMNAPXD4Ff3fg31N9/6iU/KOjo/3/4z/&#x2B;I3/VqlU3JCQk5Ol0uggJF6RJkzaR7B9nL7BwHqnp0zOPxPEIjPf0m5ESHIS7stMwNSoCQf5jn&#x2B;jU0mvCkweOs1hfY3cv9H4aNApf4UuFOSiIGt3t9pkjp7CltBIBYt10QydiY2N&#x2B;JtZmTLomz0NjQwN2C6C7ePFihAxDYZ/8wT1iuVkzZ7KQX319PafuHz9&#x2B;HJPT07kMgKL9cfHx3LYvQ0zTBwYOe//6hb/3&#x2B;muvITYujvfRlT35q1/xGAoU6zcIH9UkfLiExERuIZiSksJZCa&#x2B;&#x2B;&#x2B;iruueceTts/ceIEDuzfj5ycHPhpNLz/y5Yvx759&#x2B;1BXW4vS8&#x2B;cREhaGRYsWMQEwHs1Vqz8lLQB3kX/Hac7fucsS8JRB4C47gHxr8T7Q0tJS9Oabb77y5JNPHoXnkgClLAClEoGRtBL01DYQXrwr8ZGXlaiRBIAkACQBIAmAKwH6lQC9N6DfE8C/nKDfHQHgTVr/iNP8ExMT/R988MGMlStXzsnNzV2s1WpDxalQSZggTZq08W6kmq&#x2B;xPYd9HZThu/rMqOjoxB&#x2B;PFaOkpQN&#x2B;ah8WyzNZBmC0mJEeGsKR9UVJsRxlHysjkuEnuw7jSH0T9AIAUu25RTxnA/01eGTuNORFho14vd/&#x2B;cC9ajEb4ikcpaQD4&#x2B;arxzM2LEKC5NpNd6wRwf&#x2B;GPf2S/Z/bcuQzo3bXaI79RQ8dMHK933n6bAT&#x2B;lxFNNf2V5OWrF&#x2B;qj9H/lrJPpHPuNojLZXIgD5X19&#x2B;mVX3aVsLFi5ksG&#x2B;3J554Anl5eZxdQIQBqfhTq768/HwWIVy9Zg16e3s5C4DaFLa1tiJ50iSkp6fjvffew769e/HDxx7jbdH&#x2B;Uu0//cbxbM61/kp1/e7AvmMHASVw7wjclUoDXAkCOvrq9hIAmua8PfGdpaqq6qM9wh5//PH9RqPR7AT4rwQZ4EkjAC7&#x2B;Hg4JIAkASQBIAkASAFeeAJBt&#x2B;9yCfuAytu379re/nTtz5swp06ZNWyKcmyQfnwmsEiVNmrTrxo4KcP1S0XkE&#x2B;anRY7agTzy34wx6fGv21EvmNYpn6a6KWhbTO9/SDo0AzSSmRwC6s68f2REhuC8/E&#x2B;lhwQgYo9KAll4jfnPwJI7UN3K0ngA7EQ8aXxWywkNxa0YKMsNDoPZQu0/kQUV7N7aWV&#x2B;NgXQMau41c708tAoMEiPz23ALkRV377f5OnTqF7du3MzgmgE3p&#x2B;iTM52iUPv/cc8/hxhtv5Mg5Cea99te/YuasWZg6bRos4hwTqI6Mihrz/SO/7MiRIzhx/Djq6uowW2yTlPfJv6L9Onz4MJcdtLa1sR9H0X/KQHjzzTfx0Fe&#x2B;wgTBECHV28vzU1s/IgSWLl3KooUT6fHrCtw7A3l3ZIDd73SO1ju&#x2B;exIHVAL/3mQEOL7sGQE1NTW7/va3v73&#x2B;5z//&#x2B;awD0B8OGTAa8cDRkACjygKQBIAkACQBIAmA8Qb6lUD85Qb97mr8vSUAvGnbN1xxP5UYC6qHHnoo5d57712Umpo6LSIiIl1CBWnSpE00q2jvxI93HkZjTy981Spui0eZAM/eshhxgXqXy1C6fFFjC14&#x2B;WYKylnZo/TRMBJDaPtdhhxhwV04ap&#x2B;mrx&#x2B;B5SOTCH46exoHqBiYhiFwQT2F09w/W8BMBkBURitggPaJ1OgRoVNCI39Jp7Od9PSv2saqji7MXKOpPZICf8CGCNL6ctbAqPVksFzCuzhuB4rcEaG7v7MSMGTM4Dd4ebSfg/T8/&#x2B;xk0whejlnd&#x2B;wn/LEcCZUvzV6ivXfZZIAOoWQJH6PLH9GbNmsXhgswD81Mbv&#x2B;LFjKK&#x2B;oQERYGO7asIHbCTrqCxABQH6ePdKvUk28ZDtnoT&#x2B;laL7jPErzuusQ4EoI0F0pgBIhYPepnffFeV3i1VdbW7vnnXfeeeuVV14529bW1mcD867AvhIhYIX7TAFvMgK8JQFGnQUgCQBJAEgCQBIAVwv4j7WCv7vpo2nb542wn7dt&#x2B;5RA/7BT/HU6na9wokK/9a1v3ZCbmzubQL8YE34SIkiTJm0i2&#x2B;tnSvFyUQmr4tMNkcTxPpUzGRuy3YupdZj68O75CuytaUBZawf8xfIazgiwcJQ&#x2B;NcSAO6ekYm5i9Khb6/WL5&#x2B;vJxhbWJDjT3Mbr55u3&#x2B;K&#x2B;P/AnxOLZYBxDsrxXzWvhvq/iu3WgS&#x2B;yX8BfMAdBo1InVaJBgCsSAxhjMIYgLHj14rKdy/9dZbDPanUo978bsoer7t44/Z7ws2GDiy3trSwv7JmrVrMWWULfo6he/5wZYtWHnTTVwq4MrI1zt69CiDdErlj4qORmho6EX7vfmf/yRmnae3i32sravjUgAqZ4iOipqQ4H64/r6riL8j0FZq&#x2B;edqnuF0CnBFBrjrBmCf5k4fwP4uxoaxtbX15B//&#x2B;Mc/vPbaa2W4NBPAW0LAqkAOjJQE8FQKIAkASQBIAkASAFeGAJBt&#x2B;65O2761a9dGbdiwIU84VUtjY2NzxHiQoF&#x2B;aNGnXjfX0mfGlLdu51Z/dIgRQ/uXyeV5F8Emsb291PTaXlKOms3swVV&#x2B;t4lp7spzIUCxNjsOS5PhR7ysRAWVtHShqbEWpeK/t6EEb&#x2B;SZiep/ZArN1gJF/gIayBKxICApknz1R&#x2B;EQz4iIxOdSAUK3/uEkjJz&#x2B;jUYB88pPIDzty&#x2B;DC2bd2K6JgYzJg5k2vtyXchhX0S9OsWvmJoWBgD7dGCahIM/N1TTyFErOtzDzxwSakBEwQdHfjd737H2yddgjbxN5lep0N8fDwCxXGn2v39Bw5gzZo1LBBIPplOJxvlOJpzvb634n&#x2B;uhAOHIwLoCuS7W05JJ8DTNIFjOktLS99/9dVX3928eXOlC6BvUXh3VzJgdfrsqSwAcC0KOJxSAEkASAJAEgCSABg9ASDb9g27bZ870O&#x2B;JDFDb/6a2fY8&#x2B;&#x2B;ujsgoKCvIyMjIUajUZ6I9KkSbs&#x2B;wYd4lv1k92GcbGjlWnq6SZoHrPjSjBwsGkZbvFZjH146eRanm1qZCPBX&#x2B;3KdvUk8g0knYE5cFFamJWF6zNg1TOnq62fwXym21y&#x2B;2Qy0CO0z9CNP6iWe6CkmGwEGRP/X4jTAfPXIE723ZglvXreN0fgL5BwSg3iuA9Xe&#x2B;8x2kpKaO&#x2B;TbJf/vV44&#x2B;jrb0d3/v&#x2B;9zkN35VRmv6LL77IYP&#x2B;WW25hX/Xs2bMM&#x2B;o8dPYqw8HCEi9eNK1dOuPr9sfL37f6kUnTfWahPaZ6RRPyHmx2gpDXgPN15HnvZgPDb24Sd&#x2B;t///d&#x2B;nduzY0egE&#x2B;N2RAt6ICDprBQCeuwQo/e0O7FslASAJAEkASAJg2ATABAT946JtX0hIiN9TTz21sLCwcFpCQkK&#x2B;Xq&#x2B;PlO6HNGnSpAH/PHcBr5wsGXp&#x2B;USQ9MSgQXyzMgVkA6BABqEkwj8iCYOEPEKAmxX&#x2B;qtXd&#x2B;ADUKUPh&#x2B;SRU&#x2B;Kq9Gm6kPfiofzgigkgGt2hfTYyOxPCUB06MjIPGgazt18iTX9CclJ7OvQVF2qqmnOn6K8FOqPbXuy8jIYB9qrI1a7b38l7/g1ltvhV74ky3NzYgQQN4s/CnyqSIiIjjLIDIykv/etm0b&#x2B;oVPVl1dze38CPSTSOGZ4mLU1NbioYcekifVg9/vCvArEQPetANUAvCOZILS&#x2B;lx9ZxP5U1zelaigq/XReoT/Xn/y5Mm3Nm/evP3999&#x2B;vdQL5FjcEgMULEsCCSzMBAO&#x2B;0AbwhASQBIAkASQBIAsA7AuAaAP2eAD4wAdv2TZo0SfulL30p65ZbblmckpJSqNPpwhWOnTRp0qRdt0bg/Fsf7kF3v5nr6unxRrX1OvGspSh7WIA/i/z1iu&#x2B;j9AHcJjDQT4NAjYbT6mcnRCM&#x2B;UD/URpCsXazzrbMXsK2iBu1GAf59B2/NlBFAGQYLk2KwODEOU6MjPKr4T1Rr7&#x2B;jAAQG258yZw&#x2B;nydnt782Z8&#x2B;OGHyM7OZl&#x2B;H0vsp5X/FihVXpF6e0v9pH0h9f0pmJro6O5lwsPuVHe3tOH36NEf2SYSQjMoAyN8if66qqorb&#x2B;e3ZtQsrbrwRN69aJaP/bszRJ3YF5JUIAHfTlNoAKs3jjQaAN6n/zkSCuxKB3t7e2rq6uh2//e1vX9&#x2B;3b1&#x2B;jG9A/HBLAnSaAN6UAkgCQBIAkACQBMHICQLbtG1HbPm8j/Je067O/i7Hv&#x2B;8gjj2QtXry4YNq0aUsDAwNjJOiXJk2aNPdGWQBPHz7NUXkC93RTNZoHoPfzRQepsYtnJIn5dfWZbc9UHyYCLOJZqPNVY0p4KDbkTkZ6aPBF2gG1XT3YV12HV06VwkQ&#x2B;jViWhPlSgoNYhX9NejLfoqs6uxEbOEguTBQj/42ORJ94p7p38osIKFN0n7579913GeinpqZyhD07JweNDQ04euwYGgQIf&#x2B;CBB3jeIIMBISEhl31/af/Ky8u5PZ&#x2B;rjgFECJw&#x2B;dQo7duxggcDbbruNsxIc/dfS0lL26ej3BgcHc7aANO9JAE9p/UrzuuoQ4KkFoFK2gLt2f0rz2P1tZ4LB3TrtBIHJZKretm3b03v37j0r3usUwL&#x2B;nLIGxEAcEPIsBSgJAEgCSAJAEwMUEgFjH9dS2z9NnFUYm6jfstn30WThKSffff//87OzsuaGhoZPEefWVLoU0adKkeet7AFtKKxHs78cp/pG6ALQaTfy3mZ6L4l93Xz9nBDT1mHCisRmnmloZ7BMJQOr/fio11men4fYpKZesv7y9E2&#x2B;XVCAuSM86AImGQFjEc/ODsirsranH3sp6zIyLxhcLs5EQpJ8Qx5Si5CTal5ufj4ULFqCjowO/&#x2B;tWvGMxTyjwB6oe&#x2B;8hUG&#x2B;UVFRaitqeHvSFE/Ny8PYWFhV9Q3JX2B5557jks91qxezYr&#x2B;tM/0O6imv6KigtP7F1IngqlTL1L7lzY6v19JANAZoHsiBJRAvjctA921&#x2B;nMF3l2RBErbsZcQKJEDNrHAxrKysrd/85vf/P3kyZNtCgTAaEsCHF8DTmDfnUCgJAAkASAJAEkAXEwATIC2fSovQf9I2vaNVNTP7bsY45q77rorfuPGjYsyMjKmC6cpSYr5SZMmTdqlRun8xU1tCPBVIT1sbCLJ9ASkFP/Xi0sZMJKRTkBKiAH/u2yOV&#x2B;v4zaEivFtSwS0IV09OxozYKGRFhsLXRioMtvobvwlctnrnIV&#x2B;H/IYLFy7gHAnl7d&#x2B;PUAH2165bh6SkJJ6HVPUrq6pQV1vLKfTLli/H5MmTvdpWe3s7/vjHP2K5WIYE97w18jE3b96MzMxM7ipAvhuJ&#x2B;L366qvIy8/nfaISBCIkFixYgLi4OHlBXSa/350YoCugr5QtMBztAE8p/57m9UQOeDOvoz4AudNiTLbv3bv38T//&#x2B;c97xPXS7YEI8NQlwFOHAHfigK4A/3VHAMhomjRpDqZSqcZL2z5P0X9va/xHI&#x2B;I3Jm371MLWrVsXdc8990ybP3/&#x2B;0sjIyMliklaORmnSpEm72IwCjJd3dOJQbRPONbfjXFsbTP0WFERH4O6cyUgLCRoRuCY3lzIB9tY0YHt57ZDjS2r7VOe/KDFmWCujtny0r6TeTxkHH5ZVib/NvN&#x2B;1Xd1Yn5WGG1MTx&#x2B;U5IHBtMpmG0vcJ3KSkpPBr6bJlTAa8&#x2B;MILWCY&#x2B;z5k7l6PtZWVlHPn/1D33wN/P&#x2B;660RDCkivW&#x2B;JoA7AXjSFchRIAIIdLW0tHB6PmUbpKen47k//AFTpkzhIE5JSQlPE89bjvI7BlukXT5zDGjZ/1YClo7zOoJ953UoLe8qi1Xpe8dtOO&#x2B;Tc0DMMUjmGEBzB5Ad5yMT4y147ty5/1lYWFhaXl7&#x2B;7o9&#x2B;9KPXGxsbjR5AuBUXB5osts8DHnxpq8PfVidf2ipHpcwAuOJMIJnMALi2MgBGCPrdAX3Ztk85rX/o75kzZxoeffTR&#x2B;QUFBdOTk5NnivPgJ2/J0qRJk6Zszb1GvHe&#x2B;An8vLuPIfLC/BmrxvOsVz2a9AH150eG4c0oKR&#x2B;y9se4&#x2B;M861tONf5VXcMrDZ2Mut/vosZgwIFyA7MgxfnJaNSSGB8PFSdqXfMoCy9k5sL6/Bh&#x2B;XVLDLYI3we6hqQKPyYJclxmBQciLkJMePyHJA/9oIA&#x2B;BRZX7Ro0UU&#x2B;E0X4SW2fsgHuuusujrCPhfX09mL7tm04deoUEwkLFy5EalraRX5Pr/C5fvbzn2P69Okc0T9z5gx279yJZStWID8/n/ePMg9UE0iP4Vo2pSi/I8B3VxrguJw3XQBGWvtv96md53H821XGgHPNv/P&#x2B;uprP8V3456QN8Ptf/OIXu80ELtyXBAxXGNBTFoBXZQCyBEASAJIAmGAEwAQE/Z5ewPAE/LyJ8A838q/Oy8sL/PznP5998803L4mPj8&#x2B;zKfhLkyZNmjRv/Qnx72xzO94vrcS&#x2B;mkYG1/6&#x2B;g89GFuNTqTEnPgq3Z6YhLkh3ycOpp9&#x2B;CYw2NONfcge1VtWjoFs9qMRdpAmi4E4AvpkZFsqJ/fnQ4CwWOxDaXlOO1U6UI1vohNzIUCxJjWUyQ2gxebSP/gFLya&#x2B;vqOCLf2dmJDuGTxUZHIyQ0lP2XmJgY9rtcCedVV1Wx0F&#x2B;HWC46Kop9NJPRiHMlJUhMSMBdGzYgNjZ2zPa3pqaGQT35SO&#x2B;//z6L9pGC/6yZM5E8aRL/HlLpf&#x2B;aZZ&#x2B;Ar9peIieaWFsyePdvrcgNpl8/vd5fe7y6135kccFcK4IkkcKcboATWHcG8KwLAeZ3OmgCugL/9xWKaPj79vb29By9cuLDlkUce&#x2B;acN6JvdgH8LvO8MYD8BrroDuAL8kgCQBIAkACYiATBGYn6XE/QDE7BtX2Jiov/DDz&#x2B;cJxySafn5&#x2B;TeIcRcCqeAvTZo0aV6AfeWbJX13vL4Z2yprcKS2CV3i&#x2B;elne0ZSRkCETovM8FDclZXGYn7NRhNONLRif3U9qju7WJl/wPY8NohnfHpYMBYmxmBWfDT0Gt9R7zc9dxt6ehGu1V4ToN/Z9u7Zgw8&#x2B;&#x2B;AB1dXW4YelStLe1cbo&#x2B;&#x2B;TkU3R&#x2B;w&#x2B;R9paWn8tysS4fz587wM/VYC3snJyQgNCxvzff3LSy9xCj8BemrBRz7k3r17UVVRAZVGA4v4u6qyEpFRUVh5001ISEiQF881RgA4g29vCADn74dLANj9ZbrG7e/DEf1z1&#x2B;7Pnc6AKz0AV9oBdo0Avmf19u4qLi5&#x2B;9Yc//OE2jI0mgDthwOueAJAaANImOgEk2/ZdvrZ9iu/Utu9nP/vZjFmzZuXm5OQs1Wq1weJUyLxDadKkSfNglgErGgVwPt/WgY8uVCPJEISVaQmI0esuebAURIfzq7qzG6&#x2B;cKhEAv4WzAKgcgFr77ayow3ExjeZtEus0CWeb2gGGBWhh7DcjOyoMBeK1OCmOp43Zs3fw&#x2B;XvJPl9LRvX5wSEh&#x2B;OD991kIj4A/Ofz/8/OfM&#x2B;AnRX9SyidVf4qiU129oxE5QDX1lxNAbtu2DYWFhbjn3ntx6uRJLjH48Y9/jJUrV3KUn4yCSbQvFKhx3kdpV9X/9Fgj74okcPe9K9FqT8SD4zJKoNadBoDz30rr86Rt4GqdjkFEX1/fpLi4OKqZ2Q7P7fzsPqfFjX/tqvbfRwnsX28mCQBpE29Q&#x2B;/pO5LZ93oD&#x2B;q9a27xvf&#x2B;Eb6&#x2B;vXr50&#x2B;ZMmVGaGhoqhyN0qRJk&#x2B;a9NfQY8fThkyz012nq5zZ&#x2B;B2sasKe6FoUxUbg3Nx06F9H5&#x2B;CA9vjm7QID9JvxizzH2bqmVX5C/Bp0CyFKEf9XkZPirVcgICxHT/RCp0yI2UA/VdZSPRSJ5W957D7esXg2DwcBAn0Dz7t27WWSvt7cXBVOn8nc&#x2B;ApTMnjMHUZGRQ5mPVxpAErj/6X//N&#x2B;YvXMj7QKUKjQ0NqCgvx8yZMxk4UXaotPFNCngC4I6AWek7OyB3zsh1ty1PYn/e7LOjMKDSd86khD36T9nC9KLrLS8v725cKvLnLoBlcUEEKIF&#x2B;KfwnCQBpEviPGeh3Nf9w2vY5zqPC6IX9rnjbPlLwv&#x2B;&#x2B;&#x2B;&#x2B;xLvvPPOaXPnzr1R3MTjxCR/ORqlSZMmbfgWqvXD1OgIVtA39nXCOGBBoADrrb19eKekHEfrm7AsJQErxCvIT8PZApSq3i5A/v6aBhyobRzydEmMr6vfjMlhwXioMEcA/&#x2B;AJfewIVBw8eBBdAiRnTJmC6OjoSyLiBJZ1ej1H&#x2B;UlIjwB2W3s7mpuaOMpPon2UZn&#x2B;5hfIcAZajlQtg/9Zbb2HVLbcgWIAiUvQvu3ABKWlpWLJ4MZcYrF69mjMXpIL/xAH89mmO48PdvJ6&#x2B;H8l&#x2B;OIN1V&#x2B;DdVScAd&#x2B;PbTkY4lgdQpgqBfroWqRSZiC0beWAH/vRuF95w18rPB5dG9uEE&#x2B;CUJIAkAaRPRxI3kem/b5xz1v&#x2B;xt&#x2B;&#x2B;j97rvvjlmzZk3W0qVLb4yKisqUoF&#x2B;aNGnSRm8kwrcmPRk3pyWirK0Tfzp2BsXNbVxDT6n7jd29&#x2B;PPxM9h6oRqz46JwtqUNJvMAKjq70NBthK&#x2B;4S2spWi1c3eSQICwKC8GnctMQpr0&#x2B;OqtGREbi7JkzKCoqYpBBf1N7PmqlpxHAo12AfSIGqC0fierlFxRg2rRp6OvvZ2IgIT7&#x2B;iqjkE&#x2B;B59plnsGDhQmRnZ1&#x2B;kl9TW1oY/PPssCvLzWWPggU2bsGD&#x2B;fP490saXeduuT6kUQCnl31MJgFKU35lscMwocI7ieyIUlDIF7MDfrtVFLyLi6EWRfq24F9n1vBy7BTgAf8e6fVct/xx9X6sCESBbAHo6h1IE8MrfBKQI4OhEAEco5nc1QD8w/JT&#x2B;K922T2letfN8q1evjty0adOs3Nzc/ISEhKliTMi8Q2nSpEkbgXX29XO6f2KQbki4z6XvIF4Hahrw9&#x2B;JSVHR0QWXzCUjUz2S28LLhAf7w81UjRh&#x2B;AScEGqFU&#x2B;nOafHREqvr8&#x2B;pVeswmdo7&#x2B;hAeUUFThUVcUs8UuUn34t8k6kC9LNSfnMzTorvGxoaOBNg/fr1TBCM1lrEemn75AtRNwHyZQjMx8fHcxr/P958k6P9MWKf9DodJqWkoFR8f&#x2B;L4cQQKkHT//fezvoBSpoC08UMAOAJrR9E8ux9s/&#x2B;ysqO/42VkI0Hl5x3mUFPpdvSuJCyop9yuJ/7kS9iPATziDXjoxxu3YwdVvIktLS7sBgx0A7C&#x2B;7&#x2B;J9zi0Cl1oCOYoADTkSCJ00BQIoASpN27Zm4gUy0tn2eUvqdQf1wQf&#x2B;o2/ap1WrfzMxM3be&#x2B;9a0ZixcvXkBt&#x2B;wToN8jRKE2aNGkjMxLoo1T9f54tR1l7B9fuL06OR0KQDjkRYdD6qi95KM2Mi8LhuiYWBdTaOtv4iH8E7h&#x2B;YmokbUxK5zp9KAq4XsEgAgwTyKDiRm5MDra2WmGrjK6uqkJSUxPX&#x2B;J0&#x2B;e5JZ9yeLvtbfdhkC93u5TDD4wVSoYgoKQkZGB&#x2B;ISEMRPRI8X&#x2B;PXv2ICcvjwkAOi9/&#x2B;9vfmMAhIoBaDX7zm99EVFQUzot5G5uaMHXqVMyZMwchISFDnQQk&#x2B;B/fphTBdwyauYruO5ME9umOywx320rv3ggEOn7nuJwjULYHL&#x2B;maJMBPkX7HAKRzdoGLbTrrSg3A&#x2B;yxZVz67UvRfCgFCZgBcURbQbjIDwLsMgBGm919J0A9MwLZ9OTk5&#x2B;nvvvTf99ttvXy6cqKniXIbLx/gVdm7p2rBdN/SZxLwIOPAJEp9NlgHu&#x2B;&#x2B;1pcEuTJu3aMkrpf724FFZxwQZqfGEW13K/uMZ14vk3KSSII/fzEqLRZjRxDf&#x2B;p5lYcEuC/obuXBfxIG4CezOEBWqyZnIy1Uybx/eF6M/IZdu7YgRIBpruFL0U&#x2B;CtX9kzDesaNHcfTYMQYhGnFcCwoKkJeff9X3mXwiIiMO2HQKpmRmMuAnX8xkMnFbPxL4o6wEyk7Iys6WF8w4N2eg7an1n6vv7OPd1burtoGOEXqlTADn5YbT/s/xb8IY5McTcUbXm72m3zk7wRlTOBMc9EpLS1uOTyL&#x2B;/XCdAWDGpRkAzpkAzu0And/t4N&#x2B;K6zgDQBIAkgC4pgiAK6TgfzXa9nnKArjqbfseffTRHOF0TM3Pz18SGBgYIx/dw7c&#x2B;C12z1IN7sPaturMHBhLwMhlh0PihS1z39cKRp3m6&#x2B;/oxIC6x3n6zuA4Gr4eOvkHV76qOLlbvphPUJqYRUOg0ifvGgAUBpAQtrttgsV46fbQs1f1qVL48HxEGVAOs1wxWcVCUkITFaN/8xTUbF6SHSazHYrHyfhytb&#x2B;ZBECum0/dd/X2I0GoRIpYxi0s60N8XBj9/sT3ZXkqatNGYWVzw7aY&#x2B;btl3vrUD2yuq0dxrQg89V31ULOZnsYpnobim1eJvs7iH0HXrS1Fqcb3TtZ9oCMT0mAjMTYjmiP94BkbvvfceA97P3Hefoq/W2NiIc2fPco1&#x2B;eHg44mJjER4RcdE8RqORa/vLSkt5nfeJ9aWmpV3V30f7UyXAPtX3u/ptRgH4f/bTnyI7MxN33nUX&#x2B;4OkW5CYmMgvmfo/8YgAV8BeCfi7KhlwB/yVlnX12RnI27GC43rdEQD29dhT/MnfdwT9Sr/TkbxzPi5kqampK23A3&#x2B;wA9p3LAVy9PJUBOJcDSAIAsgRA2jVgYxTp9xb0O4P4ywn6HUG5N6DfFcBXAv0jbdt30bRNmzYl33///QumTJkyUzhX6T7S43D15EZPjxGaAC2aiNQSh69SOPBUe1vR3imAtw&#x2B;KW9r575WkzC2Acn1XD9fkUgSvo28QUDeKdfgKMB6mpXpdFSIjw9Bm7OMHjL94eAaI&#x2B;Z89egp7quo5GigetRztp&#x2B;cPk4JEoNE/8fgK1/vjnpwMNIj90ajUDM4vtHfx97QMkQq0D9TGyk&#x2B;8ihqa0dlnRrAA9V1if1oE6CBQQessa2vnz/Zt0egIEL/FKPadpkUG&#x2B;HOEcl3GJKQEB/Eyk8Q7zUeDxd9N/bI0adIcHC5xr6B6fXrlR4VhVVoCqjp78Na5Czjb3Mb3CAL5Vtt9x1dc2xG6AHwmNwPhOi3X&#x2B;FP7volwk66tqcGbb7zBivtQeOxQVPyJJ55A&#x2B;uTJXJffK&#x2B;53x48fh8VsRnZODmbMmMHzUaoxvfR6PTZv3oyXXnoJ3//BD67q76NfdOjQIRw4cAA33XQTq/lTwKNP/KbDR47goJhO91cSIaTHLomjzZs375Pl5aN4Qpq7VHt35IHj8u7S9JXaBNrncVTu96btoHO0ngJ/BPrpeiMCwB4IdAb6zmUGjkFCx2Cg499QTv93FgKEC3/b0c&#x2B;2uvgMN9Ouz&#x2B;eRPATSrpYFBASM17Z9Y1Hjf9Xa9n3uc59LEqB/YXZ29uygoKA4X1/f61taeMDKT4Pzp0rhF&#x2B;CHU0fPwiwA9KmiczAJgN5Y34Tgu29ET6AO3b1GTsHtFQ4otd9iNpxXYcUDBVlIDTVwBD5SOO30TtE7PwbaAkgL550i/n7iMy1DabuUxmu2WOAnnH6jWOe55g6EaP3dOvj9sOCWyckojL04CkZ1wooOhMNTr6evnx1PqjX&#x2B;66nzqO3qvgTEc39eWy1yi9HEy712upTrj40WM/S&#x2B;GpjEe7j4nQY/DZMC6WEGBi/UV5xIkFAS/xHrIIJEa8saIjKkpLkdOj9fcYx0vA2aRy2dXWmj4&#x2B;hQ2t7O5Bil0fuqxofwHRF/aeKe8fVZ&#x2B;ajr7sEfxb3ncH2DuEd8IoTbJa7Xk00t2FiQOa6uE1Kyp1p2V0YK/M88/TRuv&#x2B;MOrFy5UnEdBC6iIiNZsC8vL4/F87Zv344P//Uvvp9RZsBNN9/M8zU1NWHXrl2ceZh2laP/ZIbgYNx9993Yv38//v7665z1SV0IWltaECDufVlZWVi8aBF3HpA20e9PVo8A3BNZ4AzQlboIeFLy90bp35FMYKBIGYVinFImMIF&#x2B;O2C3ixG622d323AxjwrutavsXQEco/fuSnQl6Hd3nmUJwJW9AZBdzyUAIxTzm4ht&#x2B;0ZT3z9s0P/AAw8kLlu2LHPp0qU3Cacs&#x2B;boD/WIo11&#x2B;owYAYh9WlVSirqBXXXy&#x2B;OF5XAZOpHhwD25ZV1UPur0dbbB3/hgPfrtVALRGGYmoGweQXiZkn197axTNeddTBwZRLXGF0jlFofKB6OlObb1EvRfh&#x2B;oOV/ACr0AyU09Jt6RKJ2Wo&#x2B;tEIqht100Q1YCKv2k5T06&#x2B;2WLF3MQoRIhrjNL7CUBHis&#x2B;kCE7kgd5PzeslkTDKDNCJfSIyQq&#x2B;5lO99Yv8x7Kqsv0R47BLSQezjV2fmIi8ynNXL23pNsIoDcqSuiY9HdUc3OsQ9zdhn5hRnmp9AGGU6cDuy4CAmQmICddhfUy/AjhGBfr4MdBIMep43WbyHBWg5wkmRzii9zuU&#x2B;S5NmJ7Vqu3pwpL4RpxpbcVK8LGLc5UWF4cHpOQjhEpnxZ2&#x2B;eKcPrxWWwOvir/eKe8usb54trYvzctp9//nnUVFfj/s9&#x2B;llPaHf0fSn2ndP3bbrsNQQIo9wj/hnwGIlL9xL3QIMBGamoqq&#x2B;HX1taipqYGxadPs0&#x2B;hFveznOxsxMfF4eGHH8bnN21iIE1if6SoTwCFou12P2UsrbmxDVvf381nJkDcqyalxiN36hSPy/X29nIpg03bCJGRkVek1aC0a4sEUEqDV0r3V9IJUEr591Qm4DzduTzAcRqNT7qG7EJ&#x2B;apv4qKvf4SwK6Eoc0BlTuHqfNGnSanxSAuDqZYH3pQBKegBK3QAAqQEgCQBJAIwtAaDT6WTbvrFt2&#x2B;e4jFrp&#x2B;3nz5gULB2m2sLkJCQkF4nxdF42gSSCvuqOLo&#x2B;6HG1vQKcZlc3M7dr&#x2B;9EwYBnCvrmqEP1qNHDG&#x2B;dAOMQQME/wB&#x2B;&#x2B;Aixbqa2WAP7Gtk5oKYovprMQX4/RNRgX604NDUa0WI9ZXCdUz0sHXyeAKzmzFFmn&#x2B;l6K4sUIQEvzMzngMxgVN7PAH3BBbI/m85ROT8Ca&#x2B;oRT6QDVCg9YHdveDooF&#x2B;toyDvzUgzoAREjohVOcJAB2r2WAgcXkEAPXHG8pq2RywNMFSpH9ny&#x2B;bw&#x2B;UL7gAZkR2txn4mI9pMJlR1dLPuAQmYtRiNaBG/vavfPEggWAchTj/f08D7TBkTWpsIaFqYAT9eOBM&#x2B;KpkdIO1SM4pn28tFJXit&#x2B;Dw/e0IEIKObX48YX1QvvygpDqvSEpmYuxxG195LYvth4h5B6fuBfho0ivH96Lxpo1pvh6kf39&#x2B;2H83GT&#x2B;45pBfyi2VzMTkseNyAHYrW79u3D7t27kScAOvTCgtROH06&#x2B;wSHDx9mQE/K9yTQR1c4Rcz7hT9CfgP5JVu2bMFnP/vZIfE&#x2B;muYr7mOV5eUou3ABR8Q6qior8YUvfYkV/K&#x2B;E7fjoAL725f9EW00najsb8Lun/gsbv3yXvBileY0BnFv&#x2B;KYn9eQL39s9KQoLOrfqc351r/&#x2B;1ifuTfEzZwl97var&#x2B;VwL6r3&#x2B;5K84AsOTl5DT4RAFQiAMzwTgfAEfh7agkoCQBJAEgCYKwIAL1ef7217Rst6HcH8r2J9PNr0aJFoXfccUf6unXrboqMjEzT6XSRE/Xa7iNnWQDJVuF0H29oQWNPL0fjywSYbjWaYFar0NvSgd7KemgEsOwz9TG4NDW1QU3q21X18AkOhKm6CUarBdr&#x2B;AXS0tgtgrIalrQOTN66BuiBdXEQDLkcfAesoXQB&#x2B;uWIug3I7KKDIu&#x2B;Ntx47RfRxAvNqWRWC1XV8PvrNdAJfB1HxFwCFeCYF6PDg9m0UAKROABPuIXOijntfGPu4NTiCaQBDVE9NGSWWcwDhNH3xZhjoMUITdm3sk/b5VaUkCZPkJoOOP&#x2B;CAdZ0PE6vUwWwe81gGg37ujohZPHzkNH4dnrT0/j3aFbiNEDdBxSjIEcklBWogB8QYdYoMCESmAnnMHBGkT22iMB7oQvCM6q7S1E28Ul3JrPRoUGtbKwGBGjADn06LCsbEgizNOxto&#x2B;/Y8PmdQaqtsXtjAxBp/Jn4KIgJHxrSQQ&#x2B;KMdB9EtrmEa40TQkXbI/7txwbjMamgWIP8oqfKLF/kRK2&#x2B;6ifvbO993yLc4duwYzpw5w8Ce7ot3bdiAlEmTLpqnrq6OfadYW7SflMevlHV2dIvnSD&#x2B;aG1vQ3t6J3KmZCAjwlxeoNK8xgBLQVwL53gj9eQL9StOc6/odI/2uALo7YT934obu1uVIDCQlJa1zAP/9CuDfEwHgbUcAOH2WBIAkACQBMFICYIQ1/VcS9AOXr22fO/Dvqb5/VEr&#x2B;8&#x2B;bNC7nzzjsnr1279kbhFGVORNDPESUBaM&#x2B;LV11pFWoEQD945Az80xNR76tClw3cD9jE8jRaP/gIAFD9kz&#x2B;htug8/AVg7es2wkfM6zMwCBxUYn4LKfALEGy11&#x2B;URABXrmv6tT0M9IxtWGzuuhGb/Y8E05EaEjfh3UUbAUweLsKuqntP53V4gYv9&#x2B;uHAG1wx7Y4OK4lYGEgT6KeJf39OD3n4LA&#x2B;xfHzjBJIY3x56i9gTISfeAWpHRvmrFceMyBHG8MyNC&#x2B;YAkBOk5IhoqwA91KSCVcj8bOWC/YLaUVuLFE2e92i51JqCyhqr2LiY7TOYBxIhpRFxMj45AoL8GBQLgUYkFaRE4Eyj066jUQucrSwnG2/VOZB71vT9c24TDdU2I0PljVVoypsVEXDI/jfM9VXU4KOY7VNPIQpc6MR5oPUSGRQfqsDQpDktT4lmfY6xst9jm7w&#x2B;dhFFcG/703KRntQCICcF6fHF6DlJDgob0LzxZd58Z2ytr8FFZFaq6evgGT9lMGnGtfXF6NhYlxo5rYTjyHbZ&#x2B;9BHOnTvHKv6kjk/pxW2trZy&#x2B;X1FRwTXyyUlJyMnNRU5OzmVJ41cyY68J7W2dwtfRQKcPgL/WT16I0i4LAaAEhr1J/feGFHCV2m&#x2B;fTi87TiACzQ76nUkIVwDfjjmU0v6d9QW8Tf23vyclJd3qBP5dkQCesgBGQwBcQgJIAkASAJIAUCAAxgj0KwF6b0C/J4B/OUG/OwLgsrbti4iI0Hzve98rWLJkyez09PS5AvSHT6TrtkeA9VOnzqLo8Dl0Gftw9vhZnDlfiTrhoHVTRF&#x2B;MvYwHb4NuWoYA8GqorA5Cd&#x2B;Io9ReV4ezTb8LY1AofihwK4Erg32oh4D&#x2B;ods&#x2B;XjnCufagdHqX/07VlMiP1jiUI/dSNsHT12sL3LvZPgIpvzs5HgQChdmBMEfEAyiwQnwnYk&#x2B;NP4Jgi5Half7J&#x2B;uiZtqvtbSqvwzOGTLIrn7lZMAoHLUxIZCIyFURT&#x2B;qUNFXomlUQr/poIsrv2v6OjkFoeU2k&#x2B;iCK29lFlgZYIBtkglETD&#x2B;4ljbWwdSdDTOoOeIKIGvgzUNONbQ7NkhF&#x2B;u8Nzsdt2WmcHvEXrEfJxtbBCiyiv2v4fN3prmdyQi9H7VIU6EgKgJaMR4WJMRwJJhECt8&#x2B;V466nh5MDglGmACRORFh0KpVUmX7Gjaq7X/&#x2B;2GkcrG3kBBydOKcEhuk9X4DH1RnJyIkMdbkstdD87cEiJg/EUGF9C7pGKROGzv&#x2B;ChFjcnT3Zo&#x2B;6FV8918TrX3IYnD55ARXs3ZxlQeQ&#x2B;RF1TeMyUshDMCIljBf1Ack&#x2B;5ddNXRPtlbAp5saMW51jZcaO/kzAW&#x2B;hsR8RCCQ&#x2B;J&#x2B;3pN81ce5qa3HixAl0C/&#x2B;G7oNZmZmIjolBeFgY&#x2B;xbUsu8vL73Eav7Tpk6FlnqHCyAyKTWV5/XXXvlKtQExNh777pN48fd/hy4wAI/&#x2B;6Mu453O3ygtR2pjjAFcRf0/p/0rg3hstAMfvyWe3tdseAv2jjfJ7C/ZdkSDOxyUpKel2G&#x2B;h3JgAsTp&#x2B;diYABeN8ScFitACUBIAkASQA4EAAhISFXsm3fcEE/ML7a9nkqARj6LM6/78aNG6lt37KUlJT80NDQVAXCZNwZRV6OHSrGoT3HUFFei6P7TuBc2QWoTSS2RyJ7PsIx1MDHbEVkYQaSbr0B/oVTYO7suXhFAoVbu4xo&#x2B;cfH6Gjrhi5YD3WYAQO9RmjDgmEWq1MLVKAOCYTF1A9/eqfaeZUaajGvuaMHuvQEXFRa78phFDNQP25qp0fp9zp6sFIEXyzTJxx4jWpQnM/XrpYrXsFaf&#x2B;4C0N3fJ8CxH0e2jwsgTPW9nu5THQIoPDyrACnBgbwdWpYi&#x2B;qSxR20A7e3/vLEOkwlf2bKTiQpPy1D2wMzYSDw6f/pFv52yCEwDFpSL80bRVwIuNI06ClCtP&#x2B;1vpzi&#x2B;RBrYa/ztQoTeqv5T1sGjc6dhVnyU4jmo7&#x2B;5FU48R5QL0Ha1r5JN2sK4BIX5a9ItxE6r1Q3xgIHZX1wrAp2EyJjFQz2KEKQJcpYUGc714unhXS62Ba8bo3FL3ibdLKlg0skZc55zF4TNIhtH4uSk1CXMTo5EVHuryeXuisYXb651ubOUxSJkoNAZp&#x2B;ZRgA&#x2B;YLYD4zNgpJ4poarVH50dvnKrC3pkGMyR6&#x2B;ruzk34DtOqMSBnrxM9&#x2B;mu0FkBbUL5XuA&#x2B;Kf38xX3lSDMjItEbmQYMsQ962p1NKgoL0dLSwty8/K8jsSTv/HYD3/IPsS6W2/ldxK/o44AVNsfJK7Fuvp6NIlp2VlZuGP9&#x2B;mtivFHXl4//tQ97dhzhsXP3Z25BRnaqvBClXTYCQCkjwFstAE8EgGOLPTvgV9v0dTxF&#x2B;V0Bdle6Be7E/5y7A3gjEpiYmHiHC/CvVArgjRCgJAAkASAJgNESAAaD4UqAfiUQf7lBv7saf3cEwGVv20fvmzZtSl6/fn3hjBkzlgUHByeK8zPu85mrOrtQQ&#x2B;CtqwfH3vwYbz/7Buqr6gGO1g8gIDwYfgKkaSNCxB18AIZJceJoqKCJDkeYAP5WnT9H6z85gyzPDx/14GFTkRK&#x2B;GN8DVO/OTDeB8AGoBQgc6DcPzivQ80DfYAmApdcopltYcI6mQaFNDkXnaJt0aRCQ8KVong9dZwMMLlS2MgJ6hAxc0qZn8NnCStBqFf/tDRi21wFzrZ7PYPYCRbkJYFBkkfT&#x2B;fTnirkG4Vsuq/wb/wdZ8YdpBooGuYVLVp&#x2B;09dfAEPiyvgd6DU2/lQeiDn94wCwkG70AS/WaKfBKgIRKABA87jH2oFue5WXwmfYZ68dkbsE3RwxvEeZ8REyV&#x2B;j78A60FekRwEwIi4oJaKpBDfY&#x2B;5HeWsXEz1kBAa5PGLAyn3ZOUMhSIf8yAh8Kney9FKvJYfZRn69V1qFt86Wos88mBKvEueNUuYDxbU7JyEaN6cmcQtOV&#x2B;OxpLUdzxw&#x2B;xSQR2WAry0FgHqzV4Oa0JNa30LvQGBiu1XX14lh9E041t&#x2B;J4fTOPYdIv4GeydTAziIzIOyIHokloVPzKxCA9l9HkR4UjNcTAIqJX26hV30v/938ICQ3lVn2kyq920vo4e&#x2B;YM35uio6IQFjZYCrVt61acKynBihUrGPRXVlbi1MmTaG1tRWBgIExEQH71qwgNDZUDXNr1R266Uf9XAvTugL/jsvZ57HX9zun93qbiezttpN&#x2B;5IgfIEhIS7rSB&#x2B;z4oiwG60wIYjg6AJAAkASAJAHcEgNjmtaDg7266tyn/V7pt36hA/yOPPJI&#x2B;d&#x2B;7cyTNnzlwQGxubK86JZtxehGIc9XO0tgcn6ls4MndcOMlWAUZ79xSh9lwlgsMNsMaEQSdA/4Bwiv2CAgBS6KfxLJx0HQF3DOb5WwSgvAigk6CeWJelpQMgdXkBfi2dPTAbTSCpOEt7J6APgKq3D8ZuI/x0/rB0dKNHAFKKuHUKcBiTmwafKUmwKtwvaGq/cNhvSIpnB532hZx0UrPvsZi5bSCRAa29vTCaB0XxBnysXA9MDjITAhgUMyMgQAQIlRF4A4F6iJjwGWQdLA79gB0b23KnAkrBt90vBveZ6vV9GfDSvkaLY9At7jvUQcBb8EXA6t689DFLM/np7sM4KoCRxouoJh0nyiDgTAqxB5MEwCNNgXTxnhMZxgQHRUi9IQW&#x2B;u20fzrd18vFx/o1WBmZWFo7878WzkBcdjoAxSA&#x2B;XNrZW09WN90ursK28Bp2mPi63ofNHZBON71vSkzEzJgqpoUGXRM0pJf9wbSPeKakQ4LyNiR9ffk5a&#x2B;ZqgjJA16ZNQGBuJuMCxEZWj7KAGcT9o4iwVk02g0IfJKboWKeKfFxUq/rbwNlXXYEkK&#x2B;QaHDh1iUB9kMGDNmjWs6G8HFfv37cPuPXvYfwjQajlboLCwEC0C7J84dgzlFRWIiIxEiFg2PjERO3bswP69e/GTn/6UggrD2pe9O44gLikKSeIePJwb0jtvbMWHH&#x2B;xCjBgbcYlRuHejTO2XdvUJAHeZAEplAq4Av&#x2B;O8jtF&#x2B;x&#x2B;i81cFvcN6mp7p9b8kDx/31VgvA8Xt6JSQk3OUE/kfTDcAiCQBJAEgCYJgEwAij/ddb2z5vRP2G9b569erITZs2zZo&#x2B;ffpsAfrzxRgYtypENPrKaxpRWdeE00YjqsU4rGzrQovJyLW4rIKPQbX3QAGozWJoUrR6wGxBlNafx22MLoDBa3iAP/5VVuVCn3WQXFD5&#x2B;6Hz7V0oe38vVH0W9IntqcWYHxAOODRqrvE3i/WpBaij6D&#x2B;BfIr0E5GgEoAyQK9F3o&#x2B;/CDNFEBXuh9RfPFTsx89umMMp4yM&#x2B;LlYrK/E/tGXHYDaBh3sGCdg9NCMP/WIZAqjUKYBq8AkA9Yh3SrenXabIqGnAzPP1DTkMnzzNBlX/IUCP2kYSeLe/WeEhSAwORLIhiIE4vVMJQqROy79luKDl3n/8i4e7jxfHKVSMA9pORXsXawAQUCPigMBcqAAbNHaIAKByCnrPigoX34P30Xm//vPjAyhuaXNLPNjbGJJ2Q2FcFLLCQrjFI7VPlHbtGJFnH5RVY3NJOY8jP9s5pXFBZQL50RG4Pz&#x2B;DO3Q4G2lVkG7EM0dOcfnIgPhH5CJdM6TNER6gxZ1ZabghKZZr9a93o/711NKX/ImDBw9ipwDwJNQ3f/58iOfUkI9B8124cIHT/am935q1a8mZ53sYRf5Pi2nUvq&#x2B;0tBS5&#x2B;flYtWrVsAX&#x2B;5mXegZLqC/jMvbdjxaqFmL&#x2B;kEEFeXJuPPfIk3tu8nUnj7KkZeO6Vn8uLSNpVwwHOoNuVoJ5SFwD7d86gn1520O&#x2B;8Tuf1uAP63oj&#x2B;eVp2JPoA9vf4&#x2B;Pi74L4EoN8J/JuhLALo2ArQAuUWgJIAkATA9U0AhIWFybZ9V65tn9r&#x2B;95w5cwwPPPBA/s0333xTRETEZHFODOP1WiPQVtrWgT1V9Shr78SFmgZ0UsSe0txtZ4LqcEm1nQThKH3dIEBeuHiRIBepxlN6L71TRJbS5Gmdvz10Ejsr6zhq52xqQyA6Nu9EyfNvYYBa2qkdTvtQb7lByGm1pd/bFQDpq77GVsz86Zfhk5cuvF2j4m/r6TPj32blYVFy3KiP0&#x2B;/E7/nXhWqPUWaqgV&#x2B;RkoCHCnNcglUySo8mMoXExGhiN7XJ6uphAb1esXxDTy&#x2B;nulOrsoqObnSaTF7fEymjoN9MisGUNk86CUCgxk8ALh/EieNORMKU8GAGUGlhBgbOMRTZ9FFxpwBn&#x2B;6CsEs8eKXbb7cBuBPi/NbsAiwQQoxr/082tnDGxS4wDOo/nWzvEbzRzGjiNKSKKQnj8qJEcrOe6f9JoyIoI5X36wY4DqBG/X&#x2B;0h84C6FxTGRGDbhRrUi2NHkeW8yFBMEevJEa9JIUFMOEi7&#x2B;na6qQ3bKqr53kBZAJTCT/cLk7gGSO9hYVIM1qVPQlzQpSCRMnGoXv&#x2B;AeNH9ikQh6d5DooFEutF5Xp2WzOMn4TolgDo6OvBfjz2G1LQ0LF&#x2B;xglv3kT9RXFyMHdu3s4&#x2B;xdt06Bvp2M/b24jvf&#x2B;Q4Cha/yve99jwML5LuQ0n9YeDj/PVJl/7//5T3s23kU77&#x2B;7HVUVdcjNn4JbN6zEnffchPjEGMXljMY&#x2B;Fng1mwczqQKDdPLikXZVMYAnkO&#x2B;p3Z8d8KscnmfeAHpX&#x2B;&#x2B;GcITCcZbydx9UyzlkCZHFxcXfDdQnAcLoBKJUADEgCQBIAkgCwWXBwsGzbdxXa9k2fPt2wfv36tDvuuONG4TzlBQQEhGEcivkRsOyzDqBWAKtjDS043tDEaa8EbEmBm1LiCZz62KLeFJX9j/nTkB8Z7nUE&#x2B;v&#x2B;KzuGtsxdcgka1AHz9Zytx8ifPc4mBWu1ruyZsd3C71L&#x2B;t9h5WOykwwKUFA0YTMtYsRPC9N8MiwJ7SThEg&#x2B;FxBJm6ZnDzqY/bu&#x2B;Qo8ffi0Vz3Jw3Va/NeimaPKOHC0r72/i8XKvBHgo4wHAsuUbUBRUxIqgz3ib&#x2B;&#x2B;44DOoiUDAiSLrBMQpah&#x2B;s9UNkQAC38IsI8Gfhv9hAHX59sAhVnd1eDXQCck&#x2B;smM&#x2B;p0s5Gkd5mMc6KiRToM2N3dT06xblsNpnQZezn2moVEzw&#x2B;3IUgxN8f3eZ&#x2B;Hq9u79HiReTUI3OnMqAsae1AiRjHuyprUUu6AkYzIvRaZIQHY2pUBHKiwrh2226D3SAGmIRQyw4DV8zoPG0R19XH5TXs3dF4JMKPNDoool8QHY5P52YgxEVbN7pF7K9twGunznOHCxojZptQIKn2z4qLwkMzcobOr&#x2B;YqCfJdTjtZVITIqChERERcBCjITyEdAKrzP3/&#x2B;PGJiY7kEgDICyK/Yu3cv&#x2B;zFLlizhuv6amhqcOH4cH330EeLj4vDw17/OgH&#x2B;sra6mEYf2ncBbr/4Lb762BeGxofjaNzfi7s&#x2B;sRqi4NqVJu9ZJAE&#x2B;Cf0rT7KDfVTR&#x2B;uODfXXaAp2WcgbwnQsDbDIC4uLhP2cC/JyFAJRJAqRuAJAAkASAJgGsA9LsC71cK9LsjALxJ6x9xmj8p&#x2B;D/66KM5K1eunJuenj4rMDAwdjxfVw3dvSxeRSrwVFNObd5IXZ2ipo/vPcYRXHvEnqK0UQI4fbkwh9vmeWNtwqF8RgBlitAR&#x2B;PRxMcL6T5Ti9C9f4ru/mnp&#x2B;WywcfSahLQ0BVnpZxDVETi2J7lF7LY0aVvG3pceI1HWLEb5uIZMT7nrwUaYCpf5TmjCdUIo00jboFTCMaBalsH/no/1oMfbaMhKUjdb9mbyMMSEdyM61tHMaPInvebrjU/bF3IRo3J6ZgmP1zXzsSbeByguoZRmRAkSK0N&#x2B;0PqqjVttEGPke5gOeRu905gbEu8HPl9sFenPzIRBGKugPz8z3Wpm/UZxPSuGmrgpEcpxp7uCa8R6xnxabAryPF/fomfHR&#x2B;LeZeZd8R&#x2B;u60N6F000tOFbXjIrOLl4ndRIgFXpSk48N0uFoXROKxLGalxCDzPAQHiuSCrj8RoQRtQzcV12Po2IMUNZIoGZQN8Qoxmuovz&#x2B;WTorDjWmJLksDKGNme3kNdlXViWtag0VJMXyvIvLqdFMr9lOmQHUDVonlKSsnQOM7YY7dyy&#x2B;/jPILFxAVHY2YmBikpqQgKTkZOp1uCIiQDsBrr76Km1etwg033HARSCF/o6O9HYcOH&#x2B;Yov1aA/vj4eM4CuNw&#x2B;1bniC/jgnZ148dm/I9gQiOf&#x2B;9gskJMXIC0LatXuvchDq80bMz&#x2B;7TOy6jBLTHghBwBvVK2QFKQN5b7QBX88fGxn4Kn9T&#x2B;O2sAOKb/K4kAWtwQAFYX75IAkATAxCYAxii93xPwHw9t&#x2B;4ZT3&#x2B;8pwu&#x2B;xbV9oaKjm4YcfnnL77bcviY6OTomKisoej9eQo3q93dk22xTU&#x2B;QDZpr91rhybz11gQsAesadROC8uGvcKMBvqFIHjGvd&#x2B;M4/Xrr4&#x2B;fqcMAr0A6c8fLcYB4dCT6JurOxSl&#x2B;vceK0EfgUxSBg8KgKmzB76kiq/XwSrW50vq/rQdilIHBgyq9FMmQoA/1//rhKPY30eCgu7vgQT0KGJPPAFlN/iqKath8OlDNepUg0zCXgQWovQBHBUnEBspPjOAFfMGEAAW0184ftYjqKXjQtHGF9YuG7Ne5S&#x2B;fPMct1by5EdD5/M68aZz&#x2B;/AnA4g6L3JrN1G9BVWcnA/ozLW0s1FdF5QXintYjPhPo5nuZdbAGg8YCETP2Bgmebjh0LL87fxoKY6NG9Zup44B5wIxnj55BbWe3VyByWkwkvjg9m8&#x2B;lkr4BRYepT/3JpjZ8WFaFuu4ePudEFCUJEHK2pZ3HGmVDUEZBflQYawnQWJF2me9VRNaIc/3CibNMWtE1Zy8lIqKPMkpmJ0Tj7qzJLktw7JkvZFRy8k5JOV46WcKE12wxHpdMisMccT&#x2B;bSAQAWbsA8NSqr6G&#x2B;HrV1daiprmbRP4v43c3NzeyrUBeAxUuWcAbAwQMHePqChQupd/dV3/9e8dx466/vY9rsPGRkTZIXgrRr2J9SBs2OKf6O766IA&#x2B;dlXdX8Dwf4O67PU4aBtyKCw80OiI2NvccFAaAkBOipFaAnEUBJAEgCYGISACNU7x8u6FcC8Zcb9CsB/dG07RsLJX8G/atXr475yle&#x2B;sjwtLW16eHj4uO0rRk5zQ4&#x2B;R74cxeuW6SYqM/6XoHF4vPi&#x2B;Ak99FtfphAmxvLMhCc08vR45be42crl/Z3sWicuSsU9s6ErMjR73TaIZK&#x2B;OW9VNvtq3IXmIePn63mXwBNqvEcqv/nh5FtGj1ACYNzJoCtHR999qEWgH3wVItg33w/lzDYrl9bX29a1N5OTuVAjrDons/gEOwfsEDto&#x2B;LfRuKH3gAHAv9UZz43PprT3amWnWrRg/z9uNUfrYN0EvzEgaJ2gFYPYnz1PT34/rYDXnUdoPX4i&#x2B;P&#x2B;&#x2B;PL5TL54a7RuisCT5kCTcMbpvFIUlv8W7xSVH45gYJh2EEyH6/y5NRoRK9FiDHqjH3AxWLfge9v2M0j3dswHiWM/OcyA7IgwTAkP4faDSrKFBPRJnJEyJSj74FRTK5NaAzanZzBrxAchAX6YlxCLzPBgzBBAciKmkl9rVtzchjfOlHGpiIlIQnFR0r2HSIHcqDDcmZkixpZyRhJ1LfmfvcdQ0tLO1/ED4j5GmhSVHV18/ooaWtFm6uNsAepKMV7t7NmzXAJAKv5EBBw9epTF/vLy85Gfl8daQZQdoNfr8fHHH&#x2B;N8SQmXC2RmZSE2JoaJAldWcrYc2z7Yi/s23Q4/N/eSAXFfpCj&#x2B;1i270dbRickZyegzmbH&#x2B;3lVISUuCr0ZeK9ImNgFg9&#x2B;F9HLr4uIqkOwvyOYN1JZDtbruuPg9tB&#x2B;B7HZXVWQYGPSJP5IG7jgOeSIOYmJh7bYDfXRmAN1kAjsDfIgkASQBcFwSAAKDjvW2fykvQP5K2fe5E/Ual5L9p06bkdevW5c&#x2B;aNesGAv3i/IzbEBFFys4IILO3tgGZYSGYFR/Fbe1senroEmO33dTPgnLlAsjvrqrDycYWToe3XnL9gYEvpdgSABywleVbxDRSkydwRGBJbQsPk24AlACtmKQSzqiPmvL/zQLQq6ESn80kVEcp/mKfCHmr/TUw02dKnyOQ3ifmpVRsylwQQJQ&#x2B;W72oB6fad1adF4CB95GuORtI9IFdXoAeeD5DyvqD5AA9NNW2eSn93HdQgHA49wvxsgNJ6nlO79Rq0I9rAAcfykSc2GvkU0OCWMAsRPx2ql2mOmgCzdS54H92H8FxcX60HlTN&#x2B;dz29WNFSiK&#x2B;PCNnjO57wHPHirGlrFLsv8qrBfipbcVQmQUddxKKJEJocXI8twTMjgxBoiHIY790AnFf27KLj4dn8E8RYAuTBlafwWOs9/NDSnAQJoUEYr4A8JG6gEsyWRzJAAKXTx89jYM1DRd9R7&#x2B;jnx0qH0yNjsBnCzKQEBQoveErQGJSRsaT&#x2B;46hyWji&#x2B;xhs1za1AfzmnKks&#x2B;qhkHX19eK&#x2B;kCg09PfiovAZaMQZJd4LHpY8KhXGRuEGMyYWJ4zft/PixYzgnQD2p&#x2B;HNXBTHmZ8&#x2B;ezS39KNp/0Tg2D5KI3gj5bbr7P/DXVzdj7frluH/jnZg7fxoCXQgqGnuNyI27iX2bT31uDXq6jfAX962jB05DFzGAxx//CSZNjpeDWdqEIwAc/XdPuMFbsO9J0E9p3a6m0X2uqKEFSeL5FyzuCyoXBISn9Q2nnaADAeAc/R9uO0BJAEgC4PogAK4R0O8M6l2BeHdEgM8wvrsm2vbNnDnT8Oijj87Pz88vTE5OnjGe2/aR1XT14Hh9M94vreTo2YacyZgSFoIecz9HdKkdGwlklbd3MmCndH17tNvPAVwS2B8cy7be9Tbwq7JFwqk&#x2B;nITiCGhRijs50oF&#x2B;ajT2mGwgyeWFzG38Wv65E921zQgIChCOowk&#x2B;FAGn5YRzrxXgzGzqg5FqvsXtvU9cM36BeqjE9kzie2oBGL&#x2B;gALqb5mKgu9fjxfGZ/AwBmn15nwjgU9s9AgS&#x2B;PoMpxZS1QIOBRN/axfSWbhP/HgL7dvV9itDXdvZ4fQ5oW3R8rLCJmfkMlhsMNTWwiwbZPvdxNsNglwPLwGCWA1W70zTKEiDwTGn7fipvALCVAdJvblrIKfBjYaWtHfivXYc5O8Db&#x2B;zX9TsoooKNAY4Z1C2y/u8/WQpL2NS3UwN0kUsOCkR4azNkmiQJgOEbr/yDA&#x2B;LvnKz12XKBMi8liHXdlpeFgXQO3iqvp7BJjdJCEoPttgHow44Lq/acLEJ8itu8sUmjlbRbj4/Jq5W2JcTRdAMevFuZ5JQZ5PZtpiDi0DoH3kRh1xnj6yClxXtuGyEUi60jQ8fvzC90SRFSS8kZxGV49fR4Gf1/OyFmcFMflIq5EKsej2f0RjUbDkf6x8JvOnCrFe//YhhefewPVdfXIz8nEV//9Pty4evFFGQEWcT18et3X0SGeK//7u0dRXlrN2QP/9&#x2B;ybKC45h29&#x2B;90F894dfZbJXmrSJQgIM9xrzJMCnRA4oAXxv5iEx3C&#x2B;/t4MVi55ZtUT4Pp&#x2B;g4&#x2B;Gq/7vKCnBuLxgdHf1pXBz9d&#x2B;wGYIHrLAAlIUBHAsAK16UAkgCQBMD4IwDCw8Nl277hte1zB/o9kQFDbfvmzZsXvHHjxtzly5cvjY2NzfL39w8Zz9cHR8jqm3CgugG7GppZ3I9SZUl4jyLODawar2JQT6n9BMAoPd2XdfVUQ1kB9rsmrS8vMoyV68lxpsg0gTkSSzOJZemdItthAdqh65MEuj68UInXikvZKXc5EMX10PPxIRQ//SYGxH7Q35TiT&#x2B;n8agFWKdIOG3gcEA6lioQDSQtjCCALQC0&#x2B;5/3qGxgIM3A2gNLFQTXsd2Sm4p6c9OE50Q4q4RRJp&#x2B;0SgbDxn1uHSBBPy5NaPimX04OX0otpPbSrfQMWfmcwOpQqiMEuC/aBTuU/Dk&#x2B;vAa7Dt3psfTd0XxLHPiFIj9WTk/n8TwoO5DKNoXM1gvH1iz1Hcbiu0eM&#x2B;&#x2B;GAwKvupnAwBrIPQbepHSVs7ytu6UC3AW5vRONRJQsW/W8XHlML2JnFsKBuCyJcEcY9MJkFKse9xgXr8dPfhIVLB07H/xuwCzI4b1B2gMUBlKkWNrThQU4/arl7WqaDjT8eXtk8dAShDhtK/acyTCCAd8l/uP8ZEmqftxYtjnRUeglvSJyFKp&#x2B;WI9HUP&#x2B;Ekno&#x2B;gsmsR9h1pPdotj3mrsw1pxjFanj04Qk0jN/9px6KKqn2idDv99wyy3Wht0HVHW06mmNkwS4J8ya1SyywNbrXhulJy5wP7KjLl5LlX/W8Rx&#x2B;9c7u/DyH/&#x2B;Bj7btQeG8/8/ed8DJVV3nf9PLzva&#x2B;q92VtJJWFVXUACEEmGrADYPB2Lgkjh0bcIKJnb9LnNiJnR7Hie3YcWzjbmNkOogiIQkhCfW2aquy2t7b9Hn/c857Mzs7&#x2B;2bmrSSQBO/oN9opr95337v3&#x2B;84535mLb/3zI5g5a5qU5BsaHMG3vvo9/ObRp7Fg0Uzx/nfS/VNA98bltM33fuhGTJlSA1NN07R3OmmQDPyTwbOeLkBqKoHR1ID4e041/OmeRqnExLonX1&#x2B;1WOZ0mdYxup9062kEQKYIgHQEQKY0AJMASGOm&#x2B;&#x2B;ESsoKCgrcb6D&#x2B;Xsn0Tze8/ayX/a665puiOO&#x2B;6Yfvvtt99QWlo6w&#x2B;v1Fl/qfYnrxrNaOavs76TXCIGrIHvOGeQzqCIAFnEoBEZdMrkrJ4DiIjA7u7QQO1q7pGRWaudgYP&#x2B;uKZPwqcUTCx9nkuEPNIlkbx9718d1SPYA&#x2B;wNo&#x2B;sN6WGjCaLdYRkv8qU/oRGeIK8/HxQPiufgKAbo5n34PUFoASyS9N5ojHPLdrgmDf7bkvG6f5uF66uhJAQ9eAx71Xn8Q/3b9FRJmzmRLlz8goJi90J0jI0KgdI8EZHucV8/1znkZBk0jtEwoGpFcZ9XbboHXadfK4RkcDGifnCv/LwRg2dvKRFCeyyVAt9TjRrnPQ6A1V8Bqntsp3ncGrekeSqzMv/5Ui7RnVvKB2r3M58X1U6pFOZ9tZU2FDL4D1BdZbLAvEBRhSAbiLQTIOfeej5HTLfgkmWhq7O4loNcjufc&#x2B;TUDSCKxmwcOFSRUqvHa75P/z6/YZkwWQxiMDOKqB26mdjoE9y5uaW1Hgdku7XDe1Bif6BrPuj0kePrbnjjfjlZMtmFKQh/c2TEV9UZ5EbrxTjQmnIbreL544oxGNVokE&#x2B;X3jcemf19Hz5WyIEm7rrQRWmb6xaWlH/nAU0yflZ9WV4HuIj2V5VRlMG2vHDp/EX3/&#x2B;n&#x2B;DNdeOJl36EcCiCQ/uP4sSxM9i5ax&#x2B;qKytw90dvw5333YJ3f&#x2B;BabHjxdfz0B4/hvjv&#x2B;gsD&#x2B;bHjoWdfYeAynjrUgFA7h3Xdejw9//A4VJGCsCJpppr3TLdmhmZoGnLpMap59MlmQDG6TyYP4eybseWz7fWOTaAE9tGyeaDjpbSMVLKf&#x2B;lgqg0&#x2B;3foLPWkuVztu9NMwmAS8cuAU8/8DYs21dVVeX6/Oc/P&#x2B;e6665bOX369OUej6c4NcTqUrROAo&#x2B;vnmrDczShZvDIE&#x2B;F4&#x2B;D6HtTptFgE9rPQ&#x2B;v6JEGoMnvywM5yZQtLujGy82ndbK2CmJi&#x2B;on0Lm4ohT3zpsxsYk5beLHuw&#x2B;Jx1UP/DPItxMA7Xj0OQT7h2BlcBi/BnrXQkn8l/gcoXMun14Lz7VLEKBtZLphuGQhe//Ph7FY2G8PHs8afs7GHuEl1H4cARC3Es&#x2B;oajxHUugZM/LcJ/tDYYRpgGYlfg5djykWApen0D7sN1STXijwmDoIc/SGog3OXNGB&#x2B;8khcGpHBB6bXRqKowJYU6AuP5fArwOT89Vw&#x2B;GKPR9I7&#x2B;JxfIhBnt1kNjcQc6fDFKxYlwH/yZIG3t1QDX&#x2B;8igM19hSMkmAw43T9IYNwvBIGFznmEzp/7aS69EuUJDZw753CnA4IMPCvoutw6bTK9gD5/CPu7e0QnY2dHjwhcstZAD7UTl4zzuRzIFnPAZMHDyxegbSSApw6fwN6uHnzt1e0SgXHTtFrMLSmSdAa77Z0HgD6zZI5cz066rlxxw0aPZdZW&#x2B;O4b&#x2B;4S0fD/dn9V5PkNCilyhgkX81h45gX3tPXDYrUKSMRHw4csacOPUatObfw525eoleGr9/2JwcAT/851fYsO6bdi6eRdcdM8uXDEHbSc7cfJ4C77&#x2B;zw9J2H9NXRUW0vV9/olXMfuy6ZjWUIfVNy1Hfq4PZdWlWL5igRrJZSBqxzTT3ongXw&#x2B;wJ/&#x2B;uB6r1IgLSgXJ&#x2B;zwTAT/YcltTBG&#x2B;trxIERFwHMNA&#x2B;OkxKpx5COaNAB/xZkFg9P9x2y4BrF7EEmAXBJWGlpqVm27/yX7TME&#x2B;u&#x2B;66666&#x2B;&#x2B;677/qampq5BQUFdZYUWjLbw&#x2B;xitYGBYWw4cAy/27YfHTQhLlgyM1HDnj3&#x2B;H543DbfNmJJxG/sYpKzfJgAruZQd5/JPIrDy11cumvBx/RdN6jeebkvr9eRQ/r4/rMfxJzfCygJSmmcI8WvA7a9AIyMso0EBSQRBjED/pDuvRSAQzHgsTIYwiL26tvKc25t3va6pWQBpXEAx003Liv53zZ141EE8V9&#x2B;XBJw5HJ3D&#x2B;X&#x2B;&#x2B;97DhSTT3Xydti483HInJ9WVNASaHHBargCSP3ZYgBgaCIfTSPpoHh2RfLpuaDsLkQQHXAadrtZ/AcI4jeyUBbve6vFxcZlBJnb3z/Lq5vjZxrVmfgisNsFbFttYOAeTDYWO6A6zVwFEETJYYyelmRf8rJlXIi6MTOBqGvcuHCLQ2DwxlBf98vkUej4RY1hfk4nNL50mEwZaWDonI&#x2B;f6OA3JdJ9Nvd82ejoaSfDnf&#x2B;Lpvd8DKfe5frluJF5pO45f7j0r6EUcG5Ltc2NTcjj0dPdRueZJONKukSEQxWVCRH0lcnpHbak9nN7r9QSFk&#x2B;DsmjLhPuyw2zCsrxB0Nk6W6hGnnjEqw&#x2B;dWd&#x2B;Ldv/Ag7tu1D7ZRqfOnv/hxXrbkcDbOm4Af/8Uv8/EeP4&#x2B;//nwtvbN2LTRveoPEigBkz6lFXPwl333&#x2B;72YammXaeLJNHPRNRkPo9E/&#x2B;naCzjKEKulBIXb47jfr15cLp5stHjPZenkHnlTQLgkrbz5OnPBvrTgfg3G/SfS9m&#x2B;iYj6TbhsX319vWfVqlVl99xzz7L58&#x2B;dfRaB/itVqtek9uPTyljIwmReFHW08iXXPbMRjj72IY/R&#x2B;6tWLUHrzFbDFVLV1zqt&#x2B;kAAIg5lM1kzA6rvb9svkPBn8RzVA8udL5k742Hgi/8qpMyhwu9IOAFFapmntBti5hjoB0iiBARtN8K0Om&#x2B;T3WwnkKfSeJfBtLExA5xUJR2CTEoE2RAn0T1m9GLaGOkSDoYzHE6FD&#x2B;NNFsyUE/1yNPfocLeHIAv7jk2hWmp9XWnjervtWApLs/cx1ZQfgXNd&#x2B;VW017ps3g0B7twD6g919GKH1ucoDe9zZQ69WQ9DEAlljgboB60R47RbEAw05DJ&#x2B;XPdE/KMsYAavch66ZXHVOo39dvk9eqCzFoopS/OW6TZK6YmgQpP78g50H5FotLC/GVAKXy6vLUeJ1Z103j9p3bmmRvBjA//Nru&#x2B;S8Mx0r9w0uM5jcNiXU51h74aaptdjZ3omNzW1SUvDrG7cLOXJDfQ1mFefTvWeTsnasPJ9cbvPtZuxxun3GFMwoKsDzTc3Y28GAPiDaCxz1wlUt&#x2B;P5izz5HAsTJTE5t4nbhZWwaQci/cerSzOIiuq6lImxqMb3&#x2B;58120bjAOgALL5&#x2B;DsopiNJ9oxV89&#x2B;A8IDIVwYM8RFJXQNXxyPZwuNwH&#x2B;d&#x2B;NdN16F1TesgNtAapBpppmGtABb733qd8nrpCMKUnUFWDiYSX4em1mTR49MyDbnzQTsDc6ZLWcJ9s2Hu9F&#x2B;ZIoAvnXMXAJoJIkAlpWVXWpl&#x2B;1KXueTK9rlcLtvHP/7xye973/uWzps378qSkpJ6PSZS73PywyvbQ1nv2mfbxvmyLgLOv/7Zk3j0h4&#x2B;jq52AaCSGmhuWo&#x2B;IjNyNK&#x2B;w0HwwJA7p4zDe&#x2B;eMTnjE5NDrL&#x2B;yfqt4O5NBB5&#x2B;VjybXn1g0S0BXRBTs1dJ3rJjvJWDOueohAuf&#x2B;SFgrkado27Hid4eaxFObdt&#x2B;c&#x2B;z8cRIiAVSQQIkBPwD/PCxsLsYVCUOx28VIzcIvxa3AYVocDiscJCwEAq1QgsCCnvBBRBvVJ&#x2B;XD6u7NgTkmhkBwcos01w4PRCMpzcpDvdEh4fY7DiSIpA6dW4uDydAz4mEhhIkPEBmn9g93d&#x2B;MbGnVnDlHl5BuqfXjxHwtvPl/3jlt2q&#x2B;J6BPsY6A/9xw1Wo0PF&#x2B;syeAFdIPd/eLxsCRnn4B&#x2B;Mf6BqS8o2gQRFl3ICYeWKvk5Fsn7KVeOamCXuWSQsCh7&#x2B;dyf3xl/TYRfMuW280pAuxdFiJDIwv4XFhwscLrRX1hPuYQcLy8shQl1Db2DMfDpMg/btlFQLUn6/HxJKvc58WqmioREOS8f73rxJOwTafbhMzZTfcw30&#x2B;rairxKn3HmgXLqstwFX32Ot7&#x2B;PD4TkHupDQ729EpuasdwQO5BJpyi2vOV&#x2B;x1fR&#x2B;57nKLCaUtLK8swvbhAIgbcdhtMOzvz03N86&#x2B;bdeOmZTaiqq8DkKdVYvOwy5NLzmFt/5&#x2B;v7kEN9mr38v/rJE9j&#x2B;&#x2B;l5MmTIJn3zgQ7j1vdeikPq4EDtvk6oJppl2sZgRZf&#x2B;JvHfRePJduo&#x2B;5dO&#x2B;q2kr85fKFCITDuuJ9qWKEydszIhSY&#x2B;r64uPjDGC8CmCwAqFcJIJryPgb9agCmCKBJAFz4m9Rydgd1Icr2ZfP&#x2B;n6&#x2B;yfWeT3z/hvzfccEPxww8/vGb69Onzqqqq5tNlcBi5FOnyqdLlWGViP1PzsM53/wwTOFtHk7RvfOk7OE4P8Fyvmis76&#x2B;7r4bvjaoS5JB3tO9fpxJ8ScF9QXqILCBmgsygdhyn/05Y94pVMLQ3H3mD2gLJHjcFKhIATC8Vw/li/AEcLBgnss4eZtxPUQsvjpe54H9lAGsf3WjiP3G7THtPaAKKVvOPfuRKAqvVn0fIB1JQv&#x2B;Z7Wi4UiWcF/YqLLNeARH6RGiYGYpr7P4J4Bok1C4u2aen0MOU67EAAsLMZAjUPpWb08GxDmXfRRO//43WtQ4nHJOZ1rj2gbGsaX12&#x2B;nc4kYeDBBwOi31ywfE9mRtZ9pavicX83nz/nwA3TOp/uH0To8hJFQFBPp2iwAyf2U&#x2B;w5rUPiov9Tm5WI5gVwXtWex221oOyzA99VXtyVKKWZ6mubYHVhSVYrm/iEhDCKKWtudSS5el/POuSsV0XWdTAByDh3XnPJiTPLljAPd29s68W&#x2B;v78l6fJxuEKb&#x2B;E1XUCg6secDnyED1Mtq2HmHEAJeFBrc0d2BHe5cQEUxcsE4Hl7H7wMx6KSvofAcIpina/dbrD4iXn6MC&#x2B;Dt&#x2B;luTTs4jvv2oCpaw84RMRQdMZdK62f/dhfO4TX0fT4ZMoo/GiuLoAgz1DsMSsKJlUhOLSfChB4PVNO9HS2o7iwmJcf/NKPPTXn0R9Q63ZgKaZ9hZjjImWA4x/x3MAdtp85I8vSdlbjg69qrZK5oRGywpmKwGYbjmNALhPA/h6pQCTX2Ed4B9JAv0mAWASALiYQv0uFdAPTDyP/60u25cp39&#x2B;a/HnRokW5DzzwwOLVq1evKS0tnel0On16oN4oAZAurOpsQ6HSRQ1M1EIEtP/3u7/Guqdfxd4djWpOt1ZKcvptq1Bw13WIsNcfqmDfXbOmSZ42A&#x2B;bmgWG4rHYc7uklQOJEU9&#x2B;AgIkzBCTZa9bjV&#x2B;vI650Bez4FDCqq4j7DV4aGcUE/&#x2B;U4AtCLvlaQ8/czAn9fj44/K4zhe9k6xaIVo4wQA7YfJgNEENYt69WOKvkjgeQAglqRzj183Pr&#x2B;oEkuo7ls0UGJ0e8Vet3AXZTleEdXjfGdW32URuFq6TgyMOTWBgSeDxEyRBT/adRDrTrTASNlsjsq4ceokfGT&#x2B;zPMWN/cnT28QpX4j5EdMq&#x2B;Cg3gdqY3A1Cb60/JuHQDqLAJZTuyyqKBHwXVvgEw&#x2B;v3tZ/uf8InjhyMuO&#x2B;&#x2B;RcusfjJBbNw24zJcq&#x2B;wXgGr&#x2B;7/e0iE5473BoCzn1iIDOLqF24qJnjKvF4srS7CovFTCI/k&#x2B;&#x2B;7NnNmhVCawZJ2hTCvOxuKIYW1s6JT&#x2B;dIya47/D9NaesCMuqy4UMKPK4dNvrtTPt&#x2B;Pete0Wsk6NUOD9zXlkx5pcXG4r2MM20idjuHQfxwP1/g56ePuTl&#x2B;fCHl78PLja6bcse/OLHT&#x2B;DJx1/AA498DN2dfRih&#x2B;2bZygW4/YPvQll5EWD2R9NMu&#x2B;AEQPL8NJbiCJEywjR&#x2B;cUQyG49fD76wES0DIzSHo6kUzT/ePX0y3t8wRZvnpS9FaCQSIdvfcyQA9MoAmgSASQBcUqA/E9C/GMv2pSMHzgb0n4&#x2B;yfbbZs2fnfPazn51/5ZVXLps2bdoKu92ek03ML12Ok9E&#x2B;linfymgfzaScmjYHi94fbDyB//i7H&#x2B;KZx19Grs8LJwGUvNoyhAlclF61AIVLZyPMLkcNqPOmOKybvfP8PhobFRbjh7wIutFyokCepo68eOST8s3iaD9eHcDCBAABYthsqgQrA3L6KjrkzzwxZNxOIMseiSLiJ0DFwJiPMarl/0d4m1apBhAloMgK/y7OJeXyd3YrbDwQhei8CDjCxk95AwQP56pb6ThZQ0BFnpLGIL54DdxDIgCYBIlJZEHiHKLqoCilCs&#x2B;BdOB2l4oFnLZA77nto6LKr5UXpN9UdX27CP6x2F4hnTd/Zo&#x2B;nz&#x2B;EQwoAFGr/48usC/i0GADgf7j&#x2B;sWYbaPN95eeBtONWC/9y&#x2B;L1FZIpMxwOdz4bxtBtd8RHYtfSAebh&#x2B;TNA41KoUXyZFrZSXgW4Ryr0eiBdg7X0r9hMPEv/Dia9JfM515VNvXT26/dpzXnIE&#x2B;CwnubO&#x2B;WkoL7O3vVvHK6HvFl&#x2B;RpxdAC3NesOVPg8UlkjUyg&#x2B;n04gHMUDSy/DlTUVkjKxtaUdr5xqxb6OHomAYOLMKWklblxdV4Wl1eWYnO8bQ2YcJiD2wvEzWFVbgfrCPNrneI2HYCCEYDCIvPxcc1Zs2jnZr3/6FP7yT/8OP/rtt3Fo/zGcOdWOro5ubN&#x2B;6Fx2t3Zi7ZAYee&#x2B;b7yM3PMRvLNNMuMhJAz/Me/8tjWuvgiIxDt9TXynyAxVK/&#x2B;douNPX0y5jFs7dhmmOxaOrH5s&#x2B;SaE6jIf0TCf2Pvy8qKtIjAFL/mgSASQBctASAWbbvApTta2ho8H7&#x2B;859fvHDhwtn0foXX6y0/m2t/vjzyekSDUYIhncDL6DGprlL2VL7Y1Iwnfv08ThCQqFs2l/A2geCSQthYJI8AiYTA&#x2B;4MJFCJrW&#x2B;JbsMh7Bq8MbgXAs2gdi70Fw0hXOcXC9dW7&#x2B;0RLwMZgY0QF6sG2bvrNTt8FCYBE4cpxY4jADQN1e4jAeiiEqR&#x2B;4Dn307LVG9EPyLTkehHccQtOjz8LK7DJ7v&#x2B;mYhjt6YaXz8XiciNC6EQ4XZwKA9mUjAMYK9sNDfhWo0THkTa5GKesdxBRkrABD5xBt70HP2lcBnxtRlwN22lYutWGEUDSDNl&#x2B;uF86ifAJ9EWkrZ24OFAb89LJz3j&#x2B;XzSMAx/oDUcbqoYjxDmJNktZVRm86JelvvKKBjGZMcIiAoyKrxbSwPV6IwTOHlPOAbaRE2ggd5/tn1&#x2B;NDc6adlwcfA&#x2B;Uvr98mYdnZ7hw&#x2B;p8kEUB&#x2B;4fJ4A9/aREQLCvWjjcnojAfGmqxkeVokmYU8Ff45qDBYLFMZrxBcQYK72eTFI/eHMwGBW8oG7xMcXzMS11EeyGacUHOntw/bWLhzq6pWcc0WICpscDxM3fEw5dnvGlAMOTV9dV4nP0PlaU8iIo/39eO1Umyjcc367k&#x2B;5ZP11DBvcrqstx8/QaEbCLCwjadQgOrnCxb&#x2B;chbN2yB0/&#x2B;9iXabhSf&#x2B;YsP46Y7roHDYWr9mnZ21t3Vh8/d/1Vs2bgLS6&#x2B;aj3lLp2New2wUFOeioroMtXQPuQwIjZpmmmkXhghIBeASTUkf/2P7Xuxq60InjblP3nULwlG1ag6PcUxK/&#x2B;rgMSkp7KLxdyAcwo9vvQZ5PPdD9mgDo0RA6l&#x2B;TADAJgEuRALjQoD8bwD9foP&#x2B;iKttXXFzs&#x2B;MxnPjPz/e9//7WTJk2al5ubW2W0L0wE5GfSADCyjUzefKMVBMZsgz7vae/Gv76&#x2B;W0KZvS4XXPleRBnoMygKMUsbU9Ph4/c3TdJs7K1m0M7edd4KAWYrgdfo4AiB&#x2B;ABstN4AbTfP6YRrSYMGnlPwqtuJ2P4T2P9vvxCvvIO2Gx4JynYtohJP4J5TD2gQifH5EGiW8H86rsLqUsz83iMI9g6mBeMuWu7oV76P1mPNtG2n6lXnn7RohEQ7xRGyRfXYKxhtvwi1yez7b4PvXUuhhDODcQuB&#x2B;YFHn8X&#x2B;nz1NwJ7aMBIRj6uV2oA&#x2B;SNqEM8cDCwsOhkJyvuDoAtofH5/F45Lzc9PfKB3j1OuXwbZsNmKRqJGHk7SLxWYRckNONR6BEInK6UmIXfw6KpkjDNSmMl4mjoHroopizC8rlXA/DkHnzXPNe&#x2B;UsHmrrT7XgO1v3we3I7v0PUjt/c81yTC/MH/M9kxdMTBzs6cPJ/kGc7BvCif4BVUuCJiisGcHElcNqSVxv7qecv8&#x2B;/OG3WjECcr9XCyhI8vHzBhB/WpwcG0Ur3zGsE1Pd39UgOupE24mvH0QL/c8vVaa8NHzOXMXyjtRNPHT0pERF1eT4soOvDIf5c5k7P9u1sxLrnNmHd0xuxf9cRBENB5Hi9WiaMBQuXzsFnHr4PV61Zas6KTTsr62jrwdOPv4jfPfoMdu3ZT&#x2B;NNDqbOqcEXHvlTrLpuqRCmpplm2vm1M0Mj2N/RLZFgBWnKJE&#x2B;EEIi/OO2Mx/lPPf0q&#x2B;oMBcRY8evu1Ev3GJmkBrAUw7MePdx&#x2B;UErd2mtN95YpFqC/KT6QRpM6D9f6m&#x2B;z2dBkFhYeFbRQDokQDvOALAfHK/PUE/cG5l&#x2B;6yYWAm/t6xsX1VVlevmm2&#x2B;uvP/&#x2B;&#x2B;6&#x2B;ZNm3aUnpg1FosFqsRQJ2uVEomcb9sTGbyeqnvja6ffEyZSAX&#x2B;rpuA&#x2B;vf3NKKRQBEr23NYuITID/o5Zh&#x2B;h9h646LuoxtTKevSADx45jcEXtqOvb0DCqAd6&#x2B;mGjBQI0yFhY&#x2B;dwfkpD98OAwpt2xGs6ls&#x2B;nxmAKeOVJgYBhHfrgWQVreyh7yEc7FVx&#x2B;ZXI7PYrGLV9pid0FgoMUlD5kw7af6vdeo&#x2B;4vnIeicX&#x2B;&#x2B;6reg42gwXh5TGzu7Ba/EHUSBpD7Gsd6KTAH3Htv1wF&#x2B;dLtIQ9Phow8Hba4eTqAex95xQAp1PCv5VAUA4/zGUF&#x2B;wbl92HOcKC2cdx7Iwz5/6ktWXDuxDd&#x2B;DGthHmx0zRw&#x2B;DxwlBaAZNvInlSFA2/V63YhKFIQdFrdDjdDgtmZRnnifYbIhpkVVTIDw5OvDnu1XT7fDwaKGHGFBQLUsxyOVDmryclFK77lEIYfqF7idGXUNNpxupePMvn&#x2B;eaHDYfir4Z8txOOTF&#x2B;0VNpZAU/dTex3oHpOLAplNtQgRwpMAQRzpYbKL2blN7W9aSiyHaNysbn41xe/BraVWZeOJ/sOMAXj7ZklVdnu&#x2B;HmcUFWQeFMuprN9XXSklOLr3IZQjtlrHtzWkwHe3dWPubF/DKc1uw64396O8dkiiVHOo/udacxHOEyY6tm/fgwH1fwdUE1D710L2YM3&#x2B;GOXKbNiErqyjCRz/1Adx9/&#x2B;04fKAJLzz1KjZvfAP33PEg/uUH/w93f&#x2B;Q2s5FMM&#x2B;082zfpHuMyvH9F4/KVNRMbs5hM3tfZK6lzs4sLUZOfo6V/qs4TJtE51dOWou2kaCl3Cs0lij1ufHz&#x2B;LLzW3AF7UkpoOgdW8jxObx6caW59AUwxe5hJAFwI0J8N&#x2B;KcL23&#x2B;zQf9FW7aP/37iE5&#x2B;YfMcddyxavHjxlUVFRQ3xnH4javvZAHkm7/tEtABSiYBMDz29ZdMdt/YNXiOg9psjTWg63gIbAf0hAkWOngEB1f6WbgLjI8ilTTU8ch&#x2B;G4z5cBtEWBS0/fw5djSclnL4Park2bYdqSBgBt5hihZ1ASOktV4qi/zjMSgC/8yfr0MdK5DQ4yGCg02vHtpeCSCiKEgJdnvnTEOXweL325DYgwN6&#x2B;cTesOW4hCc7mCc26AZMum06zVgJcUiosEwImMH2kGYOSuuBQIwxSzyF&#x2B;HTXgKyoHGuCzxFE0LxYKY&#x2B;qaJbBMqwGCwezg2&#x2B;NCeOcRtO85CovLLl5&#x2B;qXjAOg0c5k2gn9Mw8oryEaRr42JF87JCuPJ8sBf64KG/Fq4lT9fEU16EiMspJMKE2oyrGtDL6VI1HxhsM6ju7VYJDs5P99pVQofL4PGynHPPRAH/zad9VvpyJCyQKw7son7hsWUfUriM4O0NU4yRFFpJN36xMUDmVAMuT7izrROnBoaw&#x2B;Ux7xhJ9ycaTnl/vP4btLZ2YX14i4nnsAZloiTi&#x2B;Pw8aKDUo50Db39PRg796eQuWVpbj6slVUlkgnWgf6zvkJXl8eF&#x2B;tZzqwZeMOPPar58TT39neDRct46Z2KS0v0iUZ&#x2B;R5nUoAjddb&#x2B;9kWsX7cNf/b5e3DLe9egdnKVOZqbNiHj/jZvYYO8Phv6KLZs3imRT6aZZtr5tRebzogaP5ehXVxZOqF1nzxyEj/bd1iiyJgwLqE53Q9vVaPPYnHny&#x2B;hEB3FhqOT5plXSQa0y1nKa6FA4hCoa642A/XRzW/354cTn2aaZBMClAPzPt4J/pu&#x2B;Nhvyfbdk&#x2B;I6H&#x2B;57VsHwFV2/Lly/MfeeSR1Q0NDXNqa2uX0leObA8Xve&#x2B;NsJOZSIFUr7xRL7/e9&#x2B;kefnpkhhquZUVo2I9HDx7B86c7JN&#x2B;7/ds/Qz8BfyUUgo3AV1yN3ksTtMlf&#x2B;TiGculBHVZz&#x2B;C1eF0IENAeaWiRPH0kXc1wHJFA1447VQEURgWf/eLDc3ouTz7wGG3vnDTK3Uh2AjmXyB9ZA8blZzU13uRgBMFvvIIYI2FjFy312BK2b2mPS&#x2B;69BOBzNemBW2mfni9skl/9chx725uddOV9NrTBw6A4CZWee2wIrXR&#x2B;&#x2B;hsmgXEL/I2oJw77eATBHH&#x2B;A0h1NtamSCykiIQq8QObT&#x2B;5Mumo&#x2B;izH5D0ByPA3&#x2B;52CuHAKQ&#x2B;WmEpIcYqIiD5qYJhBcfwy9AWCAiQ5LDESVQXw2JteRX3NxyQBp0RYbAb6g4KaPB8Wl5eedVsz8cAvFuB7&#x2B;tgpbDrdBkMlD7R7rGVoWIiD9adaaXLkkooLa&#x2B;qq0FCcj9r8vKzb4MiSf9u6V7QOMinvR0VMUtE0NoAjdM/u7ejBxuZWvGtKDW6or8m4/sDAIF557nVsePF1vPz8a2jv6ILL5oSTrl1xcUHivs92r3AfKSjMRSQSxre&#x2B;&#x2B;j386v/&#x2B;iC9987NYff0yAXWmmTZRczjtuGr15WZDmGbaeTYm0/94pEnI5SWVZRKVZ8Q4su5new8LARDRqkDxnLBzJIBf7DuCD82dkZiUK5ax8wFJR5TQf6uqsRMMYk9LB/539yGEI1HcMr0OOR4nQqFI2pRWvYja1Hlt6rKp83LTTALgUgb9mYD&#x2B;O71snx5BYEsF/TNnzsz55je/ee28efMWlpWVzXY4HL5UljAdyDaai5/p4ZSJYMjEdBoFH&#x2B;m2OU6kRXsd3n0YPz5&#x2B;Co3hEHJyfej51Qvo7&#x2B;1XQaNb9VqzUiuDuMl/cgeUugqWG9da1wp7Vx8av/eYCPZl81WWzJ6Kovethp/Af2qYvj3HjY5fbkGYRfaynXNcvY5BUCCEKUvnwLlyHoIZPPJMTvQ9vl48&#x2B;FYNEMshaJEKUuoPaqSCGtmgH&#x2B;5eQkBYmTkZCIUzHmKMS&#x2B;l1D6B96z5Y7ef&#x2B;GLT73LBMroRiEID7jzSjp/EEbKkq7loUQvy8bcnRBnrnQa9Qdx/KrlmEgJHxk0P&#x2B;hkcQWLcdgw4rvOXFsBfk0PH7YKG/FtEksIrnQPplWE0vYKAaB6tMTPCueILCeYKdUtyR2tMICKdFPnJZAzwO2zm3OUcSvNDUrIYmZumOrLIf1UpVstK&#x2B;3a6u0&#x2B;MPSVrNUbqnuPrC8kmV4nVZUFaM6lx9ZfNtrZ149XSrkBCZjEsG1ubn4lT/EEbCYUwpyJVwzMVVZailbevpAXAptRee2YRXXngNO17fj6ZjzUIuub0uFBUUJJ4RsQlOloTgoQlhXr4PbS1d&#x2B;Nz9X8HV1y7Hw1/7E0yfOQWmmWaaaaZdeGvs6cdxGjO8QgDoE&#x2B;X8/Oc0MV/S/IEr8Pzu0HGU53jwiQWz0E1zKQbweW4nnjverBIAmsdfZlEp6Xw8RrYMjuCVk2ewr7OHxq1BiQq8ZnI1/mThHIQzgP908/NUwD9R/SzTTALgUgH/RoH/W1m2z0hI/7mA/nRgHzCY08&#x2B;vFStW5H/kIx&#x2B;5bM2aNasqKirmu1wuX6aJ7NlapnWNpgBkUjjNWnYtTThUKosaf//CYy/ix6/tRojAnZcA&#x2B;MgfX8WpZzePeoy17bG6fkldFTyLGkS0DlqEFxMDx//79xggwCfidVpWgKj/y8M4BlUqTC09V3HjMvj5WBKq9EoCsCqnO3DmpR0EWO2IEGBSj9Ei24iLyjBQ5Bz1WDQmg4uVAKaNQFrlB66FPxKFNV37s7BbcwfanntdZQ4sqmebjyNM63PZPWeuBzECozEuIyjVDeycEC3571y&#x2B;L0q/sRhV3vzpIgiX7QbmEPyBx9dj8FQ7LBwZYUm6hvIafa&#x2B;kXJd4m4whMHwEFnNcKiLPKoGvoH/vUQQCIdgYRJ4L803r5pUWQZkzVQQXs&#x2B;J/AqX&#x2B;zUdx4MdPgFoPLgKE3I45NNGIUTsWN9RJhQXf9BpYqc3dBIZBEwrucwqr6ysxVSOBxRXpjSOJ7DF2vBZsam4TtfvJBT5U&#x2B;nwyYTkbY5HAdtpONtFD7nvTi/Iwu6QIB7t60ESTq4BWKcEphIddFZuk83v9TBs2Ebgvp/stnu/P6Q4ctRAnQH6x/zBy0gifKdrkLEj7vG7KJNw3rwFnhoalsgEfg17ZvqHBYezafhCP//Z57CTQf6SxSTbkdrtQUJCbNrrobJ&#x2B;BohFC1/yV51/D65t34a773o0/&#x2B;dzdKC4rNEd&#x2B;00wzzbQLaC&#x2B;faIGb5kQeGiuYNE421p5hEVrW22FNnj9fPDfx228OHJe/HyPwv3JShbxf23gCgWhEpiVMCBRzyk685DOT/EImA99/Yz&#x2B;O9fbj9MAQeoMh0Ydy2W14F41h91zWoM3LLGnnr5nm1OnAfrZIXtNMAuBiB/5nk9tvNMT/XPP6jZTtywT&#x2B;s&#x2B;X3n5OSPyv4f&#x2B;UrX1myfPnyBQ0NDavcbnd&#x2B;/PiMhOzrgeqJgPF0gD4TO5nN4z/R/esdO3vphggwPPjhL&#x2B;MMAeiCu94FDtyPNp7EkZ8/ixgBeWlA7ThZnK4gLwdTPvUexBigxVRlcg5r9x85ia6DJyTMQioERNXa9iwOZnPapHydhSsG0Dbz3G6459Ujwh7fcT2XtnXsNAqWz4Q1SOtyfj1tz0brKC7aOgFZOwFJLvfHYnX2wlw1PYEZZgLq4cpiEeZLJ1DH&#x2B;e9hGqEmPfBBEd6zs&#x2B;c1GKZjDkh4OwMzTiPgnHgOR&#x2B;MUAbvDJtECUfqOc9/Zax3u6Yeb8//D2RX4rdQWERoMS65ZIgr4Ya5aQANfdDigRhtopRAjrPROoDfqDyFGA6l40MORUTabCQ9ar3LBDBVIZhvMeD0rXeOjzSqJca6Ajs6jYG4tQlYtKiLbedN5tW3YBcXjlPJwTPxwX&#x2B;073SaTgYHjZ6SKBBMkLA7p4WtH//Jm1EjFCO/0GjgIyLqL6Bp7PUL0KFbjj01edDPtiycxnM7C4oJTC/JRnetFTa4PcwiEFrhcWXPy2TPxf3sOy&#x2B;Ql0&#x2B;75avjoPP9y2UIUe10SJnmwqw97Orqxv7MXx/v64Q8EpfQeEwLxcMtBagOutLGzvUt0EGaXFGJRRQnah/1oGRoZV/aPj4cFl5x0bTl/f830SrxnZr0cWw3155qUaALubzu37sMr617Hs2tfQVPTaURC1N7U7gX5eYirUbwZk6N4apGL9hWiPv7df/4pXt&#x2B;0C1/82z/DkhWXyTPINNNMM820t942N7chQOP0g0vnj/ttmMal/3pjn&#x2B;T3r5kyquNyqKdPhHE5am1ldXnieybZD3T1jhPvffV0i5TelVQ&#x2B;2tfaIydkGQ7i4yi1eWVFWFVTmSAgYgbn5HqEgNHwfjMawCQALlXwbxT4n423/1wU/LO9f0vL9nm9XttDDz0087bbbruqvr7&#x2B;8pycnErLBO76iYQPZfO2Z1P81yMHMh1POk2AiTzoeOLddPQU/v6L/4FmArUlH7lFDWXnUmj/sxZBAgU2ApsMujgPW0rIWayY8ulbEaPBQBkYTnisudFHmlpQsWqR5GfbfB7YCGDZWDG9tAA2AiDO0iKE&#x2B;wcJvOeI&#x2B;F&#x2B;EQY1eaTMCTc6FDZhyxQLEuEyeQwO6DB4dDlGkl/Pi0HBhlSEK9eKd54gBVv7PdF15OyV5yKksEsjGCrQSnsah3ZqSfzws3svfc2417cfDYdwMQBn4KmqpwFggJKA4m0WpHfNvvRIFTrsQBkq8tA2XSuSceBpMZZ/0e6xvGIHuPiEmLHT&#x2B;w2c66FjscMSiGO7sR7C3D2XXrzDsCOec/sHDJ6EwgcF9IV7SLvHXqkUgaLd3iiDhWAIgipyGOihBQ7UHEOlTdRZsfN7KaF8co0PgVssvKtSew&#x2B;098tUAnzMTSA6bEAeWHA/cLgfmff5eDJcX0m/R7E9LTR7Bo3nPuQ9xyT8W89vRqgiI9tE26wvyRViwgUD3jMJ8KUuYl1JrnHMaG7t7JQxfydjWwJ1zpgn4lwGP2pYnN/xiMoDDLXsDATxN992ZgREpQ8jmoHN3aSQET352tHdhW2uHrB8H/3HQz5EBrCMwvaIEV1RVYHpxvlRSGN/PFRw7chKP/eY5bFm/E3veOIgg9VdPjhs5Hi&#x2B;sOVaVWHoLBYrtdI6FRfk4sPcI7rn1QXzic3fhL778SbnGpplmmmmmvXX2&#x2B;8bjEpG5uLKEgHyZztwREkUWkvF2dFb17JFTCXHe5PllkceVGE04ZW5PB49jXdjV1kFjnE0i2ZZVlaEnEEQFjVlLKspobCyE2&#x2B;FIVD&#x2B;KZXCO6c19eV6qVyVLb96eLq3XNJMAuFjB/5sB/Cfq7c8W7p&#x2B;pVJ8ewE8H&#x2B;o3k9KcL7Zf3dXV17jvvvHPymjVrLluwYMHqvLy8SfSAcEwU7KcrpZcu58io0J/ePrMdV&#x2B;p&#x2B;9L43so3kY2bwf&#x2B;rQcbx79SeRU1eJWV//U4Q4H95mQXDrAdirijFpUhks9NepEFAk0MW5wa7qElhrK6D0D6nAUcvd5zry&#x2B;dcuQ7GTQDkBFh5UVA&#x2B;16t3mZXkZATk8mDCoDkcy0bOIjPjVbTMpET9PAjDQCwOPq8syYRF/nxGZ0kATCWqAlzcXTZzLuHaL138PY9wyEzE5j&#x2B;Rz0dIjWGfAkudLnJetygNHbblaUYH255lTr/5Ax5zPlDm1b3QkoIbFG3h6MFFScetVGB4egS0QRrCtG5FIBIo/hODAEIF5NdqBSQkW6&#x2B;E8fP7LkQ&#x2B;IEwVW&#x2B;YKunx2&#x2B;hjoJzc/a7/gatveKLkNGjJlEDFg0IMikj6pOCBEYwuAw8gsrESz0SeWCrKfNefdOp5xHVIuwYHLHxrnpVlsS16Rgf2e3NDWHOXJJQCYDZpUWoo6uybTCfBS4XXjheLOUwMzUrdSMFwuWV5XpD350THNK1LD3FdUV6B4JYlNzKxq7&#x2B;yRKoD8YFCLAQcfn4UgPTZySyxDy31wC/XNLiqSSwDKarHGlglRRP55AnWw6g82vvIHHfvksDu4/KqU4PU63AH&#x2B;PJsyZjTR8s43FAKP2KH7w7z/H4f1N&#x2B;PNH7sOipXPNmYFppplm2ltgPTTfW3f8jADzyhwvuuhzadL4kAmsnKR5A489HDmQPCcSz79W4efvN&#x2B;8QPRpV5R8E&#x2B;HPwp4tmi87AmLmvBvwTY2gGR1mmqgCZKmFl&#x2B;t40kwC4lMD/RIB/JoV&#x2B;o58nmtf/lpft8/l8jnvuuafm9ttvX7Zw4cJV&#x2B;fn5k&#x2B;Oefj0hkHQPASMlRFIfMkZKkmTbRuoDKt1nI&#x2B;SFkYcch0If6erFt57bjKkPfQi5ZUUC/qUkHCEmFtCbctMKAZicw61Y455xRbzsMQnbHwXZagqAVcKPYxziz6X3EsctCgAi2ybgkgB6ag61ktTBmP2NaqJjAo6hDiacoy/MsBaCHUvC5hEGdlbVg2rk5uJUBFa0V7TBR87NqnrCxZuvxBKCNYq2T0vcT6rtlyMCLDHjACr5HOPCe1bZtAJL6nJRjAX3ms5C0gWfAAlhEY2EkjtWoZQBbDBC10gjSfxhhIMBEXEMdPTykgh19SPcP4zIkF9SHIQgGAkhMuxHcGgEpXPq4STwGc7eKWH1eTG8o1GNdjibQTeuIcF6CHYniq5agChHDmTz/tNKocZTOPXC68ifOgmeugq4mVApzIOV9Rv4aorWQ1SugdsyOixxH&#x2B;ujPvryiTOqECH1g1yXQ6JasjnKB2mbd86qT5QQzGS87TIC5O9pmCL9u2VwGIe6e/HyyRa0Do6I94T36bKp6QCXlRVjUXkp6gp84zUI6Liajp3Gple2S9m&#x2B;xoPH0N8zJLn3Ljr2kuKiCw74dduAPUK5OXhl3Rbs2XVIarxfsXqxmRJgmmmmmfYm27a2DpwZGkKe04mXaNx5o60Lf7l8AWYU5Wddl8vb8ii0r6MbG5vbpGTf5uZWbDrdrmk0KZLfX&#x2B;nzYHJ&#x2B;Hm6sr8GUgjyUaARDYu6lM9/OpvR/NgA&#x2B;vk48WsCMAjAJgEuFJMjm9X8zc/nThftPJJffiIf/rEL8CfCXf&#x2B;pTn1o9Y8aMBeXl5XPo5ranA/PpQHI60KwXDZD8IMkWup8uoiDdNvSWSRfCpLeNdGUFU7dpt9uxv70T33ptN/wEjPIddvHMx0OqOS9bIdDPgM&#x2B;ied/jD2tLksc/GYhyGRn&#x2B;JhJl4B4TFjimgRxRjecybjSpZ6DjyRDqG9N&#x2B;52W9fAwEHEMMXglQMSDycig4bZO3x2FpkagqvldAgD4Qi&#x2B;IoAdZBTjWI55/pPOB5AAjuOQI/AVwHnxOTBvm5sNB6XP4wpzhPPOxSmYCWd3s9EpoepGNx0TFxOylut1QRiLnsmiNcyXgjc/4cg7mIEAaqECID/5iidX5uJzp&#x2B;m5AolgT5YY9XJFC0Orka42Gd6ABIxy5e&#x2B;LguglUlbxS3HXZPrnyXO6k0URJQ6HoG7RyWH4kIqRMlUMqpFe6iPITtSQxMOuxO19Dd1YszL21T903tzKQLUsUNjTwM6XhZRM4zozY7&#x2B;OfDynWjf/MetG/ag46t&#x2B;&#x2B;l0rcgpyYezvAhe6vPeSeVw10&#x2B;Ct6wAEepHTHJFmbSic7bKS0EuixBqmxthrYksx8x9e3VNJe6dO33iQJi2zaJ//Lqipgr//Nou&#x2B;KMRiRKoL8zDNHo5dUBxd2cfnlr7Eja/vF3Af2/PgAj5OejYi4rzz6uY35tmdGg5NEkcpMni5&#x2B;7/Gm557zX46rcfhNPpMGcBpplmmmnn&#x2B;oil53/HiF80aK6pq0qMvz0jQRTRXIaJa55zDbA&#x2B;y/Z9&#x2B;NvVlwspkMlW0Bj6kz2HRTvnP7ftk/GPhWg5pc7OcxjaxZ8tno2lVeUo846mp7Go4LdofCukOdunl8wddSKdQ5m&#x2B;TNpZqXNwo04y00wC4M0G9hMB/xP1&#x2B;p9N/n4mb781CwEwkbD&#x2B;swL78b9r1qwp/vCHPzz/iiuuWF1WVjaTy/bpefezheTrMY3pls30YE1lJtMRA0ZL/emRAUZTDjJtQy4OLX&#x2B;8p09qirMquVMTlOOtSCiXBRpIVUSrnx/qdsn7hwpAUtT6mRAI0nZmSVizRWV36adij1MUZbmWe7nPK6Fm1b4cKdvWT/t7dP9REUAbTyYouH3GZFxdW03HqohAGgN/DsFm4RiGzm6HXdRkrVqZOIHTWjDCR594SfQA0iMtOgca9E5&#x2B;7w/o6&#x2B;iFK8et5lbHtHr0UKMDOFIh5le1Dxx0/NFwSKodOD0uUf5n4cKZd1wNx61XQBkJZPRuc3PWFeTi/TOnyHsuzxaKqhEOnP89QO3B9e15CywE1xMIwEXHyec7yCKBdEIKjaZBAoQhiXSwSF14o8alduKCPIkbPwHeR7O/lXDa0RUWAmN2AtCOskJVf8HA/rlJQtSGebOnyvnFWrsxMjgEK517OBBQb&#x2B;lYlNrbISX9WA3IoqVjjAPXtD8Xi0ZOKqXzybJvah8WxuvZ0Qh7rjdBWo30D2Goqw/de49JG7KWRNGMWtioz7rmTkURTWhQmi&#x2B;CgyyayEKDSiAkUTE2AxMFXqY6L0f6N5MH1rOdXND&#x2B;3kt9hYUK9UoXsoL/a6/uwB9&#x2B;&#x2B;Rx2bj&#x2B;Akyea4XS4kEPnUVxSICkNFz3o1zFOCQjT/fCr/3sCAXpefPrz96K&#x2B;YbI5YzLNNNNMO2vwD/xg10ERwWX9mtVMAGi/3Tl7GtZMrsYfD5/Ac8dP03zLhmYaXx5vPIH75s3IuN1bp9dh/clWHO8bFEcFb3MuzQ&#x2B;42g6r&#x2B;t89axpunaY&#x2B;v5lg&#x2B;OHOg5JCV57jxRY6lqmFeeP8JunmyNl0uLI515Ln&#x2B;nopA6aZBMClBv7PJbR/oiJ&#x2B;Rr35b1rZPgL7hffff/&#x2B;CRYsWzZ82bdrVNpvNpQeiM3niswHsdA&#x2B;EbGJ76cC9EbE/Iw&#x2B;ydNszUq0g&#x2B;TcGJE19/fjLF7cgl0Asq6EzmGIIGCbQUF&#x2B;UL0xtqceNnmAAdXl5BNyiKKXvONyLw6J/te8IkuEXM7683t9ds1xyygVoJvLbLWqeuGWsGuzaQ8fFm&#x2B;vQ8dK7rXZcVlqk5lprYeP5BP75XJyaQBp/Hwe0Sryz0hsmG7oI3Be6xzLX8WUk5N5uRaS1E6EhvwgRRjUCwgo1111NMVCERLBo2wn5A&#x2B;KBtlJ7cUWAECvWM8ikwY7Jkmw3dZjakPO2F1eWGXoAxI&#x2B;XoyriJAcL5khddWrLN9o68ZO9h2E19DCxSNhdLwGqmOTlxWS7MS0iId70Ni29gnPPuT/wfiyWpHQFzesuOglGjfpWrLQQk//ibiFVQs0diDLhdPwMgrThwL7jCIajCBw5JV6BWPcAwqFQIh/QKuXrFCEfojSpqL9tFcLsFeYohkz430X9ev0ODPYOwM7CePGJA&#x2B;3bFtc00FIwOg4clxSA6KbdaMn1SolC96Qy5E6pgndaDbz0PprjNnzKvzlwDC&#x2B;dOINZdL0n0fZWTKpEBYthToAM8NI5ziktGvPdyLAfO7ftx7N/XI&#x2B;Xnt2MMzSB4i266N4oLS5KiCbFYpfuhCZeKcBL1&#x2B;zxXz&#x2B;P3W8cxP/88h8wZXqNOWsyzTTTTDsL4zlOU9&#x2B;ARE2mRl&#x2B;ynBCXxP3YgplSFefHuxslevJIT3/aucnoulZ86cpF2NvRI8/uSl8ODa0KvvjS6&#x2B;LA&#x2B;OCcaYllt9OchSsNsL7NjfW1kqrJooNx0WE9wJ8K5pPnsjGtklA2YiDTnN6MADAJgIuZILBk&#x2B;c6o1//NLs2nB&#x2B;TPi5J/bW2t52/&#x2B;5m&#x2B;umDt37rz6&#x2B;vqVLpfLp3czx2/k&#x2B;EMhG8hPfR9fT2/9TASCEQLCaG5&#x2B;NiYy&#x2B;ffU4zSSnqCK4rFAiw1fuWIxinJcePrwSbxyqlXAHw8S/2/lQuQQeOJJOAMJq6YMH0ekfzx4HKm&#x2B;Vz6WW6bXJjpdVFPqR/xcZXXtYQ1VzG39yRbVO5ossKe9L/AQoKEBKSZaBKPgOvl9KmkQP&#x2B;9WAokSuWBRz0eXdeOIhVPtCBGghsM79lrE95EqHGOzjtmPxW4Rb7StolgqI2Ty/ltUHCwq7ZYJPgQ8SSX7kkPospWrS94OR218dslc5BIA52vaOjwskR6hSAydI37xzHPu&#x2B;bDkm0Nq3Ee0yIQAaxCwiJ&#x2B;QRCqBZFRjIWGRCKK8ApdOpDYQacjLZ8HLQPzy2ZJ&#x2B;EW7vhSXPK4RAzO1E/&#x2B;v7RQBwYP8xDhCA/0w7iorykX/9UsL&#x2B;4ez7H/Lj1NoNsHpc6W6mRPvYXSrJw8tyFMhw7yAG23vQveOQkEyzPv1&#x2B;2Bc1GAfvdNz9dIwbT7dKmz117BTKPB6snlwlOfyFBNi9BtXug9RHN77yBnYR8H/uyQ04tP&#x2B;4mpJC28jL8yXu8djb0IvBJMCpEy341L1fwp9/4aN49/uuNWcHpplmmmkGQb&#x2B;SEr2ZUROKfrt5Wh1&#x2B;eeAogjQ3SBf&#x2B;nzr6c2ompxSwDdN84Svrt8l&#x2B;3jV1LGnbHwjJMd00eRI&#x2B;MGsqFleUSPWAdPPWTN75OFGcTALozn8yaAikLmOaSQBciuD/XMvzvRlh/GcF9uN/fT6f/Qtf&#x2B;MLcG2&#x2B;8cXVdXd2CnJyccj3gmykPPhPAzsYWGgHg6TzzRkr3pSMVjJT1S0ckZEovSN5WlCDJpNwcCUcfIHDxNIETDlVmADG3pBC5BL4Y7EU5LDsJWMS90a82t8UrhSdwVC1ta2lluaoonwzSFWUMY6xoIn6HO/txtK8fPodjHCBjAFZBQDeHBp9o3OOsEzWR7jq1Dg0LQE0FRKktEjzdjohFgWM0fmDCt6qTAIpSnAdLOKqRJOPJjPhn5lHYG3w&#x2B;jNugiUCqoVAiq0q/sCBdjgY6i9KAYjlkapMRKcloQZc/IKkJnH4xFA6LWn33iB9bWjsTar1ZsX9MUT3f8f6ppXAgwhqHo/kG1rwcqRThXTSTDiEG35ypsl542C&#x2B;kg5&#x2B;AIFcjCFL/tESyRCDwcht3o7elE1YOn1cMN6w6mbBZhAxgTYwCmtj4Lp&#x2B;FQJaUAyGIuEwfn5&#x2B;kW1gkkoLX4pKD&#x2B;4d7cKC7V0SSPji7XkIuM11fBvxPrX0Fm1/Zjn17Gmm7Ctx0DfPzfYYJw7eDcUrAyeNn8LmPfU3&#x2B;/vnD95mzBNNMM&#x2B;2SM9Yy2tfZi0NdvWgoKcDC8pI3ZT/tNGa&#x2B;0HRawv2/dMUiVNN8z6hxNCdHgvL86cqainHAg0ecIrc&#x2B;MXBmcBh/v3mnOBOm07zoPSmpW6tqKjGLAH8c9KdGuGUC8OlK&#x2B;qWW/tMD&#x2B;&#x2B;nWN1MATALgQgJ8I8udC/g/m/x9IyD/bMB91rJ9Ho/H9uCDD8687rrrFs&#x2B;dO/dat9tdTDe3LR3oywZ4M5UIMSK&#x2B;l&#x2B;5BkmnynY1VzCQYmA7IZ0sf0MtpykZKxLQ897WNTQIQ&#x2B;V&#x2B;EQNfCipKEpzcBmrV17QRwthPwO9zdR&#x2B;DcngSsFVxRXa4KvmQhYOKb23SmVVWH1zk29kZXyoCVWSMhXTRF6/AIXBLCnrTDVG8&#x2B;7SPQ1iU53mOA&#x2B;7hbLlmzfyxRwGDVmZ&#x2B;DmNullSS0jAX/SZoGvCZ7fEs8nvPyEGEW/US/MQKAr2dJzij4zzzYqueaoxEztQ7fuGWO9Q5IKF/I4LGyHgSnZfB22avA6STxtA/xTEBNPYiL&#x2B;sX8gUSTSyS7CEkq8M6oU9MVglnrDkhI49Hfvii6Foja1QcQRy3wDxZr9tKQ8fYIRzD9T&#x2B;5AQEpWZiAAOH2gfwjhplbkTKmGpSRPxCKD/qDcZ4Vut5Tsu5ImQDNp8lOgQ8BEaOJ1&#x2B;sQZ/PH3L&#x2B;LlZ1/DgX2HMTwUgJdBf15eolTkO3GywmKGLFr6T3/7A&#x2B;QX5OLDn3yPOYMyzTTTLilb13QG/7l9r2j3fOnKxW/afn6ypxEbTrXK3ExPgybdCLKrvRuP0rjDHv5pNE4tqhwlKDgikHVtOOS/vnBsdQB2Emw&#x2B;047fH2oSB0xtng9/u2rpOMFadjykcz7ogf50c/Jsv2Wa46dG/JopACYBcLGRA&#x2B;cC/q06743m5p9XZX4Yy&#x2B;u3fPrTn66//vrrL1u0aNHqwsLCqTJ/z5LPPhGPcDZAPRFl/WRSINM&#x2B;9ZZJR0ikA/epYU3Z8vwzER&#x2B;qwJ0iuVfxZfz00N5wqg0&#x2B;u&#x2B;oDz6e/l1eWqYrnesdOD/7fHVCF0xKjiEUFb1MLc1XF&#x2B;jT6C8nbGiQAt7ejG17erzJO/QVhAol17OVUktMWlET6QPIaqWXlOBS/ayQgx6SkAv/4Z94Wga3h7kG1vr0SR77KWIyvpCME1M/RcBROOm&#x2B;LXS0jaEkRRkw&#x2B;JxavK3J7JDIhE&#x2B;Fj1EYiERlojTxQ/HSu0wyU8zFq&#x2B;zt7EKBrZM1yyHyaTDqwByJIQDpmUei698pvBzt7RYegZciPYCSMgVBYJkVMMnGKgl2rgiB9TRNGjAZDxg&#x2B;StlX&#x2B;0ZtRGopicPcRBGm//o4eqWgRi6r1Izm9gP9KhITOjIi9/8XTahCZUkGd1p&#x2B;eumUiiyY1gy9vx/GfP4uY04nCBdNQu2gmFl6/AnMrirGsuhwVPq/uJk4cb8ZrG3ao&#x2B;e47DmJ4cESU79nbX1zsHr1HlGSpxnfg4EjXyUdt&#x2B;KXPfRttbZ148JGPweE0pxGmmWbaxWlHevpQ4KbnOI0PVq1qEY9t7AywvYmYk8cMHz0bOc1PD0Q4tcGb54QtQyPY2NyKHS2dODkwJNF/PG5/aO50yeGP2wEas1mQONdtxeLK0jH7e5bGsJ/uPSTkwJySQnx68VzdajXn9PzPEgmQOn9P54zLNnc3zSQALkXwny20/7zm5Wf5a8u23L333ltzzz33rJo8efLsioqKOTabzZkJ6KcL00nnwTeiyG8EWGcjIfSOL9P&#x2B;skUsGAnhT8eGZjrWEQLd7hQP8JNHTxLwCsJOD20O7b&#x2B;lvhZVNMEOa6HdlmQigt73&#x2B;f040tsvYoDJ4fUuiw0VOV7x6iraRF3RytqNAeAaxu4NBgik&#x2B;2FjMkIZf7ysvC/KsFqpwqSNjffmJ4F6Adr0Z1ATytMF4/HV/CEMtHWontuRiIRsszgcv9gTrbCoHwF7Vo7nkG7FogLFuIYCA8eIPwBnvg9SqM&#x2B;SSg8g4flXy//FEnVvU/umJQMZle76cvg/K&#x2B;pmU5hXoKZtcN75&#x2B;bIdHDlhIG0iQPu9vKpM&#x2B;lTc6gtUIuK26XVybhwZwJEnx3sH6DhjONxFQJ3anz/z5KUvGJRrym3hsRufUHCERP7K&#x2B;bDSOkWrFolgYKCbtt3cicCxZgydaoW/pQfRvgGp5CDh&#x2B;1zPmF9aVAiXPSxePheRkWDGU40RWI&#x2B;c6cDx37wIi9uFmQ11uGblAlxF4H/2wpm6IPUEHcPLL7yGN17fh1ee34Kerj7J6Xd7nCgsukTK9l2IQZL6TEFRHv77n36G&#x2B;voa3HH3DVLa0TTTTDPtYrPvbN&#x2B;H5oFh/OO1y8VrbtVK957Pp3pT/6B44HmMTwAAnXkBz9mimlgxO0n&#x2B;&#x2B;439Ei15sm9QExcGcmgsWzmpTHL3Z0tFp9Fp1C/3H4GD5kQLK0rHbdvB4sE0bbxjZh3um9dA4P/8PZPTpfvqzX/1cEImUUCTBDAJgAsB8s&#x2B;WGMgG/o2G9J&#x2B;r1z5jKL/esi6Xy7Zy5cqiT33qUysXLVp0VVFRUT2BO48eUE8nBJIMurN50FM/623LKJEwkeX1zkVPaFCPmMhUoiSb5z8d4SEiKfSemed8jzMxOLAYy&#x2B;OHTsjkWdIB6Lt7LpshINoZ94gmUG2MZfPRSMDPyznOiTx3VW3cRQCHWe3TA0Pyl3PF80RTQC37wjYYCqnMN62/qblNfrMpSlKA/ej5uWm5l5qaVY8wvWexO2al&#x2B;ThZvZbz0VVm2gI/7cvlsI0pVXiyf0ifKEj6G6NeWXvn9YgM&#x2B;RGlbdt9Hihchq97EArnf3MJwBE/YjwwulzSiaM0kLMmQYyJAgKnEfrM5fBiBBT1gHfyDcoEQBwIR&#x2B;NlBpNTBtIMZunsYFePlALMJgQobUZtPrXw/EUAHO3tN1R5gFM5VtVW6P4Wn6CwGB5bqZYasbq2Uv4OBcMIxqJoowlKz0gIJwYG8Nyx0xM6zphUPFAkhQAs2FhdCjcfz8q5UEJRhPuHETreDH9HL7p2HIS1fwTD3X2IDA5xvgt8BXnIWzxTLQ2pc32lYgF1ZE5Wce86gg/cdQNuu/cm1E&#x2B;vQ27e&#x2B;JzLfppoPfPHV/DKc1uweeMOdLZ1073jEKG7ktLCUQLMBP1Zze1x4Wtf&#x2B;Hfs3dWIr377QbNBTDPNtIvKOB&#x2B;eS&#x2B;PxdGoyjSXn23iY2NbWie8RkOcIzLmlRYkqM8kOCbvm7e8cDkgIP3/XTnObE0dPaQLBVkwpzBPPPZddnlGUl6iuxLa7vRv/t6dRdAV4PL1zVv24Y5lH&#x2B;/76qsuxsLJkQpVuzoYMSJ0zp2oRZcMGqdoBpgaASQBcLMSA0XJ/Rl5nHZKfBfBn8vaP&#x2B;2316tVFd95555xVq1atqaqqmm&#x2B;z2dyZgHQyiE1dJlv&#x2B;vBEPvFHRvXSigkbDt9NVAUh3zunO0&#x2B;hxpytxwlzzq6daJAT8VP&#x2B;gAOURAq&#x2B;cP8515hmA8UO9jEDItjPtNEj40Umgt4AAcAe9L&#x2B;ZSgP4AAppXlgF4cm49HwErxX9twzYMcJQBq7lzvXQeQAgc9YdDcFhsUhaGPbnMFLNnV0LhxwCqpIgC&#x2B;u0PjU2JESwuHCj54AoTKNZRgB2/JhZoJECMjtGRtrpAfGRU6DxKb7tKgB6nNrAmgJS4s9qkzYTcCEXUAZRLEUZiiNCgKSXkvG4JJWfCwMqVClJy0vWyCDj6YmdbF/5&#x2B;0w75jduIa/G6CZzz&#x2B;MypGfyZ243PI4/eszAjEwcFdI3E&#x2B;y0qvnb67EQjAVUjwyzvh/PxqnznR3ugY2REvA25LmfWZTkEcGZx4Vntx&#x2B;dywAeH9D&#x2B;28h4P/nCoyZByvi3HTdcyJiH8/NeiMiFyPaGE1T5AL0cB7eHy2fDRBSi57UpEOwcQGRjCwMHjGGlqRUVDHVBGx6&#x2B;RWIqikjdMpvH1qsnNkUnTirJiVK9aijyahKVaH90zb2zdh8d&#x2B;9Sx2vr4fp0&#x2B;2SAUODx1jWWmxVMZQFNPTP&#x2B;HJA903nFbz658&#x2B;hauvX4bV168wG8U000y7aOy7b&#x2B;yT8YoB85sBioM0Dv3f7kMS4TeopdDZNIdASNOr4bnUj2gZjs48SmNRj5TOVbCsskxy&#x2B;nmewdo0l1eWjqk2lGwbm9vQ2NOLap8Pn1kyR&#x2B;YTqXY&#x2B;UwwzgX&#x2B;9eXGyCKCRVN10lblMMwmAi4kMSAX72T5nC/U3EqZvBPjbsn1XW1vrfvjhh5csIGtoaLjK6XTmpd582XLks4n&#x2B;ZWZGlYz5QhMR70sH3DMdq1HRwGzRDoJbdOqcZmuPuBeRQfDG0&#x2B;346Z5GsJZiiAYKt8MmQmy8VoHmfZXwfgL939i4Q8BoTEkSSlFiiZA1J21D2GTLaPfjX9S8&#x2B;4jkfzEJoP6sCrrFxfgURWWimWxwp4D/ccfPgm/aMpYk8T0RtIF9nCxfCvwbpceTqfJkWlwDhFEG7izep4X0a5B5NHpAWz6k5X9btAEyMjSipgtwBYC4MFxKKkLqcXEbdtPgyx5t9Vqq3nlrEjcR11CQVAr6LqxE4ab9sCAfh9Pznoq0a9ZHINxls46rNDDmWLRtcurB6y0dUte3ikCrzarugysw8O&#x2B;OCYTrnaG2MFIzQZSCPcZL3WUzrlRh6Djpug4&#x2B;swXWolz4plbDQucb41QOPleOIuFoDfYY0HnL&#x2B;0gSmZXvhavQh7L6anDdQSVKfZvW4QgAnixxmxV5nFhQVoK5ZUVYUFEsOhbjJmahEF7bsBMbX96K59ZuwMlTZ2BVuGSkC0VFBQmPBd9bpp2dxUlB7uqf&#x2B;OAX8di6/8Zli2aZDWOaaaZdcNvR1okmAtxctjdTtZdzMfbcMwH92pl2iYpkQoDnVly551B3nzqbofnJptNt4gjgOUih24mPL5gjJfuiWuRnNiuhcZwr13xh5QJML8y/aNpYT/0/df6ebr5vZBnTTALgrQT86bz&#x2B;Ewn7n0jovmFAr7P&#x2B;uN89Ho/9oYcemnnrrbdeXVtbu8jn81VnAqqZvPLJ36XWus8EusfgAJ1SgenWN6ItYISAyAbQjaQSZFo303LjCASoYns/2nlAvPc2i9oew6FIwnOerMDPocweh21MKP44QJ0MMFMAdTxkzK6Xb6UBYCVBGaQgd4s&#x2B;gFRTE0Z1AXgPMc07H9fr4x/UtHwlQUkkEwljzkfvHBJMQgqQVt2y8j5xSjGtOgKfC4O4GMYTC6nnn7RPBt42qz3dKY85d/7dpQXas&#x2B;AfD9T8qUtTyE8O0Ut7fvSeIww4WuCN1k7k0HsG0VwGsszrFfKBow0m5eeIDgSL1HGKBk8MJhfkStQBR3xwLWBejwFw88CQoUkD96dK3/kpecj5ioe7&#x2B;xOVA9I/Sel50dOPYz9ci5jTDldBHhxFucivqYC1vBgFs2phLy0UUoBOSI0S4KiPOIkj5Qmj4vHnPscTKu63LOI0vSgPV06qkDzO0hzPuOvHCv4H9x/F2l&#x2B;9gM0b38DBPUcRpe9Ywb8gLy9xrxotnWiawcFTI0c/d/9X8bO1/4aayVVmo5hmmmkX1Lac6ZD5C&#x2B;fRx0n78w6A6blXm&#x2B;&#x2B;jfbWL4&#x2B;W3B4/BReP35tOtaoQh7fem&#x2B;lqc7B&#x2B;QuSBXn1ldV53QIjIalbC6rgo3T6uTiMSL5ZmfLc/fBP4mAXCxAv2zXeZswf&#x2B;EwbyBl6xXUVHh&#x2B;tjHPjb9lltuWT158uSlbre7yGq1OvSAaTbLVj4v3XLZcvWNAvtMD4VsCvuZco6ytcNEyvwZiSyIv3c7HFh7uAm9gSANBM5EVIBd85qN2b4GlWPRWMI7Hd8Ni8aowjU6A4aihvUHCaBakjzO8cEpGUtLHrVWF52PYcy2Ulz6HMYf0wYof1gFYTabRYCwUxMaDMeiEpEgEQjK6P54P55MXuf4ydN2OFzOyloFKoJT6QObun1FU55PePM1UkVhJsIyel0UCStPr/6ffJJRZTRtIZl9j8stWJSkBksKb7ClEC2WFKJA9/zih6B99lGbiBaEBkBPDwxq19kiwo6J40kQBzZEqI3zXS74qI2c9Jl1HdqG/EISZCUA6Ojq8nPPy4OTNR1YDDCb/5/L/AWOn5HyhHbq//7BIQz39KP/yGkB&#x2B;3avE96CfHgmlcJWWYy8aTXIr6tArCAXFjo3jlnxjwSkT/mcTlxWVoI5ZYVYVlUuXpDUe49B//69R/DkY&#x2B;vw&#x2B;oZdaDx4HP7hgIj&#x2B;&#x2B;ZLID3OS8eaah65Ne1sP/vUbP8K//M&#x2B;XzQYxzTTTLqjt7uiWVEsu&#x2B;3q2dqCrl8bbESGdpSqSjsWjOHme9sSRk0K8c2SUi&#x2B;YJH5/fgKU0dp2rled4L7r2NRIpm2nObFRjyzSTAHgrSAEj3n89ImAi4D/T&#x2B;&#x2B;TlU9&#x2B;PebGY3wMPPDBzxYoVcxcvXnwDe/rp5rEa9fIbuTmThfLSgeh05eayqe9nIwQmUqJNSVPz3qg4oZFSh5m0CDI9tDg/lvPoc10OYX9ddqsAvJFwDF6HVcOJo&#x2B;JzPGC43U4p88Lgj3PIHDabhKBz&#x2B;HM4GpU0AWuSYB2D7TICOkuryhCMRmg/Eclj57wzEZ&#x2B;z2SU3jVfhMjgRGpw4d/zRfY1qGkLq8dPvDMM5J&#x2B;2WqXWS/8542x&#x2B;OwGN3yHY4/5zz1jgPm8EspwqI8j997yXg1TY4gieOnkxUMohHAYyNBqD9dPSgd8NOBBjE0359Xg8I5YIz5GxauDd8HkRtFtiG6bypbWwlBQT4w4gQSHQV5sFGbeqoLkfUaYtzAvpgXLtW&#x2B;VpZHiY4uG05d09RK9LJuXL78HI2LQ1D0YiU5CQIFm20SpqAZRx3ggxkALedLR59IUKP1gTZwLoCCb4hKYWByZqhUAT9msYBh6zb42kg2Qg9erUMDmP9qRbqbw6aRHhEV4I9FK4JKgSfHBiQ/mzNsp4lx43hA8dhcah6CVzi0ZpUiojvmaGefgzStWe9hxY6z9zifIRoed&#x2B;8ekyaXodlN1&#x2B;B6SWFWFBWjMlc4jGlZXmCdWj/UWzesANP/HYdDhw4Av9QAG6XS4TpnEwmADAh/1tnQmzSc&#x2B;B3P38GedT&#x2B;X/tHUxTQNNNMuzC2t70HrTT2cU79ZWVFZ72dl0&#x2B;ewYsnzgiJ8NDll0FvuifzMYsaeTmlIE/me/X0d0llqYgCvq3Bk041gGzi2pnwiGkmAXAxkAHIQAZkigLQA/8ZwXwKAZDxt7vuuquaXlfOnj17RWFh4QybzebQE7rLdJNmEvFLx8ql86BPNERfTxcg2zJ6gN1oBYJ0ppeakI4USXe82YgRfv3u0HEaAIrxwdn1aB32E5C3CkA&#x2B;0z&#x2B;C3zceU9X5GXgSEPrg7OkC4kXAj8OhtQGFIbOXFfbpPYvNvECDEXt/4/tkrzELwnx4/izEohE1zJ/3r&#x2B;W3yxbiYdvxQ6TPTxNAZ4Vc29iOoi5GAMtrc2ABAWvQNhEvu2dJvkWUJLd58raB072DeOb4KYRjyWBUGUsG8DHS&#x2B;R99fAMBRPV4LU67mpfPwn4s9Eefw&#x2B;GIeNDt9FnRzg3xvH0WIhwYxuJ//wtYqkuAcES/PGHSTfzFlQsllD4Uicmx8CH2auV3mAAYCAap/dXQcyYKmOBgkqU7EJQtMOhnj0CA1u/2B5Bcvj7eRKkChAycWcqQiR0WGLRr4F4N/6dzsCii3ZB86NZ4v4Kq22BLKDEYB&#x2B;5MMOxp78aejm45p3KfS0if6lyfRBUwITAp34scuwO1&#x2B;blw0nVgwT&#x2B;LzmPwDLWzkQGa&#x2B;9PgoVOwpolQkHuDySk6p1AgJn14mNpz5uwpuGHJXKy4egnmLp0znsikV3trF574/TpsemU7tmzYiRFaz8mEhtsJT5F77PPCHMsuiOXm&#x2B;/Dojx7Hu9&#x2B;3BouXX2Y2iGmmmfaW23fe2CtOkFum1Zz1NoZpfnKib1AcM3V5uUg3/PFcgQec4hw3/vqKRch1OidMsF/MZtQ7n26Z5Lm0kTKCppkEwIUG/uly/9ORAXqif5nAv&#x2B;HP99xzT83q1asbVq5ceUtxcfFUh8ORa&#x2B;SmSQek9QBtOi&#x2B;3EYCcjRAwAupTHw7ZzktvO5nYR72HTzr2MTXyIdODMHUbyZ/ZS/7bg0fxF8sWYHpxAeoL8wT68m9cbu0nexs1NkIRT/NU&#x2B;r0mL0fzQGuOY8vofthDzKX9LKmECFSRGQbqYQKYSD4nDdQr9H3ycbNwjWUMqE8FzIpUHWARtriSbbZBIFn3gIEne5z9kehYBGdJIgN4V1437C4HrJwPF1MS3nKbx6URETFQf1frwWvHZ9XOLE4nBOgYoeXkJ84hTmak5OKHqI2YYKng/PNxUN1Yv&#x2B;PzDIYj2NDciu&#x2B;/cUAmGalANRWAzisvQl1&#x2B;nhAP3SMBdLEKMANfup79oZDo4Y3Q&#x2B;4jUCFYV6RNVHBQlcRo29vxbVOGdcdcsteSiZlz5QMpE0mEOBCISzXGYy&#x2B;wxqWKxiLAhXys&#x2B;LxYM5BenGXBJolz6nvtlocuFJpoI2bI1FYtGnu7AUM8AgXyrbhsGA3SedB04ZHzuwhlYcdUi3PLeazF1ei28Xve4dTpau7F1y278/hfPYPf2A2hr6YLTaZeyffmFeRMm/96SweQdnNfIoa98bb/z7Z/iez//hkRkmGaaaaa9Vfbk0VNC6nOZ4vUnW&#x2B;AlQP7eGVNE/2ci1jw0jLZhv5rnr1NSNm6s6s9Pexb05ejLrDo5l5BFaH7Q0tKC2traCY9/RipkZdMBM80kAN4q4G9J81u6igCZSvjZkpaz6YB8vffy126322666aay22&#x2B;/fd7ChQuvqKqqWkYgKCd&#x2B;g&#x2B;gJ82US4zCS364HaCcSGp8OEE&#x2B;ETTSSNpApxSHbw8NI&#x2B;UK9agCZtqPn&#x2B;RegRn/3d3ajfXgElbleAYzRxDaBTgKBw&#x2B;GIePbjTvR8pxpSH1P0H6hRBuMRJQlZjoJXWzLoTPWC6hAlHBmg5vHrAGBZXkFfMKCK7Blkh0e1DCCq8yx214PxKfkJ4zw5GiwZzPF5WzG2OoAo/o8yBiq2taR&#x2B;tgrQDPv9kpevjDuPsdxdiLY7Qu0uwnMTBHKqgKIi&#x2B;gMuOj&#x2B;JsIAyNtRcB4Tzp0pfDu6dN2PMMrzOYDCoVXtQRfaCkaiE&#x2B;w&#x2B;FQtKHmgdHJO&#x2B;e24cnNKGogu4Rv6QtjCmrCCCde0IE77QUhvgEyKGRFrw2EyIx7Tr20D647CTbq6dbJXySd1FIIE6EK7OQjtxGva/uQpSvp00lYHj/nKfPSv5sDXOmYunK&#x2B;bj2piuxZPk8eHRAP3v69&#x2B;w8hBef3oRnn1qP3q4&#x2B;ag&#x2B;bePpLSgsvKsAffxbHNAIrGAwlIoCkD1MfdTkd1FXfWROcF5/diO/966N48EsfN2dZpplm2ptiHKXXSWNijVYWj/Pw99Hci/9GLDEZr39z4Kikwj1w&#x2B;bwJbftk/6BEAYgIr0ufyGQHya62biHUG4ry31bgv7e3Fy4674MHD06IANBzjCXPj42UCTTNJAAuJCmQCfTrkQPpyv7phfbb9EgBAvt5Dz300BXz5s1bWVlZudxms3n1gHumGysdwD2XPHw9Vi9ORGTaTjYtAr1tZotO0Hu46P2mR45kSj1IRyJkaoNMBAoPAltbOlCW40ERgZZo0nIMdLsJsHIut6LE1f0tInDGIEJBuggFq3iM1V0n&#x2B;5kVEeMDMudcjTlH2p/TZtUA7fhrIdULCPAFOec7eW9pHuSp15C9gD4C9uPisMdUHaD9uBywuZyI&#x2B;YNj8sRHAbxFf90xm7QiNhQYTV9IrTqA0WgIBqKpEQ3pGOjUzzElqc2pf9lTAXgchKeQADFtUhJXnrfEqxeQJU8q8l2ZPaWs/8BRAb87eAzPHzs9FvTrVU/QiB4mKcIRNY1BhBy1nAWORhDyQrveFq3CgV0jB5jEiWpVGDhVxZBacTiKQO8gHLleBAaGZL926gfFBNpXX78MV61ZiqVXzEdxSeG4VYeH/Vj37Ca8tv4NrHtqEzrbu&#x2B;QcmCDIz8tVo0CUiwf483FwesrwIKchOODLyxGCYsnseYhQHwv4A2p6w6Afhw4dEwIjx&#x2B;d5x0xycuma/ec//hR3fPAGTK6fZM4qTDPNtPNmPBY&#x2B;dfQEXj7RKqlr/3jtSnV&#x2B;RePbR&#x2B;Y1YG5JMZ45flL0iBjArz18ArdOr5PcfOMEwJA2D4hhJBLWXeaJIyckxa7I68L7Z9e/LdqWCfxAIIB9&#x2B;/Zh2bJlcDqdEwNQOtUA9ObR6T6bZhIAbzXgT/ednghgtggAXS9/b2/vDxobG19&#x2B;5JFHXli/fr0/Dvrvvvvuhmuuueam8vLyRR6PpzIdyM90o2QKe9cDs&#x2B;k813qg1sj3RtMCjBIVesDMSBpBprZILWWYiUDIxmzqfU7eLw9CLEIzJT9XhOaS983/9/qDie4kOd42SDRAOKakBdYM5hjo6xX44xy0bFUTxhw3VM8v5/qPVhhMXsYCP4G&#x2B;IRb7I1CTDL6zhXIpWpg&#x2B;iwTGxtxc46MNLDQwu2lAHhpoZfc0xooJpMq4WXTIBNoXtVukn0CYdSz4T33PpAeDYJVEUdFkOkIrq85E3MOrB77j3yVdbyVNP&#x2B;SBNpM6bnL/5AgHDv1nT3xMA&#x2B;u64RXad1wV4pZpdVhaXY52CWUMYCgcwvGeAemfTQTU2SvNHhQmo7ituI&#x2B;5JHdfrUZg0dIobEYAMU/K6P&#x2B;8D6xB7g1L4e0dRj31r5Wzp2A6TYwmTx0PAsN0LXZsPYC1v30eWzfuxsGDR2C32CUVIL9gtGyfkoEAequNr9/wkF&#x2B;qV9RPr8XKqxfhquuWorKyTEiA8soS9Hb3S9s5uboFLb93dyOeXbsej/3yWSlLyGHxNta0eBtPemx0P7Ng5C9&#x2B;vBZf&#x2B;rvPmLMM00wz7bxZ57AfvzpwDMFwDLNKCsbMErj07a30bF5Cz&#x2B;Jf7D8izhgWv93f2TshAsCC&#x2B;NzAIl7&#x2B;BeUlY2YhO9u78BN6tvOz7stXLBax5ovBTp8&#x2B;jZqa7NoHyXOMttZWVFRWitef0y6Hh4flu6NHjiDX5zs7YJVlvp1uzm&#x2B;aSQC8VUA/E&#x2B;DX&#x2B;z413z&#x2B;dBsA4UqCgoODKZcuWXfn000/fu3379t/RTVZWXV19I4H&#x2B;MrX/jwLJiYjuGSlvl6msXbrljJQBTAe&#x2B;0x2r0VSFbBUFJupFM1JSMF2UQTZtgdRtMVA70Tcg4dQrJpWPaysGcf3BoFoaTvuOS&#x2B;kZOAnpUjGMjzQPhKOJzqdkIi8S56lIffkYxmLtRG6&#x2B;RZH8fS75VwCX1KyHDjliSdl2fN8MHgtcLiEYEqH7ySguvh1qC1dFIZRjpwCPMwXQKmPPaNzJiYwebA4bgv2DyEmKABi7VHKZRYjI35jAggz9NFM/dNnYk68PvlM/x9JUqjDSj5P7JxMGTGAYGSY5nWBOaZHUQJ6d5HGPR5mcGRqWiAAuc8TChrvbuqRvHunpl&#x2B;U4r5FTDXgZp82WpsKBmgYRjqlifsUE3KdWlGBFbSXm0WSpUCcckkH/of3H8fyTG/HsEy/jxNHTCAUj4kUvLiw0nNLzlg4c0vYxDA4Oo7AwD3fffxtuueMaLL1ygYD8Y4dP4aVnN0vaQndnD06faJU8eCvdY//907/F6uuW4&#x2B;prl&#x2B;E9d92Atb99AY/94lmJRnFeJDWd3yzjiIhnH1&#x2B;Puz96G6acgxiXaaaZZlrqM9kjToz0M/sKnxefXzYfH3p8nQjuTjT2alphrkTMsRbPK6da6HMeKvNyxDmy8XQbtrS0w07g/7opkzC1IPeCtsfIyAi8Xi&#x2B;NUYPYtm2bIQJgz549UjlnRkMDDjU2oryiAidPnpRttLe3o7WtDU0nTuDee&#x2B;45L9dLnX/EsooFmmYSABeaEEglAzJFAcRnubrAH6Mh/2J0k05ZtWrVwyyuwTdtMBg0LH6XCh6SPZdGhfnSEQKZyIPk7SaHMmcC1EZu7Imet140wNkSFOlIkkzgz5BGAv179VSbqMDOLCkgcB/vDorm7bdp&#x2B;dSj22YA5qAHsY0Glqim8y4eWSk5py7IIfJ2Td0/FWtGNEl5Jh8YfCeK7ynxCAO15GBUU8/nMnZlnrhquuodT6j6wyJpCmHNW87rIjpa3zWmefi5skA0Sagu4d&#x2B;3qn73mnyfCMzlEMhR0nmqWTCsKJ9GrwCiDi1lgLfFHm6t4kAiHsCq3nKKeM2tzDKoHv5IDEH2aktFBKRkDYzf70AgnMiJT0M1GOqnEtmRrCSQKsaXtA6HhMfiJMlZpOMkf8dVCZIZIL3KA/I9fXDbrIl&#x2B;kMhVsqrtWqvlTE7KVcWNrqmrlr9D1Ae5zx3q7hViir0nPPmJascfJzQkrYG27eYyS&#x2B;XFmFtShCVVpahIU6/44P6jeI3L9v3&#x2B;RQLKBxEJRKnP2wkou&#x2B;F2G38eXAgbGhiCy&#x2B;vBw1/&#x2B;JN79vuswedok9PcO4tc/eQJ//N06HD7YRJ8HYKe2YKKAS3nyuYwM&#x2B;/GNv/4v/PA3/yDXetkVC&#x2B;TFhMDnPvrVt/8IS5ezvb0L3/7a9/Dfj37DnG2ZZtrbzPzhKHZ3dmFheYmI7r0ZxmPPvo4eyeO/ob4mMScyDj5ZZDcqkQFIGsNYNDkSSz/mzCwuRAmNT5wCxxWC/n3bHimhzOfM5ZjzXA68b9ZUvK9h6gUFr/v27kV7Rweuvfba/8/edcBHVWXvb0qSSe8JqRB6lyIdRIqgoIJYsPK3Fyysu6ura1t11127rnUX1wIoKBaKCtKr9F5DSQIkkN7rJDPzv&#x2B;e89yYzk/dmJvQy58eQKa/cd1&#x2B;59/vOOd9BaGgorr/&#x2B;es15L73//vvvmSxYvWoVbrv9dg73JzKAvP852dn8uV27dpg8ebIEEo2nDyZqpQf4vP8&#x2B;AuB8IQW0wL67lzvg70QA2Dte3FRhYWFwJQI83RDuhPY8hdu7A/&#x2B;ecuO9VcZXIxrchVN7m37gibjw9gGsVRFBrd1aHn&#x2B;tvmUmVoD7HXkFCBaAlurQrsvOk8GrjQEV1YglJXijg3eUVl2Xlc2l6eh3At4EZunmrBWAIoRANA22DQ1NtN44X7/ejM&#x2B;27GEwHknbrzML0Gnj3DilXn29aGNJrZnD1EjpfWdBMXt2GyGw88w9SPz2rQBtyWEhHCZOIJbUdG02C7cjNCCA90GHEWT0EwOkhUX2CHRSSbvcqmrevipho3jGxXYDe3ZAsqUBBrHt2oISqfyf2KdVgKf68irogwOkDhKfLaQgbxTbJ107sS55ky1UJtBPgPG6hqaI3vWeE20jwSDab4PNyur7XGKPBdp0rLBvL2sInXMtP&#x2B;U7GU3TRMBOGthUWBn5M3uPbVavRTPdieLQt3QuXMkKtbgJ8tlTnr/yo5N2JLRJuhDZK92rRSz/pSoHq48e5&#x2B;uHrgGd/F1adBj6JMShU3QE2kWHO4s4ynYwPQuLflmNbRt24/fVW1BRUiVAv5&#x2B;YfARCZ7owAGx1TQ2GXz0IDz95By4fIJW1e/fvn&#x2B;GbL&#x2B;ehuLCU0yn8RJ&#x2B;FhjUNk/QX5yo0rCkhMuraIbjvsVvw1X9/vOi9HjTOUbTH4p9X4aprr/DNMHzms4vEfkrPxLwDWWKc0eHD0UPO2H5eEWMHVa4JFc/Za9p6L0ZHej9zRBup9C05ZHq1iJG&#x2B;p&#x2B;pCYuJyWUwMj11a1oJTCVrif9v3yeOylL5J8xsiva9t2xJXpCac8/Owd98&#x2B;BAVLRH55eTmmT5uGmydORFxsLDIyMvDjDz/gyT/&#x2B;kdPOasR49tvChRg1ejSuGDIEWzdvxuLFi3nZCrHuyJEjOSJAf4bEDL1JC/CZjwA4l4Bf6707wT81DQDXl&#x2B;YEiYgAAjOUd2M2m5uAAa0SfWrL2BlOa6PXVosJ9ARI3IFzdwSEu1B5re/dgWqt9ARP&#x2B;UPucrk9HYMn4kLLSuokJXUKtf5&#x2B;fyZ75G2yF9Yoe&#x2B;lpbT&#x2B;ZFCCATl7Xf63dxl5vihCw2CRVcQN72RvLwFEEALHsjqCT1i8TwH7egSMkii9X05N&#x2B;o/1x2ToBRBQBOMnxrmPgrs7YS&#x2B;vSgEniNptPFEhtZkE5qQ1KiTq6qBtkUUEpUMBmB9q0o0A/v6Z3k&#x2B;OeBHg3dUxFcpfW4ngt9tx67hk5rJzFAWnfFPquk0L&#x2B;rfUW2Mz19ioA1hozLA0N6ofi4B4PEsCVCJnteYXwF&#x2B;/D/P2570nlnogRajf1O0UtkCgj&#x2B;bzrLQ2IDQoSy5g4fYDAL3m5idwxqAkBOhEBOlmLQDqvSvqFM7MgP1JcdAhsUN&#x2B;sAsKheeakv&#x2B;Q1CQnw94ps0Lx/xKuophbl4plEfdJSPKf6J8fjMjH5oT4IdPEMUN8ViGtm0c&#x2B;r&#x2B;bV1026UFpXxxIMAckRU2AWT60fPz5LiMvzl5Ucw5Zl7&#x2B;Lt5sxdj1pfzsWbFZhYnpFKE7iY6dNz3PHqL6u/xSbFe11e&#x2B;kI0IEkrv&#x2B;PfrX/oIAJ/57AI1Iv135Zcw0T8wuQV/R&#x2B;liVMY2KST4jD7HDpWUycLCfqoTdIPT3AzIKC3nuQtFrmWXV/GYPeXyHvbIgf6JcRiQGM/jWm5lDbdfy8YIkB8dGMjbrOXKTUZ0iolEl9hIJyfO2bCsrCy0atWqyfck0qcA9gW//or4&#x2B;Hj8Mn8&#x2B;7rn3Xsz56SfExMRg2bJluOqqq9jzf/c996BXr17sfPzh&#x2B;&#x2B;/5&#x2B;9SUFERGRZ1d8OUD/j4C4AIgB9SqAOhdCAGt8H&#x2B;PBIBiJLwRERFhJwLor1pNek&#x2B;kQBP1cjfid96oumvduJ7U8NVudE&#x2B;MnzfEQ3NJhOYSJ2r78kYfQfm9jHKnBUAlDMw5ajY5BFsvhbNLaux6hxFMWs/kJ&#x2B;VZWzklQC9jQhuXbLPJ&#x2B;f8S3mzqZSYYTyKCTfpb/uwqTmPHxS7R6joX0X0iCBSSwBGyBspVLhWhPSXLXid7zRsd4o6AVp2gsdZRtIO5SVi&#x2B;0hirrd7ulafkBsqd5vNhNMhEgdgvhVwrJQttKghaxt00YFN0BQ38Nrmv6cY8XAoWwtNzioPUMXSOKMRfKpkokS4UBmji/ep40hFgdO1XpeJAY29RygZ5L37YexAFNWYkhwYhhkrf2XSICPTn6AnqJyIhqK9pIDdShoOKLoReSZGgfaietMbUACZ8oPOKfNO873TScY5tk4LBqUlcaokUlV2tIK9IgP09mP31r9i8bgeK8ku5/UEhgXbF//Mxt9/dPe8vjvN/376Oq8ddyd998MaXeOOlTxEgzlNEZCjcHoboRhICvO7mq9Chc2vVRRbMWXnpTDLEdV1QUIKcY3lISon3zSx85rMLyPKqavDyms04KJ5p17ROtRMA/mKgMp5mEFevVKtx2G6AGBPNLiWJbQ4TGSqTu6ewhMfZHXmF2Cf&#x2B;lsvlWEn876EendAvKc6&#x2B;bmJoMF77fRs2Hs/D6LQU9JYjA7RAQH&#x2B;xbn&#x2B;H9c&#x2B;F7d&#x2B;/H7O/&#x2B;w4vvPhik98MspOkqrISgYGBGDR4MD75&#x2B;GP2/o8ePZoJgf9OncpAn4y0hMjxSNEARBIsXLAAS5cuxZQpU6RtnSXw7wv79xEA5yPgBzzn/sMF9HsTBeCVORIBdINSPo67/H5P5fY8eb&#x2B;bG&#x2B;LuFXAAvPaYa7XbG&#x2B;DuyTPvbXUCT&#x2B;kEnggHx/J5pWLgsYDK5&#x2B;nt4njKJaOze7gbvcCO6&#x2B;pk4KasYXUAc40A0/OAa5WQs5x60KikrnMAjDY0jQbXErS3j7Xyd1ZZKFDaV&#x2B;Mx8nubziFE3dXbrd2vOjVySjkGWczAJosRUiSAE6XgVpHf&#x2B;fg4&#x2B;sFFoV/SKDRI&#x2B;gqOm9LJpIy8HRZOlNtBOfZ6BxJEjQhQjoy86NN3HZTubzGZqZdJuVBZH4Heh5sCeNJDf0PkihCUs0jVFCiVIsLkz/snYUadCwHUhAiQjdJQoOgp2BrJQFszBmSaHPVJbDr5qaysxurlG7Fm&#x2B;WYsmr8auTkFMIgJYSAD5DCP5ULPW/BPUQwFxfhi9hu4Zvwwbv&#x2B;TD7yChfNXcWUCnRxFo3nvifVrxPkeM/5KvPLOkwgIaFpC6bN/z8TqZZsQGRV2SQysdMHWVNfi8IEsHwHgM59dYJZfXYNc8byn8cTkd&#x2B;YA4qYTBViScQz3CsAerxJd5TjEHSmrkNIkdSS6XIm/rdqE6voGOeVRj5TQEAb9V7ZMRJtI5zD/hYePYuWR45wSMKr1&#x2B;S9OShhg6ZIleOihh&#x2B;zf1YnvAmTxnKioKJSWlbHzID09Hfn5&#x2B;UhLS4NZYAjy/BOoj4qUiPj169czmTB06FDMmD4dE2&#x2B;9FR06dsSAgQPPGvhXm3P4ogF8BMDZBvtan3UqZIAr8Hf8zVPov6oGgDdEAL2I0aMHAJEBjmH9nsoEuqpuNqfchqdSgN6G0qsp6GuVK/Q2HFZLpM8dyNcC7N6UPGwWiSCWqSLvslU68&#x2B;TtV8LiKR/NaJDU8A3ib4DsVVbWJcBXT&#x2B;HdjG11HGpHwI880JSvTgOdkn/dVARHAqKUH26RUwdoV/X1EszXOYTWE0iXlpGAsD8tK6cluOJKJeKglsPO5SoE1BaDBGL5WPR6u7I85QLS4TbILD4r9dpD313uMAf2gUT99AIMG0x&#x2B;sFoo3L&#x2B;BQ/4MVIu&#x2B;QSpxqJdL0nFoBZWuE22iMmOEbjldgNpgbnAmAVzLJcif6x2iBaTNSg1iWUGZBJC87Don4kPhB3QuFQccAb9OPhfKe4XACZXDFzmyQn4cMBHAO7Ny2gitl1NRJQkG6mSxPYuVvel&#x2B;Rqmf/Y1aivzOOgR&#x2B;cjUK8naQUF8gaScYjE4PO1cR0SbPES5p2chdErBduXgDVixejw3rtyNj/xG&#x2B;1oODTQxmlQgWb0m/89Gojx958g6MuWE4f/7k7RmY/tlPiG8RayfUtNe1wlxXj5FjBuHTr19TfWYc3JeFf7zwMZMkl5LRfbx98z5cMaKfb9blM59dSCBBL4HqOpvlzIH/4wV4fd02joIrqzM7EQDKU7RGzAt2FxRzFN/sfYflcVKKxKM5TXiwP9rHRGBYaiI6REeySJ&#x2B;aHS4pR7vIcLw0pDes53iY8jTvzc3NxfezZ&#x2B;PmW25BXLxEnpKn/9333sPAAQMwfMQI&#x2B;AcEsFc/MCgIVw4bhoMHD3IVgA7t2yPn2DFW9W/Tti3mzZ2L1atX4/kXXuDt3DVpEpMH5xSINdNR6DMfAXCuiAJP3n&#x2B;tlIFmRQBoEQEB4iYnEoDEAmmiqSbS4c6r7Y14oCd9AK1ta63nLZHgKTzYG8V/TySFu3Z7S1popTzoHDzKBOQZqIuBbGKnNuzBpTz5ouoaBmIEBn/PzhODUJkk0gawEu11bVMRZvJHSY1Z8txCyqkPEsCxoLqa861poCP2WvICO&#x2B;vYB4nfb&#x2B;iQhhBxrehZa0CHYrEtWirSFMCNK66ugz/V55aV&#x2B;il07ru9h3k/TtjGTh7Z0DU2imvJW7nEIekN1CE8MIDZdrOY1AdT/hkNSuIz6QZw&#x2B;HOtGSH&#x2B;Rh5c5x7I4v04JSXYHGXsdGgoLEXlul2oJ1Kk3swif4agANjEy1JeJfrJCKMAmFYSM6yshr84HmNQIJMkRAT4B0l11U3d2sBiblAFxMpx0aek0CDUW6TwfwLh1aJ9BkiRDXXiPYFaHRMFFln9XgL1VpdrgMgTAuTOInzqaQ8kMkjsgs4haqAxzLGx6kGTeAk/ZX9Wifxwl7fhYCTGSGGOFAJJBEI8gfTAAL4&#x2B;EkODeOsk9CdpHTS9d5XnCynZ7919ED/N&#x2B;g3rV2/H4YNZsDXYEBDoj/CwUKlPZZHDi2H47tS9LZ59Vapbn3U4Gx&#x2B;/Mx1JyS3s1U&#x2B;0nkE1VbUwmvzw&#x2B;kfPYPR1V6g&#x2B;fw4fOIIp9/4NwWJye6k5PKiP1izbhMeemnTGBKZ85jOfXZhGFYMCKfJNjOeVDjpYlE5ZJZejLRJzj1fXbGFNI3oa05j9h37duaJNjVgvNTTYSSdAy0jYeGlWDl5dvQVxwUGY0rfbOTnmgwcOICExESEhIZrLUE5/SGgoomWgTuPQL&#x2B;K78ePHY/68eey5rygrw5ZNm3Ds6FHk5&#x2B;Whc&#x2B;fOGDJkCMrE90QMZGZkYPwNN6BKzCOfffZZhIdLERHnGvw3Z57vMx8BcCbAvTuxP3dVAABt9X9Hz7/j76dkJPRBLyIA6EVRAa5EgCeBL9coAE/A9mRAtbdt0GqPNyC/Oe3wZllvyAlP/aOUyJPK8Ele9vakkE7hZw7h4vQ7idHtLSgSwFYKD6b1UgWYGpaWyJUAFME&#x2B;Ftuzt0MClJml5diRV&#x2B;QE2qxyeb/BKQlIDAli4M5BCDpJN0BBZkoZQPbay6XcaHvrs/MZyDockNQu8TpeWYVhLRM5okDpE1pPEjOUQJ9eVsiV8uj18j5J/V4MPiXl2JpX6NJ3zu/1AoQe&#x2B;3UtzGbJ88/ifuJ7EqkxGv24/6wWC99KBjkKQIpsoTALi1ROMMCEjn&#x2B;8DfqOLWGtM6teT5Q3X2NpwMCklhz6VysmF5TTXmauh9nSwG2vF9ujaA0iNBp4H1Qar4HL/vgbpDKLOZXVfA53F5TiiOg/o0zkqNYWhBLwYOPtKYRCg12bw8aEA0WF6GUNBYo8oP5V0it0rhu3OagbuhIBMkGgnBdqNxFMx8rKmYgKExOkNlHh6JsYJ12ripikXt94fi3krd2L31dvxS8/LMWh9CMsTkrPn7DQkMZ72XH/HtI9LohJaK0Zo6&#x2B;9guvXm8U18fpLnzLBpFXlhH6rqqpmgnbwyD64/9FbMWR4H9Vtr1yyHn957HXkHS8QE7rgS26wpXtrx9Z9KMwvRpybnFuf&#x2B;cxnl54lhQWz04QIABIbpPJ7NIZM3b5XjsLTIT5IKslH4xYJ8fWOj8HQ1MRm7adEjIc/pmfwOLxNzKNu6RRxTo6X5i&#x2B;Ud3/HXXdpLkPz/JjYWKTv34/3/v1v3D1pEnv5CcC3b98eAWI8/s9//sMK/ldffTXqxBg9SSxDpQDJaMymKjZjxo7lz/37&#x2B;aKvfOYjADyRAmokgRYZoEUQOEYAGE4HAaAYRQLQy2QyedQIcFcBQA3AqoF1rUgAR4V&#x2B;T4BbbR/uzNMyjsSHp8oGyrLe6hV4SwyotxkSSITkPSZw3TIsxDkjXCwUFxLIdeSVHwjsbTqehz6JsY3bt0hgrt6htjz90jo8DFuOFzJgtE&#x2B;uxatKgFTKi4tQyTl2vSZsspAeDaREGmw&#x2B;UagK2mi7R8srsaegCF1io7hurtI&#x2B;KYxeWse5362NN5L4jkrFrT2Wy&#x2B;q5FptN1fNpCA1EdLd2yN26H3oWyJO&#x2B;90OA04PKHjNAqQf27UiMf3lxKUo27EF0x1Q3ZA449WJZ1nEMb5WMmGATf0deA50DU6KzCxIqpQClSgdwSKvRGw1Yk5WDj7fsVuc1HAdy0W/D05IwPDWJVZPzKmu4L&#x2B;oaGlBYK0VpFFbVcGQH9WuNAOBVdfXiujWgtqGeCRdKJ7HpdCy6JJVvbCoGCZ3OiQigbVnlKJL20eEYlNwCHaIjkBYRJq4fvbxKY2xGxqGjWDBnBVYu24Btm/agttosnjV&#x2B;MAUGsOo9POb02zQ&#x2B;n/9kANeKFuelV98u/LmstALLf1sH/wCjA8ei4/60WBpQW2Pmfuk/pBcmPTgB18higa52Iicf06f&#x2B;hC//M5tvDaqGcEmGOsr9u2rJRtx05xjfTMNnPtMw8twuXPgrJk687aI5puKaOi4/rGWUImdkAVw9FmUew5pjJzjUnyINqezefT064AoxV8muqGQCvXVk2EmNKiQATBVsrm3bCh2iwtEt7tx4wT2NAQcOHMDx7Gxcd911/Pp5/nwsWLAAt0ycyHn&#x2B;mzZuZIDfp29f/l3NYmNjOVLgVIzKClKEgi9qy0cAXCrA3xXguy7jTci/q/f/tKtrKBEBjkSAGiD3BFpd37vLsdfyhnvavjeiflrtUSMN3LXFkwihu31p9Z87YUXnvtEhhIXXpOWyBIiwpTqvR&#x2B;AxWpwzyk&#x2B;j&#x2B;rTsARcrHCopF4NkrRgkTep6CXI&#x2B;NkUVVIgHfyQp3zu0jbzv207ko1d8jIN32f05IY9wamgIpxZY2TsNJyJAuah/P5aHni1imZ1vGo3hBgrabAw8rTop&#x2B;kDBqa7r2sRxRQ/tgeKt6eytVo3acLkTXekKv/AQHF&#x2B;3AzE3D&#x2B;PtqZJPctnFE5VVOFhcit7imJRqAO5ItCakF/EzZiu6x0YjgUoCCvAOuHAoDs5w6ufiqjq0FRMOoz3SgsIarNw31Ka6egufN2ojkTm0qzrR38crqnhTpO9QXFuHXQVF2FdYCqiIDyqgn7ZDlQvaiUlS&#x2B;5hIBv4UJhng5&#x2B;fSp1ZkHDyKLRt3Y&#x2B;6s37B750EUF5TC4KdHiDiugAh/u1yDImjpvW/fNeJD10xC4OxGEdAp9jf54cC&#x2B;TFw&#x2B;oDuX&#x2B;Bs8/HImASgShVJMKCogOCQIkUSmXNkeN95&#x2B;DUZdO0RVPIlSJ76d9jM&#x2B;/&#x2B;g75BzNQ2BwAPRG/SWd52igMpyrtvoIAJ9dskbRVfQ8ISeOlk2b9hU&#x2B;&#x2B;eTji4oAoCoC5Jy4s2t7tIsKb/K7nxivlAkzpQNQ2UGaF7WKCEXfxHgMb5nI5EDbyPBTageN168O7cuOmnMKOFxKdCtWUFCAyspKbNq0CTHR0fzdiRMn2JPfuk0bvm4mTJiA0tJSbN68GWOvvfa0t40iD2g/q1auxKJFi3Drbbeha9euvpvXRwBc9OAfXoB&#x2B;QFv1X837rzuTM1klIoBu2urqav5rcxHv0sqx98Yj707xX4vNdFdJQEsnwF1ZQneMqacqB96SFd60x1N/koX4&#x2B;9u90&#x2B;lFpXZhNMdlyRveKiwU&#x2B;&#x2B;l3eVkKTTtRWYPooEBNooRAeqoAukFyrpyBc8IhO6p12HiiANe0reJBzgrvNBVCxaDcJjIU23ILuV02p9IAOtYWoNI6JTW1LATkqS9cyYsoUwAGJMVhWUa2dGwuoIvXofJ6ndMQ0aMdCvYcho41ELyIynC8IcU65upamHMKgJYtxDa1S97Ra&#x2B;uJQgwQwJhq&#x2B;3qrMdEY&#x2B;i4dp0kAOvIgHBfH1hhB0LT6AE02KA0is6wCrcND7WSIsoqFPPt6aRJEFsxA3cYpDinhIY3b0&#x2B;vE5CkC/yzc4lDt0MakiUUWFKRQym6x0ejRIhqdY6IQSNENDmwLE1OZOVyub&#x2B;53i7Ftyx6Ul1TytRQkzk&#x2B;4uBacSDkVSG9z86B0hPo6rwgB16WbB/w53YUID9KcOEVFp9DQIHz63jdISI7DlaMGYOqs1zFv9hJs&#x2B;n0H93OPyzsz&#x2B;G/dNgWt2qRI6SouVlFehY1rt&#x2B;NfL36CA/syECj6NDjUhAsxJeJ0m8nkj71yNQyf&#x2B;exSs8zMDLz77rvo0KEjHn30URQWFopnToiYv5mclktLa4WIiMiL5ri3HC/AiYpq5Ihno2vpXDsxYpMi3IjAvq59K1buJwFhHsNOY&#x2B;UB/7OsdK9l5LRznHeUlJRw9a&#x2B;5c&#x2B;ZwyD6lPO7duxd79uxBcXEx&#x2B;vXrxy&#x2B;a35OKP0UA3H333SqC0KdmdE2SiODll1/O&#x2B;50srtNt27b5CAAfAXBJkQFqZf/Uwv9d19WpkAGnJALYXCKAygcSg0gPCncg2Vtw7QnsNwesuwPgVg2vtTcEhRZ54G2pQLV9Nad/HMFleIA/C/YRg32iogrV4nzQZ0fFf1L07xwbid2FxfCTS9qR1/ZwaRm6C0BpgbagYrDYlhJWH6yQPDbpQiOBvl8PHcH9PTqzMr43fUaVCYYkJ2BDdj6C/JpCbMI4JXVmrDx6AiPTklXJIK1&#x2B;08kaBKPEepuP5/MxGhzD1GUWwFpvgS48GDGDuqNwb4aHShU6VVDKCn6mAJRt2Y&#x2B;4jq1QV1nlct00Ak0SY9yeV8AihrpmXGNNvhN/O8ZE4pdDx&#x2B;Cvd2iLS14&#x2B;nePSulpszM5FWnioEwFir9bhSLzYIxJc&#x2B;kBcGCkCpNL1VCy2p1QxoJBGKtXXNioMHaOiEB0S2OSRVlJShiW/rsXKpeuxaukGlBSVszigKSgA4RGhmpE43j40bRoPUG2fv80DMaC1tvN3EaLtFP1UXFgmgHbQKQkJ0WHnnyjEQ7f/FddNGIHJf7oL424ZyS9Pdjw7DxvWbOdw/30C5DZYrAhzONc&#x2B;A1ftKCup8HWEzy5J&#x2B;/HHH9GyZSquvfZaDvG&#x2B;447bOF972LDhiIyMwL596XjttdfQqVMXhIRcHDoh9ExdLcY9IsETxDGRQ0DNlOhC8vJTZB6JD1&#x2B;sNmvmTPQfMIAjx4xGCYK9&#x2B;847ePyJJ3D02DFMnzYNrVq1YtX/tm3acJk&#x2B;IgeUeXJ4WBhuvOkmFhA8nbZ161appGBJCRMUgwYPliJFxRzW2ypdPvMRABcjGaBGAuhVAL8a8D8rBIBiJEgVGRlpJwIcNQK0Qu/VgLmWQKAn4UBvBPa8BdOeVPcdw&#x2B;q12qm2LU&#x2B;VCrx52GkJKVIuG&#x2B;W6ZZc3oKyuDsW1ZqSG&#x2B;jUBzaTA/u3eQ403okDa&#x2B;wpKMLFjG84Bd0CIToCTQPS17VpifU5&#x2B;kzZR2PeGnDwMS01Cy/AQu6fa3XFT&#x2B;bzucdEsCrctr5BrzbuiOnq76PAxDE6OZ/DpBPA8CEfWN1jRKToCA5NacF6fQc0DQH1YUQ2/LmkIFO2urqji/HdO9re53I5OOfnOmJCogdKdhxF3VSl04YFcLrApFAWTECcqq7EnvxhdiXCx2TQJKHcaFxTZQfWGqfqBUvpQrQwhfRNu8sc6cW5u6NhaElD0UIpS7fqk5cOCTIgg5X6dVKFhUFICWkeFIjooSGaCGh81JcWl2LFtP36cuRBbN&#x2B;xG1qFs6Aw6BJOn3wWcnkpouk0DnqspAminEdgURQnVPTRev43ns0FcW4mpLfDKW3/A5x/PxpzvFsPf30/VM&#x2B;/189PfyPcE9dmCuSsw&#x2B;vqhuO7GEUhrl4rIiFCEiuuzpLgM/gH&#x2B;2L/7EAsk7t6RjhWLNqBQ3L/WhgaYAk0w&#x2B;vmG1iYEgLjuSTTRZz67FO2JJ6Yw6KP74IsvPscHH3yEzZs3YcaMGTh69AjeeuttbNiwHl999RUefviRi&#x2B;KYqapOelEJv48K9GfRXTWjykGklUNRiNGBpovy/NNc/PDhw8jIyEDfvn35WiDl/sKCAi7V99///AfXjh3L41z3yy5TTROhtF/K&#x2B;z/l8yKH&#x2B;ZNVVVWxnsDOHTtw/fjx3C56ffP116wBQBUFfODfRwBcCmBf67PrbzoVwK8VKXBWCQBHIoBYQ8o3o4eLEhHgCbi7y6/XAifeRgqogVBPXuSTBe3epiVoESJq&#x2B;3AF/WrLkzo81bA9WlbJgDyjpAwpIUGSyroMckjtlnL54wUQK6ypZeBIrwMCsPn5GVj9nT5L5fkaga5V/pwmgMhAAca35BY4Xaj0GynbbzqRh3ZRYfI&#x2B;pTKDejlNQKdTcrobHfHBAjTd0KEVdhYUqaI62i7VlKfc8yEtEwWulggK2rpF7g&#x2B;9rHtgkyf6BKIsMqNP&#x2B;7mpUxvsLSxBpbkeqgJ21EYBqiLbpqB0xRb4C5Brra&#x2B;HzmiUlfGl7ZPyOh8Xld&#x2B;zkMidBXqDnGljs6KgKBOxv61H&#x2B;J2jxLVvse&#x2B;r8Xilz&#x2B;SRmH8oizUKAuXceMdSdgpQJW0Fg1zxQP5nD923iYNuIc5tUmgI0otLOGSxyb0gXxcBRj0Kq2tRJM53fHCQ0zWpRTipXYMEMO&#x2B;5rD0iA0yIDwlkdXXY0310qK6uwfYte7FC9MH8OUuQl12IenMDi/hR&#x2B;LpC&#x2B;niFyk8hDV9LDlCLLHC7W7oXGiThPZqY6ES/E9A3ij7dtXUf3v77Z/jvN/9Ea3ENv/m3TziVwbk/m3cgtH0C&#x2B;vTspDSJubMXIzYuCoEmE6LjIlBcJJVXIoE/Eqgyi&#x2B;tU0mQxQhfg5xtN3RgFJknVPXxTD59deNYcTyg5YBYuXICrrhrFyu00J5s&#x2B;fRruumsSxo0bz97WsLAwBoUPPvgg3nzzDRYYvf/&#x2B;BzF&#x2B;/A0XB&#x2B;gVYzCR7SS0q9fpNJ/C5HyoFc/UCFOAGFMDL8xnm83mFJJP4JnOb7143vmJ591nU6di&#x2B;MiR8A&#x2B;Qyhb37NkTs7/7DjExMXjq6af5ukpISGjWPnNzc5lA6NrNcylD8uoHBgby3xXLl&#x2B;OaMWOQnZ3NegJ0bdK2fvz&#x2B;e3G9XoXg4GCOVKmsrubqST7zEQCXAuh3BfJqgN4dKeAaDXDaygCe1AGKB4prRIBaaoAaMaAVHeBJJNBTTr47YG5zEWPTIiVURfLgOVLA5kbF3DVawNtjaHLsRAKIhzsNBpS79lN6BlZk5SBaADCLDIqJIKDcer2Dt5b2VCMGy6927GOgTgKBESZJ0Z/SCYKMfmIQMTDItXuQNa5Eym&#x2B;PDQpisUAC/3HB0oBaUlPHQLTBYoPJz8ie60LxnZ8APBSaRyXiahssTTAT17wXyy7MOIrDJWUIE0Cd1OyJAKCIASpdSEJ3IQL8UChfeW29GPCNTGRQtQPSRKipb2B2n9qkOg2gvhb7jhw7CMbUOJa4M1fVwj8ihFFDQ0Epi/vpgk2EICBQF4MJFtETEwciBWrKqsRnC&#x2B;qpWyuqxfIGDqNXO&#x2B;UUybA1txArjh5nIoYONlC0OYR1EGy8f3&#x2B;xTRMJJMp9QZ8DxHpmAjDyeyrXOLZtKjI2l9uFD9WuH6UaxbGySiSHBHO&#x2B;o9UhQsARqrojBBrEAp2ioyQSQtYMqBXncO3qzdi1ZT8WL1iDvTsPosFsEYN9gASGg&#x2B;Vr3xX4u0PvJ4&#x2B;fT4kgUCMHamtq8eSz9yOlVQIWzF2JY0eOI&#x2B;PAUVSUV7IX47d5q/DJOzPw6FOT&#x2B;Fp75x&#x2B;fieeeP06lCgH1F03SQkID&#x2B;TorF&#x2B;ettKRcTJhOMHgl8skk7hm&#x2B;N0iQ0zdJ8mo8IkJNp/MpSvvswrN58&#x2B;aimwBaaWmtVX&#x2B;n/On58&#x2B;dh0qT/42fHW2&#x2B;9gU8&#x2B;&#x2B;RRXXjkM3377LS&#x2B;zc&#x2B;cO/nvkSBYL/W3fvh2ff/65AP5WzvunGu4UwfTiiy/g73//xwXfZzzey2NZXlUNl9elKElHW34kB7P3Heb3D/TsBN0FqJdCIHrevHm45pprWH1/3ty5SExK4lz6t954A8/&#x2B;9a8s5rd65UqOBGjZqhVaivVaCMBPBIChGdoE5K0nEE&#x2B;kEoH/kNBQt&#x2B;MYLUti4WvWrMHIkSO5HRGRksYEef0pHYV&#x2B;HzBwIEqLi5mEqKyoYJFB0ht4YsoU383vIwAuaZLAm7J/eg/vz&#x2B;nEizxUxDgTAUAhP0rVAK2HhpY3XUscTwmhPhnBQU8efa1oBa38f7Xteip96Kk9gHe54vQi1fWFmdkMJksFOMuvrAGKdU5K6vSeQLjjVJjE/WZzDrzkrSeASN5IJRKewCan9osvKLqAPju3ycbh7blV1fh06x5OK7CDShJLgxT&#x2B;rpdBJwnvsPauvDoJ5Ogcr3wH4EfiPZSisCu/iAGxwQG46uSIfIUBtykXvU5nF7wzcPk6vQND7prvLb0zJkQjKiVOErGkbVnlWvN6qVE6F3E6HZWzE5MnIkY4WoBIATFA1lsk779No1oetTVA7ON/2/ZzuziEXy/pA9Dx1FgaxPnzR3iAHyob6sXu9axiTP1QZa5nj0aYAIBUyo/6zU&#x2B;nxHdoCSOK/rZaWFAxKTRYIor8jVyWkNqjCCxSO/xUUgQU1WACn/SXJgH79x7Arz8tZ2X17Zv3snBQgH8AgoODBOh3bIfV/SPIndKfmj5fM3E1ncvKiipezST6k1rj5&#x2B;AB9kYFYOf2vXwN3DvlZkSEhHN6w4H0LCz5ZQ0KcovwwrNv4UR&#x2B;Pp554RH8Mmc59u5IhykwUKWxzWM3lOtFqt5AL3ny6gdVctJn7lkfI5VJNfgIAJ&#x2B;dv0aOEvKAOs4/Pv74IwHUP8P69Zs0Qdkf/vAHAZo2YsCAgWjXrh2CgoKQnn4AY8ZczeQAvRYvXoIbbhgngFU6evS4TGz3E4SGhvE2SN196tSpaBDjDZVeuxiMBG2VpytVtKEURUVLiJwCm3IL8MmWvRxB&#x2B;EivLugcc2GKH9K1Qh59On/9&#x2B;/Vj9fz77r&#x2B;fS/aRmN/Hn3yCsWPHoqSsDKOvvtq&#x2B;Xnx8fLP39fPPP6N79&#x2B;5MAJDnn65XR6NKAkRCkBHY//XXX3neT7n8w4cP5&#x2B;tw/bp1WLliBYP99h06oH379mjbtq3TqEjfUfh/ZGSk76HgIwAuCiDvCuabMY11W/7PXfj/OYsAUDNFLJBYQaVqgDvQ7Qp4XfPttUL6Xc3qpjSdO0LAXZqBO7B&#x2B;OswqC&#x2B;l5WzmAjNTY20VHsDddCeE3GQ1uLimbHYPQZiiFwB6nr3MBJ7SAUVso0WYPx9eJgdfl1jao7Vvv&#x2B;TZwQGR&#x2B;YuLuB70zMtOMiZEOSFGgd26jGvSTvxGAml5WtXY55i2o7a&#x2B;mnpXytXCdQ0VFCZiKdQKMOju5ouMUigZej36rrDezjgOnT4jPheJ&#x2B;kUgOCaBzdQfxPZEbAQZtnk&#x2B;5Pmgfv4sJ0PKsHAZCsQKo14hBmTiOVuGhXCawX2I8UsKCnSoFEOgnTYQG0baDBzOxcvFG/PzjUhzYm4HK0ir4CVAdGhrcCEblCAZ1RK920pQL0DsQp3p9uJtQl1fhTy8&#x2B;gHqzBcsWrkFRQQmqqmrkFA3Pu6Cc&#x2B;qUL1uG3eavREGBBt3Yd0Lp9Knr364bH/jwJASZ/5J4owPwFS/HzD0vx8bRX8OKf3hX9tJ5V&#x2B;GUKzE2jz27JwUvVKPQ/Oso3mfTZ&#x2B;W2LFy/C1Vdfw&#x2B;HSZOQ53bJlMxYuXMwRlWpGHv5Ro0bivvvuY2G/efPmCMB3HWdn9ejREzfddCM7Xh566CHk5eXizTffEYCrTZPt3HzzzXbBtwuI1wM05mEUCZgSFmJPdZy26wDSi8rgb9RjR24ROysoUnBwcgsMTU08b4&#x2B;R5spBQUGavxMYb926NcpKSznHn8LofxFAnbz7pKRPEbh9&#x2B;/U75dQnmpMW5ufb56RLlyzBggUL8MCDD6KDAPLLly0T1&#x2B;lCPP7440hOSWHH39EjR8T1dxNKy8rw9ltvcVupooCf&#x2B;I3U/ZXr3BUn9OzVy/cw8BEAl5xplf7DSYB/4DyIAFAzuumVfCCKBqC/7rzh9hroHrzlWmKBWt58x2Vdt&#x2B;8pzcDd8mrbtyuuq0QrqKULaIFs1207/U4PTwHuqIzN7vwie9mbBoUAIWe2XidjagWm2aBaH88R7zroyzlGEbgeu1pkgyrc0znvSio71wiebR7qvzk5hh1AsVytzl76UBHGU5ZnAC2Db5sH0ojX4SIJOnupQ/Jy6&#x2B;ToANgc1rdHCUBKNLZXSHBW5HckEhyF93UyAFa0EmgRiocwyJEH9M/AwoTuHhk2j2QKVR4gcqNagPms0gqkRYSgU0wUKx&#x2B;nCuAfbgpg8O&#x2B;oEHz4YBa2btyNebOXYsvGnagoq2KPNN2/VLZP/fr3FOPveCV5yMK3wT055OG7mrpatGmXirKySky47Wr06NMFL//5XWzdvAchocFeEWwE8ulFSx5Mz8KB/ZmY890iRESFIy42Er36dcPQof1Fv&#x2B;nY8/&#x2B;vD57Bg7c9g/S9hzXCKz0lITSXH/aZ58mrDZFR4b6O8Nn5C2bFs2b37t2ct0/29dcz8PPPv&#x2B;Cjjz7iCEo1yxeA7IcfZmPOnHn274KDQ/HYY5O5lBpFQI0YMRL33/8AOnbs6Hb/Zxv819RbUFhbg&#x2B;TQEK&#x2B;edI5PSbPFyiH9FGnopxHCTtFxEzu3wXsbdzFRTimCizKO2gWKKR1gUvf2LFzsdx5HBv3yyy8M7ocNG4bWbdo4zfvoHEdHR3PUCH0ef8MNDPwpBaBTp04nHc2xbt069BIg3FEMkNN6BXDn6EoxF6ozmzlXf/GiRVw5IDsnB3dNmoTfxOd7772X2zFixAgWFaR2ko4NpR&#x2B;sXbMG40Q79T5xPx8B4LMmMz1dM9fTIgX0Ln/PO1OIAHoRQ00RAQqoak54q1Z1ALU8fneVBNylG7gCd3eEgxop4Y2goVbqAuBZSFB5T3n0I1slYmd&#x2B;kQz&#x2B;bRz2XVprZnBHZACVCaPwfhoQlfB419ZRqDmHwsuh7NwHMlkgeaX1nFMbKIeF24GtQ3sbxO91VGaP15UCAWibBMQpWsGo1zsFIlDb/A1Gbo/BHtbeFChSq6pI3IY84JR/b2ngX2mdGosknEcpDdQXpA9ApEitRWor5dDTd5Rzr4D4Juebgh3ENig3kqMaLMycwBgcCEtdA2ykQRDgzwKARAqQJ16vAH//ANjEMZNWgE0MntbaOmdGw5X9kIUWDZSbaJBC8jmtgLZFHc0pBlKn8xpym6TUCqt0w&#x2B;uldAUbebVdySNaxSLpJFC/xAUFomdCNDpHR3EVgjDRRiaDKA2A8/ptKCwswfJF67Bm&#x2B;WasWrKBw9ypgkJwsKTgr0NjysEpTHc9kwU6L7kEl6cmpzOIvqgTfR8cFIQ3X/kv/vj8/RwN8JIA//l5Rbhy1ABsWL2dPcMM7r2YjDDBJmtjmEgoUpz7nGN5yDh8DD/OWsiaB1TacMz4K6Xa0nTRG3WaHirPj3abl0OGzzwZecE6dmnj6wifnTOjZw2Nf3q99pRML2urFBUV4bXX/o5XX/2HJvg/fjxHvE5wrvS4cdcJsBeKDz/8iHOtKc&#x2B;fAOCrr77CCv/no32weRfSi0oxMLkF7uvR0ePD198BpLeNDEcH8eqdGIfyOjNrA6kZbTu/uga/HDzCOkexIYGc&#x2B;kalawckxaND9PkT8UBzYALyrtdMaFgYDqan44033uBUj06dO/NvNF&#x2B;mcz9o0CD&#x2B;TNEfNI5lZWWxuGOfPn1O6hr97rvvGLAPGDCgKWiTHQPbtm5FQgvRt4WFKCkp4euV0hAI1NeL&#x2B;ZGS/18jp/uSTgFVEKCIlqrqah/495mPAGgGuHc3A3SnCXBBJDySCAi96IFGVQMop02rvJ4aGHYHoLWAshp494YYcLesp3aqbc/tmOehzKEa8UAgmkrrXZmagLXZuTALYEi12p/u34MBMQFnAve0hoCuWJaZg00nCjhsn0G42F5rAfKuaJmIQjFwkko9gebS2nqYjHrOPycyoVQMuiQUuPpoLihoXu1CG5qSaM8xjxXgkRj/SjERDxQgn3zRkaYAFvHLq6pmIEqMPIXrzRODdRgpmttcUZ4N9eL4KFzvipQEFAuARwM/tbmyrl4cg1TmyMYiiEb2dFeJY04U&#x2B;64yN/CgQ6TEP9du5TJuBr16BIdB7Nu8JxNHpi&#x2B;ARWzTFBbCALxWHDMRA0aqACDabgj0h7Wqhp3&#x2B;AeHBsIpt1ojBLZCIgopqJF87BIae7WCrroNTroWLWUnkbcU2DrPXm/xgFOeLU0DE54Bwse&#x2B;IEDQI8EpRAf5xkRKBIn7zDwyEMUT0IXlCBED3jwxDvUE6fiJ3rFwJQYcY0Z40cU4HiT5rGxWGWBLnk8IKJNAvlissKMbqZZuw&#x2B;JdV2Ll1P45mHRcA14awsGBEiO06kVE403nnNhVuQC3SwVEtUr7&#x2B;zRbxDKlEdGwkhl3Vj9Xyj2blYvJdz/PkhYiBth1a4cMvX8bOLfvx7ze&#x2B;xK5t&#x2B;8VkpY6FC5tTcogn8wF6ToOQ0jKsTDJ88clssS0Tl&#x2B;tz1N5whe0eFAA0iAB7DI4bIsCXVuBqZnHvjrhmsK8jfHZOjET3CJS9&#x2B;urfVcOeXY3AU4sWCSzI9&#x2B;uvv&#x2B;Cdd94Xz&#x2B;LGiKs9e3Zz7XRS9X/yyT&#x2B;iuroK27fvwMGDB5CSkop27dqL7/&#x2B;ABx548Lzsj2PlldiRVwSzxcIOCk1AKovHEnin0rOKjW/fCquPncBb67fjwZ6d0VmDAJCWTcOg5ARUiGcA6eyEUtqa//lXMWX&#x2B;vHkYN24cAoOk8Z&#x2B;ulwgB/lvExWHosGGcR0&#x2B;AXyEACKRnHzvG3vgdO3dyhAddW5s2bUKcWOdkbOGCBTxOTp482f7dkSNHeHuKs47GyFZpaVxFIL5FC6SmpnJ7v54xg9/Tb2Qzpk/nNlH7SPE/TXxPJQgHDfY9h33mIwB0Xn6nBfI9pQHoLiQSgEzRCCAioKysjNlItfB3dx795gJmV/DuTXlBT9UK1MgLLWJCzauvFe7vTiDRlZi4sWNrbDqeL3CrjcVvbuyYxnXjrfbtgcuIUVk4KoNDAy0BYvKi51XVIkqAodFpKQy49ToHuKXsA1KURnJICN7btINBpT1PXs5RP15ZjWcH9OBSfxYlFF/GJjqljB&#x2B;UkHzpWAjMR4prYMaeA&#x2B;zFdwVABMAzSstwS&#x2B;c26BIXxaG90Ck&#x2B;aZ1cy13XWBZHZ3egc747AeIpfbvjfzv2S5MLbrPLpIOAc&#x2B;tEhHZpjewVm1CVV2zXFLDpHEIWrFJkAO1Taoecv28Dlyu0VNaga6sEVAYJYNlg1by7/cVxmEvLkfnLGgH4QyXVfrlsEZUcJPV9vZgAMWHBoFL8LranNwUwiLdQKTiDEVF9OiHy9tFMDsSFBKGNAPs08WktAHyMWJZy/zlagVl8nQD9Rdi3&#x2B;zB&#x2B;nLUA69Zsw/EjedxvwQK8hoWHNkZ2AOeB2Jyt6RPR5kwC0ESjbaeWuOmOMaKb/NC6XSriEqIxYcQjMBgk8G8Uf7OPHMfovpPwwB9uxVuf/BUH9x/B&#x2B;69/jt3bDnCKjB&#x2B;VjdI3D0ArUUtECkREhttLNzalsLSPTp0c8KZmgavI4JkB/xRlotMrFU3Q7D46Z1eOaCyRWFeM6AOf&#x2B;exc2KxZM/GnPz3lEfwr0QFJSUn49tvvmMx86qk/CaB/O&#x2B;bOnW9f7ssvv8Sf//wUv3/ooYeZEFi6dDk6deoiAOBGTJ36H9x997148MGHzsv&#x2B;IM8/RUmRGDHpzmgZla/Viec8gfYODik8v2Vk4/2NOxEbbEKiGwJBsdggE7/Oth09epTL8XmTXkEaD0uXLsW1113HYnmHDx5Er8svx4oVK1BcUoLBgwY5hfTTPGH16tXYt28fTGLO9NgTT/D1NXr0aNX5K42P7hT/N2zYwG24RexfMRLy&#x2B;&#x2B;D997kdt99&#x2B;O5MD5OSgqJSklBRkHDqE68TydL0&#x2B;&#x2B;thj2LVzJ8LF8U776itU19SgX//&#x2B;vM8rrrhCmuv4&#x2B;/seBj7zEQBeEgPutAAA7UoBWuteMEQAKYlSJAARARS&#x2B;6Y13XgtUn45ltUgBteW9ESd0F9qvJlroKXLBdRkqL9cvKR5LM47BX4DIxZnZuLtbB5itVschgQfFiZ3aYNa&#x2B;wzDYJDX46nozpm7di9hBJiYIrFpkhHg/rFUijpRXYNmRHC5VpwBGArD7CovxwZZdePzybg4R7y7kh0PqgE4GvTd0aIWt&#x2B;QXYm1&#x2B;MIH8/J/09mh6R9&#x2B;DVNVvxzyv7egRlrv1rtupY7I7qA3&#x2B;9&#x2B;yDCTf4SeHc0KvMnJiaxE4aidG8mKnKL4BcS4NYjrdc5CNmRYr74UJ5XjCP//QkJT96KOorod4poaEwFaBDXecLEq1CxL4sV62kQlqovSCDST4fG9AoGYQZYxUBM10kDKexS&#x2B;UNzFbBlH0bfNx6duyejV3wsh/tLJfv0ElEh1quqrMSm9ZuwfvU2/Dp3BbIzc1HfYEaQmDiEhoU4k08OVQ/Ou4eIhlAETaDLSyv4OJ64729ISI6HnwD9Pft0ZkKARACzDh9DxsFsPPnw38WEuQ1uumMs3vnPc8g8lI0PXv8S&#x2B;/dkop4mp3Tt6U6mad6TJaeinKBNEkB1qVM9kzSBrK02cyoJbYqey0SWBAUHntfVCKhpfQf24Hb6zGfngoBauXI1z2c8jVdRslAlvY&#x2B;JieUXefFfeeVlp2WpLODQoUM5zJ&#x2B;U1r/55hv89a/PITQ0hNXW6bfmlHc723ZMjHM02lMZ4AANoWJ6omzNLWAtnK6x0axRo9hSMZ&#x2B;5LD4azw/uhdDzBFTSeaZnpBImT6HxC8S5ufe&#x2B;&#x2B;1SXz83NZZV7Jc&#x2B;eztm7773HSv0HBfjftn07DgiATc/ZTh07ssDftQ7gnFT0b731Vj7Pl/Xo4VYo8Of58zFsxAhOiVMzUvMnj/2oUaOcUhG&#x2B;nTULL7/6Kj768EOOzq1vaMDs2bP5b7IA/TfedBNSUlJwSLRz6eLFHIH66KOPok3btjyHd5fu4jMfAeAzbeCv9rvOy/e6C5kAUAZAejBS6BEJBSoRAVrgzhuvu5p3XQ24e1Paz906WqUFtcgHT&#x2B;J&#x2B;akSBpwl3jeir0a2TsfDQUQSJ9SgKoFd8DLrERrGH2w4JBKAc3ipJDLRFyCotl0CUWL6otg6/HMrCY5d3R6VZnYBhYkAApevbp2FrXiEqxDrkoVdaZhID047cYlbc7ZUQwx531b63OZfjqxWD6J2d2&#x2B;KVkq1NRRMhRS5klZTjp/2ZuOuy9hz&#x2B;7w6IOZ1jSCUIr0pLxqLMYyivNbNYkPOdJ&#x2B;Xe6wRgSLppGLL&#x2B;8xPqLTYXj6dNG5DK4F0f4IfDG3YjYtUO&#x2B;I/uB2tFJVTr2jWIpUMC0fL&#x2B;cTj4yQ88uNqXa1Q7lN5SOUbK6RfLmOvNiIgIR1rbFIwZdyX6DumJDu1T4e8nA1dxXDQ5qKysQlZGDpftW7V8A/bsOABzTT2CxD4DgwMQogu0kzw2l3OhBU69lPA7bUYkjU7nnoSjYz2w9zB2bN7LE4/4FjGoq67FrGX/RXRcBNYs3YzQiBAEiAljQUExDu3Pwsyv5uNfL3yMOTMXYtyto/D2p88hJzsPb708FZmHj9pFIJvgaJy9J2vTopXNpRSan4DQZKvi&#x2B;n/1vT&#x2B;LCaSJySjShMg5moeNv2/HqiUbz&#x2B;toALpkhl7VzzfD8Nk5m8sQQH/llb8JsL6QFdvdgUgiCo4dO4bvv5&#x2B;NZcuWCqCYh48&#x2B;&#x2B;thpuaFDr8Sdd96JxMQkVvSfNetbtGzZ0ulZeD5bmZgrKCWHdRrPISL6iQAgvaHr26VxdKJilH5IKYXrc/LZSdE9LuqcH9PKlSvRuXNnnrMSIP7m66/xyCOP2Ks3UB48jUsUEUBGivmkiE/K&#x2B;FSSL5JKZYu57scffcTXTLfu3dnjT7n1tIzaeDd4yBCv2rZIgPNrxozR/J1IhjFjxyIzIwP/fO013HPPPaw9QOA&#x2B;JyeHo3Lfe/ddXH311VwGkMC9ozYFHXPf/v25GgDZyZQY9JmPALhUQb/OS2JAjSjwJh3ggjZFI4Dy4srLy50iAjzl8jcBNRpg21uQ7g0p4NoOV4&#x2B;&#x2B;NyKFrst60kNw/Usie3GBJlwjwOGSjGwOt/906x58MHqIs2Cf&#x2B;BsoJvPj27fEcys2cq4&#x2B;5Dr167Pz0S8hD13jopk0UN8fEO5vxI0d0vDu&#x2B;h2IDg50gRk2TNudzmF68eK3Bo3oBsfjpramhIfgkV6d8cHmPfDXOZaWky5oKvGzMOMoOsZEoEtMFIN6LXJI7XxResFT/XrgvY07UFpXLyYX8pYdTqe1vgHhfTojpaoGh2csALzOG2wEXqaoMBz8aQV6CGBe1yJCjLQWJ7FEnXyHWkUbTD3bI2F0f2TMWAhjVKiULuFA1JDqbr25AYEChHXr1QG9&#x2B;3XHVWMHoUOnNggT/UWpAQSUDUYjqgToz8zMwvzZS7B29RZkph9FWWkF/MljGxTInoBGIsfq8mjxDA69KfB3OifQopV87NRmUiLWApzkfQkNM9rvO1L/T0ptgc8&#x2B;mIW3X/0MtfV16N6zA55&#x2B;&#x2B;RHc//it6HF5F2zbtAtfffoD3vvH55j//TLu00kP3YA/P/wPsa1Q54PV4oDOABOiBeV1GsvpmrVFd9RO0z3RNXL1tUMQEuasKh2fEI1lC39HgKx3cD4aaTF07tbON9vw2Tkx8q5On/4VK/G/9NKL4v2MRiBcVsZh0UpqAM1xbrvtVgH6TyAyMopLut199z0cYu1ob7/9DsaMGcvAi0BnaWnJKbVx4sSbMXbstZg06f/OSp&#x2B;QRg0ZaQCQg0HNfkrPFL814DIx/3AE&#x2B;IoGUUZpObbk5uPZQb3Pi/O8Yf16dOvWjZ&#x2B;DGzds4BJ8pISvgH8qgxcmgPxTT0mpG5QTn56ezt72xQKg5544waUYKbf/8ssvR0VVFVrL&#x2B;fSnaqTAr/V8phSDVAH0r7nmGh4z582di3nz5uEPTz7JufuZmZksEnzfvfciIVG9XCKRGkRU&#x2B;MxnPgLg5EgAT8u4KwvoiQy4KMyxfCCFKdFfMkX4TQ3sK7m5HqfGboC1GgDXApq2k8iZ1iICPBENyvdaYoH0/wQBzA8Xl&#x2B;FYRTXn0606ehxXpiZyKoCynNli43C6volxnJtHarsUuGURYPLLXel4sm93FhJ0p4FAtXTzulTjFwHKjXLYl6LMny8A9Eebd&#x2B;PZgT3t5Xa0Ii8a30vb3J1fjF8PH0WYAr4dBQ/FQu9v2IW/Db0ciaFB3F7Xc6NG9EA&#x2B;ttaRIbi9Szu8s3EnQmQRRCdgJOYo5ppahF3RE9Fb01G84yD0wc3LI9QbDairrsZBATDT/ng76kNM0Ftd4ZxExNSXVyJqdD&#x2B;Ub92P4qxc6P2Nspq9GUFiv916dOQydgOG9MQA0SZS5bfJ5AAdX53ZgoP7MrBZ9Mn8H5Zi/65DKC&#x2B;r4DBtkymA86DdX59qOeTeI1m1YPPTIVVXW1uH1957ikUYv502Hwf2ZvJExeQQEuo0uaSIFQJ&#x2B;4riDxXX72N0v4vqbRuKJZ&#x2B;9Gy1aJ6HxZe2RnncArT7/PMg5vfvIMdm1Lx6Z1O5Gbk4&#x2B;p789EdGwEAkwm7zC0elz&#x2B;GTWbymDQ/IgMb6usgIUm5/&#x2B;4jEmmlmnJHD1SK54n876j&#x2B;uTG8zoFgDxwbdqn&#x2B;mYaPjsntnjxIsye/QNHMnbr1tXpt5UrV&#x2B;D668fZP1MYN4FAihIgL7&#x2B;WJ58U3yn3evLkR5CcnIz&#x2B;/fujVauTB4tLly7Btm3bsHDhArz55jtISko8s3M5P2n6T2T/TwcykRwWjOhA6XlL4r5zD2RhxZHj/Pneyzo5rUsVjnaIF1UCGNA&#x2B;HpedB95/ZX5KBPTmzZs5h1&#x2B;Zn5Lt2rULT0yZgrkCXJeWlIixOBLt2rXD&#x2B;t9/53OdlZGBcePH20s1vv7PfyK1ZcvTRgCoGYF7ur4o3SBFXEOk5L927Vrs2bMHd951F88p/u/uu7ntRGJpgX&#x2B;f&#x2B;cxHAJx&#x2B;QkB3EusA6qkBF5UpREC1AFZK&#x2B;UDnCavOKyCuLOcuHF9LlE&#x2B;NbHAH3LXEDN1tT41YcJfmoOb1pvy4yb274qll61mMb&#x2B;HhY8yok3q&#x2B;1QE5UF3dh3t1xnsCDOdWVjM0ICdrbkUN5qVn4Ym&#x2B;3VFdX6/uVZf/ju/QiqsMLD&#x2B;SgwAxsNhTAcSgmFlazjoBY9u2ZGFBnUb/O1qNAB0TOrbG/uISnCivlsoV2hohJbWvwmzGV7vS8QJ5AXQWWGyNF76NyR&#x2B;wSj&#x2B;TEXopYkGJJyAnRP/keAzPT8SqIydYK0GncmRWAcKTbx8FneiLvMNHYSQywmZTVBEZFFGYIi&#x2B;tpCzQvhXhQ7Hf7N2HETxrMWIeGi8Ae4PKeRUvSpHQAwmPTEDlWzNRXVCM5NQWGHHNIPQb2BO9&#x2B;nfhWuYUMkkpAMTKk&#x2B;Bf3okCLP9tPZYtXY&#x2B;Na7ahorQKRj8DK9FHRIQ1eo&#x2B;9AmmeMtF1zV7bExHgacs0SZkpgP&#x2B;L/3wc1934HtYs34SP356O9H0ZMOoNTHA4Xkvtu6SJPtYh49BR/rxkwVqsFuuktExA2/YtsXThOnTt0R7jJo5Cr75dsGDuKmQeOsZAkUUA/YJRW2NGQICfnNnh4bhtGn89HdxJkgVqu1GhlE6BynHeG/VBYKA/npvyplTVw088O/RSyU4ipwKDAvkeON&#x2B;GG7omKiuqMXRkP64K4TOfnUlzFVkjgEXgnEjIJ554gglJStlytPz8PPt7IjVDQ8Nw4403OtVf17wzxY150003YcCAgRwh6ckI4LdunYbwcEmQjiIpqb07duzAN9/MEkDwENasWYnJkx8WQHXeGe0rigakeQClCe4tLMFLqzZxnj8R81tyC1BSW4tw0QcP9eyMVhHOUUdxYt2/D&#x2B;3D8xiT8ezACBLnIyE7JZxfFdAYJSeCVG2mAe&#x2B;8/TYeeOABdO7Sheeq0dHR7ImnqA8iAPJyc1lFv02bNvxyNALgpwNwEwnBcwWH&#x2B;VVeXh6H6M&#x2B;fP591B6rFHPrrr7/m64FIidtuv53TSUijYMXy5eIazcd999/vu8F95iMAzjIJ4O53dxEBFz0JQEZsOb0UIoAYdhoUaVDzpiSfJ0DkSe3fExGgBuLVvtNqo9VNuLwW6eDa1noxKUkODUZSaBBHAByvqMKP6Zm4pk0KgsVAZTDo7TV2aWCd2LkNXlm9hcXxaFMBBh02nsjHhpxcFhWsd1CotzUKnTMY1xv8cLMA7OuyT9iXU4y2/zOV9/P35/x7Cv2TqgE0isRYZR1/R8AYZQrAs/174vX120Xbq1nF3w5nxD8q/bc7vwjf7j2IkWK7RHgQcVAntk/7JPBPwJ&#x2B;2rZQBIhEzap9RtK/CXI&#x2B;rW6eg2mzBtrwCe/SCy8wOxsRYtLhnDGzz1kBPwn1U6UDsx49Kx4mJXUNJBXQCMFrF&#x2B;garlP9vJTHBerFuUAAixPIV5VVocaIQ9TERTdAYpUZQWKRObDNBANUef5mEy8VksWvvTkhKiePlLfS7XO/gxPECLl83b/Zi7NiyD8ezC4hB4HBCSgdQljs9ftmTUQNwj4fdr&#x2B;kyUIhzvH3jHtx5/ZPo1qMDho7qj4&#x2B;mvYo9Ow7ik3emcyUDuo6VMHQCqH/9&#x2B;2R&#x2B;T1EQ69fuEH1fgdbtWqL/4J7o1K0tjmYex6qVG/GXx19HvjjvQQEmGP2N9sbp9S6kH6syqpXkc4PqbSpfnwX9AJtGP3NkhNUmlZgkoUqjQdyzjXXJdR7OdXCIIvZHqTJ6vv9Ngf6N351ncpEUPaM36vHUSw/CZz47U0ZK7C&#x2B;//BKHbb/22r/s99MzzzyNGTO&#x2B;wcCBg7F27e9oIcCeaxWAVatWY8yYa3HgwEG8&#x2B;urLHIbtDfhXiNERI0Z6LbT21ltvYMqUJ7kUG9lnn03FI49Mxvbt23H33f/HoeczZ36HceOug9lcB3//gDPWZ4NTWmBRRjYKBUANFGNygZibLMw4hjoBVv30BqSGBePhy7uga0xT737H6Iizen7Jm08h&#x2B;sOGDWtC&#x2B;JBeg3JOKU/fLOagFApPLwL4c&#x2B;bOZQKguKgIzz/3HAP96JgYfgZv3LgRE2&#x2B;7TXWfScnJp6Xt/37/fUy89VaeCyrihPQd5fLnHDuGmd98w&#x2B;&#x2B;p9CC1zVFrgHL8R4wcyeSSIgroM5/5CICzB/q9&#x2B;c5TBYCLviA0kQBKRACFKilqu94K/mkJBHoiDLypCuCOZHCnBeBu&#x2B;&#x2B;6iEdSOhcDwwMR4AZIPI0iAnDXHTmDz8XwOwwuUB4Vg8d5ENe8FKAgRgNaqeNJlT/bn2/fhaHklC&#x2B;9EB5kYeOdW1QgQreeSgQSqqwR4JUa/a0w0thcUKg2zh&#x2B;1Trt&#x2B;Xu/ajWgzyZXV1DO7p5/L6ela3p7/hAsT5iW2V1JglUkH8Vycm8kQcZNuqINUBcBSq0yFATBjmHzyCTQJcG3VS7WBqC0U8kJZBcU0dHxvt10&#x2B;0l/qgrNYs1W6niZRYJkAAIYOG&#x2B;CJZfWU1DAkxaDn5JtgoEkL0l1WAQgOHShhgEdccl9cjQkUAdQ7Lp4gFIgNkQT6r2H99nQTCJILHhnpWDrZyn7aPj8Bl8THoFR&#x2B;FyKHBMBKRZbXZoxaOZ&#x2B;dj355DWLN0I36du5LL&#x2B;JHjlTQBwsKD7JoMUr&#x2B;crZBsmxtioCkwdidRp4aNCcRRDXciNIhAWbVsI1YsWY/5vyzF5EfvxCdf/wOb1&#x2B;3Ax29Nx6H0o6z0vnt7OlcAaJmWxOUMH/zDbejdpztmfjEXhw5k4Z3Xp2LvtkM8CQsPC0V4SAhsaofQ5DBtGsSHzTu&#x2B;1ZOa3xnC0ZwmIi6UtDYpTGTQhI6ulfy8QtRW16Fe9DH1hbsUAntEgfJM0inSXTpohzycW2KArpvHnpqElq2T4TOfnQmjHO4nnngct9xyC77//nt07jwDkyZN4t9Ir2jJksXYtWs31qxZg9raGqxYscr5GhXjxsCBJAQXiccff5zz/b21L774nNMAYmO9q/mekpIq1vmfnQD47bffmACgMTY1NUUAvmgGuuSpPpPgnywhJBgvDumNaTvTcaC4DDYxBoYH&#x2B;CEmIhRXtkzE0NREjlI8Lybm4llHZfZcn3Jz5szBWnFe//Haa/bwf2Wus3fvXuzZvRttZMFHUu8fMHAgli9fzmr&#x2B;v/z8M3r17o0IFXG/00VakFElAnLEUPvoGjx2lMbIYCYfJj/2GJNNBPTV5pqkTUFifz7zmY8AOL9IAjXvv9bsW3dJdIx4gBFL6RoRQKbGkGt5z9U88mqh&#x2B;Z6iB7wRolNbXmsf3nr91bQLSOF9VOsUHCotx868Is7DJzBcScDbwYtvkZXmlfw8xWgAqRYg4bu9h/k9bY9e5BCloHmjrMFAugIE3snL7uRNlNtCHnkCu1/u2Mc/6dlDb2PvN4FwAuAWarMcUk/f07ZpW1TDnkC6BNmdA5upK/SiMcfLKx2ACokF1cntB8rMRB3ouM3F4rpgGkHXqD9czSkFOjtwVj2/og8sDRY5KdosCfhz&#x2B;b96DvO3UH/WOdQsbJBuP061EMuAj08C/ERSENHSOTocl8XFoFtcFNdD1lMqgU5qC03MSssquGQfAd&#x2B;lv/2O/OOFaKhvQEhoMEJDgjgNoLGYwukr&#x2B;Xb6iAE1YAi3vylr1lTVIDwqHAOH9uLfjEa9uK9rkHMsH3s2HsCtSx7HyOGDMeaG4fj0m9ewc8s&#x2B;vPLMB3y9FeeXIje7gPt6395D&#x2B;O33adxXzz31FmIjo8XEK5SfC1bbyVIlWoH4OvdA2KZzz3poqSue4uk0GowsfHj5gK6cGmK1WMQksRQrFq7Ds0&#x2B;8IfpZ0odo7lnTju84O6UJ3VmHzq1xz&#x2B;RbfLMGn512o9BqAlXvvfcO500HBQULYN2H3ys2YsRVePLJPyAuLp7F9UjQzzWE/N1338OmTRvRo0cPAcJbqu6LasmnpjZqWJDnecqUxznF4J577lVdJzMzA/VinGjfvj2PsTSW3HLLREyYME4mn61MXjzyyMMCDK7HxIm3oWvXLhz27ahJcCYtJSwEzwzqhWwxbteKcZUI&#x2B;wQxphl059eUVUnroDGZxPyoHB6p41O1HfKQU2rFQAHuCWxTiTwifqi0bxvR90NklX6KElm9ciVuuuUWdOzQgcUbTxZc0/mntFfHsn9UNYLaRHNf&#x2B;n7WzJl48OGHpZLCYpyjKIAff/wRnTt1wnPPPSeVcPXz893IPvMRABcI2G9uWsAl4f13RwQQCUARAY5VAzyV0nMF7Fph&#x2B;Grrq&#x2B;Xnqy3jTTqCmtigu8&#x2B;ubXZdjurtPtq7M15csRm5VdWc725Q0LHSHp00ObcpJecc2kqfg2SxL2V/ylRemcKbYJA/29QvPErPEOsGOebt6Wk3RhccZGgE0Q4RBFaNftPJuf6KwCBUsVMjuOfjcvRc2qQ8fTCxIccY2OQwcIc22OTQaThGW9BfJjIk0oLKCehkMoXKFdKyBPolL6sNYQF&#x2B;SI0KxcCkFmgVGYJW4WGStoFYVifWNYpBuaSoFAf2Z2Le90uxef1OHNgjJnMWAfqDAxESEuRB48I18FuNAzyX5IDNu98FUL7t3utx5/03cEoD9UlpcQV0fnrUVdWiWry2b9mL/33wHX5ftYVD&#x2B;&#x2B;9&#x2B;5Cb8&#x2B;YUH8PfnPuQydYEUdSG216f/ZRzuPvaG4ejyenuUl1bYr6czf3xqbv/G67ApXlY5NzaNTem8fybSvlokxbBXhyd&#x2B;4pWU3IJJAIPR4PWR6dDcFA5bMwiT0zUGQEzSq3HTHWMQHhHqm0n47LTba6/9AyMF&#x2B;Jsw4UYG/wTGv/tuNp5&#x2B;&#x2B;i9OIHzz5q1MNGqBLarl7g5wE5j8/PP/4W9/e9n&#x2B;3ZdffomoqEh8&#x2B;GFjaUDK66aa8nR/k/3vf//jSJ/nn38BR45kskAgkQGU/3/HHbdj37497P0/fPgwi/4NHz783IBrcbO2DD8/7lFX5wrl6jvNd8Tfffv2cZleitzo0rUrp3W8&#x2B;8477NmnyAoC4JQ/30kAbcdUDqrU0LZNG7QT54C2Q&#x2B;udrBFxc&#x2B;LECQb8dE6/EtcDCQbS58&#x2B;mTsX148bhSFYWt4u8/fQ92dNPP20nM3zg32c&#x2B;AuD8Bf3eLnNJgnxvJ71UQ5VexNbTw5yIAAXQO5IB7kQA1cC4twOIu2W0ShaqgVtPUQfuIgqUbRMgpXr3d3Vvhw827WbGXfKoSyHzDQxuJYDuOODpJIyu3nbH73UO3luODtB5LUDGEQWkGUCidkoUBnm2LRIa19kkz7lephaUbVFUgF6jFCQZ5fnX1jdIofQ2Gx&#x2B;H1Q7Odfyi7RHQt5gb&#x2B;BgogqHeZmXwXldvhclPr0pk0LIELo01FAkglg8J5pz/&#x2B;to6VkX3t1HKgxnmegptNKJVUhwui41Gr/hoJIUFc5SEjUMX9DAG&#x2B;KGysgYHdmZg7YrNmPv9ImQfyUWVADGmQBNCQoPskRda59s9EPU&#x2B;b/9cPvooTF3R8KCc/seeupsFjO4a9yTKBPgvLChBVV0NEhNj8fjT/4fn//EEVwTYvH4Xdm9Lx5R7/oYuPTrCarEiSPTb6HFDkZTSAmltU7Bu1Tb8Omc5CvOL7JPkc0N62Fze2jw/7R2FCG0aXI8bfofumvo6M5557HUu59ehY2v4&#x2B;RtRXFSGvTsPIjgkyLMeioerqvlXkzfXJ07qGqVykSTUees917l9rvrs0jA63&#x2B;S1VeqvkxFgLygoOKnSZVSVhFTzCUS1bdsWEyaM5&#x2B;098cQUzqOm/RFIpwgBb/P5tayqqpLV2RV7&#x2B;eW/oby8DK&#x2B;99k/7d9XVVRg5cjjatWuPH3/8ib&#x2B;j&#x2B;vIvvvgCEwDTp09nhwjVnf/LX57B&#x2B;vXr8frrb2Lw4CHs0SYSwmdSqT7y4reWw/Y//OAD9OrVC9eMGSPNTSwWdO/eHbt37WK9BArjp/NLc8wrhg51ey21atXqtLWTFPtbxMfjub/&#x2B;FYMGD2ZCgMQmly5Zwgr&#x2B;dBxUcaCgsJD1B&#x2B;xki8HgO8k&#x2B;8xEAFwER4E4boLmRAxe9OZYPJCJA0QjQmhQ2F5S7Ak9PIf6uy2lNvt1VJnAH9hlUK2r0Dvskpf&#x2B;OURF4fnBv/HfrXmSWlbMGQHywCS0EgCVhvqKaWgbI5gYLA1QSpiMNAS6r5iCuqOyvRgA0yrMnAsEiN4uE&#x2B;qz8WfazCwBvNOjs4fwujYefeAWICXu5mFiFCHBGOgRUTSDY5MeAhYB8mCkANfX13F4ajOvqLcivrmHSwqmf5PcNot39k&#x2B;JZUyCGFIfF8RCwJ9KjQTQ0RHxPIfikS8CpCZSzL7B&#x2B;jLhOqB9Id4DqEB8rr0SQaI/V5pzOIB2oEQ1bdiF78QZUiv1RSKC1qgbVYpmI8BAkp8Rj8JBeGHXNQLRukwyTXvSfjnMfYBD7Not9Hxb7&#x2B;H3lVixduBbbN&#x2B;4VE75qBIhjJUE7UvxXQtS5faftTtaKMz95OHfqTzypLZYGK&#x2B;elh4QFi&#x2B;MPwwO3PYM92w&#x2B;w0n&#x2B;i6M8Bg3th6Oh&#x2B;rOy&#x2B;6OeVyMrIkVTqg0wItJlwKD2L1bYp9P&#x2B;3&#x2B;SsRHh6GnGO5HH1B932oSx37cwxN3ABfBfA7A2W6l3S6JghffdMOUfakT7Fv1yG&#x2B;R/ZuPyg9Hyhdh/Q7DPpzeDXZmkEO6LQP0OE3Oq4Pp77AqQ6eNF18RMDFbwTWd&#x2B;7ciT/&#x2B;8U/2744fP94EEFHE4Gef/ZdvOQLzjqmDR44cQVJSEud5U/lR8vR&#x2B;883XDP7Gj5&#x2B;AF154iQEgbffDDz/AF198wQJ/p2p6qnIie2u//XYWPvroQ0ybNl20o9GDSyHdL730MmsR5OTkcDtHjrwKH38sRQhQPviOHdvF8f8ZY8eOxe2334HvvvsODz/8IK66ahTuvPMu30UCqSrCgl9/xaOPPcafKZJUEfij5yVdL3QuSDCPiAC6FrIyM3FZjx520uBsWGhYGKe3GsT&#x2B;ExMT0bZdO3w7axZrCrz8yit2x1dKqq/0qc98BMDFRAToTnI9nzkQATTQk0fAUSzQFVi7C7nXWtYdKaBFBHgiG9y1R4tIcKdhQDn2lGv&#x2B;QK9OeH/jLhRV1TLYJSX8dgJwkngeAfgyAcbrZSHAnIoqfLEjHZV19QjyN9h1A3q1iGE1X4ogoIgCIg1IYC/UP4DTDCxi0AwWn8mbnlVWgTkC7AYJcKZ3wDU0sMaGBOPh3l3YU0migqEBEjBn8RoxyHG0ggDhlMZQK8B5oCy2M&#x2B;9AFn7cfxgmMSgbdQ7h&#x2B;pAqCuSJNkzokIa0iBAB6m32FAIO7ZdVDq2ywB6r/9tkHQQ5zJ/yET/esgcHi8sQGRjgfA3Qe9FXun5dESkmDsU/rkClAK4JLVvg2tED0KtvN/S/oqcAoKEC7&#x2B;uYkDCI46qrM&#x2B;Po4WNcmm7b5j3Ysm4XCguK4e/nzyA2IjLcnqpglUG/zWGXZw6veApdP7NRAyTY1rtfNzz257vx7fT5WLN0Ew4dOMIl5gYPuxxDhvfByLFXICE5Fls27Majd72Indv2syaD0U9OIdGBwb9EAFk4VLOqMp/JA7BifYBTnruWn7m5R6ncY0Q6nBqYtrmF1ERgsiCkVa7vYJO8OkHBJucMAtVTakOA6exFPtjU6YzTtFX1z3Rv0Dm47Z7rcNXYwR5JXi3i10cMXPhAjkwBzjNnfiNAsbMQJIVrFxYWYPfu3QJEJbAA3g8/fI8lS5ZwPvXw4SMY5Cm2c&#x2B;cODu1WrEuXLnjqqafRoUNHJ2X/iIgI9OnTh1MDKDpAy4iQoN8d87jVCYDG9AHK&#x2B;6Z1nnrqzxg8eDDefvtd9kQTaUzlADdu3MQh/UQAkKNDufveeedduwK8473zwgsvnlbP9IVudO4o2kIpk8eEj9z3ijo&#x2B;Ae96MW/cv38/du3ahaNHjuCGCRPOWhvp/FKUCaV3UPQBpRa0SEjgttLL24oQPvOZjwC4OEkCn3kwRSPANSKgOWkBapNKNTDu7nu1ZbyZeLqbvGq115EcIMCfGByEp/p3x7837UZmSQU&#x2B;2rwbf7&#x2B;yL5f/I69/XHCQvD0bUsNCEGEKwNRte1FUXSuV1xPbO1hciuEtk3B5QjR76XXyfmhPXWIj5LB1Sfu9R3w0qgWoX5qVw7n6Blk4kPaRVV6OZUdyMKF9GoN/ilQIDGrUBVC0BzhagKIQ5Az&#x2B;Gzq0Qoxo1zd7D7HXXolQoMgFf72B2/fW&#x2B;u24uVMb9E6MlcCThsAiHbOrpYaHYEqfbpgptr/peL5oh599UkVlAAlgUrh/2k0jMWhQD3T1D0DPAd0QGxfNAock1kehyFR&#x2B;LTe3EBtWb8PPc5Zh385DKMgtZrBIqvWRkRHq142rAxgOnx3Q1dkjBTwBslN4iOn0XLN97apNeOwv/4cHH78V0TEReP4fj6K8vBL5uUX47NNZWLloAwoKqNqDH3t4qUSgFjDUyaXuGvvS1qyj89YoTaGh3oKQsCDWKTAY9ewlPJ3WIEDNXfdPQNfeHVj/oK6mDiWFpTiRk4/5Pyxz2J&#x2B;bc&#x2B;KtKP9pKlV4MrUBvNcUaPp9fb2ks/HQH&#x2B;7gibC34q1a3/nIgAvTNmzYIK4DC664Yih/JnDvCIwOHEjHzJkzsXbtGk4Huvfe&#x2B;xiwk1f/p5/mYtu2rdi9e5cTAUA514odOnQIPXv2Qo8eTUO&#x2B;aV5xww0TPI7ft912K5MAzTESEiS9gMrKCjz66KOYMuUJTJ78qLjuzXjkkYeY/CIdALKff57PUQA80TY2nWqTIKDPJFPmf3QtpKWlsYBex44dkZGZiZtvuYWdFLdMnMjg&#x2B;&#x2B;sZMzi8Pj8vj1MniHg53VZBYsakF&#x2B;SiX0LXHY01ipGX3yzGhc2bNzMRkXwWiQif&#x2B;cxHAJyfQN&#x2B;nEeAV4NDZywcSEUB5UzQQqJEAnkC&#x2B;luddbXLpKaffG2FCb9ZRA/6OVQ7I001h/w/36oLnlq9HUW0t/rVuK27v3A6dY6M4pF9Zp0FnQ7uoMDzZtzv&#x2B;smw9X1Fcqq/WjDfX78Ddl7XHoGQpEkCrz&#x2B;jdxK7tkCYGtU&#x2B;37uVKAwZ5OQLrCw8dw2EB2J/sexlCA/wlTQKVC9vxeOg1onUywkz&#x2B;eG/jTk5HCLSTAOD3OWIwJXJjbNuWuK1zG9TTsVutqufI9dwQKUBRAA/07MjrbMsrZDFB&#x2B;hcfFIhW4lgGJMejnQDwEQN7wk&#x2B;ATQL9Sg35vLxi7NmRjp9/XIYNa7ehOL&#x2B;EiZNgcd2FR4TYb03N8&#x2B;exLJ0zKaDoEzr&#x2B;PTNkgO2UiQA65jpx/fgH&#x2B;PHk3N/fiPQ9h7Fj2z7M/X6xmFx3xlXXDkG3nu3x1qv/xaJf1kIvrkMi78JDwrzsLO&#x2B;RrO1UMLDo6C9/eouXXv7b71i/ejv27EoHyWxSdALl29tOUXAwVFwvJIjYtkMrp&#x2B;8zxH3z5Wc/IDmxhUMVCA8kgOsBn0W9SG8kK9W&#x2B;126WzX4PUILRB9NeQVx8tKp4qzckqxZB6yMCLhzr0KGDU&#x2B;49ee4VAE8g6sEHH2RF/vff/4CBPnlUycjDTlEBmQL4uSq0z5o1E126dMOcOT9i3ry5WLRoyUm3r6yslPP49fqmU2CKXpg6dSo6d&#x2B;6IK68cbidHFSMvNWkZjBkzFitXLue0AwKCdAwUpVBdXcOlB2fMmI4FC37zXQxeGGlBUHm8mjqpalCY6OMDBw/ivvvus6vlB5pMmPbVV&#x2B;jfvz&#x2B;fA3q1F9fZmbDpU3/CkgVr8MX3bzmJmJKwH4n6UUrHypUrMWjQIDHnMDJx0bt3b9/zyWc&#x2B;AuASAP5qJf58d/4pEgEUUuUaEaDmRXIFip4mj57C9d0RDd6QAu4iClxJB9flSCAvSQDcF4b0xn8EKD9WWonPd&#x2B;zHH/tdxt5vCr1Xlqe8&#x2B;ZTQYNYPmCbATW5lNYfr11sb8OX2dL4ABybFw4KmYnVKKUIiDYamJqBa7HfG7oPcvyZZiDDAoEN6cRk&#x2B;FGD9jq7tBbgO4UgA1/5xPAYGkWKi3zshDk8P6IGvBYA8UlqGYPLUy5EIFD1AZAelCohdYHhaMivxW2xQ7X/XfqTIgiCjH6corD1yAnuKSrhkX68WsYgJNLEXn45NL5&#x2B;Pmpo6LF&#x2B;0Dr&#x2B;v3orlC9fh&#x2B;LFc9swEhwRy6T5pPwpwOb3l0FxlCrQw56nNE9QhHG2zQVwvrgKbakZe2j&#x2B;/&#x2B;AC2rN&#x2B;Fxb&#x2B;sEVto4NB9/wB/zt/OOpCNQ/uOIOtoNt79&#x2B;HlcMawv1q3YyqH83gNpmweY6Z3QnFaVvkZtPhsCgwLQs08Xfo4MuKIXykrLsWHtdqxashEL561E3vECjvSgaBGDg45Gc55R1LdLxaQw70QBTEEmTmcgKYB1a7YhNMhRxM9dRr7G8do8vD/J6gMnQwS4a4LWrumaqauuxfP/ehwjrxlkr4LiLm2qOaSA2nJq5VZ9dp5MLAUoojD&#x2B;Lg4CaIpR6DaB/FGjruKxfuHCBRg2bBj&#x2B;&#x2B;tdnsX37NnzxxedISEhi5X1XkDhp0h0YMuQKsc5ip3SA5pte9spLNxZ5dUlgjkiLxYsXYfbsb/m7hQv78XVF1QSorRs3bhC/L&#x2B;Z67hT9NG3aDN7av/71umj3/5jkqKws59z/5577f/auA76p8ouedG9oSyelZe9V9t4bZAqCoIgTEQEFlSUgIIiAoigCgrJBQDYosveeZRQ6oLQUWgoUumf&#x2B;371pSpLmvSSlLfw1119MSV7e/N737jn33nMnapUmmE3aiEAhFX8C16&#x2B;//jqTPyTqSJ9RKUCLFi3g6uaGMZ99ZlA9P&#x2B;TGbRak7dW/o1HbvhUaBb8AL631Bl8NR8NmgXkyAGi/VqxYwWUJ1EqwT58&#x2B;/LmPr6/5Iprt/w97KQulDdPLBS6hPyKvfllovGu&#x2B;LDXedV9WGn9b5/xb/bLW&#x2B;IzeqejTWpznFebhZpyR80gaAfSiei9N507OyTMkDCi1rCFHND9pqHL6A7rAnIzq64Pj4vH96UuIT0tHKRI2qlyWo9sZwjGx0FgP6QPEJKbgm&#x2B;MX8Cg1jQE2pf9TNL9LeX&#x2B;0DigJZwHUsmXYLALNF&#x2B;7FYc2VEMSlpXIGgBpfpArHh34/plFtlHcthnSNaL2U063IUe&#x2B;/n5SCb4&#x2B;fxz2xf042VlrAIZsJjwxU83DHiAY14GJjw&#x2B;Be6vzonjsqWbDKyZygc6AU/6Y0fwsB6OIfPUV4WCR2bd6P08cuiQd4KCuRU8s&#x2B;An0KHSLJeN6vAMOvGhgwt5Oh4tm/NckBU3c1WZz3tLQMeHi5IS01g9PVSeuA0u8pNd3C0lILwtE95lPKEz8tm4rLZ6/jtwXrcSvsLtfze/qUQKWqZdCuUxP0GtAZdyLuYuLIuXxOCw9k5S8xnT4h8sfZ2QFfz/sM9RrXZNFBbimZM5dE3onGHyt24MTh8yxmSMdItfimEgFMdqWpU1WtYW1rzYOaen3T/ZT/Z6lCBqIrDPMmRagXqZAgD&#x2B;j&#x2B;69C1GRaumcnnwtRxYowGgKG5WUps0Jw5UPTP7169euLYsWP4559/UKdOXRbli4mJxbRp07hm/ty5sxgy5C2e5zp27MjR1ObNm&#x2B;HHH39isT&#x2B;qs9cFz3fvRnGtPYm96UupN8Xi458gMLAmwsNv89ggZX8qJ&#x2B;jSpYsA7z/h449H8j6TYF9sbCwmT57MtemUoVC5ciWxXDf079&#x2B;fCcfjx4&#x2B;zGCGlp69du44j00QePO8&#x2B;/teM/D3KLlMbKevTOaS6egoOGWNE4gx740uepxaumWFweSKGX2n1LoaOHIi3P&#x2B;r3bHw8TkBxV2e9Y5sILBb4K1XKPK8UPF57U7yRgEh6znumnnf131k5r0yNvzVf2Rrvmi&#x2B;lxrvmC/oeb/9mjGwmAAqWALDW824mAJ7DEhMTWSwwLSc1TBNwyjl2zxMZMhXoG&#x2B;NoGrNOWwFIrsTFY2XQDQGgk1mo7/XqFdC9QmluZ8e1/DnHRXX4UU8T8WdwOM7ee8BCfwSMSVugrrcH3g2sygBcXRKQZx9y1hGXnIpZJy&#x2B;K7SXBQe2wULcCsR7SIuhXpTyalPJSCfXJqHmrbyZq9/coJQVbbkZgZ0gEilOUVAerkJBhdS93vFLBH7U9PagLH3/HrRCVSr0kg/pvAhcUhSbH4Il4SN8Oj8S2P/fh2OGziL4dI8ZLMuxsbWFnb81pmwU7v&#x2B;lmChjIHlBAuoRAB8SpSitU5zg1RTXWGaSqT47GDxU6tfTUEuv1IT1Qq15VlPL34W4LTx49QdClGwgNjsDhfae4Ld8zATqVin18fCK8vUtgiHB86jWswdulcgDKkiju6oK42EdYvmQT9v91FEkJqRzxLuLZG/rz5PPeS0SQPX2SiPJVA9CqTSNUD6yEug2rw7/0M&#x2B;Gxx4/icf7UFSxb9CdOHD7HWSEODnYm3e/q884R7pxdUYlaWhTCOIP0GNOXDVAQaor5sPTUdDRuEYgFq2YIB94&#x2B;N/pvCLwbQ6Dqm2sMrUuuM4wxXWbMprLY2Bh4enqZ/LtPPx3FPdj37t0HHx9vzJv3IxYvXoTz5y9g7ty5OHbsCHbu3MlAqm3bdhxZ79atGxo2bFQoAmrkQ1CKtrr16DffzMDQocMQGFgrlwDo0eMVlC9fgVv2/frrYt4f2scNGzawlsFvvy0Ty4ZxyreHh6fW&#x2B;ilFnSL/JFKnFqp7XiB8/PhRtG/f0TwITTR6Fr7WaTiXAe489rvWdwlPkzgLUHOMBV8NE8t/hGWb5nIGmdnMBICZADATAGYC4CUzIgH0dQ2Q0gcwRAwYWl4qomRqRoExTqrmeklEL/JpAiYdOoMMAYitrSzwbq2qaFTSg1XyLaBS2ud0fgGGn6SlY8mlYJyKiuGWemTUMjBQALteFUsjoLjLs3R0qNLkVVFTFWgikuF&#x2B;Ygr&#x2B;Cr&#x2B;Dg7ejeZ25jk22ao7sU6UcelYso9rHHACaSernihzQLpYjUcLkjCz&#x2B;zo66BginaNPNCOwRAN1ajyp7GqXkW1uhf7XySBEPayIiAoo7w97KErW9SmgtS6CfWjHZ2llze7prQSE4c/Iydm4&#x2B;gFshkUgSoJ/U&#x2B;6kWz9LK8gVM2HLRa9MQGNXh16xTmcmLG9fD8SQ&#x2B;gc85Ra0p0kzro1R0GwHmqW0jpfJni&#x2B;t9Nnw7Zzy8P2CceBpmcQS8UcNaKFW6JL9W/7aZiQCFlmK7hbif0lg8r5gA/LXrVYOVONexMQ8FmE7CrdA7yMzKFKDO4SWKZukjBZ7dPxShT01K4VaDJbzdUatuFXTu2ZJbF7q5q8S5UpJTcFOc29lfLcbJoxeYtLKibJWX8lGoM5Y0W1I8z/AsAGKAW5CmpKJMWT&#x2B;s3v4jPMX5zsrJ6DGks1LYxKypJENhrP//2e7fv88p&#x2B;OPHTzC47Llz5zhiT&#x2B;CXwOuYMaPxyy8LBXjeiKtXL&#x2B;PLL6dg7NjPWRTPxcWZSdq&#x2B;ffti9OgxcHZ2LvRjadu2NZYs&#x2B;Y3F5cLCQlGxYiUB2KNRr15dRERE8nWnrIMFC35mAqB791cQG/sA7mK&#x2B;6Nu3HwsZ1qpV67n2ISTkJqZOnYKVK9cYXJYICMo&#x2B;uHQpyDwQNezUsUsoU86P5xkpo/ln&#x2B;OBJOH3iMs6Fbdf67t3XxjLIHzZ6kNa9fi8qFj5&#x2B;nuYTbCYA/nMEgDlHyWz/F0aOAr2IBHj69Cmz7nRjqtlcOTV/Q/X/ur8xpOAvFV3Stx6plH8pHYK0zEz4CfAyRoC3FVdCEZ2YiOUC4F&#x2B;OjUN9H0&#x2B;kZGYgIzMbpQRYppR70gh4pZw/XG1tWN2fsgjodf5eHGKEo/VeYFVu3UfePgFuauGXkJbBSv&#x2B;kA&#x2B;CU054tUIBuyii49SQRarhO6yeiYZMAS3efJsHX2RH3xbu7kz0ep6RxloCNlSqLwF4AqBQBQGn9VD6QKK6PIjfVXfkMyuTkt1uJt/jUNBYH9BIAk7ZvK7ZX0a1Y7nUl4E&#x2B;p1gTqou7cY3G3IwfO4uKZq6xKT6JAFLF2E7/JlrmuhW/6ar7zhmMpCk&#x2B;tCK2sLPJGuui0ZJP4kRN69e8MXz8PTB37I6Ii7nH6fgmP4ihXIQAO4txXqFyGSx0eP3zK7Q3TUjMx4ZO5&#x2B;HzS&#x2B;0hMTmaSxL&#x2B;0L9LE9XB1L4ZKVUujZmAVrofXal0vNkh1j/RKEdfw0N4TYh&#x2B;VTKIQOUTRkmf3g1S2QxHmn&#x2B;d9NuOZ/oEK1dqK&#x2B;4BKHsgRjBX3wI4/92HL&#x2B;t0oXyUAnbq0QqsODVGtZkXUqlsNS/6Yhb&#x2B;2HcC0sfOR8DRZ/Nb6JZz5pFpQwPjzrk&#x2B;aQCGxnAnkAI0ZP39v/LJmBpeeZGmU8yiNvB/l2qbK6btIZQgYS8LKzfPmzgNAUNBlPH78WOszEubz9/fn0hlNI2C7dasKbNFcQhkgCxcuxM6dO1CtWlUBnmtg6NChAoQvRXR0NFq2bAVPz6IDXKGhIQJMX2QCoHhxV7i4OOZmNqivMaWZEzFAPsasWd8y4blv3x4MGjQIrq5uRm2HjpvmdXUGjOYcT4RCtWo1tZYnsoRKCHTHGREpDg6OZqdPwy6fD8aIIZOx5cBi2eVobJYs5Y3IdXnFF29cCcNrg7vmOd9m8G&#x2B;2/6qZCQCz/d8RAVR/RWl91DWAau3UgmdSnQL0gXs5AK/P2dS3PjmnVK4VoSGNAlK&#x2B;r1zCFROa1Mbqa6E4HHEXx6NicCLyPqfLWyoEQLNQgvT5KLpOIJ7WYKN2OMQ67QSIeyAcdNIJII0AVT97BTKzs5AogKGzHQF/BdLFv&#x2B;k9S7zb03pYuv6Zgr1Fzrk9GnkvFyQo1eckZ985o0BB6TAKrd&#x2B;S2XLLQJURPKDMAEuFBTwd7dHAtRga&#x2B;HigjJsL3ASYp21lid&#x2B;RantGWgbu3Y3hfvM7BUgLvhyG2PtxApxacdq2m9uztn3ZLx1Dm5cIoH0lcE&#x2B;R6Tu37zKBpamSTYvR5Yu59xDjRsxCYkISp&#x2B;I3a10Pfd/oihq1KnEKI0Xn7917gEWrZ&#x2B;KDgeP53xTtX792B9p3aoaffvsKB/edhr0AwVT/f&#x2B;TQGbG&#x2B;b5GeniErPEhkC4laSQG0vKSGIRT54s45ERvUBYIUvmks0RiNDL&#x2B;PBd&#x2B;twvJFf6JB01po2b4hWrVvhF6vdeao0Nt9v0B0VCxnQEgFywtQf6&#x2B;QyBB9eydxPaR4BCNIADqfpDnhW9ITyzd/h4AyJXNbY5mSYi8nnmooU0vqt1LlAnLPBqn9&#x2B;i9rClhaWmkB/cWLF2P16pVo0qQpJk&#x2B;ekluTff36dU7dz3UoxfxMddxTpkxiVfSQkDDudf/aay&#x2B;u5d1XX03jlPqePXvB3d1dzHMqcF27du3cZS5evITIyAgmPZKTkzB9&#x2B;nTUqVPHaPBPY2LRooXiOPtjy5bNrF1E7QHVRqUD1LKOPqdzFx19F0OGDOH9adOmDXcVoHM5atQnrJng4PDfFg9MF89/6khTI7Ayz0PHD55jAl1NqsTci8O6ZdvQ&#x2B;/VOKBWgLcBXu15V4UOl51nnhj0/w9vXDPbNZjYzAWC2wnVNxQPxTkIijkfGIjEjnevLK7sXRxlXAnvPV0tMzhcRAeRoEItOD23N6JMpHQJ0l9PXuspQ9F/OiTXWwdR1bqkWnoD7kJqV4GprjYN37nFtNwMU/hkJ4in57/iUNBYAVGiqx1EUPWddT1PToa6EoXcSHEzJUJ0vLikQ66Fac9IPUGiAA8YAOYSAvXAIn32p2o6S8b4iDzjK1sAQBM4pS4HAPREVdXy9uMVhfV8Pzkig7dKeWIljpNR2Emy7fC4Yu7YewPVLoYiJjePfUrTfpZiz/msJpVZq&#x2B;8toGQIgeXmXwI&#x2B;/T2Hl/Z&#x2B;/W4mwGxGcym9jbcVnjI6JnG6qYyRQOmrcEFSqWh77dh/Dl2O&#x2B;w41r4bh9OxJNW9XD6291h4eXKwsVNWlZF206NkHZiv44e&#x2B;oyvvx0LpMkmemZ4vxncwo/d9PIHZcFBTzlQsovngjQbE9nZ6fKDCBy4Mj&#x2B;Mziw&#x2B;wR8A7zQe1BH4ZzXR/e&#x2B;bbF43jq9uRzQoT1e5NGZdh5MQPZGcmj0SyKnSDPis8kfwL&#x2B;Mr1ZfbH1zq7FkgKFsKmOfO4aWN6XTi75ngLHr&#x2B;/9&#x2B;fj/TcQgPD8eSJYtZ8T41NSW3lp6M6vep3R2VAJw6dQonTpzgSPvOnX9x2nxRlA6RqCCBaoqma14TEu0jgN27dx&#x2B;u5z9//hxWrlzBaf70vbq8gUD5wIH98dtvv3Ongb1793JXAlLxNxqwpqdj2bLfGcgHBJRG6dIBWvtCIoGzZs3CBx&#x2B;8j48&#x2B;&#x2B;hi7d&#x2B;/GG2&#x2B;8yZkWS5cuFfP6bUya9CVCQ8PEeV6GN98c/J/2H7/9aiE/75Zvmiue/xbwL&#x2B;sLa1tVK1cqh5vx5c/YuHIXkpNTMW7aMK3flvB0Q716NfKs0wz&#x2B;zWY2MwFgtkI2qglfGXQTx6Lu42GyAKcWqhZ0BGgpPbxzOX&#x2B;08PdFcTub59oOgRpNIoAcgWwdxXopMC7XQkqqdZVUdF&#x2B;qnl&#x2B;TTJCLjOlbn/o8ErDvX60CKrkXx&#x2B;IL15GcngE7a2ut6LcyJ&#x2B;TOgDtbydFPzS1YqxXKNQgCCzUUUDwT4LPQKS9mnTPhCBIopZT9bALaShXg1tz3JAb4qhXSv4lgyMxpy2cnfttEgP6KJYqjqrsrfFwcuLSA9Q24FWA2Eh4lYM&#x2B;Rozhy4AxHrB/eewyFJdipc3F2koA3GteIdRGUWn9rvhe1UbSdRIhsBeC0zNE/IJAfcuMWZk1eiJ79O2DBimk4efg8lv&#x2B;6GRHhUVyHzr3qxVkmUP/N/C84vZqU&#x2B;R8/fML1&#x2B;XUbVEd6Rga69W6LtNR0fDRmMEqV9sbD2Hhs3bYHZw5eRtitCBQT54yyAmyFo67bbQDQox2nkbGhVOaXIFA5ZgQGbbUIPtPj5qTpoP6ZWs2fx6A4h6rIvqnijs9gO91b1DIQsMXjuCeYN20plrv&#x2B;yaUmFrlK/rod7vXjY6kmfy8WCiplUL1SCu1p77VS&#x2B;iBJhb185dJYvHYmXMWcRJkscpF1fWSAofnQGFBvCJCbQvyask9y5Ma/iQigFHR1tJWE8E6fPptLkB88eIBb8VG6f/Xq1eHk5Mwq&#x2B;jVq1BCgejy6dOlaKGJ&#x2B;Wj5Gjso&#x2B;dQbo3bsXatashR9/nJ/bOYBEg3/8cV5ORH4L72v//q&#x2B;hceOmGDZMBRgbNWrM4PuPP9aKdfRG06bN&#x2B;PPp0782eX/ouhP4b9WqNZcTaLWxTU9nwUPa1g8//MAEQJs2bbmN4Z07EXjyJJ63v2XLVsyf/xO3luvff8B/2od8pU87dOiWgZDg2yhXMQCubs/EFYkgr1ApAP&#x2B;cXoU5MxZz4ICy3dTmJualYaPfNDvi/y5Tmk&#x2B;BmQAw2/&#x2B;BEfDfGXqHgaejzbMhRmD1UUoafr90A3tvReHzxoHwc3n&#x2B;Wjc1EUAPf2LzKSpB7/S52kkzNiNAzuHTB/bllpEiA&#x2B;TWpbsvpOyfJcBkoLcHxjWxw66wSBbrc7Sx5FR6JwGKSDjwiXgoUrtAe/FvEthLFb&#x2B;h1n6WlgokCEDqrNm/nUC6&#x2B;A0B&#x2B;hQW7lPCkWo3c/bFEhZIyyZ9ABued0krIF4ATkcb7RrpLAHifRzt0TKgJF9Xbyd7pIiHsaNwzOjaEwkQ4OIE/2IuIBxM67eytWGEmSBAbfCpIOzauh8Xz1zHrZA7XB9P0WrnYo6mRf2gzPO37ntREQEEUKvXqghbe1tERkQzyOS60CwVMUM96ffsOoJ6LWqg7&#x2B;tdsWTdTJw8ch4/z13Fy1Pq/tO0RHw6fDr8S/ni0plr8PL1EM6lE979uD9at2&#x2B;Kw/tOsNARiWk9eZKA26FRSEpNhpOdAxxtHXTq/KWxoL6MAJ1GEUaTATS&#x2B;3T3d4OTigLDgCD7vdnkyfeS7J5CIYXpGOuo3q40ypUvyeEl4msjdCZ7GJyDs5h2O&#x2B;BD5QR0NbJ&#x2B;TQCSn0c3VVYxjcb&#x2B;IdVpY6Par0E9c6OtLIOWxvBxwUIoIUOhB&#x2B;xrXR6k9JyU8SUS7ri3w1ZxRKO7mwuBfF6QbAvJSAN6Q0r8h7RYpAK/5t252l5w4oTEdZKSyyOT24f/FvL2f9UWn0qDx48cxYCaBOgL9JIxHRuV41MIvJSUFbm7uRbJvkZF3sGnTZowYMQJffTUZ06ZNxzvvvI2zZ88wMaG&#x2B;1vPmzcPatWtZc2DGjJl8fxOR&#x2B;M4772DOnDkM2Bs2bMip&#x2B;dT&#x2B;T5/RGDfUd15ttrZUmuaGmTNnYOvWLUxINGjQUMzTCWjfvj3q12/ApQCqZW04G2Hbtm346aefczRvrMS&#x2B;NkdAQBn88ssvGDVq1H/Sfwwn8eBdR7Fr8wEu&#x2B;5u7eCKKF3fJJYLvRz/Ao4dPWQuoZEkvLfBPVqFKaVSsWsbsiJvBv9nMBIDZitIeCmd98flrrAqv2bteHVej/u024kEXk5yCqUfPomelMuhSzr9gBrMAnuSQUCogZQQQEUCRAM1ohDERfzkHTk7sTyr9VCoKJueI6pIDBOhLOjngvdqV4SdA8qHIaMQkpcJLfPZG9QqwF8dO9fx24tw&#x2B;ThWAKS0dbgKEpgpQvSskAlcfxsNOnAcqIaCoex1vT9Tw8oC3gx13DXARDglpD1DWAan4p2WrVPqtxPbpmm4JuYVrsY8FqM9mwoH2mM7qvaQU3Ip/ytfR18mRgZ/W4VDEVjygFWLb6QK8nTt2CSePXcDfWw8iKvIe0lMzYCccTEdnR71ZFgX3BNGfIfA85IBarFCL0BHvjVoEolmr&#x2B;pg/ezmiI2ORScKI4jolJqbwTZCVloVDf5/G/t0n0PWVNujxajssWDkdpw6fx7rl23E7/C6unL2BR9GPUaZCAF7p04b72z&#x2B;4/xATPvkWOzftx4PYhwywafskXmdv72b8OZPTlUP&#x2B;MgAeP0rAL6tnoHqtCti&#x2B;cT/&#x2B;WLEdN67eEvekgh1ohYXuxrVBKGWulPBwxegv30X3fu35WKwsbXLr&#x2B;Ult/kHsI5w8fAER4ZH4Z&#x2B;dRhAlHkcbOM&#x2B;Cev3GR9/dKA5A/7zdSQXNDJMCLJQmUBn0sGtNEptLXk78dhUHv9OSylcyMTNn5Td98aShab&#x2B;pvpUhXfYKCUnO&#x2B;ocwvY8sYjCnr&#x2B;n8SF7SxscXDh3H8d7FiLhg5chTKlSuLiRMnYtCgN7RS&#x2B;&#x2B;3tHfhV2EaRdALTFy5cxL59&#x2B;xjI&#x2B;/qWQocOHcU&#x2B;UTr9lVwCgLLH/vhjvfi&#x2B;ZK6CP6X3T58&#x2B;TYB0VwEoi3EXFCIz6KXPqLVfUlICypevaNT&#x2B;lS1bFrt3/43Tp0&#x2B;jbt16&#x2B;Prradi6dQf7IFQeQef06tUr&#x2B;Oijj7B//35ukbho0WJ4eakECT/99FMuIzh48DB3KfgvWqx4xr0/YLw47ylo2a4Bl2vVrluVu7Y8Ej7MT7NXiOffPiZ47kfHYemGWXrnLLP9Z4kCM1lggpnbAJrbABaozTh2HmeoL731MweBAKaVeNhSCUBiegZHnq25JplU77PxVYt6qOFZ8NEDekio2wfSQ1gtFigHtHUdNKnPDf3G2O&#x2B;NcQy11gOq4bdCdGISll26iStxcShd3AWdypRCM39fJli4fFORA2/F/ygqvyssAn&#x2B;FRiE9O5Oj/1Ra4OFoj87lAtDC35tBcEaOerFmHFAFcsW3SgVORN/HcrHNp&#x2B;lpnLJOmQKUwVHO1QXty/rB29GBo7YESildm9LekwVwu3LxBk4fv8SR7stngpGakQZHAdysrK1Z4V5Vb/pyPLRlyQAC71mZYn8V3B6PliaSy0ZDPZ5rFLOymV6gtn2&#x2B;pbzx2eT3Ye9ox9fl3t1YBF8Nx6E9J3D3zj12Qil1PrBRdfQb1JVFj86fuYoyZfwYaLm5ueDs6SD8vf0wzp68jPi4pyhGHSCsrTTAhlTEuoDgpUZQWKFBGKiHK0XkPbzcceL6ZnH9s/i&#x2B;exT3BJvW/oW1y3ZwBwcLBhU2UFjqz&#x2B;wgRfke/Trg&#x2B;8WTWeCTxlxUxH2E3ryNR4&#x2B;eIKB0Sc4QqFilDJ8X2vTBPafw1Rc/iPOa9YLHj8LkU5m/XxexNyV2NFXcv36lfTD4/T54a2hf1pQgMS7duUzX8dZHdOZn3pNL1TeWJJArBzNUxiV1LPrWYwh4SJHExmYcFJUR4bNt21aOoFObUHp2DhjwOl5/fSBKly79wvaL2ggS8UAK/iNHjmCAP27cWC4BJIKwU6dOsmKDpBNEAn/Ozi5Gbe&#x2B;ff/7hjDR1aYAhcmL06E9ZL2Hnzl382dixX2DmzG9w8uQJvPnmIO5AQMSEv38A3n//AzRu3FhLT4GMSgLo&#x2B;/&#x2B;KPRZz&#x2B;4aVO9Grf0d&#x2B;hmzbuAfjhn&#x2B;LGT9&#x2B;xt1u1i7bhuZtGmDWpF/w6qAumPLZ9xj4Ti&#x2B;8P2IA6&#x2B;pUqVaOfQ2z/WvwGtVuqFsAar40W/&#x2B;p/63bAlD9dzbMbQCNMvOdY7YCMwKQEU8StMB/kgD8jf290KVsAIrZ2nBk&#x2B;s/gcATFPuJoNJECP5wJwsRmdVG6WMH2BCYgSi11qDyAWgcSEUAPavV3hpT8pepODU0MctEguU4CUk6gtuAduFWglwDvXzSpjeNR9/H7pWDMF&#x2B;fw7L049KwUwISAMkslJMg3uQBTvSqVRVMBRlcFheDqw8ecbh/1JBG/XbyO6w8foaGPF6p5uHF2gFIn9zsrS0U8NPL1Qlmx7lPRMXiSmoFa4oFd3rUYlxcwHCYleWopl5KCMAHcGLSeCMLVizeQmJTEQn529rawd7J7dsxEOih059wCblhuEoWs1EsK0OeUaujkXAxKhyz06/MK6jaqwQ7KIQFEKU2d6sgJmNNylPLv4GiNeUsmIV2M&#x2B;ZW/buYot0sxR1SpWR7tOzdloP/znOUoJkA&#x2B;ObbRd2PRtlNTHBbr2/BoB2xhI8DzfdyJjBbnVZw3cc0pSq6OTOp/XumLXus7j/k4r0puGKEFEHl8iWtO6eETPpmDXq&#x2B;1R9XaFdmZe2f4a&#x2B;jaq604ziAsnrcWVy7f5OO04zIQ7VVTNsOxg&#x2B;cQFnILnt4l8CQ&#x2B;ESPfmYJL54KRkZUhXpkoKcZfh64tMeDt7qhWozz6vN6JiZT9f5/QyDB4YXBZD6TPe86VMiUFhjoOFOWdwC1JU9NRprw/Fq2dwS0o1a1X9c1NhgRRDTlSctkDhjq0PG&#x2B;HF0Pzutw8LycYKzX3G3sOi8povlbXzm/YsBGLF/8Cd3c3LFy4CNeuXUXLli3h4&#x2B;Nr8vgx9ZjUdf1kRAJmZKSL53dxhIaGomLFijhz5gxq1aqNR48eomrVKhw5J1FCqqWnZStVko/UU/q4seBffQya1yo2NhYzZkxH37798pACag2AP//cxL7Ghg3rsX//PrFcYzx&#x2B;/ATDhn3MrRCJhKAsRSn7L4H/W6GRGPfxt9j39zFERtzDtO9Gc61/lZoVMHHUHFhz2SLw0/fL8cWXH&#x2B;LDTwehZftGqCrmfrP9a01ZxL/7bxMu5gwAcwZAQVlsUgomHDyNlBxVaBpadXxKYHTDWnmWPXk3Bj&#x2B;du8oLUeq5rbUFlnRpzaUDhWUUmaSyACIC1PWrulkBpkakDEXtjRyfpo5nVWRe/E2ZFPeSkrEj9A6O3ImGk7UNmgig362CP7fWSxcOh/oOp6h/anYWgmIeYUXQDSSlZ&#x2B;bW6tN6&#x2B;lYpi6Z&#x2B;3lz7n67TVSGXMcwRGKT/k2gaxbpJnZeis5G3o3H6xCXs2LSf67UfxcWz&#x2B;jrVkKrS45V6FOj0IB39R44X2YiN9p/qNifPGglvP0&#x2B;cPRmEC6evICb6AUcx&#x2B;g7qit3bDuHalTA&#x2B;L1TLn5GegWFj3oS3uAe&#x2B;GjuPoz8kWJSemY7hnw/Gx58OxoK5qxDYsJpwdJ1ZJHDDml04vv&#x2B;8qgUj/WelgI24ptkaqtz5PALkJ/ZMDitlNJDzzIKRpKuR59yoSKKU5BQ4F3PCK6&#x2B;2RbtOTdG4RR3YiHNmYalA1O17OLz/NFb/ugXXr4UxUULnM/f5I9aRkZqJLr1aY8qcUbyrnw&#x2B;fyXOIm2sx1GtSEzUCK8FXjE8iWohksbSywKljFzGo&#x2B;yheV14Y/dI8hQyQMYavVlEdFV3LtLQMbsM1/LPB6PdmN5Qs5cljID9zlKG/peZXufZ9cr/VN2flJ&#x2B;0&#x2B;v&#x2B;n6hggJfet80VH/Xbt2cQ08PRO//no6R6xHjx6D9u07mAz6udWsmOM&#x2B;&#x2B;WQEpkyZyir8xtipUyc5E6xRoyb873feeQtTp06Hh4cnFi9eiNat23C0Py4ujueE5ctXcOcBIvKp3v6335YK0P1nnoj68xgp9VMGQLNmzREVFYXu3bth8OC3&#x2B;DsqidD0K&#x2B;jckdJ/Wlo6Nm/exPMl1f0TgdGsWTMmMEwxClQU5LG8bPZA&#x2B;CAdGr6BJuIZQS1/z566gokzPkLQxRDhP&#x2B;yBh1cJlC7rx4Kt7To3Q9vOTbUy7cz2r8Vrb&#x2B;BZ1J&#x2B;iderIv&#x2B;a7&#x2B;pUF/ZkAmlF/cwaAmQAwEwBFYRT9n3r0HLeTUwPOTwT4r&#x2B;3lrpeu&#x2B;yssAr9dvAF7a0tOUx9YrQJ6VSp88RYCNcTS04se3GqNgPyoOhvj4JpCMBjr6Gq&#x2B;W&#x2B;WQGBSZ3x0eiSsPHnOkvnflMmiQ0/qGVP65zZzCQoB44G5iCvbfvosL9wWAFU6LVU47AH9nJ3QuH4DqHq7cok/f/tEbgVly2O5FxeL0ycs4vO8UTh&#x2B;9iMePE2BtZcUCbVasFaCU76mmD&#x2B;noLqQX&#x2B;ZjMIDz3PEIRKkrpT3qaxErET&#x2B;ITuFNCuUqlsGj1TOEs2nEUe9EPaxB&#x2B;8w4TAaza36stK/tXrVGBW/U5OznBubgj1zcminVRWcCu7QcQfTcGdtZ23AO6aDGBQs9zTyVc6ejkII7LHvHxT5nkIdCdnanUf7rFx6R3QJFjSysFuvVpyzXjpUqXhJeYA0g08p44RmrBt275DgRduMaRf0sxXkiILyM1A8XEedp7djUcxDZpG1cv3ETFamXg6urKG0hKTsbD2McID43EzWvhOLj3JM6duKwnDVRqYL1ockCfCKK&#x2B;G0IBY0e8sgCPjkox/AJ8xHXrhXdH9OcMnYyMTFnAbSwgN7WVntR8bMocLQW&#x2B;TY1QGyNSaGwJQGEr5OuzdevWokOHDnmE&#x2B;u7cuYOwsDBue6c2SmWnfvSlSpUyev20HgK9pIBP0XsCw0OGvC0roEelBsnifqYsvU6dOmD48I/Ro0dP/o5E3/bu3c9kxLx53zPBOH/&#x2B;D6hcuQpnUhGgvn79Gr799lvcuBHMy2q2ASwI&#x2B;&#x2B;ef3VxeQNF&#x2B;Ehmktn2tWrXK3XdbW1u&#x2B;plu3bmXQf/jwIRYUpHPXs2cvo8UDdY1IjqVLf8UXX4z71/qKq5ZswZ6dh9G5R2tERdzDj7OXs9ixvYMd3h/5OkaOHfLcIq9mK1ij4Bndqy8hAaAL/s0EgJFmLgEwW4FZKkWbNW4WEotzy6ME/sx57VIugBXrV1y6wQrz&#x2B;wQgbRXgC1eJ3xSUkaNCgIJS9mhSIyKAwJ06G8DYlE9jUkfluhDoIw6k1idXPpCRow3Q0NcLtTzdcSo6FttCIvDz2SsI8vdBuzKlUKa4M2dakP5Cppj6fAWwG1ijPJqV8sKyyzcRlZDEZQF3nibw78uJ5dWq/7RtldicDdfAJxF5IEDcsUNnceboZURGRcPa0poj/RTJhjFCfob6q6mLzfWiHgUMK5kXLNhjUToBVCmSTRFt6k1M4JiIgKrVK7IQ3y/fr4abezFMmjUSVy&#x2B;HYNsf/7CoEUX269Svzmr&#x2B;/qV9cSssEtMn/Ijzp69yPTVFzAjweri6sYZC0Zu&#x2B;&#x2B;mZwC8PVO37gTBNyeJ2dnfDRW5MQGnybnVvKcGBwSBkAdAzO9sI5z2KSgMijbev3Yu/OYwgo44shw/pxaydfP0&#x2B;8&#x2B;V4ftOzQEFvW/oMDe04iRow3cqa79mmLilVKs&#x2B;NH5ANFfK5fDcXE0XPQtlMz3p&#x2B;rQSG4LcB//KOnePwonkkWIijynrYXET835Vwb06JPe5&#x2B;VMt8&#x2B;z9HRtc7IyEKimAOat22A&#x2B;b9PgXsJNy5dMfUeMWYukwLM&#x2B;kT8yHTV&#x2B;03JKtBXZmVM2r7UseWXRJDqdlA0jns8PvtsDBo1OpaHADhy5DDf2wRs16//g9vUdezY0STwT0at9Pr06ct/U4o7gX/dZyX1uvf39&#x2B;fnL9nVq1fx448/4OHDR0wgUMSbFP4XLlzIy732Wj80aNAAy5atYHX9qlWram2zfPkKLEpIoKSgwT&#x2B;ZnZ29ap7LyOBzVKFCBRYX3rhxPcLCbmHq1Km8HHUSsLe3xbhx4zkrQX18&#x2B;TUiPBYs&#x2B;BmffDL6X5kFkPA0CcHBYajbsAaGD5nE5UUb/vpJPCcj0Kx1PZQu52d2povIiDyrWLGSwXmJ/ORJk77E3LnfaQmAFtIDUqnnQak00ntEPpb7z5qZADBbgVlWto4CvLjvnAykbfWoUBp7wqLwND0dMUnJWCsc/mF1qxXJ/tKDmhwLciDowf7o0SMtIkDOkTWl5ZWh74wRspJzktXq85S2T8Crlb8vKgogev5eHDYGh&#x2B;NEVAxnVzQs6cnANVWANTtrS466utvZYXTDmrj64DHrM1T3cOPOAlytLJbltDuxjfjHCTh28Cx2bdmPWyFRuHnzFte5OzrYsaJybo95zWNBPir59U37Ct3PNSPQUs&#x2B;Hgne06disbbSnTGrPN2nWCGxYtRMrF//J5QGUvjj4gz4o6efFu&#x2B;Hj48Ft5i6evYJvJi1AaEQErDIsOdqheb2zXyKmWVViYsFtmCgax60MxXihjAWKEqcgFT7iWMtXKo0atSrC0dmBOxXQud&#x2B;97TB2/LkfT58kcrQu5GYExgz7Gn&#x2B;s3Y7uPdqjVftG4hy5YeinAzHw3R4sjkgEgpdvCXE&#x2B;LJlkImKElKAJnYaHROL65WWwzGn3xN0PLBVwcnbM2df8DCrNUVq44&#x2B;b5yBj5O0iqiZ&#x2B;xtIdKKDVJAC4fjJ/xEbr2aA1XMXdQCrJcVNuQNoqhtnhSc6RcpoCUroAxwN2YfTe2PasUMauPJNAnPGvICCgT2Wpq3T2VttG2dGvMqT3dqlWr9Qr4lSrlL4B7L/zyywLO6iKhP1KpN9WSxLNbndlw5coVDBzYH&#x2B;&#x2B;&#x2B;&#x2B;z4&#x2B;/ngEf/bDD/Pw7bezMGvWbLzxxhsq51MAiZCQmxg69EPEx8dj/vwf&#x2B;dhbtGiBEydOcdo9Rfqlzh&#x2B;B83LlCq8enPwDAuC0HVdXNzRq1ADe3t7w9PQUIP3H3OXoM2/vTs&#x2B;1LboP1efP19cHtWsH/mtLAKg0cOu6fxAUtZsFXge&#x2B;3RMVKpdGw&#x2B;aBZie6CI26Yrz55ps4deq0wWXp3j169AgLghYyAZCfB6Qxy5nNTACYrVABNdWHK7SdTycDaXD0cK/l7Y5DEdGsTr/hehiG1q2GokySpAc9ZQNQuh&#x2B;lLz5&#x2B;/DiXCJByCOUc4Pwsp&#x2B;uwGttaUNdxJUciTfztaW&#x2B;PruX9UdOzBA7cjsIf10OxPeQ2bEigjuqqBYgi9X5fF0c08vVE45IqsEog1MrGmmu948XD&#x2B;dL56/hn5xGcOHiOReoo6ksAzNnJ8VkrPaV&#x2B;oCKF5U2GWsZM8QpDoE/fQs9fPkCXMOLWXXiKMbx6x48sYEfXYOPKnfhh1u9MGJDoXVRkLNfIU6Tf2cZRVRiUuxdKrfaELw&#x2B;hl41hgyZyyQxT8gKoOznboVP3lqjXqAZaCCDv6eXOWR9WVtbIyEznMVNudAD6vN4FEz&#x2B;Zg&#x2B;CrYbAW3xHAP7DrJEKCbiP&#x2B;8VMMercX0lLTWAHau6QnSni5iXN0n0mD5MRkXL8SinOnruDiueucXUFaEjralAXsT0jUNLyw6yEX8JCG&#x2B;cb8Sp1cQ&#x2B;efSJV2nZvi04nvoUbtymLeyxDgP8PgfGQKuSlFBhhS9TdEBEgRCqa0WjWGCNNLuErMy2QE5J4n0n/p0kXExNzH&#x2B;&#x2B;8PNel3X3zxOZo3b86K/ZpGwL5ly1Z6f9O8eTOO6hH5Tb9Tt6TTB1ApWlilSlW939PzU30uPvzwA4wfP1Gsdw4GDx4ijucCTp48ifXrN/J3agKAsgwoXb5fv9c4wkiZUK1atRSA2wZ370YZfY1MsePHj6FJk6ZGLUvX8dtvZ6Natao4dOgg/PxKcdS/Xbv2Bb5fw4cP4wwCImSIYKhWrfq/1k&#x2B;kuv6UpDTu8jLl21Fmx7mI7MKF8yyiqSaaiNgaN067zOTAgQM8BomEouzGq1eD0LhxE7z11lsIDg4ulEwbiYefUudvQy3&#x2B;jFnGbGYCwGyFZXYsFKbQAkfWBkT9aOnyxYvh8J17/G9Xe1scF0CgWSnvoicwxP5TNgARAfoyAvRF6vX1ipZTqTamhZVU2qqcwrTW8sJZ46IopQIlnezxRo0KqO/rgaNR9xGdkIyKbsXQwMcTnk4OcBIANUv8LNtCwcJsWekqQZ4zJy9i364TCA&#x2B;9wyI9lN7vQBFrTrdW5gJXGA31Ve9yevUmuVRKGRwnqS1g6PlhejQ4QZzPUW9PQckAH5VgiBhDISG3ERP9kNNC6SZQZitha6MCsXm3qnsu8dIQATSsKBJMJR&#x2B;VqpRFs7b1uVVh2fL&#x2B;sLGzziGclLhxPQzXgkJxdP9pnD15Be&#x2B;N6I&#x2B;33u&#x2B;H1h0bc5mIq5sLGjSphYbNaqNlu4ZcBkFjzd29OIKv3cLMib/Axc2JMw5YUCs9k1s8kdifDZehKHLBvy7eKjg/XClDCOQntl5U5IBRbNizJfiaZiJLnF/qYkHK2s1a12enkFr&#x2B;6fup0oiSHmMIUlOzBowhBaTmZKnfS6nz65u/jckO0Kzpz0&#x2B;0X5&#x2B;VKFECmzZt0ksASJEi9JyiSHTDho1MvMct8Oabgw0uR9H5qKhIzJ49V/&#x2B;zP6dsj7oGUOs7Es6bOXMmQkNv4s8/N2Lduj9432k/o6Pv5QCMVPFMUWXxUAbAyJEj&#x2B;b1z50746KPhqFevXoHfOUuXLuUsA8p0kLK7d&#x2B;&#x2B;Kfd6AsLBwnqfOnTuLadOmc2YCZQw&#x2B;j9HxEZlw9qxqnWQUdPj7779ZdHDBgoV4&#x2B;jRBnL&#x2B;m&#x2B;LdacddinD2WkJBodpoL2Yi8X7dunRjvr3Nmz/79B5gQ5OtQvDg/T6m7Rv369VlMk7QrAgJKcSkLjUsqj712LZiXr1mzZlGUMCn1kACGvje2ns5sZgLAbIVl9lZWsNDRW6R0c3sr&#x2B;Zo4Uq3//XIwTy42wpm6GBP3QgiA3JtCHIe6rpCIAHVGgKZ4k6EolKazKAfmdZeTIg6kHFp9zqnm32p9gMrurvzKpNpqAVJZHYVa/uWgqojwKOz5&#x2B;xjOHb&#x2B;MC&#x2B;euIyU5GY7CObOztRXv9kaBAOn5VmkApSsMztBGNQmAgUeCpP6aHPiTJwSoRCLuQTxi7j/MPT8kSOfs4iirJyF91vISAtqHWbSgk8Y8tfOjun3fkp4gFQmKEEfcimLBw9PHL7G6f1zsI&#x2B;5UQAKGjZsHIj0jFR7e7vh0/Dto0LQWatatyoBffSYp&#x2B;nwtKASOTnZwcnEQ4N&#x2B;SRSUtLSxhaW8Je4WdHvCT95prfqb2TQomU8CYEsSXwWRFNDSuoyWTOclJqXArUQzjpo5C555tuC0l1fpn5gj96RtfhrRP9AFjY4C9ITLAWFLAmP2VuhfltAGM2a6lDumtzx48iOW0fHt746Jn3t4&#x2B;CAoK0vvduXPnsHfvXowdOzbPM2vSpMmFMsJWr16Fv/76C0uWLJE5L6p3AvRz5szG77//hlKl/PjZSbX033wzk0X76tWrn3tv7tu3RxyrL4OUCRPG4bvv5nEmwYoVK1G5cuVCOZZ33nkH3bp15Q4HHh4e/BndF3v37kGXLl35&#x2B;v7&#x2B;&#x2B;1JxDHPE&#x2B;ZyEH374sUC3T90O1q/fgAED&#x2B;j97htjY4MCBQ9ixYztmzZrJJOjWrdv&#x2B;tX4iZcVRK78q1c3t/ArbVq1aiRkzvhbjbYC4f39lrR21rVmzhsUtAwL8cf78Rfz8889M9B08eACHDh3i1qBlypTBe&#x2B;&#x2B;9y&#x2B;TA3r37iuqBpjTiIWwG9mYCwGwvkznZWHMZgPquJPGwpIwMgwQAfe/t5IB7icmwEoAjLP7py/GgsrZmllRfaYApnQLkolaGnGy59Faja1uBnLZ&#x2B;qrr&#x2B;VG7TqOB0/jPHL2Lpwg24FRIpwEEKRzwocm1v55q7noJXQTVU6C9f66wPxyuU&#x2B;dhsHmyv0BYezNOBQM/&#x2B;KVUOjbWeqbQw1GPVxEBu&#x2B;UUhkgO0/9QHfsyX78FCAJ209DTY2tkhPv4xbl6/xX2cKbrfrFV9rg8o5uqCrr3bcDYEAc3ufdoKgG&#x2B;fe77SxHiLunUXZ05e4a4RZ45fQmJCCrcKzJkxIFskopDH4Zqnu/AyBYzxPV4msUFV&#x2B;vbDuHiU8vfGux/1Q/d&#x2B;HTijg4ic1JQ02TGrmf1kTOq/FJGp&#x2B;5khcG1qKz2p&#x2B;c&#x2B;UNq&#x2B;G9l1NAJua4t&#x2B;376vYvn2n0csT&#x2B;cw6GNmUXaC9HQKqRVkbvnz5MgHU9&#x2B;Hvv3drfU7lBu3bt0O7dh1yxlgWgwtfX18EBgbyebt27TratGnLx0Ft&#x2B;qg8YefOHfxc/fzzzwTg3cH1x3Q&#x2B;58z5jgE5nVc58P/w4UNcvHiBCRVjsh22bduK7t175F5fSv9v1ao1VqxYzq0OyajkQrNd4QcffIgjR45xG7&#x2B;CNmpnSCUEmkKBdD0DAgI464G6yixf/hsOHNiPnj17/yv9RLrGNA&#x2B;ZrfCNyLvo6Gi&#x2B;x0jodc&#x2B;ef9ChQ0ckJyfh009HclbAr78uxuHDh/HPP3v4HiHRUPJ333vvfbz6al/cuHGDy3Rq1qz1IggAKZV&#x2B;Y9L9zSUBZgLAbEVlDgI8avorNJlo9pOXs3o&#x2B;Hth4PYyzCEiM7lFKKtzs7aSgQJETAdQ1gJwOElqitCiKGkiVBsh1EZBbTq5OVV8US8pJlicH1CULYLV2l&#x2B;LO8Pf3RXRkDFKTUzjlWns7RXX2DcmZ6cHrBT27ax6zvsNW5uyTQqp4IX9lBM9DBEh9JkcGqMkDEnGkxRQKZc6nCq3dpXFw&#x2B;eJ17m4w4ovBSBeLnT15iaONgQ2qo3qdyry4j68nR/9V5IkFgwH6LdXzU3aEUvz7wJ7TuHA6CJfOXUd0VCxH&#x2B;2msWTE5aKSAoykXW&#x2B;eSqC&#x2B;tuoxAM1ug4AkCfePDZDnM57asrGwWbCQSZsCQ7hj0dk9W3qZa62Rxr8ul0ZsCyo0F9foyoozVE8hvTb8hstVQa0I14M9vXf&#x2B;9e9EICQlhjQxjjaLgJNx3//59TpXXNBLVe14RLnqGOTs7G1yOVPoXLvwFmzdv1Ton3303l0EFgYeDBw9z6ztLS2sBqlegTJnSHD28cycS8&#x2B;b9wOeMOgzUrFlD/O47TJ78FQP4e/fu4ffff8/dDypfMGSkxt&#x2B;//2to0KB&#x2B;bscBOaPzR2n2RACcP38WderU47KDOnXq5JYekF24cFGAbVX7QRJGW7NmLZMRNWoUPOAhsE&#x2B;12GfOnM5T4kEdEHx8vDgTYvv2bf9aAoCsftPaZoe5CKxKlSp8b1EZwNChH3DHHLovIyOjxP37Mb78chI2bfqTdSfovqZIPwWJ6F728PDkbhQNGjTke4&#x2B;&#x2B;//DDYZwZUMQkgO6D1VjwbzYzAWC2orRGJb2w&#x2B;cZtOFpbcbp5goaglJyVLV4MGdlKEORPEw5q8MN4NPHzzr2XF18MxmtVyqKYre0LOzYiAqgGkLICqJaPhItoYpTqGmBKXatcz2vd32guq9kiS25ZfQ64wkLBQK6OeN24Fo4Na3bh&#x2B;IGzeBDzSCVeZ2ebA5AM1RcXBqiRK&#x2B;tSGCz6MhlqyVUsqFekUJrw43ztRYETBLqZAvTvhKQkZGVkobirM9JS07lkgdR9szKzxd&#x2B;WfM1JhZyGlZOjAxZ&#x2B;v4rT9B3Eg3/s8G&#x2B;4/WHNOpVQu341NG1VFyU83DiNlwglG7GuX&#x2B;evxaWzwQgPuc3rfvzwKR7FPebt03rV6zZ8MZQGSBYjyQI9mQH6ODrd0oGCEx1UmkxyPY8RwKd6/mLFnVGvcQMMGdqH2yhmZqmAvxw4lgP6UvORFNiXmvNMEUY1pvxA7hiMIRf0HZ8a9GuWfRljKgV/WwbFZFRvq&#x2B;oH/2x7FMUmx5rqcvWp2Ksi/PqPk7LRnscIFC9dugQTJkw0uOz&#x2B;/ftZpZ9aCM6ZM5cFApOSEhEaGoqVK1dh9OhPBZg/j2PHkgXgj&#x2B;BI&#x2B;saNDwRIHyB&#x2B;8wW38KOMuWXLlmHXrh1wcnJG7dq1&#x2B;fgoCp4fmzBhApo2bcYAWm3USrBs2XKoXr06gxPaP/qbgA8BarIDBw6K/ViOs2fPwN8/gDUJ1JaamiyuRX&#x2B;uu//zz83cFo3Sowva6LpTpsHff/8ltqntFxExMWbMGE7HPnPmrDim&#x2B;WZn0mzPbX5&#x2B;/ky2DRv2AWtrEKlHkf7WrVtjypTJXJZDz4tXX&#x2B;3Ny9H9&#x2B;ddffwsfV5UBSoCfSgg2b97MHQOsra0Le5elov&#x2B;GygBMyQgwkwNmAsBshWFv1qjErfyIAEjLykZsUgoquRU3&#x2B;Ds3e1tuI8gOrAC1j1PTtUDLb5eCcTLqPnpULMvq9lYWLy4ngJxCNRFAZQGUEaAmAnSdSn0mJQgoFeE35Eib0ppQaxnxM6r/pY&#x2B;oDc/4acMQdfs&#x2B;tm7Yg927D&#x2B;P&#x2B;nVhYW&#x2B;aI11mow6jPJd1XQGQADO6HUkN0sCB6pesVYNd7&#x2B;AqYVqqmKOQzp5EKnhMRrtGoErp0bYty5VW9vh0EoL95LRxJick4feISHsc9QejNCCizlOyY0v03a9IvKFnKG33f6IpGzQNRvmJplKsUwIrONKasBPin3yxftAkblu&#x2B;Ahfg3gX/WRLCy5O4HBTcGlAVOQmkSA7q3UcFnCRgiBEwnjugaEAmTnJgCtxLF0b5rM7z1wauoEVgJllZW3KZNd46Qqtk3VI6kbz1yAFsfEWlojjKkc2Kog4ocCSq1r2qw/zx93AmMvvHGm7kEALWPo2wxTZs9&#x2B;1tOhY&#x2B;KuotFixbpXU&#x2B;xYsXzRP8Lwg4dOoDLl4Nkl2EyT5yDrl27ctYb1QR37doJq1atYQKhVq1aOHz4EGc3LFjwC6Kj7&#x2B;Lzz8di0qQpPG41lcIpW4FU/zt27MhZdM9TvkDgg9L3d&#x2B;3aySKJlM6/cuUKHDlymOv2qXsAzVdUQrF3737&#x2B;Tbdu3Zkkr1GjBo4dO44PPhiKwYPf0lrvK6/0wIYNG3H27HnOUmjZsnWO&#x2B;KhxRutfs2Y1A6iRI0flOUYiQaiMYvfuv8X6vxdArJsAYX9pLUPaAHSeKVvhm2&#x2B;&#x2B;4f01m9lMMcrKOXnyBHr37pP7GbVoPn/&#x2B;PE6fPovy5Stg3rzvuSyG5qQ7d&#x2B;7w/enhUQJ&#x2B;fn5i3M1iYk4N/tXWrl07FgqlZYrI2dMH&#x2B;uU&#x2B;N8bRMpuZADBbUVj/quWxK&#x2B;wOLIWzdTjiPpqXMuzIZOk4lw&#x2B;SUrS&#x2B;p3aCJCi4&#x2B;soNVHBzQdUSri/8OMlhJEafHBti9ym1Uq0RYIxytWRkXo9zbegzKSdZM0NAyjGnGk2qB6bj8QvwxsdfvIVB7/bEuhXbcfzAOdwKi&#x2B;Q&#x2B;9hQNVlgYAmYvmhBQGFxaTufdqE0r5B4zmuUDSiMECgo&#x2B;AqzPSOTN1s4WPfp1wKixQ&#x2B;Du6crkgFp5v0nLOrCysMLj&#x2B;CdIF9c69EYEwm7cRsTte1yj7&#x2B;PngTr1qsKvtG&#x2B;u4je19qNxc/rYRZw8chF/bz2Au1GxcC7uCGWRPYZz0zMKbPwpNS6Jrq6AQoEiHt&#x2B;GCQHS8khJTRNgzQENmtXGJ&#x2B;PeZoV/S0srdvQyM9NkwbruvGOMeKUUgSm3vCwZaWBZObCvuR7d&#x2B;U6KGNA8Vpr3ngf0a9rYseM4nVZ7rDzbn/DwMG5/R2Bz0KDXJdfz669LCmVkUQcIQ1E8SvX97LPPUbZsWX4NGTIEw4d/xOKDBMDnzx/G6yhRwgOvvfYaEx5qZXF9Rt/5&#x2B;/sX2DH89NNPHKWna022bt16JuG/&#x2B;moyypQpyyBcbZTBQNeX6p7ppc9I6OzQocMqEVJLeZeYnu/USpC6HKgJIwJYJKA2bdq0POUZW7Zs5rZqBMwoSECWkpIsxoh2u0XKWLhxI4TJC4Xi5WkFa7aX2ygLlUg6mr9IaPPChXNMIqnHIY3nYcOGMwE8bNiHPB5pDJPIKBF27777Lo83CmZJzQtUAlCEpjQS8CsNEAZSy5vNTACYrTCtqQD8&#x2B;2/fZVB/JDIaVx74o7qHu&#x2B;xvohMSYWX57MGXoqsdoFSJCjpYWb90dzI5AlQzSFkB1DqQJmW1cyLn3EoRBcaIBhpyzqWIAblluQVbhvi3AIukYv/hJ4MwYHB3nDhyAf9sP4yTpy8gOykbFpYWAkzaqNanVOpAE0PJ&#x2B;IVNEshHVZUye2o0HNdcrdLI5bi&#x2B;XqktOGiUsnxBAFpVZ4Jpcz9Fm05NOBU84WkSIm7dxfY/93LEv3zlMohPfIJmTVWtt&#x2B;o1rona9avC3s4eWdmZXBdItf0ZYmwkPElAeGgkDu87jXOnghB0Llg44Emwd7CDk7NDEYJ/qWsuNe5MPJ96qjm0ug6ot6DQ4X7yXUYgRVXlPQ5aL3VSoOh&#x2B;CS93dOvdGn1e74xS/j6wtbfl7zLUyv4GWt9JAWVjsgWMJQX0tis10J5Paj36tm&#x2B;IkNAF/&#x2B;Qw57euX&#x2B;4&#x2B;o5TaWbO&#x2B;wZUrV7By5UoGeiTkp97Ozp070bJlKxbhcncvIbmu0qVLF8qd4u7uyhF&#x2B;fXb06FEBbJux4j8RAARYL1&#x2B;&#x2B;jH379uL27VsMFqpVq4ZNm7bw8Uya9CV69eotC/51jQB5hQoV87XvT58&#x2B;wSefjOJUZBLJo&#x2B;tH5ENUVBQmT56EihUraoF/&#x2B;vzWrdtGP8NVIqTyRmUR06dPxeHDR3M/o3Ny8OChXIV1mieplSB1c5g7dy527NjJUdX9&#x2B;/dh0KCBAqRd4DaA2telhNlxNJvRduzYUR5bFMXv06cPxo0bj9DQEDg4OPG9SSCf2ldStD81NQVffz2NP1&#x2B;yZClrw1AWD7X602fr169HvXp1uaxG0&#x2B;Li4jjgVcgElSlg/nm6ApgJATMBYLbCMB/qL29rjaep6SghQMGck5fxbZtG8JRJA74WF88tANUmF4/RnX6epKXjbPQDtCrtA0uFxQs7bnIqiQigjAAiAigqoc4IIAfDmHZXcv2mdT831I5LLvqvT7xQcxmqCyOg6CgAXZceLdGhazOcOxOE3VsO4frVcISF3EGmcBAdHR0ECLF8tn95IL6cmGBRRL&#x2B;NSbeGLDmgl7ow1LNQaeB5k5tXDiOzvvOfGp4truP4rz9Gm85N&#x2B;LpSSj5FjX/6dgU2bNwh7jsbHiuuJYohJvIB2ndujvS0DKQkpWDVDuHsZynh5ePBAP/UsYu4cOYK7oTfw4PYR2LMW3DnCCKMXi4zxkdQSJxj49wFpc6l1CQJNMUGCyRzQKGCJ&#x2B;kZWVy2Q2Cjcs3y6Nu/M1p1bIKS/t6qtp/inqQyDzmgLkcOyhECxtb4667PFME9uWWNUf&#x2B;Xmt80a/pNres3xiIiIjBhwnhxf2WwWrabm0o0luzBgzgB&#x2B;JN5GWr1RjXgJAw4cOCgF/KM0hzMaWmpLDh44MABruMnAoCyRiilfdWqVUxoVKpUWQDsKahdO5Br78PDb&#x2B;GXXxbg009Ho0QJ44Er6SMQKTJ16rR87fv27dsF4B/M&#x2B;0yZR1QKsHHjRgQHBwvgP5LF/Q4ePMgigdTv/JNPRmD27DkFev5atGiBLVu0W/SR7gCVAp4/fw6NGzfhdH/KCKRxEBx8ncmJx48foW7dutyOc8uWrUa3hDTbf8OIFKKyIUNimHRvUoYOaYjY2TmI5T3h4lKMv6MOEzExMTy/ke9JWSnUapMydfr27Yf33/&#x2B;A7xFD9yiV09BznQgA8l9pXVTWsnDhAkycOKmwT0U2jMsCkFsGeHn79poJALP9u43q/3tVKoMfTgehuK0NdwJYfPE6xjauzW3&#x2B;8kxqWdk4czcGtlYqATJy3IrZGV8rSL9ZeeUmtodEoIGvB7pU8BfbfXFigZR&#x2B;RWmgmhkBFHVREwH6HFdTOwlIiWcZah8olVWg17lXqtK8U8SLolgNGtVGffF68vgpjh06h4N7T&#x2B;DM8cvCuXkiHBo7VQcBiqqpty1J3CiNB16FDgyVBoG23JNEr4yboceQ3ApNWplUdsWzz&#x2B;gBXrKUFzr3askt34i4Cb4Sis49W6FV&#x2B;4bw8/dCWnomGrUIRLXq5eErlqWHP7UMcnCyx&#x2B;6th3Du5BXOvqFhQVFlShWkGn8HR7ucXVXk0CeaV1hZ4G0JC/b6S9E8BTMulVJ8Tz4IAbo3U5NSkZyWIuaVEmjSsi5ef7sHagVW4VIOInNIxFGZrTQooic1N0iBbn0p9XJg3hjxUqlty9X&#x2B;y5EQmr/V/V4d6S9o0E/lXpQyrna&#x2B;58yZzS3tzp07x&#x2B;fszz83stJ8WFgYC/e99tqriI6&#x2B;h0WLfuXfOTu7oGrVqkU26kl5//79GK0UdSKLRo0aJcD8QgYUJUv6Yvfu3QKIeHMtPCnjz5//E7eoU/8uLS2dSYGBAweie/fuJu1DWFioZPSQQDzVwVOaPqXBk1E7Mh8f39xl9uzZg9jYWLi7q56rY8eORWBgbXz//Tw0bNhQAJ6fGOBwWdLpU3jvvaGsAZBvJJIz9tX7TOeLNBSqVashrrszl87dvHmT0/c3bdrIpQRkf/zxB9djp6enYcSIkZz1MH78RNn2hmb77xplqrRu3QpBQVdyPyNdCyINO3bsxP9mLR4xDknEj6L9X345kYm0adOm4vXXB&#x2B;DEieMc8f/00zG8HN1Dv/32O4v4UflNyZIljdoXGrdt27bjMpc&#x2B;fV7F8uXLeV44fvy4mPOKrD23mgTINhLs6z60zeDfTACY7UVau9J&#x2B;uCWA4u7wKNgJYB8U&#x2B;xA7Qu/glQoBrA2gaQcj7nLKvzoDgL71MEE0jNXKBSiJTkzCyiuPcS8pGaMb1nrxN1cOEUD1VUlJSRwVUGcEyLXgknJ2jQHzUgKDck66XGqv&#x2B;jtydlJTVbXE1FasW6826CJA5PXLITh84AyOHTiH0OBbyMjM4vIAijKrsx6egWSlRDGAXFO/ogSRSgOoPO/&#x2B;yFEZBUJr6MX3SiMyBVRG1yDm3kPcDrsL/9K&#x2B;iL3/EL/&#x2B;&#x2B;Ad2bjqADt1boEO3FighQGTFymWQKpx7Sh2PjI7DvehYBF0IRkJ8Euyp5j9nlbZ2tnq2qNR61/385SQCjL32&#x2B;eQWZIgAhSLv5/yZ5qVm8i0TqcmpsBRzW5Va5dG8fQO8&#x2B;loXBJRVOXMZ6ZlI1tFKMVQvbywZaKogqWZLVEPzijH6KHJCqXIEqhr000tzni1II/DZu3dPjvpeuqQS1CORO0q1HTduLGJi7nPdbK9ePTgid&#x2B;3aNWzevAm1a9dB48aN8w1G80NipKSkMGG3detWJiIoOq5qvQls2LAee/fuwccfD&#x2B;e09eDgGwJA1&#x2B;VadiKs9Qn2UYYAveSMnnEkiEdaB5omVXJB26KMAhIW/OGHefzMpKjj559/gZ49e&#x2B;Uu169fP1y5chVvvTVYHFcqHBzsuVWZ2oYO/TBXyyG/WQaadvr0afj6&#x2B;ubqFwwZ8hZHaukQSBDtyZOnYv96MAFAadOuru6YMWMGt14rV64cAyhqgZgfo0gstYOkIILZ/t1G44zGkppko4DRiBEjON1eTQAsXLgQ7du3w9WrQejevStOnTqF6dOn4e&#x2B;//&#x2B;bsHepy0adPL&#x2B;68oel/mjrfEElHpUA0BxApN3z4MO4AQnMdZXsWEfjXfSDLAX9TVP2VBbSMmQAwm9kM2YBqFXAx5iHiBaigyP&#x2B;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&#x2B;lS1d&#x2B;SZncPlOnAuqsYEobxRs3gnHr1i0mAP76axd3D6Co6qFDBzkNm0AR6Rm0bdsGgYGBfP1btGiOt94aotUJwVgjjQPKcKDU63fffUerVaHZ/r1GZSGazwUKFhEJQONLXaKzYsVyrvWvW7ceZ&#x2B;GNGPExzp49zdo8VHb63ntvY/Toz02eH4is0xT/a968Bb9Ig&#x2B;Tu3Wge&#x2B;xUqVGAikwjOInrYymUAANIp/1LfG/Ku/rNZAmYCwGyFZk4COBDYn33yMhTKbAHQLXEhJg4hB&#x2B;PhIx7ELgKsRyYk4lFKqgD9Frn0X0knBwQUc8737GGp0yJwqwA49E3TUt7wd3F&#x2B;YeeDJlpi9J2dnXmCj4&#x2B;P55ouTcfFUPst3eU0U3SNLSkwVpzLmNpaApdkpBXQrHU9NG1VDwOGvIJrQaHY&#x2B;MdOxEQ&#x2B;xP3oWI5WWttaw87WViNiLA21NLvXy5MCUkCsMAkCQ1BfoQN95SUS87dppTyroCYHxLuNjRV2bT6IitXK4pUebbidn5&#x2B;/Nzr3aIXY&#x2B;3GIunMfxw&#x2B;ex66tBxAVEY301Ew4utjDRdyDykJU9NPMEHh5swWM6TL0HG0JFaoODVRqQ8Saq3txBLasi8YtAlnJv1LVcrAR9w3dZxTtN1QqpC&#x2B;6b6qgntwcJAfajekCoJuur490NLQO9bbUkf6CUvDX3RY5vZo1uRcvUp/79ZwNRanzFF37/PMxnDJLoJdqwamPPKWC0z6ZAjaljBz0KVMmifVrt40j8S&#x2B;KQmuCbxIeJEE6IpcJRFAEOTQ0jP&#x2B;mDhEUWffzK8Uq4aRB8Msvizg1OL&#x2B;ESXh4OGc7UN272ijtnbQNKE0/75jTHi9Dhw7llndubu6oX7&#x2B;&#x2B;2KdQBAVdZvIkIKB0gV5Pan82adJXstdb9zxQOQFFWQcMGIDOnbvwMhQdpRR/antILQip9IPaHD4PwaO2adOmi3GjwNdfz0RUVGShjGuzvRymSZw5OzvlzGmq77y8vLj8ZvnyZYiIuMOaUjQePv74I9y8GYJbt8K5nSV14KCAErWttBW&#x2B;dMuWzbF69TpxjxuX7n/06BEW&#x2B;fzoo&#x2B;Ea80oEk09EtE2dOpUzbHx9S3JbShr7RXFqYFz6v7ElAWYzEwBme1FWz8cT01vUw88XriImMYWj/hlZ2QiPf8JVwiT8b62R&#x2B;p8iHJ5AL/cC3QfKANgecht7bt1FxzJ&#x2B;6Fet/AuFGaoWSiXYQSOWVy0WmJsyb6QzbGobLUNdBQxF26TWSX9TGqda58DDyw1t/Zqgeev6iHvwGKePX0LQheu4fiUMwTfCYKWwEg8sa25BpykgKAWpNEkBbXhljGq6PlBWlJ0I5JsNyhECknsp10BA6m/hcEz6bA7WLN2Krt1bo2GzmqgowGUJTzd4&#x2B;3qiXqOaGDy0D65evomtf/yD3TsO51yXws&#x2B;0UGpdV81sEEWef7/cpjRIQqnvK7rfqSVbdlYm3Eq4olSAD9p3a47A&#x2B;tVQvWYF2DnYqUT90p9F/OXq7aXE&#x2B;qTmBH3zgtTcYqw2gCESQf25PtLSGG0TXdBfmGrUBLB37dqhBexIUOuDDz7E3LlzOCK3Z88/XOdP9bEkiNejR0&#x2B;TFPGNsXXr1nKPes2IMokKUnnBvn0HmKSoVKkSJkyYIJ4rlqhefSoePXrIqepERFB6MaWuEznx&#x2B;&#x2B;/L&#x2B;BlDCv8FYaNGjRRA3V&#x2B;LACAhMoqWk8q4ihBIx6JFiwR4&#x2B;TiPACHVG1MLPbqOq1evZsG8BQsWFTj4J/vqq2l8DvQZ1U5PnDgR8&#x2B;b9wOeSCBTKJqlatRquX7/Ox0NRVxoPMTGxmDLlKz4&#x2B;EvWjdRpqq2is3b8fzboQ3LXFyuya/xuN5v1vv53FwHvRosVcq08EALnAdK/QnNK&#x2B;fQcmnRYu/EXc1&#x2B;O4ZR8p9pO4JGXs0L3&#x2B;6qt9c7tOkFGpD2UcyYH/0NBQzkSlqD4Fn4hAqF27thYBQGKVNPaWLl3CnSpoLiFS8ebNG6xdUkQPUU3wr0sEGEMMAMZpAfznSQPzLGO2QrcK7sUxqWldjDt4Golp6SwoZqOH3c6gNnRZ2ehYvlSBbp8yAuytrZAqJt/VV0LQtXwAwp88Ff/ORi0BgGytXgzTTpMxsb2UFUAtVigVUlMjQC7yb4zTbAwxoHbIpdZtSKRL3/ozc6KZTAZ4u6H3gI7cpuxJfCJ3Erh4/hrOHwsSDk8cEp4kcos6inJKdUvISwTIyd4p9BABRSkyaIgQMLxPBvc2P48t4WCUcHFFZNhd/DxnBZYssEbd&#x2B;jVQr2ktVK9VETUDK8PF2RFNWtRBlerlECOuzaUz12FpbfECCJS8ZMD/jyn1klE056UJB48i&#x2B;Zze7&#x2B;6Khs0CUaN2ZTRtXRdlyvnB1a1YjpJ/JtJS0/UCfWNJO2Nq/KVIRd1ovSHCQZMINKT4b0h/RN&#x2B;yNCcQeFSn&#x2B;BemUXu&#x2B;&#x2B;HiVaCuJc2napUuXOQ08JSUJGzdu4Hr5lStX57s&#x2B;3&#x2B;BIEsdP5DCpeGs5bVYWmDp1OtauXcOZB2XKlEVExG1O1aXU&#x2B;4ULf8amTZv593Pnfi&#x2B;Wt2a1cFIZL0ijTLaKFStpfUaihwMHvs7RbGrJR9kHFMmk1HhaXqHRpWfMmM/w1ltvMrnRpUs3Tq&#x2B;vXLlKoVxXam1IgKlr17wlBNQbPSkpEaNHf8ot&#x2B;whwlS1blrMkaH/Gjx/H465evQb4&#x2B;ecFrAtARgT&#x2B;8xiNMeoKQcQRGekG0DUkH8Bs/06j9n1z5nzLQpInT55k7RD1XEglOTNnzmRygAgxUu3/4Ycf8eabg7Bs2QpcvXoFVapU1ZsZQkTUrFnf6gX96nZ/1J6UugEQAUAlMffu3Rfb9&#x2B;KS1O&#x2B;/n4tu3V5hMm/NmnWcCTB27BestUHzIM1xRHYWgWlmAOj729DD11BpgNnMBIDZitrc7O0wpmFtjNl3DM454kJ0N2aKiYXes7KVYhlbjGxQE24FHEVRb4yU7J1sbbArPBLbQ8KRlqmErwA9PSuWRgt/H3bSX4RRBIGcM4o8UA0gqb/qagQY2/pPjhAw1IvbUK9vYzIHdJdRpzezMm1xJ3To3BztOzXjzIDwm3dw9uRlFpsLuxmJROEs0vI24hrZ2ljn9FTXUx8sA7kUuUKD&#x2B;oGYcT3jCwv8w8A&#x2B;KWR7FJi0l4q8q88W55EEGunf9PexQ2e5mwOp/deoXQmBTaqiffvmKFepNKZ/PwYfvzUJt8LuMuB4OaB13uyAlzUrQD1mSZGcxnR6ViZK&#x2B;nqhet1KaNmmIZ/vshX8WSNDBQayWWTT2MweY7RDjNX2kLt/pbIBpEoRDAmQypEO6nfNdn0E&#x2B;gsDXJORsrY6Yk&#x2B;gi7ZFNf6lSvmjZs2aeRxtWoaI2j/&#x2B;2JhLSDC3Vkj7R1E6AtC65urqxkCWotYEIgYNGoTBgwejV6&#x2B;e2LlzJzp16ozPPvuC03YpSl1QRtFJAgRdunThYyd1cN2IY1zcA84wWLt2LQYMeJ3rk6tXr8ZAl0A&#x2B;1Rc/AychAgx9h5YtW/JyhWWXLl3CkiW/4ty5M9i//6AAX9VzvyOF/gEDBmLChC/xxhuDWGuBOgiQMCKdfxJPJPFeqvUvaEE&#x2B;ira&#x2B;&#x2B;uqrAui9h&#x2B;nTZ3BpiY9PSR5nhVl6ZbbCN9JzuHHjBurXb6D1&#x2B;SefjMLixUvRu3dv3L4dIfw9Vds&#x2B;isFQNgCBfNLRGDZsGHe3IN0P0u9YvHgRXFyKi3uphsFtkw9J5T7UkWTmzBnYuPFPHk8fffQRatWqzcuULVuBy4KojKl27ZqIjLyL33//ndtnUlYA&#x2B;aS0fWr5SftEJB11AymSx7zh2v9sHVLAlPZ/5hvLTACY7UVYBTcX9K5UFrtC78Da0oK7AZRxLYaE9HTx7oKu5UrzMoac/&#x2B;cxkgfYcuOWCniLfaDOAfPPBvHfTf28X&#x2B;j5oUmXajIpFUxNBKhLAzSdaSlSQEpkSw5IGAsmDIESOTExNRghFpmim7RMcVdnNGxeG/Wa1EBaSjruRt7HpXPXcf70VVy&#x2B;dh1xUY8obsrL29nbsnK1MdE/KapXAXVrOqnyAUhAbqBo9ATkvtNsR6g&#x2B;CukmgHpPhM5hEdnlKBwAeoRmZWTj3MkgHDt8BuuX7EDNulVQv0mtHNVffRQEZD6X3asCJwN0dQQUueeqaMkB9X1CKft0zxJAJFHFshUDBHjwR4PmgWjZtgGXW5AwI98L6ZlMEMgRa4badup2FDFWUE/qnpUjAvTNF5r3t1z0X/N73fIB9e/VLfu4zaQBUE0Rb3//AJMyAohUpeUJvJKQG4F5UmqnuZYibp988glmzJjOytvHjh1DYKB2z2xq/UbCWJQaXhRG&#x2B;6VrJEpHjjidnyZNGmPVqhUCJLzO3y1cuJiVwxs1avTc2yahQIpWkqBhmzZt&#x2B;DMqJ/jpp59Qr149AUh&#x2B;ZcCqqfRP15DUzIkAIPKBIosERIYP/1gsT&#x2B;nOz1ofHjx4kMX&#x2B;Ll&#x2B;&#x2B;Uujn8ddfF4nztBpTpnwptntIiwAgYH///j3OpKBx5&#x2B;npxR0cKGuic&#x2B;dO4nnsh/LlKxQSSQjMnz8fa9asEYBvKJydi3EHAcoMpIiumQT4/7Xhw4czkRQcfBO7du3kmnoikqjkk&#x2B;r7af764ovPsWTJEh4HZcuW5nFJWTEUoe/VqzfPVQTYq1atzG0C1fe5IaNOJEuX/obfflvK7ZnVczERzMOHf4RZs2aJzx14O6tWrRLzSBM0bdoUc&#x2B;fO5XmP9KlGjhzB89/ly5ewdu0fSElJLqqOFFnIG/U3JAwoF/U3A38zAWC2l8VaBfji0J1opGdlI1k4ym/UqIiyAvxbG3D4CKCr8cXzu/VKzjwg1RVbsd108af9S1RzRw4ACTwRkCAnih4a6vp6Y0S&#x2B;DDn&#x2B;&#x2B;SEEDJUjSK1LH4mgUp99ViZAJQBlK5VGxapl0b1vezyNT8SVoBsIu34bVy7dRPDVcCQmJCItLUN1zWwEQOA6YAujShMAqXZ9atComzWgKzYoB2YLEuCaQkrIS9wqjNnbnH9YWZMWgw1Ho5OSUnFwz0kc3neaARmJCz07t1LtB/X2KoR2sUbhmr5WhPqEBQuKGFCXzmSLeSxLvCclpcBGjGNfPy9UqFIGdRpUQ6Vq5VCtZkUB&#x2B;kswWCLATyUAuoDZFLAvd78Zau2Zn/UbWt6YuUhuv9VRfnoZEj1TK2JT5J6c53Xr1hsBsrJz087XrVvD0XEStqJ02c8//4w/pxTvBw9iuQbd3d2D2&#x2B;GR4N/69Ru11kWRdxK5KyqjuZ/mfU0j/YGffvqZ/6Y6dEdHlYAYlQoQMaBO930eo&#x2B;cOCYHR&#x2B;ocNe0YmvPZaf&#x2B;54MHv2LE7d9/Pz51RmtRFxTcrkBGIfP47Prbn/44/1TEqQuj1pFhDYJpX/JUuWGr1PO3bsQLdu3fJ1PBSJpVr&#x2B;hw/j8yiZU791UlS3t3cUIK0zj0ES/6NXYRqBLDrP1LqQXu&#x2B;&#x2B;&#x2B;zb3cle3X6RyiYLSFjBbwRqNYdJwkpuvGjZsiA8&#x2B;&#x2B;IDbW/76669MANA9SqReu3Ztea6hciIXl2Is8kelJWS6&#x2B;hw0dX7//fda7TDljAD9tm1bue0oTbHqfaS55NVX&#x2B;yAxMQE1atRkAU6ae&#x2B;vWrSPW/wMSEp5yF44hQ97mmv/bt8MQGRnF&#x2B;iHki9K4JLKsSB7lz0gAfUSAvuXlVP/NWQBmAsBsL4v5uzjBw8EekU8SYSMmoNknLmJJt1YGf&#x2B;dibcN3bbqYiOI02mDlhUWGjdKfS4n9sBTbD3v0BM52Nqjp6aYFEmIFEKLl3AQoelEaAeQUUwSlePHiTAKoiQDd6JicQrcpqt2GfmtKqYG&#x2B;f0sBEbWAIFU9U3TUpbgTWrVthNbtGzNr/eD&#x2B;Q9wOj0LQhRsID7mDG9fC8TD2MZKEw8kpwuL6WOdkCNDv5aZ3pQ5o1FcU8IwQ0PdLZT5HXUE&#x2B;H6W2/yw7QGng6afVzE757NpQpoWVlYPqOlnoIVb0VVIo5OgG6JAqRX/edLOHpLIG5MB&#x2B;bhaLAPzpGZlITUnlFEoHRwe4FHNEszb10KBpIKpULw/3EsXh5OzA8weVvyQ8TeatygFhKTCdn/Z6UvdyfsgEKVLBUGmQvvtcrTWijvQT0JHqDa9rlIZK9axUL03A6Lvv5hl17SlNfvLkKZg69Svs2rUL3bv35EyA9PRUnDt3ntv4Udp3Os8l1mKZvyTX5evrg0qVqhTZuCWQQSn3muC/TZu2uf&#x2B;mcoV&#x2B;/fph&#x2B;/ZtrExP2WMTJkzMtxAhqYsnJCRy9H7BggUoV668FsghcoFeTZtuEwDifZw5c5YBjTo1mK4z9StfvXoVOnbsjIEDB/IziwA4CZ&#x2B;pSRyqdV6wYCGTMfJERAaDHzrmiRMn5JsAoDaM33wzQ4Ds97SyKh48eMBRz9mz53Anh/zoSxCQ09UtoLIN2s6RI0fw5ptv6v3dokW/CPBVn0v/aPnGjZtyZsnJkye4/SFdeyIBzPZijK6JuouHOqWeylioHp4A/dmz5/g7KhMhH4RaaGoaCeulpaVh2rRpAkjfYUC&#x2B;bds2XpbKTqgTx&#x2B;eff8FjjnQf6KXP6F42FvyrNUPoN6RPsnfv3tzvqKSFRP&#x2B;ojIdKb1T3hTdefbUfhg37EGvWrMKsWbP58/r16&#x2B;HDD4ey0KC6C0oRdqTIlgD&#x2B;uqn/2TCt9Z/ZzASA2V600YQ3rF41jNlzEjZWCs4COBgRzZkBsg9x4WzHpaTwXb3v9l009/fRgUHGPbyzxCTZqKQ33q9dhde1PSQCScLRsMoB1bHJKfjtYjDC4p/yFOLn4ogWpXzQxM/7hYsFEhFAkQNKJVOnGWueV7WDLeXUS4EDfU6/5m&#x2B;l3uXAity/pfqQM8jKEi&#x2B;FUji&#x2B;qsgX6TZ4&#x2B;XrAr5Q3txgkAHb3zn1ERtzFtathCAuOwI3rt/AgJk6ALZWAmrW1FaysLWFpYakiBIyE01JQX6HRtlChBZ2VEsD2RXQb0Pe5QvaXCglcr1BfW32r16MtkNuSUFy3XEYhT9KEIVK&#x2B;MDMr5IkBNQmg&#x2B;c46CaRPkq1EQmIyt1IkwtDByQ7VAyuhfuOanLHi5VMCAWVKwt3DVZXZQpoXYgwn65CUhkpzpNrt6d7fUhod&#x2B;lL0dVvtGZoDDLUHNJTaL7W8uq6fgLs62m8q2Nq4cSMrtKudUVKnVoHyZ88NavVGKfLjxo1j0EeCePPn/8gCcOTQkrAbKfYfP36U6/wpNdfJyVGA5w28j7pOvK41a9ZcAOByRTbv07FpRqy3bt2MBg0aMTgkR56yFDZv/h97VwEexdVFL4QQJBDc3aFosRaHn6LFixcoXkqxCsUKFKdI0WLF3Z3iDsXdJUCwEAghxP1/525mmWzGNoQAYW67H5vd2ZnZmTez75x77rmb6Pz5c/TbbwNYXv82E/UtWzaJ35nM7H8Ac7&#x2B;//ppM/fr9FG25W7duMWAuWrQo74NEAOB3Cq0FYY5XpkxpOnz4MLfKa9OmtVWFgbKN338fZmh/RowYSf/8M4elx7ZKCL0AySNl0CdPnsSdFNavX8ct9qSAiSIIiZo1v4rR8fr77&#x2B;lsGogWjfLxjAwsFAtS6YQ8kOUvWbIUd0AoWNCXiaeRI/8QoKs8HTp0gMtPMBYhBTfj/QTGNEpU0OoTZBVKbVA6gq4XxYuXoFatWvH5RgvMSpUqsnx&#x2B;wYJF1sQMCC/cq3At4lpNnNiRATjer1OnDv3886/iOi73TubWuCZhdolr0jImLePy9OnT3EKwc&#x2B;eO/DcIOXf3Z&#x2B;K7tGDSAGAfpoOIRYsWx&#x2B;nxFnPZwOfPn18/d&#x2B;7cQbJk/8NVHhGk3hGANAgBkxgwCQAzPpTImTIF/fJFCZp08iIldkhIy67cotdBwdSwQC7VzxRI60Lubv68/EWPF&#x2B;Izt6lpwdwM6He6PiS/4BD9GyRZzAbbFs1PyRJbhn6rz/JyZwKeNIgJ9rzz1&#x2B;m8&#x2B;wtLyYFY99XnwXRRgEuQFD&#x2B;UKUoZkyd9b8cNN3Yw0cgMgAgA&#x2B;ywRAVo9vfXKArRMwWzBgRq5oNdqUIts0KohhnQ6PDyUQoJDrCUQWbJnpGw5M1OFamWZEPB45knuT57T/buP6eql2&#x2B;R27zF7Crz08qLwkDf1xUwKaLQPM1KNH6EguE8QrWRAa63vOvsdYRjmq9kEaGocIhQ4Bq1ahGibTWAhDBJo7bdSn4d3G6xCYUl/GAWJsZYksRM5p0hKjmLyVqNeBcqTLwe36suRKysVKpqXkiZLYgUloSFh5Ofrr3itaJnuxaQMwKh7vhrpZ89yai1J9Vr3SWEr79er69fzGpHA7alTJzibi5ryDRs2sYEcWlahXvXUqdMCxGaiQYMGcUYc9eo1atSkrl270507d6l37x95krxw4WK&#x2B;d2KCbjRKly7zTscgpMWQzUvu8shAoiZdag3Wtm07LlcAuIS537x5//CxtTUai2l07tzNSoIgc79gwT/RCAD0Ix83bixL&#x2B;vfv388mfvLz3ahRI36O3ydkOqGaQEY7JoH7fvbsOTkLKR87R48eplWrVlPDhg2pUKFCXG6A/a1WrZp1GRip1axZk5///vvvtHfvHnHshkTxLED2HZ/T6&#x2B;KA93Gt20ryYS7o7u4RbcxWrVqNM7zJkiW1jl2MNXweBADGEcz&#x2B;UJ4CEmr&#x2B;/Plifw&#x2B;L49&#x2B;Fvw/WV778F2TG&#x2B;wm03pPIRnd3dwbr8IJASZAE7BFQAuTKlYuNNyVl5rlzZ5gUGjp0GF&#x2B;bIMUgq69atbo4twWZeLQ3QChcu3aVfQH0AvcPaf/gWQIfKel3FGabV65c4vnj06dPefxXrlyZevT4gX0vEsSxCbaYvz46e/bsvi1btpyeNm3abVKu/9er&#x2B;ddr/6c1GTPbAJqXuxnvI0plSkeF0qWmGy9eMh5YeOkG3fZ6TYUF0E/hlJgqZ4/asqhqzix00O0JP3cWP6Rbb92nM089KKEABw9e&#x2B;xiu4cctLqlNJh&#x2B;dARBbbj2g02KdzpE/9GFMGIRx5v&#x2B;G5yuaeOIC/fJFyfdKAkg3eWmiKBEB0g&#x2B;QVhbfSI2v3qRfC&#x2B;ToAX2lyb6RtoLyvy1t0qK&#x2B;ni59GsooxlOpMkWoQbMa7C0AAgDEwM0rrvTwwVO6d9eNnru/pNfevlyvndAhwRuncUdtcKL/KxGhAPMjFOBrAhXkHJcqAfv6C&#x2B;gWPNj9UxuhUEJgdKtvX34BQglDMTjIYr7HHSoSJqAUKZ0ppQD1acT9p3T5ogLk56fMWdNR7nzZKUPGdBbjRDFG4NaPLL&#x2B;/X4AmOWG0zl4rM2&#x2B;0jl8tk69H0tm&#x2B;pgXotVr&#x2B;yd&#x2B;XWvZh4msE9MvB7&#x2B;XLl1SzsXDIxrlDDBs2jJ2tO3X6js38kL2CfH3KlGks15069S/r5yCfBWmKGDLkdwa0WBcUBYsWLaRNmzaJCXFKet&#x2B;B44dMdbdu3aK0l0NWrlmzxiwn7t79ezYFw8Q&#x2B;towI0bYP7eekQPsvZOlRlwzywTZq1KjOZVlQV4BkgapC7XwBWLwt4Y31g5SQj7UlS5aK3zwvAdQG8b9wR4eKw5aokGLcuPG0bFnRaMcM5QxlypTVHaMbN25kIsnWBR1gzsHBMleAPBzrx/5CuQEpP7wmcGyhRsDfVapU5RKTFy882f0dPgtwWUf9N2rE9RQoZsReILMvmT7aBjLiDg6JrKTf2rXr&#x2B;Tl8IVBug7EvZcv37NlH7du3s362V6/e1nZ8OO9oK9qv389szmk0UJqCfYPiEzF06BBW5BghAKCWkQgAqHkOHz7C90vLd3LgNn/w&#x2B;oH5KRQqIEvj8jYn5qmhFy9ePHD06NGzgwcPPuPr64vsW2gk0NfK/sdE/q9XCfnJkwAmAWDGewlk8vuULUYzzlymix6elBzs&#x2B;KOn4uFOGQTAtiUAigmQ171kYZp34TrL9ZGhd/f156sXBoKotzXaxi9cBXQuvXyLkjlaLgkoC9ImTUJ5UqWgu16vxbYC6P4rXxp88BQNq1yaPQTed6A1Cx6SR4BcEaAE&#x2B;rXAthIAMGo2qPa&#x2B;0jq11iGXOKttVwm04DtLrZOlZXPmzkK582anLyt9zuSIn4&#x2B;/OD4&#x2B;9PD&#x2B;Y3K7/5Qe3HvMSoFXL33ED64nvx8aGs7gEFLvBAAyiRzEI2GUnwglCK9VZ29sRKpl6uPsd9nupWK8txF2HgrdFUUnCCA3toDFCM7Og8QD0Eeg8wFUIzlyZaHsYoxkyJiW2/HBtA/GkjnF684pk1s&#x2B;Hzm2goKDVfdbPjS1Slu0wLQa2NZbzsi1aI8PgFGVgNJ7yHZh0mrEwd823NzcqGnTxjRp0mTVZRwcLOqdhw8f8iQWmdzUqVOxlFoyS4VBH2r65ZnaqVOncOs3uFijDrdNm7ZcPoA&#x2B;2Mi4fgjgXwq0/AL4lkeKFM60fPkKce96zX&#x2B;/jcM/QI&#x2B;YcFPBgoX4b0ji582bSzt37ua/kTVHnfKcOXP4b9t9QaDUoEKFigKQFHjndcFS5l0&#x2B;ztDabNCgwZx53bp1K61cuZymT58ZBWCB1ECGE&#x2B;Hp&#x2B;YKd9iGB/vHH3lHWj7I6yLzlgfI6&#x2B;bqw/QkT/uQSgugERVI2pBw2bCgTSiBN1q/fwOvt1KkTHTt2nJfDmISnAroeoMUawD/KSdKmTcePsmXLmhPCOI6uXbtw1nv48D8U7zXy22DPnj2of/8BTAD16tVLAPxx9O&#x2B;/O5jUwXsoBZDum7ivrF69ijtLoLMIiFCMCyMBAhQGfWgL2aRJE2rfvgO/jlIYKBAQuNeBkMKc76uvvlK4Zt6UyqBMB&#x2B;MbrUK7du0qrt3fuKuHEcPV2Ayxz8Hu7u6ue/bsOTBr1qzz4lp8GQn2QxVAfxhpy/7lwF1pGSL17gCfPOA3CQAzPphIm9SJBlUoReP&#x2B;u8gye0dM8sSE3icomGX4UAnI46s82ck7OITWXr/LZoCQXuPqzwA5rpgk&#x2B;IeExnhfAtBuL0EEtybEHSKZuEn&#x2B;VL4EEwBPfP1p8aWbdEHsk68AA3POXaM/qpTl&#x2B;vTLHp5imZTknPj9OfZKigCJCMAkD7WFtooAPRWAUZm/LXEQU9CvlenUAyFq25F8EEJY&#x2B;h9qrYNLksyJMidPQtlzZaZK4jWoBAIDg1m6/fLFK3r6xIMeuj6lJ4&#x2B;f0qOHz&#x2B;jpo&#x2B;fk6&#x2B;NH3mLinTChA7P5UvkAFANSOYKcbNEHzVEd6hNEoxQidADu&#x2B;yAClJUKEQbJAbs2m0DpbyVFSeQR5NaSYQLQi38jLI787LYfFkrJkiQhRzH5ypAxDZ/zEHG/qFm7ImXOmp5Sp09NefJlJ0dxjScVYwKAESUmbD8sxoUlu68&#x2B;3rRe03tPC6wbMeizx/Vf6zrVW79Wnb9E1HGrw0jQ/zYTyp9/7sdgHNJpKXD/AriSZ8OxTdznDhw4wJPv6tX/Z30fdenVqlWhEiU&#x2B;F&#x2B;ux9JpfvXolS7ExcYcE/N9/d9K337bjkoH&#x2B;/ftb69I/hMB3K1WqlOJ7yCTj8bYxdepUdvSWCABXV1d6/vxFFEB88OB&#x2B;WrNmDZMl6BFuGzhPcRW4774Zk5ZxidIHHx8fWrp0MZd9rFixSpEYh/v65cuXWdGA8z158l/RlsuSJWuUv//77z8ec9WrV5eDFy7FULomM2bMIMbhcQbw//67SwCsX9mYEWZryOKuXLmS9u/fSwEBAdzLHaTF6NFjzInfew7LvWAXl11IBADOc6JIFemb3xhiz5D169eLa2c6nTx5gg1DAexBROXOnZt9LuAJIJGeaLv3zz/zaPbsWdxmb/PmrYYIURBN8BjYsmUbVaxYiZo2bWZ9D9crvDTatWvPxAOMP/Pnz0vXr9/iTkjYB3TsgOrGxSWV9XNFi35GGzas57EnH9NxMpOIiAgXoP&#x2B;&#x2B;OE7nR44ceejChQsvxT1dAvxqDzUSQE0BQGRM/m9m&#x2B;00CwIwPMQD6fy5fnA48eEzrrrsKEB9CgWIiv//&#x2B;42gEAKJZwTz0ZdaMtO/eY3okAFrqpE70TcHcNO3MFbofmSUJVTDD04tXAgw6oZY&#x2B;8u90yZJYpf5ZnJNR/y9L0o87j5KPmJg&#x2B;FQABZoGZxev3vHzor5MXqc1n&#x2B;ali9sxWBcH7CEkRgMkzpLCYKOGHTf4DpAdY1IgAoy3ClACDXlcAPaCjBXC0XNDlk8ewsATW9oPS5xIlSkip06SkNOlSUcHP8lhq&#x2B;cX/AIC&#x2B;vgHk&#x2B;dyLvF96k&#x2B;udh&#x2B;T14hXdF2PO8/krev3Kh16/9qUgMWZAEkj1yTCMAzmAlUA9kDBhgshWPAnfHBf8K8PUEbLfpgQyB/8EUQzqSAFex5VKIEID5muXDdizd9bzm&#x2B;DN&#x2B;JFq7CG7539Z6RHGafdEkJeLY5w8mRMlT5lCjPskVLBIbosBUt6slCtvNkqTJhW34HNOkZxr&#x2B;ZOKZcOYJAi3joPgoGA&#x2B;j3rjXcvQUmtZPe8LLYM&#x2B;W1JNbztazv1aZn9Kahu18hupph/H2aiDv1oge48WbM2bt2DQJAUy9FWqVObBcP78BWtGH/cz1Oz/8svP9PjxEwaATZs24f1Br/nOnTvzxBxeAGPHjmFnfHwegRpctLCzV50QnwLAAd0Qevfuw3&#x2B;j/nfdujfSeWT1AVJhnAhDQSgS3meg1AEBWTOuWXg4bNy4nss20qRJTfPnL1T8HGqbUUrh5vaQBgwYZLh7wM6d/0YrQcE4x36gXh/x4sVzVo3gdWdnSy01/CgwBuEtgZI8ZHDRcg0KC8jG0dpNKkMxI&#x2B;5i37593ONeakcpBdp5Ir799lvrazDDS58&#x2B;Hc2YMUvcY9Jbf7ORlQf59vvvQ2jhwgVUq1ZtJgKaNv2GO25groXxKd1XQBTMn/8PezhAbQRSzUj8&#x2B;eeffO/Cunv06EH379/naxD3V5S6QEUCAgDkHMYVumLACwVqKJhIohRBulZwDUthpGwgNkOM/xeurq63ZsyYsW/t2rUPxD072Abkh2qAfz3gr9QRQP63Etg3wb9JAJjxIQdAc/18Oals5gx0w9OLXF/5UkonRxWgQJRVTOjbF4/akxQZeH8xqU&#x2B;UwJLNtzdCwqI6bHsIELj51n2qljMzZXFOzl4DRdKnphOPn5FXQCC5&#x2B;1kIgEYFc9G2O/dp5tmrtPr6XVYNFEmX&#x2B;r0eT8jOkOlB3SgyEZg4I4Mt1bwbAfK2gELJgTwmwMfINtX2z4hCQQ8syZdHtjgs8rwHR7a9w39ohZc6dQoxEUjF731ZtTSDeT/fAP4ZefnyFQX4B9Jjt2fsKfDM/Tk9efiMAvyC6MH9R1xfjtf9/QLF5yPI1z&#x2B;AAaeTU2KLVwOyp2LMS4QBqwmYGLCoCkhy4Mff1u9E7LJv8c/T&#x2B;k2LK8WAosOf9RqNiJDA/JvzL/lUyIE9mjSEhITxxyHVx&#x2B;h0EIAPEytkU3B8UrqkoBTiGkyVOiXlKZBTLB9MJT8vQomTONJn4j4AssVFLOMi3sdEHYARagCQJ/gXrvx43dfHP9pYNEpsGTXBM9o6U2/carX0U9tvvRp&#x2B;LXCvtT5JMgrQo2WiibCVUGsFavWLFy8WBfxbXp9Kf/wxgrNokLsCuILIXLZsKbewQnsryP3//HMit6rDvQ2E57p1azgDO23aDDp37iyNHTvOuq&#x2B;OjvF/qoM6X5iFAXxEv/8R17vjPg7371SpXLitIlzNpYB0vnDhwjRmzFhKliz5e/kOckM&#x2B;6V/4HsB8rXHjhgyo4C3QunVrTdXJkCFD6cqVK3T48CESQISaN2&#x2B;uPxm26U6B306oB&#x2B;T7Nn78eDZ4w7Vw9uwZJiFgBrhq1UoGaVCVtWzZggYOHMTXj61xoBlxEyiHRFcQOPTbRu7cFt8KkIeIfv36svrjxYsX9OOPfcQ9JQ89ferOnhwoiXn&#x2B;3IN9JPr06S3WOZWuXr3KZo1K4w9mnXjYG7ly5eRrD54D//tfdXEt3qGffvqVO5p4eb3kUhEEjE1r1arDBCfMAdOkSWslK3BPnD9/AUv/4/iaDb9x48ZlcV8&#x2B;M3v27CvXr19/TdqZfjUiQI0EUGoDqCf71zMDNAkBkwAw40MK1P7jUcV&#x2B;o1RqVig3&#x2B;YqJ4J2X3uQZEGT3521b/AWLH/vVV2/T7nsPqW6eHFQFDuApndmjIIlY9p9z12hm3cq87MCKn1OvXcfIJziEtt92e&#x2B;8EgPU7iUkKiADIGjGZQWkAJtKSfN0owNEDEnpmfnogSW&#x2B;degaDWgSE0ewp/xsewaAxIsKyrFwtIK0D5oGoG4dHAGrHMUkFyARBECKWB/DHpz2eepJ/QAB5vXxNz554UGhIOCsJkHGGasD9qQclFufnhYdYzi&#x2B;I1x8cGBS53VBrHTsIhAQJLWoCy3eIsGZeJcXCm/MZ2agQn0ngYCVt5MdPmlSrHUulY2Upq5CD&#x2B;wirDF8iUCLQMi8S9KPuPqGYlISHhnNLx4T8XcIZ0AcGBHIdPj6TMXMq/q65cmejULGe7DkthkQlyn5GHuKYFS1VmBzE986cLSN/tXQZU5NjIkcxrh3ZsV8iESLCLfOB4MhuHiBgohOH&#x2B;j3s7XXW1xqjWkBfC7SrZf&#x2B;1QLxWeY9W60ClYyKV0GCc4P4BMtEoiAHhCGfsAQMGGFoeddkAnZChjxw5ikuY0Ps9a9YsbFLVoEEDrqVGXS1M3QACz507Jybs/ahy5SrWFoAYQ0ePHqGXL71o9eo1LJmtUqXKJ/f7iXpk9C&#x2B;H0kHK8iPgPA/wj/OYL19&#x2B;6tWrB/ueoD0ZatblhMx333V85&#x2B;B/3769TOKAoLENZFwB&#x2B;C1j0IENBxEA2jCKhHGfEdUJSMbp06dSzpy5qEWLlob2C34L0nWwePEibh&#x2B;JbgPh1ntNGHsKYPvI0CJji7aTIF3q1avH7QAxFgHSzHi/AXUQWjwqqxkt//r5&#x2B;fN5vHLlKl24cJGKFSvK57JBg0bUqFEDNptE5n/UqNFMrtWtW5c/99lnn8X6/qLMBFL9du3aMonq7JySJk78kwmArl27sYcEAkQTiFF4SCRJkoQePnSjEydO0k8/9ePn69Zt4H/jAvR7eHg82bNnz387d&#x2B;68vWLFigcyAP82D6XMfxhpdwNQy/4TGesOYBIAZpjxMUe&#x2B;1C40vHIZuu/9mnbdfWT3512cElOIAFxODm8m2E6JElFgSCituHqbdrq6UcbkyRh04Qfk7qvXFCQmBCgbyJEyBeV0SU6vBfC47ulFT339WR2AQGvBYAGEkid&#x2B;f5cafihgmoVaREkRYNv6KCYZTyNZfSVgpVZvrLZeLfmymu&#x2B;AEQCnBqC0aqSRTZYk6bafx/F0TpGMobJL6hTW9UnH2XLME5CPtx8FB4ew2dxD1yfkL0Ax/vZ88UqA5lBxnoLo0QN3XjYgIJi8XnoLUBtEvq/9eR1BAuj6vfYT4y&#x2B;UEolJcoBfIAUEBjI4Ri08iAvI5WFmiAlpmADkCQQgdxDLBoUEcYlMYigQIqTMfCiTDZDJs9oD/hoA7WJdDuLfxE6ObJwJMBgq3sN6HRInFNt2FCA&#x2B;rRhPfuScPCkDjFCxruw5s9DrV76Up0AO3u/CxQuwz0K&#x2B;ArmYjIKrvqO4HlKncxHrsNThQ56Pn2dsg&#x2B;W20rmASgMgNhLsY/0hvgZafmpI6LWe6xEHRokEvdZ5SuNcq0RGi4xTuy7ViASldTO5BXNVcQ5xv7DHwV8KTJIB4PQCYwDbmDBhImfqkFVt1Ohr2rJlO7tme4t7&#x2B;MSJE8Qk/jTX4F65cpkzW8iOKREdkPj&#x2B;/PMvn8xvnbzHvRSoQ86fPx8rJwCU5TFgwG8MgsVEnWuFAS7q1fua5e5JkybjuuJly5bxcQV58C4Dkvk//hgmgNY1Bsoo3ZDi4sULVsCPADHUsGEDfg6vB7kfhF5g/E6ePIVL4pRAIMoDAgMDuOwBvjkwapN7QgBAgjCXfj9xqTx58ohbG7Zo0ZwNFUGuw9Rv4sSJ0fwEzHj/oaYQka4djAtk2r/8sjzNmDGdCTGMBZQkjRo1hpWA6DAiufG/i5DuZxg/169f4xKDxYuXiufXqWXLb7jlJ0wo0coSAXUBlgfZic4UPj6&#x2B;PJ&#x2B;bNm0Kk10CiFsNA98F6Bf3&#x2B;Fd37ty5u3Tp0uOzZs26Le5FciM/pX9jgxDQyv7rPYjMtoAmAWDGJ3DDFzfGvKlcqPvnKaN0BYBhINdaa2QOkNUPDA5lszjclFMncaIMAvBff/GSOxYEChAFj4FEkZNiAPqzT59ThWyZCJxBobSW8gB4BKy6dof6lSvOy&#x2B;10fUhbbt6n/&#x2B;XOSo0EADLarvBdBCbKMKaREwHyrgFqIEQNTOlJoPXIBTVps17dtB75oNWiUE3qrPW95VlULcDGmaJwy&#x2B;sA4Wq11omdEpNTksQMunMXyM4Z8kjFvzWzD/DN4Dyy5p39C8T4BAAPD7cY3qF23d8/wFrTHhQQzJL5oMAQJgngcYAyBGTGAeKdnJLQ82cvKFj8ZqdLn4pgdI/uBw4OKPEgSpEyOSUXQP6pGNfYP0eHROQg1pcxczpWLQCcY50gKzJlzkD47U&#x2B;bLhUTFtgHSPVBPADQ47slSmTxQ0gYWdHAXgkgJSINPMMiM/cw8cP3xGEKDfUnI2UMRkwtjf6tZ76npVCJiYu/HiA3sm6tzxgpM5C37ZNq&#x2B;nF&#x2B;37ZGXut8SNtesmQxt9ECoEeUKvU5Va9ele9HAFXnz58jT8&#x2B;XPMGFnF3eiz6ue1V/aPHgwQNauXKFAPUDrSQuzO68vDxp5MhV1mOEzKZUC1ypUiVasGAB18LjWALQwKBuzJhRVLdufW5fh5ZgsVkv7Op6l0ENwDMCxA6UBd9/343Wr9/ISg74EcgJAJigbdu2g5&#x2B;j/zrKPYYPH24UnERTtiGrqhTDhw9lYglSfhAA/fv/KgDUdL4XSZ&#x2B;HAmXcuLH8HHX8aDkJcNizZ0969cqbe8Oj/jou3dTNUD/30n0LpWOnTp3kDhZ6vw1QdKDEAwQkCKBGjRpZa/a///77WNs/EOxLlixhTwDcZ6XYvn0rZcqUhY0t4VsB6f7cufPYgHPmzBn8G9q8eTP&#x2B;LiDrQFhBEYWyqAsXzrOaB98F64byB60ks2XLHuscRVBQUODdu3fvLFu27PjMmTNvvH79Opiiy/XVpPxhMSAEwlWAv5R5UWsFaAvi1ZQAZpgEgBnxmQiQB9QBe1wfUWh4KIMttcibJiW5&#x2B;/kzyAfA71uumAD9PrTl9n268vwldxqQLhgsc8fLmwkA/NCUzJSO/nv8jJKICcGO2w&#x2B;ob9niDOi2ic96BQbR6qt36ejDp9SsUB6qntOSLYDh4cknHgx4SmVIS6mSOsUpEeDv78&#x2B;mRWihJbngGslIGmnRZ9Qd3R4TQa0aaT2WXQ0wqZEJSsBQiQjQIjCUwKNUCy8tpyRXl69LqqeXFAaJuT&#x2B;xZX3JUySjtAlSWye&#x2B;liIAi&#x2B;Qe6gEuIUiYgGsE8VyaKFmPbUTk5MnB4g0BR/2IN2p/fg3bBTjn59JbCchKTEAtkNLJ2ZKhF&#x2B;tK5JjI&#x2B;p2k1ntaNfHK31sfEGuZ8GkBcq3Wd2pjwwjI1/t&#x2B;ekoVLWWBvZ4FasctnMs0LIaVAPvSI7aM8bDeZMmSKr4HcA9QCHn3gwf3&#x2B;TX008ZkfcOGDVS0aDGrdHrRoiUMYPv06SUmxPPj9W&#x2B;Vr68Pm8nZQ7AAKADobNmymTOUANloLTdy5Aguw0Dbr4UL3xjkjR49lmvi5WZoMEr87rtO7MEAFUC&#x2B;fHlj/B0AjFHOUauWpfZ57tw53H4xU6ZM7DGArD7qmAFUsC2AICgAAGDk3iFo8QgnfXzH8&#x2B;fPs3mePrgK43G3fPlSql27rqbZHo4Z1p0tWw6aPLmFVcoNQ0kcm0SJHPl6QNy5c4sJKETnzl15HwHUPvusKG/DBP4fRhw9elSMq0VizP3Df6OkqEOH9uKesilyPmNZ7ubNGzzucuXKza/jPuXsnJzP5/LlK&#x2B;np08c0adIkMeZ&#x2B;i/V9RAcKlBJs3bqFhg8fIa6J4nyd4vUvv/yCxxXM/3AdwzwSyzVu3Jil/7hf//BDT17Pxo2bxHU8UNxHH7AyQLoftG3bLtb3GS7&#x2B;riKOHDlycdq0aRfF9fiKlFv2Kbn3a5EB4WRc&#x2B;q/mA6BUAqCV/TdbAZoEgBmfatTIlZXypk5J&#x2B;&#x2B;8/YTAfrnL59yxTlH7cdYTSix8Hv&#x2B;BQNgYskTEtm/9de&#x2B;5Fm27do&#x2B;svvFhCjUymf8ibnqtVsmemtQLke4kbe8okiemIAPsv/AO4LCBJpL&#x2B;AJzK0ssn2&#x2B;BMX6N5LHyYell2&#x2B;SfXz5aKmhXLH2XGRugYgIwQSABM5aUKlBlK0AL4RoGLHD5CuY7qR&#x2B;n61fbLXgFDvudq29YCjfvb5zd9vCIiINzy4BlAwCiiMHAe1DDa/Lus9TAmUQbceKRL9e2uTPXoZdS2ne3sJJ71tal0XtgBcz0hTHtLyRgguI&#x2B;UDUqZfMvOLzZCMHW2/D4y14Nx/48YNev3am2XVly5dZuMt1IKjHKB16zacCcZnHz16xAqBRYsWMbjNnj1bvP1dQiYPIMQe0zAQt3hAgr5r106qX/9rJlJA8KE/edu2bbm2Pnv2HNFIX/m4GDNmTKy1QTx58iTNmTOLCQB0dgC4WbNmLR06dJBr6OGOP2zYcAGunSggwJ/bNeKcp0zpQnK1D8o8kI0vVKgwDRgwmL7&#x2B;ur7mdm/cuM6y6SZNmtGgQYOodu06msuvWLGMFQ9dukRtZVi0aBEmwD//vDSrIqCqgmnk5s1b&#x2B;H2M399&#x2B;G8Dmo&#x2B;ilDpNEkwD4MAJqGPg1SAQAyjRwLuE3Y7knWe59Q4f&#x2B;zkBfuhZA4hQrVoLN/0BMQhEDpQda&#x2B;8V2wLw0d&#x2B;5ctHv3bnJzcxPX7V7uLJEhQ3reLrpboDUhrhvMx0AMwOjSlpiFWWqWLJlZ7QfFzrsISPxPnDhxXtybLs&#x2B;fP981hB16VWvywzVAvhYRoPeeUu2/rSpADfibIN8kAMwwI2rkdElBHUsUpGo5s5Cjg/LEByTBZ&#x2B;nT0DO/AHoZEMSmfmgH6ChuxCACCqdLTddevKSjD93p4IPHFGbDJPz0ZQnqtesopUzsSJtu3iOPgECrGgFlCOh0UDl7Zv77wrMX9NwvkGbVq0JH3J5Qm6L5acutB1w&#x2B;0KpIvjg9NvhBRPYNMjiQABIRIGWL1STLRmqM9fqTqxEIamDZqFmhvUoBrSyxEUm2EUM4PVBthESx14xO6X2tund7gLNeuYcayaF2nvXArpak3RZc64FmveNqT8tKrbGpdiy1jqsa2aC1vNr5kdz78Uj0jsqPYFoF2X758uWjEFYoNdq&#x2B;fTt16NCBRo0ayaBqxIgRVLBgATb2A1CFmRX6V0uBexCyxjNnzozz3tXvOqCCQA08ZOcABQDxxYuXNPx5mHtJwB6ZatQJN2nSmNUSJUuWYFCPLLjeebaMpej3FnROACiy7ZiA3wLst6urK5sr&#x2B;vi8Fuc20JptR0ZT8kVBBwhJ1n/o0CGuaR48eLB1/MLMz90dPgDDqW3bb6Nsp2rVanT06DHOxBshMKEywHjDd7aAJe3PoBsAVA9ygg193R0cLK0tMX7Lli1LKVK4UIMGXwugFU7yQ4ll8F2ksgYz4jZwj8OYglmf5IqP&#x2B;wVK2y5cuMB&#x2B;DKVLl6Vq1aqxoR7k/DhXuD&#x2B;h5EO6LtauXcPqDsx50CVi3bp1TPJgbL4tsQOCc/XqVVy6BOILypiqVatyScGwYcP4nojSFoy1ihUr0YEDB&#x2B;jgwf30xRdfUPv2HcQ973/cjlApMMZxjcR2CJAfcuPGjZsrV678b&#x2B;HChXfc3d0DZABbDsLDVAB6mIHXtJQCap&#x2B;NkG3XSLs/rc4AZBIEJgFgxiceuVOpyy3hGVA3bw5afOkmS6kXXLhBI6uVtb4PL4CSGdNR8QxpqXzWjBRk024wt0sKypYiOfkEhdATP39yiJxsQTEA0qGFDNhDIdAgf05KLiZbSy7foqzOyal5kbysUNjl&#x2B;pBq58ke58fGVhEAgy6JCFAC&#x2B;Xr9y7WAlRaI0ZJT60mn9ToGGAXVauSA2jZj4iyvBdT1jodeyzi9fTNKCMQEGBtRZmitT&#x2B;v7K30vpYy9EWNHrXOkZXhppLWfFslj5LrQM/3TUk3A5Eoy87NtbRabgUwb7g23b9&#x2B;m8&#x2B;cviEnsl1YJNfZlwID&#x2B;/PqcOX9ToUJFuLSjbt163DddLVC3bbRv&#x2B;8cWf/01mcE/6n1XrFhOzZu3ZOd5I4EuCKj/lwgAR8fEAqyWYyDx5ZdfatY8651DeAiUKlWKATUMyGxj&#x2B;/ZtDJrgFQACYNy4cdyBoWfPHxlE4zl6lmMf0UN906ZNtHPnDpb49&#x2B;7di6X3IKCg9kBHArRqhD9A48ZNom0L38toJE/uzFnbxImjEgYgo5YtW8691SVAB8IJ5pIIgH5Ix5cvX84Kgr59f7ICrMGDLWZrhQoVFMBwPYO4N9doQivwNCPuAxn0Jk0aUYUKFWjv3v38GureFyyYz&#x2B;MKrS0xtgCSYSRrKTFBS0AvrpFv06YV35ewnmPH/uP3oERp1Kixdf7ztkQoJPwgKerXr09bt27jaytt2jQC6B/kDD6uBewDrht0kZg4cZL4PhXZryO2SrGMhJjXhYn7yb0zZ87cFNfzyWvXrvkEBQVpSfHDFEgBI0SAGgmg9ZqS/N&#x2B;IAoBI3&#x2B;3fBP4mAWCGGcpRLEMaS/9eMXG4&#x2B;PwFkwEdiheMRhSUzZxe8fMgBnbedWPVgDz6lCtBSWWtBt19AqhyDksbK8eEDjS0chka9995Gl2tHE09dfm9EADySTgeadKkYQkv3L3lRjtasnytsgGlTK2SdNtW&#x2B;qyVJVXL/BoFabaf1evprgXajWTitb6PXnZfC/CqHU81UsBeQGrPcvaQP0b2Qc3UTmm5mBAyWudcjxCyx2BS7zV7z738MwD88rr&#x2B;uDDLg0t/4cJFeOKMCTYIB8j8AXRRx4q2fcjmA0zJzd4&#x2B;1QDYPnz4MJdD3L//gObPnyeA6PEoy8Acr1ixYtFc/gH&#x2B;IY2XAp0AateuTXXq1H2rfbJk5yOYAJBc7&#x2B;UBNRjcxSdMmMSGaQBWIIYhlUa5BrLn6dKloQwZMlKXLp0ZZEPpgGwmavhhWgYHcywPMA5iGR1punbt&#x2B;tbH08UlpdinDLLrBcfJjeutX7zwpDlz5tAPP/zA71myxOepYsUveR&#x2B;cnJIK8FiX26xJZpTy8zR16tR30u7NjJjF6dMnufsC2lSiFd7u3buoRo3/seIkRYoUNGbMaBo7djQbNJ47d54VAGgjikiRIiXX&#x2B;q9fv47VHeiUUahQIeu63xb4S9GqVQueM82ZM5cGDRrAxMTNm7doypTJrJBJnToVqw527dpDV69eoSNHjrDpn9E2q7ER4pp1u3r1quusWbNO7tixwz1S4h9B&#x2B;jX4Wu353tXf9jj/24L7CDJb/5kEgBlm2BOZkidjo75FAvindErMLv74t3quLJTKSd&#x2B;kD8A/XD6ZF7OSLqUKRyMMcrg40&#x2B;tAS9/ycHGP8g4OZjXAOffnlMk5KXsHpHRyfK/HQiICMDFE1wD8KykC1MCeXnZaD1Dqyaq1/lYCWXrO6krgXc9NXY2A0HJk12uZqAe4Y&#x2B;JlYNS7QK923h63fSMGkUZ9B7S&#x2B;r9oxsEfRoEWK6C2ndVztIRFiQjRJIZf3GwX9mHQiayxl6pUC1zmue2l9AESoky1QoCDvA9rMweAN0vOMGTNxtwdIaKE2qFathphor6WmTb&#x2B;h7t27x&#x2B;nk9kOPypUrsyQere327dvPQFQe6Clfq1ZNWrRoMX39dYMo7&#x2B;GYoy0epMIgV9asWcO1wm8bcOdH9l4aT/JAXTJUBmgdKA&#x2B;UZmCMoPZ/8&#x2B;ZNdOfOHe40UKNGTQGAUnM3AQAz3BsBwKVuBBgLHTp8F2vHE10FQkNDrGUnAPn79u1jsgLjFCaS3bp143GJ/UEnhKtX0WqtjvjOhVk&#x2B;rjgpFsvr&#x2B;QmYEbfx/fc9uNa/ceOmAkRnYf&#x2B;M&#x2B;fP/YYVR//79BfgfK&#x2B;5P&#x2B;VmVAlII97dixSydmFCqsmDBQi5xgUoJHhqxHT/80IOTJVOnTmefC7Ss7NOnN6teqlevQW3atGHvk6RJnWj06FG0Y8d29u9IFAddofz9/X2vXLlyfdOmTRcmTpx43aauP0IDcGvJ/9Vq9e0B9UbM/9Sy/uEKQF8L8OvJ/z9JosAkAMwwwyaaFspDAWLSu/HmfXISk6KVV2/TIbenVCJDGnJxSkzJxESmas7M0Vr6PQ8IoH/vuFHiyIkUpP8oF6iZK7qRFbwAzgiwX4Uyi20kpPHHz5O3AP0tC&#x2B;fjMoPJJy/S8Cplotyd3lcDLGdnZ34gy4daUNSx2RIBRgCUFhFgC4TUDND0QJFa6KkJ1MgFo74BSmFLDqgZ1amtQw/E6nkIKC2rV1Jhu4wRIzojMnd7tmlPzbu9cnw11389gkKLWNIbF3pmgkbJMDwwYQSQQtYKz&#x2B;2tWcXkEy3O1DKwBw8eFAB0IWemJJKgZcvm1Lt3HyYAAET/&#x2B;WcefffddwKEruYsK8yrZs2azcsi44vHpx7Iktv2D0dmP126tOL4zedsOkoB5IH7Kkok0PLLNgBqWrduycZ5&#x2B;CzM6LA&#x2B;owEVF7oGfPttVMdwZCxtDQOluHTpUrR9EUCCuwy0atWa25uhnr9z5y4C9DfhdckDvw&#x2B;Sk/67ClbrietBameLrjYAeOvWrWXQj98pCWS1aNHKnNx8ZAEAjW5FyZMno2PHjtOSJUupSpXK9PKlpxjPW6h9&#x2B;/bUsWMnJp0wDv744w&#x2B;aPHkyL4eWolLkz5&#x2B;fH&#x2B;8icG1t3LiejQjRLvL5cw/xb1dxnRxnI1PsGwgBhJ&#x2B;fL5MVefPmtRqfvosQ4z70sYgVK1Yc3rZt271jx455KoD9CA2wraYMUCoF0CMItD6vtz01yT/J/ibSrv3/pEG&#x2B;SQCYYYbdJEBeeu4fyIZ/yOq7&#x2B;/qTm7cPu/iDFCiZMS0ldX5z&#x2B;fiGhNAEAeKR/X/ThtBS/68U6CwAYoEnfqFhNLRSGVp74y53BPDwC6BbXt5RlkcXgvuvXlPlnFnYZPB9BLKC&#x2B;fLl44mqh4cHT3Kl9nR69epaQEwLONmCWiOg2d7tapEAWsDbnmy0rbN9TEG/FvGhBUyNyv1tAb9WBwa9fdPzboip/4HSOTPiDaHm5aCmojDyfbW&#x2B;gxFTQCMEgtS2D5l&#x2B;yOz1akXlnTxsA&#x2B;7sPXp0VyUAXFxScEYNE9qwsAiund6zZzcNGjSEJ7pDhw6lgwcPsAy3Vas23D4OmVe5pPZTj/3794vHPho1anSU1yFFxsRfLeuHTPzSpcsU30Pf&#x2B;enTZ3Ades2aNZmQtSeQpQdhU61a9SjAKGfOnNxf3DLeon7m0KED1KdPPwFonnHd9M6dO7luuXbtWkw&#x2B;YDzu3r3X7uOD3w95VwI9gI86/UyZMlsJBjm5EhxsaTkKQgxeACAAypQpLb5nVW4tGRcZVjPeXaC15ejRY1hxsnDhAlYeHT9&#x2B;VID/bQz80RIT9zqQPX//PZP27t1NkyZNZl&#x2B;KuIpr166wGsXX10&#x2B;MwSTsYYIuJ8mSDVaYQzlHuy/EIhkWLu7Rrw8cOHBq1apVFzdt2vQ0KCgoVAXs29bVGy0FUFMG6D3XA/pa&#x2B;2ik1R8pEAGk8r4ZJgFghhnqgXr9PmWLU6F0qWnV1Tv0KjCIkiDjJibs/qGh3CEgk/XGSwzmXV/5sCoAdxg2/hMTdQB5EAnpk0V3Ds6bxoWuvvDitoMoCfCJ7J/O7t1MDIRaVQafpU9NXbcfoFKubtSsYB5ubfjejo2YvGHiiEwUSgMkIiCmzvtqgNloGzgt8GSkvZsWGFQCtUZVCHolBGpAXe81te&#x2B;oVI6gB4r1ALJeezvbfVPbByPSfC3TR61SEyVyxci4iWnpgB7AV1u/0nFXC4B8ZLRwrQH8G5XST58&#x2B;lTOymJAqBTJRkGtDRt6gQcNo75cqVZr/RZ/pefPmcg/qKlWq0s8/9&#x2B;N6cJhuQdYNMzs8N0OJKE3GJn&#x2B;DBg2OUl&#x2B;Mc4g6YGQ01eTnagGwjUxizEmJfQyaYVCGVoHy9Urj0BaUB4rfvBIlijHAwgMGgCtWrOS&#x2B;5TENgDSUoNjW3asFWgl27dqFSSaYHYaHh1GRIkXFePyZDdXgM4GAPwIMBLt1686qhbNnz/DxNtv1fbxx7do1rplHbNq0hbtmwExv9uy/qVy58tGW79y5M7Vr1549AeIykOOBJwfUMPD4iOtA6747d&#x2B;7cE4D/7Lhx464ptO57G/Bv9H2jy8YE9CuBf6USANIA&#x2B;ibwNwkAM8wwHpin18mTndsD7r/3mG56vqLHfn4sxV96&#x2B;RaNqGrpEPBcTOgOPXhqBf&#x2B;&#x2B;wSFUMG1qevjahxKKpTfevEtdSxaJBlAaFshFv&#x2B;w9zgaAiKwpk9MF9xeUKqkT6/1tSwyaCuB/7PEzmn3uGpXOnJ7LEd5nYHILIgD1v2pEgFH3fa2a&#x2B;9juBmAvwDPqYxDTDgT2KiGMdAEw0lpPbxk9MkQN5BolQ5S&#x2B;k952jfS7ty0hsUeJoFe6omXuqHY&#x2B;9ciI8EiVkBz0A5jZWz8PF3aYmvXq1UdzuUqVqrBRn5wAgIQaAB&#x2B;kHgJ1s5CL9&#x2B;v3E8tYZ8yYzvWzkHp/KqGlpJAH3L&#x2B;RgZQCLcCaNm1GkydPoiFDfre&#x2B;jnXBmRwEQVwHat7hug8F15Ejhyhv3gLcU1w&#x2B;/tCbXB5TpkxjR3&#x2B;Y4SGr&#x2B;bYu5QBJw4cPFyDpqKHl3d3dWea9ffu/PLbRRu3Bg/v01Ve1qX//X3lOX7iwxRhx9GhLVhV13mithvZrO3fuMicxH3Hcu&#x2B;ca6T3kxx4kW7duZePMOXPmqZBkSfgR1wHfC1wb2F8thWFshrhfh16/fv3akSNHbvz0008nIzP99kj81QC7Foi3hyRQe03pPSP/Gm3zZ0sGmMDfJADMMCPmkT&#x2B;1Cz&#x2B;8AoLoeUAgS/QlR38oA8b9d4GCw8K5TWCwmDTmS&#x2B;NC339ehPrtOUbOiR1pt&#x2B;sjalE4H6VKEtVEMI34G8uhDWCP0p/Rt0Xz0wV3T/rvjhvVzhO9LrO1eP&#x2B;8hycTEGgV2KJw3g/i&#x2B;EhmgXB/xmQYRIDUNcAosFQC&#x2B;0ZqqbVq9Y1K0fWAuF7pgNb21ACq0vcxQhYYIUi0zP&#x2B;MmO3ZY/qntn9G1mV0/9TOvQRe7NlXezwQ5N/HtgOGEcJGjaCSQtp3ycRPquuP6QTSz8&#x2B;f1yU5hgDUr1q1ii5fvshAHjJqBOSxbm5uUT67a9fOKMZnqAsHIWB5np1at25NJUuWivf3emSVT506LYDnJiY7vvyygubyqEWGJP7MmbN83n19fVjq/8svv4rPN45CAGAMffPNNywDjuuoV&#x2B;9rbkmGffz5519p7dq1/Dr8G1xcXPg5nPrlAXAtAezYCGzL0rLP8jeUEGPHjmEvgd9/H8bE1/nz57mTBFq54XqA0SFKBuACj2OKFn7wscCYhFO/FJLhG2rG8YA3xcccOFYx8fiIT&#x2B;HvH0Bz585h7woQP8C4//zzD7fT&#x2B;5ACXh4gt/Dvuwb/jx8/fnjy5Mlr4jic/ffffz3IWJbfHvBvNEOv16ZPLaNvD&#x2B;A34v5vBPxH6JABnyxJYBIAZphhMFIndeJHgTQu1on&#x2B;wos36ZanN7kkcWRg7iIm4L&#x2B;UL87/5kmVkjz8LfWVyNoPqBB9Al0uS0YKCougfruPUeF0qSlQTNof&#x2B;/jRgq&#x2B;rR/&#x2B;hcU5GxTOkocseL&#x2B;nOS28KDY&#x2B;gRAktPzgbb7ryNqvmzCLzIIjbgPQOtamQt8LhWu4RoASI9Mzb7AW3tiDWCMA1Umtum01WAoha0nK1bSptXw9k65EBWoBTaRl79ksP&#x2B;Nqu1&#x2B;i69Gr/9bZnpKZfi&#x2B;Aw4tSvpjiwl&#x2B;iQlsPkHvX8kot/bPSAtl0HHNr/&#x2B;msSO2NfvnyFHfuxbdTyy&#x2B;vAETdv3mRXavnkG671aEt34cIFARhX09atO9jxPz4Hao1R&#x2B;54/fz7xKGB9Xa1uPSAgkB4&#x2B;fEinTp3kHvGXL1&#x2B;iLFmy0Zo1q6hTp87RrgsAW3sDYwZyaPgsxAQQ4v4F4Dx48ECunU6bNjXdvXuH9uzZRTt27BD7us5KErzLcHZOblUbIBYvXsjHBOAdRErWrNk4cw//CRwnEAQC5NCyZUuoYMFC3DMdRrQwSoTyTJnoqP/RlqZAcSIZ7Hbr1oWWLFn2SRMAUnkHlCA1a9aiPn36chnIhxYuLqmYdGrUqPE7Wb9Yt7&#x2B;4Li6sXr36/Nq1a908PDwCDILumIB/I8RAhA7ANwry1bL8asBfTfZvxP3fVAKYBIAZZsReYPLStFBuSpcsCe28&#x2B;5C8goOpRZ5slMnZUn/brHAemnb6Mkv5jz16Rn4hodzqzzYqZ89E2VMmpzNPn5NPUDB1KFZQeYIvtoeuApeeedIDbx8KCQ&#x2B;jRAkTcWkC2hbCc2DjzXvUrlh&#x2B;Jhbe1zFBRgm1xgAaaI0DYyYEJjO2ddtKn5cmrWpgTAlc25IGahNho&#x2B;7yRoGq1vJvA26VyAYjINNIGYIWQNYCx0Yz22rZeiOEjW1mXynDb0/GX4lgst03IzX5WuaOWsdS/r5Uyw&#x2B;1DAgAPNRIpJiE7b6gJdqRI0etfgDIbmMf0IcePeTlcfLkCZ7EgrSDyz&#x2B;A/4YNG&#x2B;m//45ThQoVqEaNGvEe/DPJmzo1/fbbACZTUC&#x2B;PlncA3zBOzJs3H5MiqKUH4O/ffwDXKM&#x2B;ePZuz6xUrVqK&#x2B;ffvwZ/G52Oh1j9i7dy8NHz5M/LtPkYQAaSE3Bbx9&#x2B;5aVvICBI/YL7dJwLW3atJE9a3r37kVJkiSlqVOnWY3yYjPbj7h79y6XkoAYlpdJ4HfA0/MFrVy50loOgN8KjF&#x2B;Ms0mTJlDHjt/RmTOnxfXiREOGDGFTP5AV9erV4&#x2B;snPsb8&#x2B;fPF2HJho0Wct4QJE9CnHMWLF6ctW7byPQuGjrgXYT6BksMPLdDZo0iRz2JtfeJeHegmYsOGDScF6L975swZL4qdrL2a/D6m2Xt7AT&#x2B;R8Wy/HPAbAf&#x2B;m9N8kAMwwI&#x2B;4ip0sKAbhTUPWcWWnL7ftURybdr5gtE807f00A9QhK5uhAp594ULWcyu60ucR68ND9UcyQjkLDb9IzvwB64RdI2V2cad6F65TUIRHfIb2Cgih9pPFUGEBFJHHwIRABKBGQSgOUAKfR9nB60nkjQE4LqCutS60dnl7vdjVgbET6r2fAp&#x2B;bYr/X97G1raKRzgtL3tVeBoQZi9VozKh1PrfaIWuUXSqSBkfOi9F2QxZMy/VJdv&#x2B;Tgb2SsxCRSpUodCQQTcKY0SRInBv&#x2B;47gAgkZFGPTey1DD3i0Iuiv0qXrwoqxHQt33o0OH8up4EPj6SujhnAGN&#x2B;fj4M5NGzG47jx48fZxM7AOyBA4dYQTfM&#x2B;aZNm8IZ&#x2B;ilTplLJkiUpR46csbZPaB32&#x2B;rWP4hhBmceYMaPF&#x2B;f2DgdLy5cvYrR/dBDAGYeaIZVauXMFKBbQg&#x2B;/vvv8V3dOT9tZSMGA90fwGo14sJE/7kdpL//rtTALf/2BRx0aLFlkmn2DYy&#x2B;zlz5uJrAAqT48ePUY8eP/B1Urx4Ce4y0Lp1GzYMxO8IPo8WivE10F63V6&#x2B;ePM7wXM3E81MLmEUeO3aMPR&#x2B;gaNq2bccHSQC8jUGn7Dcj9Pnz5x7bt28/sXTp0quHDh3yJPsk&#x2B;zGV52sB9rfJ6McU8Mvb&#x2B;ym1&#x2B;jMK/o1k/z9posAkAMwwIxYiW8rk9EPp6AwwMvEHHzymxA4OdOGZpyoBYDSypkgm7ogR5CQmqSAX&#x2B;pYvQS8DAimRQ0LyDwml3yuUptypLESCX3AI/X3uKhVLn4a&#x2B;yp2dPQreFxGAB0DJ48ePWdqpVrttVPavljHWc9nXA/x6wFsNYKoRA3oZda1tatW8a5VMxCbw1fpueiSKFnC3Z/tq509NSaLV3UGNTFH7vJ5/g9IyyHCifhmAHw9bGa/tumKrbhSZUQeHRNbnx4//R3Xr1qZXr7wZUEE2DVCItm&#x2B;2beRGjRpDy5YtY/Bav379eNU&#x2B;TU466gXOzfTp0&#x2B;jGjetWp3pIe9FDHLJ0tCWbMGEit9OTAuCkVq1a/BxGe9I2jQRUFyBoYL6Ium/InW3l7bVq1RbbnMBjac2aNWIfw6lly1bW/UWmXYrEiZ1YzQFQvXv3LpbU79jxrwCXP9K4cePYf0Bqp2dvgMRF/T1UA1rHGjJ2b&#x2B;9XtGDBIiZCRo0aRffv3&#x2B;P3oUJxdEzEnSXQKq1UqRI8Zv/&#x2B;exafo3Xr1rI6pUuXqOqJNm3axpvxuHbtGi4TqVjxDbkG3wNcm2nTpmHvDSNlYJ9KgLjC9VanTm02sYxvIc6357Vr127NnDnz&#x2B;Lp16x6HhISEkv31&#x2B;kbBv54B39vI941I&#x2B;m1Bfkxr/GMD/H/yYRIAZpjxDqNGzqy09vpdrt&#x2B;/6OFJT339&#x2B;fnbRL&#x2B;yxWj08fN05YUXLb1yiwJDwzjTj64CxdK9mdwh8&#x2B;/m7UsnHj&#x2B;je6986McyRd/rsQAoQfswSFblRIAtQNLqRa8F5GNq5Kcn&#x2B;9fL5BshB/Ta36mtXwswaxEbMfFWMEKCyJdVI3zk51Bt/7VM8dT2UQ2cax1PLUJF6XuoAXy1Voty0I9sKoA/Mv6Sg7/td5D&#x2B;tgWksVUCANnwokWLuObby&#x2B;ul2K&#x2B;ENHDgAGrY0FKfClf1nDlzR/ss&#x2B;tPDZT0&#x2B;hkU67CmAfCPdZSFVByCdMeNv7pSAAGCGEdmSJUto/PjxXAogBUD2ggXz6c8/J1hfgxnjqVMnqHr1GqrbuX37NpMKv/zyC7flu3DhPM2cOYNr3ceP/zPKsgDUaHHXoUM7unLlKl26dIlb9HXo0IHHTKFCBazGes2bNxdAfzS1bNlCgO/stHTpUv4&#x2B;UHW8baC1HkgKeQDob926jb799lsGsMjWos0kCCUpcNz//HM8P8&#x2B;fvyD7Uty4cZNJj8aNm9KPP/bkOupbt26yGeXChYvj7XwAaoxp06ZSx44doxAAOC5hYREsI8ct5eDBA&#x2B;bkKTJatWoV774TJP5Xrly5vn///qvTp0&#x2B;/6ubm5k/2u&#x2B;nHpL4/pi78Mcnq69Xya2X6tdr8GQX/ZuhEQvMQmGHGu4sCaV2oZZF8lMQxET3z9aM11&#x2B;689TrLZc1I&#x2B;VK7UDKxziMPn5KDmPQDUNTIlTXassj6J0&#x2B;UiImHDyWQfYTBD9h8kAIALgBWeCgBZDkYlT/UgKnSZ6SMnO0yatlere0qvWcLKrW&#x2B;h9q21LapBHzt&#x2B;Q5q61fbfzVwqbVPWudLb11q2zdyjLTIILVjo3c&#x2B;pLEiH49ygkRaBs8hu0ZNOGSpqHGWnPyViAV56QvCy&#x2B;uVIiHy8KEbLVu2lEG8sclkkACcp2jo0CHUu3cfmjBhnACme&#x2B;iPP0bQ/v0HreAfsWHDevF3w0/m/ovzcPv2HW4PB6duBP6dNWuWAJoLoi0/ZMgg&#x2B;vLLL2ju3Nnc1mvw4EFUo0Y1cUzH04gRI7ktHmT0z565cznAoEEDadGiJVHO3axZMzmrrxYHDuxniTzG0PLlS/ke6Orqyl0Yhg0brkIY3OQuDOgzvmrVaho/fiy/jt7j2bLlYFk9AsQq5OPwftizZx&#x2B;TFUbBv9q1/&#x2B;uvv1if25K1x44d5zGFgNIE382W3ML1kC1bdn4&#x2B;ZcoUun//PlWrVo1WrlzNbQFhnghlw08/9WPZf8aMGePteMT5Qw/75cuX05MnT2THPtw6Nl1cUkbeb8z5Uzwjf0KeP3/&#x2B;bOnSpZu&#x2B;&#x2B;eabKaVLl17866&#x2B;/nhLgHzcLZP2DI/8NiXyovRai8rft8qE2z&#x2B;X/hkU&#x2B;t&#x2B;ffMJW/5Y9wm&#x2B;fyR5gCAaFEIhgB/3qO/0aIgE/&#x2B;CjMVAGaY8S4ZNjGxR6u/tkH5ac2Nu7T&#x2B;uit1LVVYgHfHmF&#x2B;0YoL1VZ5stOrqHUoqJmRQAJTPkoFypHRWvcs5JvzwuD6YQ4EIkBQByHQptQ/Uqp1XmsQa6WtvmyU2UpdvNOOv9L6WU769XgBGM&#x2B;NGPAi02i7absuI7F9L0aAFMvS6MWipN2zNAu0xOVQ6vrZjxLYdILL7krwfBIC8RaDS&#x2B;iWjwXv37vH7aLeG8T5q1EhuEwcjOVuQ0KPH90yQ9e3bjzp0&#x2B;C7a98a6sB6sb8SIEVxvDXd01FG3b9&#x2B;eM6pKx2vs2HFsdPepBMqOjh49wpJzSZUBA7qlSxfT9evX2TcB7f6kQI/xkydPsdz45UsvcnN7yPX1OLYAsseOHRXP61LSpMlZqg/pOgCdFDivAP84/vI7cFjYG6UTTP08PJ4x2AMZin3s3v17NktVqskHqYQWYzi3GHMgfEA2de/ejYmfOXPmWq&#x2B;Bli2bCyD9s6E6fXmEh4fRxYsXuf5&#x2B;9uxZ3DlCAqQoC3lz/UT9HFzZYdyH&#x2B;PPPcVaJNu7p&#x2B;/btoZ07d3Fmf&#x2B;1aS6cB1PSvW7ch2vXRokUL&#x2B;t///hcvwD&#x2B;OY4kSJVTIn308Hn75pT&#x2B;344QpI8pGpLEBxY6FDA/7pDsAxCMCMlzcD3zOnTt3ZfHixaeXL1/&#x2B;QFxTRrP8MXHjN1LTb1TCryTXj4ljvxEzP6Vaf1L5N0IFyJvg3yQAzDDjw4sUTo7UuUQhapg/F70KCnkrAiBczMKuP7f06A4Vz9MmdaIepYt&#x2B;lMcFkz&#x2B;JCIBZILIiIAIkIGW0hltNvq4HStXAstJ61ACtmuO9mou9wYmDbts6o8BW63vrgV81zwEjtfBKGX0jHgVGjr2aFN9oqYdRYkN6TzLyA&#x2B;DHQ5qca5VDSAHANnfuXDax6t69RyQB8IjKlCkjwOZJatq0aZRtBQUF07Rp0xl8or78yZPHNHDgYOv6ICM&#x2B;f/4crwfPy5Urx//CrR/7CVCrFgCS8QHUI4y4weM89e//G&#x2B;XJk8f6GrL2yI5Duo/2ho0aNaSECS3nE&#x2B;cDx7BUqVKRfesTRxkbXbt2sz5H28S1a9cyKAdwlq4XfBYqAilatWpJbdu2owYNGvDfmTJlYoAub/&#x2B;Icw/lQIsWraLsq4UQOkS9evXmfdu0aQNduXLFSgyMGTOW3dJ37dolAPdeyps3vxhPzew&#x2B;pr//PoR8fPxo8ODBVqIEgefNm7eI3Eci28tKTibBvA4SfpQooIsE6trLlftCjOUZlCaNtoEftoPj8jGHv78fqxjKli2vSgD89ttAvo/A&#x2B;wG1/j/88IPVNyJRIhhxlmQ1CEoCTALg4w0xh/G7fPny9dWrV59es2bNg0ePHgWQfZL9uGzFR/T&#x2B;JP16f6sRAmrPTWBvR5glAGaYEYeRPlkSyvKWHgDrrrvS0UfuFnARFs6kglJ7wY&#x2B;NCIBRIJypUY&#x2B;MyS0mxQA2WvJ1LRBr&#x2B;56exF5Pcq&#x2B;0Pr3nWvulJlOPybr0voPW8kqEgZoqQu87qxEQes/1yi7UjoG9pRV651OS9&#x2B;NfTMCRoYW8Hw&#x2B;MTwm02ZarKBEo0rHz9w9gkIhs8VdffcXvI/vs5ubGGVELSRDM0mgLQMxI333Xkdq1&#x2B;5bEBJId3OW11&#x2B;PGjbFmZQGcvvjiC3rw4AFVqFAx3t8/lyxZTO3bt6MjRw6rLgMAeuCApYYaYAsmYmhviEBLP2SncR4LFMjP0vkECd5Mg0CmAMAjsIweeXfp0kW6efOW9W90Wdi&#x2B;fXuU81WmTFkmZ6SQSCTbeP78Od/3pMA64A2AcbB582bq1Ok7MR5T0MaNm8U2dnC9P9QMIDHg94COKygtiOEdmDJmTM8Z&#x2B;G7dukd5Z8CA/pFkSsJo4zw4OIQz/AiUSKBdG4jcTp060aFDR7ibAo5JfAuoNSQiSiLloMhYtWoVm2iqBe4n8&#x2B;bN5c4SDx7cJx&#x2B;f1wIs&#x2B;nP3BigpQBzgXiORRWZ8PCF&#x2B;E8LFff3a8uXLt1SsWHG8uLcvmzx58nUB/n0pugRfS&#x2B;KvJvtX&#x2B;lftNXsl/vLP6cn81WT/4RrPbQkLvb9JhXRQAvz2gn&#x2B;TJIgMUwFghhkfUbzwD2RTQWcx8Qf4T5LIgVZfu0v18uWMF99PIgKgCsBEEm2npB7RAGRahn22r8e0d7vS62rbVJKe60n05fukB&#x2B;qVljMi0VdbVg&#x2B;QGwXwaqoH2/1S2q7WsVDaHz21gN6&#x2B;a53baD&#x2B;IiRIxOAMQk2f6pXMt//7y/ZarVWy3C48AgCqA9Llz53BGGnX4MKaT5P8AFJD&#x2B;I6uPdnOQksOQDsAxV67cUVzl169fz&#x2B;7qIA1mzvybNmxYR5MmTf4g22PFZkCODnf&#x2B;Pn36MniXg68rVy5zjTwURP37/8J97yE/B5hHLT&#x2B;6ICAjjbILnNMyZT7nrP/MmTNjbL6IfUGvetTuS/Hs2TPavXs3A2opOnfuwstKLRVBSuCeJp&#x2B;LWsz8ikQhBvB9MSYAKGEOOHnyX9Z6fozBzZu3UPny5cTji2hlJLaB7LyW&#x2B;gNjFCUNWC/MIEEm1ar1Ff&#x2B;NNn7Sfks&#x2B;ClIcOnRAAP/hYj&#x2B;P8b6h/WCCBPG3f/2hQwe5swJaaWIcfv55aX4dxAuIplOnzlqVDLg&#x2B;cd2C/MP5hvs/xsLQocPYUPLOndtsnFi06GdM5Ny795A/16BBI/6MGR9HvHr1ylPcsy8uW7bs/IYNGx4HBQUZdfGPTYl/XLn02yvtj2nGn0hb7q/13AT/JgFghhnxL3a6PiRHAfoxscifxoXuvPSmAPF8y&#x2B;37rASIL4EsKyalIAMAjjCxRm2tRARogWoj2XIt0KhniqcFmNXk8lqA3h7yQK9VX0xICHu7FBglDfQIAzWQr/W3kXMoX7/tMVJan&#x2B;TgL0n8JQm0bWmB2r4bIbUQHTt2oBIlLJl7tGvr0sWSJUUg24sxDvdvAEj0fsf4X716FTVu3Jj3TYoffuhJPXv&#x2B;wO/DaX7Pnr3sHh7fA&#x2B;dl9OixrJw4dOiQtRVe7dpfMWAFATB9&#x2B;lQaPPh3Bmpbt27hriNQW6Du/urVq2ySWL9&#x2B;PQG27vN7cKKPaeCzs2bNFuA7m/xsC/D2po4fJE6VKhXZiPDo0eOsMLC9XpFZB&#x2B;Hj6&#x2B;sTRX6PbDGk/2rE0rhxY6OoF2zj4MGDbLbXu3cvzshrEQCQ6APANm/ejNv9oZ7/zJmznNHPmdPyuwLZetmy5aJ8DuZ&#x2B;c&#x2B;f&#x2B;E&#x2B;stLT&#x2B;UwPm5fPkyl1ngNxfGkT4&#x2B;vlSnTh1WXCBGjPiDpk6dwoaIcmIKY7Fy5SrsETFp0gQmpbJkySrOszf169dHAEcv9veAWmXGjFmUOrXFNyJHjhzmROcDD39/fz9XV9d706dP3y/uRR43b970obiR&#x2B;MfUvT&#x2B;C9CX&#x2B;b9umzygJYAT4E8VOrb8J/k0CwAwzPv64LcD&#x2B;bteHXLcDjVjfssVo2dXbdOqJB&#x2B;286xavCAD5RFciAiDjhSLAlgjQAvFqQFQJ3KuBYbU6frXWcEYmlXpAWCurrwWajQBmPT8BpX2SDPCM7FdMAbwSWI/pd1b7flImXQ76ldr2yT0o9Foeyj8ndQB4s5&#x2B;W9yZO/JON5CSZP&#x2B;p8pWzuqVMnafz4cdwaDQqBJk0a06&#x2B;//sYqBJBfttld1KHDMwMkAnwEsM1PJXAs0e0AqggpcIwAlhHwTahcuTLP9YYOHcpSa9RV41h//XUD&#x2B;uabbzi7CiD2tgH3engAwAsge/bskUA6dZTxsmDBP&#x2B;Kczuf6fOwLCAD5&#x2B;wDogwYNEvv9QIDKutEyv1qAWgv8z5r1N2eZ//vvBO3du4d&#x2B;/LGX5nfJli0rrV&#x2B;/lpUqDRs2omHDfqfr128wAZApk4U4QPa/c&#x2B;fOUT5XuHDheDfGcH7u3r3Lhobdu3fle8TUqdP5/gdyCef66tUrdPbsWbFMfnF89/F56tu3D337bTt&#x2B;IP75Zx53RsicOYs4//vI3d1dHN&#x2B;u1KNHTyanRo4czaU&#x2B;IFak8WvGhxtBQUEBz5498xDn8tzs2bMvnjp1yoti1pLvber7Ywr&#x2B;P7R6/rcF/ib4NwkAM8z4dOKvU5coKCyMHf2LpEtFqZI6UY2cWen0Ew8KDY&#x2B;gJz5&#x2B;lCVF8nj53THBguEUyACYJyFbilpeREKVDgdGwKdWnbsa0FRazgjINmLSp7TfWooEvX03Ul6g1ufedjtqhoBqQF6tDENpu0ZIGz0SRct4Ea8BKAPoY7KNTD/&#x2B;tgX8tuaT0jaU9t32fIFUQF0wJOkoYZE&#x2B;B6dvgCjU/8OADrJf1E0DYNWrV08A/6tsDgaHfoxlgAop1IABXO0/xUB7PpiEyoEyQBTqqXE/uHPnjgCw9cXfD5lAQcYffeiTJ383AOvcufNi/Y0Vr/vAwADKkCEjVaxYkQkIqV0eSCAJSE&#x2B;aNIXmzJnNMn6UCDi&#x2B;hTms/DoAOIX5JAIAVunaQlkAVAy4DsLF78cXX1RgQzpv71cCrD4T4PWQGJNjmJCSxtynYEyHTg/r1q2jcePGs9dCly5drO/lz2&#x2B;5NsePH081a9ZkmX&#x2B;&#x2B;fHnENR/M/hJdunTm44Qsfu3adWnGjGl8/aOEAwQ2SKjx4/9kU8906dJqXuNmvP9AXT9a9504ceLy3Llzz&#x2B;7YseOZHcDdHvCvlt1/G7Cv5uJPZEzir5btD9cB/aRCBBAZl/rHFvA3wb9JAJhhxscd&#x2B;&#x2B;4/omvPvShzimRc&#x2B;18nT04mAjIkT0ouTonJJziEHvv6x1sCQD7BTpMmDT8gVYVxlkQE2JIBRsC&#x2B;LdA2CvKNtKdTIwLUQLKW14AWQFbbJz3lghLJoEc42Os/oLcOvWOo197QtvWerakfxgPAPgAjgJAE&#x2B;tWOnS3wVyNmbN&#x2B;TgBHasE2cONlKAACYQk4NgP/bb/0FuHotQH8dBqdwV0dWFR0CXr9&#x2B;xeZ1zZp9Y97sVOLMmTMMuPr1&#x2B;4kzqhKIRfYc4BVAql279txCLSQklLPxbdq0jWPAIDeYJCYk4OmAPvcYf&#x2B;gOANUGpPMIAHC0goyNAPGE44OxhQ4JFStW0ly2c&#x2B;dONH36dMqbNx&#x2B;XTHTr1o2WL19Ky5YtE/uajDPTPXv2pCZNLF0q5AaF8TVAzi1cOJ/9I1q1aiWOQ5Jo96Bff/2Z9u7dzeQd7i2zZs3hf9HlA2U&#x2B;zs6W32CAfpRPYJ3o6hEWFirOew5WBUng34wPM8TY9z927NhZcZ&#x2B;5MXbs2GsaQD&#x2B;m4D8mLfzet8Q/NrL9WoSACfxNAsAMM8ywjeIZ0lGronnpyAN3qpQrE32R1dLnOWPypOQkQI13UDAdffiUymZO/8kcE8mdHUQAFAHIDGKyJZEAWkBXDcgqgWalLHNM6vfl65ObuikBX63suRYY1fMnUFrGiJzeqCmh3nFSIjW01q1nNqi0jzj/AOQAXAD&#x2B;yKraEkPyLL89dctKBAG2deLECTac2779Xxo7drx1GZjSQZb&#x2B;xx9/0IgRIzhLCJCG1nPFillahYmJJnXq1IG6d/&#x2B;Bx4XZ/kv53P7xxzDun75q1UouBWrf/lsun&#x2B;jatTs1a9aM1RfIrMNHAbJ6SLPjOpyc3rQNxD3p9u3btHbtd6xecnFJxWqE9u07xArYty39QOs9tJcEYMd7uBdqjePQ0BAuFUCrvu3bt9H&#x2B;/fvF6xEsc0cZgBoxF9/Hmbe3Dys28ucvIP4Ot7Y&#x2B;xLU5evQo7urRu3df6&#x2B;u3b9&#x2B;iI0eO0j//zKVKlSpaWx4eOLCfli1bzkRAbCg7zHjX5F14&#x2B;B0Ru3fvPr9gwYKr58&#x2B;f9ybtLL894N8eiX&#x2B;YQZBvNOv/riX&#x2B;RPZl&#x2B;/XAfUxr/E3gbxIAZpgR/wLtA78v9RnVy5OTsru8kQwmFLOQEhnT0PbbvrTr7kPqUrIwpUj8aU02QAKkTZuWnZZhpgUgIGV/bSe9epl5LfCpl7nWKwnQA8VqTvtK27YlKtQy4Ua/nxbQVQPaSsfRdh/0TAvVCAO90gzbz&#x2B;JcA/Sgrh&#x2B;ZSky45WaRSudKSepve77kYwivYRsAX3iO9/AvzOVQP412fI6Oibi1l7SuUqU&#x2B;pxMn0Fs&#x2B;MbdYgwTYNlDjv379Rq63NkM9Dh8&#x2B;RI8ePaZ&#x2B;/frR2bPnCKcG9fU4rjgn169fo0WLFtGFC&#x2B;fE8dzA94TYDBA3qOu&#x2B;cOECTZkylcdZwoRRxyhKDSD779y5I&#x2B;8jauRh9AgyCsvHhl/DzJkzWF3w448/RnkdLv6oW0dgHOKY8CQv0pdCHrg2YDD4888/CfB6RADXStS8eUuqXr16vDX0MxI4Lnny5ObzZhk/CaKc/9DQMOre/XsmTs6fP8ftGU&#x2B;ePMkkNK7/mTPnsPEjvDxQ6mHPNQ0lS1hYOHcCMSPuOB8vL6&#x2B;Xhw4dOjN79uyzhw8ffhEQEBBqALi/Lfj/WCX&#x2B;akQAkf21/SbwNwkAM8www2jkcIleL9ixeCHaevsBlwKMPHqG/qzx5Sd3XKT2gXBmBhHw6NEja59mJTM3Pad9rd7xaiDUaFs/I&#x2B;8p7YMaOLfHIV9v//VMDLW2bVQpoQUujJAs8vVKPdXloN/W8O8NWE/I8nD59tUIC2kZrA&#x2B;11A4Olp/KjRs3UpMmTfg53Ppr1apFR48e5u2jrh81wmjRJ60PCgRJ7q0WkhmgGdEDmf5du3ZS27ZtBdA6wwQPABKk/iifWLduLfXo0Z0l22XKlBXv5WHAi3uBXqB8AIB&#x2B;4MBBhoD57t27WCp///4D2rJlM7Vq1Zo9SeTzTowXtGTE&#x2B;zByRPvB2GzphjH17Jk7&#x2B;fr6sWu/ZD4oEaFQQclJQgSOmdJ6APzRxQDO/pKj/acYrq53eZyVKVOOOzKgfCRBgmDpLmBVUgicSAsXLqRp06bwuQcB4OnpRXXr1qGaNWuJMdmODWqrVq1MV69e5y4A9kT79u2pZcsWbBJoxruNV69eed29e/fesmXLTi5ZssT15cuXQWQ8a28v&#x2B;I8Nib8a2P8QJP5EsZPtN4G/SQCYYYYZ9kan4oVo9vmrdP&#x2B;VL930fEUF06aKCtw&#x2B;MSIANdgSEQCPAAkE2oI/tSy1UTm8ESCvB5j1vAfUCAYtMz89wG&#x2B;khaCR/dfaLy3Ar7Qttf23JUIAsgCq8AC4UQL9ONcgBAAS8Rw94FHb/P33PaJl9eX/yj&#x2B;Hf3fu3EGVK1cVADEBA/whQwYxAYDtoV46V66c3G4NMn/0QIeRX7Zs2RS9EcywP3bs2EZbt25jwF&#x2B;oUKEo5w1mdV5er/i4Z89uaZ1mT9YfTu7S&#x2B;JEHfEUA7G1l22gHt3r1WjZz&#x2B;/vvmRZCNkcOlvbLo3z58vx4F4GSAoxR1PiDdEJWGvuPx5Url8VryZmEQqZaIh4EuKG8efNG&#x2B;y5HjhzmspQkSZLG6zEEJQbaalapUiXae0ePHqHu3buJc/6Cjf06duzEqg6QigiUSTg7p&#x2B;DnIFeSJUtKFSp8wcTJ1q31eNyB5JHGEMYlOimAnIFSwGjgNwrr2bZtm0kAvKMICgoKROu&#x2B;zZs3n545c&#x2B;Y1MTcIIPsl&#x2B;0bA/9uQAET62X9See1jlPiboN8kAMwww4y3iRq5stKdV9507ukL2nHXjQqkSfX2d1gBXh4&#x2B;eErHDp2hug2rUarUH0&#x2B;WCJNkTOKR2cKE3dJn25dfV/MIsPUA0HL2VwPZWi3y1OTwSgBfDQirgUqjCgWtFohSqB0DLTm/HsjVUgqo7af8fWRopUy/5OAvvW9bDiE9R4YTLeEsdb3eXJtrcTx/0wpQkvRL20G279SpU&#x2B;zcfuvWLRo1arQACfX4vfv37wmAmYZu3LjBzu0nT56gqlWrMoiCoZ&#x2B;n5ws2VDPBf&#x2B;zF1183pEaNmkR5Ddczru306TOwSZ09AWIH5nYgCGvW/IpVA/LzBPBfuXJF9nNYuXJ1lM9aWpF6sQoEJnmIsmXLMhh/20DmeNu2rXTp0mUaO3as6nIgHOAgL2X1q1evRgcOHOTnL154ivFpGesYq5Mn/2UlJCQyA74EUDJMnjyJW9vFd/BvGUP1BbD/LhoBgONWu3ZNBt4pU6ZgpQkIAIyJWbNmcau&#x2B;gIBAa9kO1CUo55HUJQ0aNIy2LanzhFKgJEBN7QNfiwsXzvO&#x2B;INauXUM1avwv1stYPsV48ODB/TNnzlyfPn36mUOHDnnaAeyNgv&#x2B;4lvhrZfPDDQB9U&#x2B;JvhmWuZKRv9Uf9BS0/7PJZWAKbR0LZv/KHg&#x2B;xf20ci2XPHyL8TyZ7L/wWV7CiO8xJzuJnxrgOtAO94eVOFbJkoIDSMBh88SV4BQZTIISE1zJeLauXNRskNGhJNHDGPls5bT15ePtRvUCfx6PzRHhcAO7QPhOwXk22AP732gWrgVgkIK4F3Lad/PWJBjVTQApd62zG6XSPb0SMa9EgRrX2XlgE4xwP103jIs2xq30Uq93j&#x2B;3IP7wC9evIT8/f15Yi4RBQCA&#x2B;BdEgpubG2XKlMlaJw1w36VLJ6pUqTLXlANMHT9&#x2B;gsmAPn168fIgDGDi16BBY0qdOhUVLlwkit&#x2B;A0eNvhv1x7txZcS5us0O7vXHlyhUxJgZTxYpV6Oeff6YVK5bTyJEjacaMGfS//9XkZUDmpE&#x2B;fjv7880/avHkLFS9e3Pr5pk2b8DoAJAH&#x2B;YOgX04B5Yblyb1QC06dPoy1btjB4bNCggeZnAfThOdG8eXMmQXBvQ3Z6ypS/OKsPshNZ6J49f4z2WRAAK1euoFSpUtN33333SYwZHFd4HKBzjEQCQTmRN29uLtMAiYQ6/iVLFlPp0qXZ42Hjxg2UOXMmAcDTWwmWmIZFLbSc1UTLlq1QXAaKDBhFZsmSRdxvjrLqSABXJnzMsD9ev37tffr06Yvbtm27Om/evLt&#x2B;fn7BOsA9pm399Iz7YirxV5P3R8TgQfTuJP72gP6PEvjHZ4xsKgDMMCMeBdoASq0AHRKEU0JKwB0CkjomopXX7tDxx8/oy6wZqXbe7JTcUfvyv3HlDmXMnJ5CQ8LEI/SjPi4AaKiRldoHouYT4E4iAuyt39cytbNVExhpZacF0LWk9Wr7&#x2B;TbqBSm01BB6pIJWaYCSuaLcwR/ZTekhSXGVCBecO3mdv3wf/fz8GegjQB7Afb9Xr57s3t2wYUPezpw5c2jIkMH0zTdNadasuQwMkiRx4nGB9n1r1qwVIKkD1a9fl4mB4cNHUMmSJcVywWzuJ/9&#x2B;8mNlgv93E/v372On&#x2B;5jK63fs2E4VKlSktm3bCFB3gAFf167d6K&#x2B;/JjMBgLr6U6dO0LZtOyhTpszcllFOAKAvPFREyORqOeyrxZ07tylfvvy8H9euXY9CAKBdIR4SSFUkd588YYA4atSISKUJlDEJub0kvk&#x2B;BAgW4Bz3k/vXrf624Dhgm9u3b76MeB7h3o6Xe0KG/07x583WXx/UO4hcBAg/KIGTxly9fwecd7fvQYQIGkwsWLBTnwIUyZMhAhQoVEWPk7fM22Gbfvr1p6tRpqssg8//ff8fp5s2b5O5u2degoADzorcjAgIC/J6JWLly5ZHVq1ffvXjxojcZk/jbC/7flgTQc/Mnnde0nsdE4m/W9X&#x2B;iYRIAZpgRTyOZAPg/f1GCDrk9pd2ubvQqMJjueb&#x2B;mB&#x2B;Jx6okHVc6eiernz6n6&#x2B;dFTf2ECIEfyCpTQpk7W18efTh27QIWK5aMskS0JP4YA8MPkDtJKyH1BBsAsEABOUgSotfVTy8Lb01lACayqgWctYsCIWZ&#x2B;eMaHaOvU8D4y2PVQ7PnJiRHLaB9AHUMe/kCsrtQOUA2wsC7dtLCuRBPJlpJIB/I0JeKdOHSlPnjw0cOBvnGENCgqmw4cPstwaTugDBw6hzJkzM7BCK7mKFStTihQpOSO7bt06GjRoMBUsWFCA0ANcViBv5Sht1wT&#x2B;7zbg6REeHsFt1WISv/zyK5NCIHngpL9z526W9KMFHqJfvz4M&#x2B;EeM&#x2B;EOAsf9o&#x2B;vQZUcgwAHioApChPX/&#x2B;ot3b79WrF9eZ37hxk2vJ5QHgP3jwIM7qg1xC4N4kQIwAqf/j8hIYFg4dOoz27t3L9yxI&#x2B;fGdIPdHRwC0/0NpQ3yPnj1/4PZ8Sve0y5cvMcHi6nqP/T5QygGVR9KkSfhYQWr/8qWnuDc4sU/CsGFD6dSp09S0aVNW/eTKlZuqVavG9xV4OxgtkcD4gLoC7v/ly5ejOnUsZUOHDh0S957vaMCAAdS6dRvFzyHTD2PL5s2/4dKDihUrRd77zGteL0JEvHz58vn69euPLF269MaJEye8yD5X/tgC/28j9Y8gY8Z&#x2B;RiT&#x2B;RkA/0Qco8Y&#x2B;QXdDmb6lJAJhhhhlvGdlTOtO3RfNTleyZ6YjbU9rp&#x2B;pBeBwfT3VfedMvrlSYBAPBvmaREv5ePGzqLls3bSKnTp6TVO2ZQgcJ5PqrjguwxpN94YKKN7Bqk4hJJIAefRlrqaTn5K/zQKf7I2dtlQCvLr1Wfr2U6aPu6Un29Xks/WzLDdhtSr3tMsmFUBjAPwG573G1BvfQ3PnPixH9sxPb333MUjxfaoEk&#x2B;AYsWLWAQABlwvnx5uYZ8woTxAvyPZ4kt5L8Ad8iuYr&#x2B;Q7W/Y0FJ3/vnnpalq1Wpiku5GtWvXYkf/smXL6E1kzAnMuyA0kyVjzwUQeEYCsviLFy/QF19YuqIgC3z69GmW7gPYwcMB1X/ffNOcJf9Yb6JEDnT37l3OGkst9RDI&#x2B;F&#x2B;9eo3HFRQCMWnnB1UJZN5Yh&#x2B;0lg/UfPHiANmzYwCQTxuLZs2dp2bIlTACg9vzSpYvUvn07qlKlMr1&#x2B;7UMdO3YUwLXZJzcOcD2iK8SePXsYPKP94YsXzwX4nktTp05hJQ&#x2B;8X6QyESgm5s79h65fv06HDx8Rx/I4E0Eo5QHpZyEBf3mrfcI9AwQSSIA6derwa2hb2aJFMy4zAPkgBdr9PXz4iH1GDh8&#x2B;zN4PAwcOpMePn5IAseIec1C8V4EKFChoXvQqt1hPT88XZ86cubpgwYIza9aseUTGJfv2GP4ZNe7Tq&#x2B;PXyv7H1Lk/NiX&#x2B;Shn7uKrrjwL8zTAJADPMMCOWA&#x2B;0D2xbLT5VyZKbDbk9op6sbeQUGx3h9m1bvoqw5MlL12hWoYdWudPLWJnJJ9XFmn1AagAeIANTPggiQdw1QA&#x2B;BKwFsN7NuCYltyQE0Wb8RcT6u2Xg2gG11Wz&#x2B;lfz7jQdnsA/ZD2Sw7&#x2B;Sp/RktLjM9euXeWsff/&#x2B;v3FmDxN5qR1gUFCQtf&#x2B;5BKwcHBxZNjxo0CD67LPPxOTbjdUfaP81Y8Z0Pt9w&#x2B;gaoQ2uvY8eOU8GCBXi5/v1/ZTM4rHvu3HlUpMhnTFioGQ/qjQczYh6FChWmKVMmGyoBwBgYM2Y0zZs3l2bO/JuaNfuGr21JFYKxVqdObSZ04PqeNm06lnurtWzEuP31119Vt4dxNnnyRGrSpFkU4kAekP9L3QpsA&#x2B;C/Vas2DPIxJseMGUslS5YQ&#x2B;x/AnhRo/ZchQ0Zxn0pPgwcP&#x2B;aTb9kHtgOM9evQI2rzZot5o2LABqyV&#x2B;/30oNW7cmMnB6tVriOv5AgUHh/K5gcS/fv161KHDd3z/qVChAmf9jbSM1IvEiR1pwIBBrCA5duwYvwYfAbQeDQjw59aR6BiCaN26Ne8vCIDly5cx&#x2B;dimTWvuLnD8&#x2B;HEmiDZs2GRe8DYRHBwceO7cuUviGN0eMWLEBW9v7&#x2B;C3APpGwX9MW/gRxVzirwX0wyketO4zQb9JAJhhhhlxHDldnKldsQJUKXtm2nH3QYzWAfm/72s/&#x2B;mlwZ2rTuTHNmbqCtqzdQ&#x2B;26NuX3PV&#x2B;84n7KH1PXAIkIgBQX0nK0D0QGUYkIsAWrerX5SqDYnmW1XtPL2BshH5TWo5bl1&#x2B;tkoEQc4PgBNEs1/fK2a0ZAvxRYB8zTINudNOkvluKjJhsB6e/58&#x2B;epVq3alD59es6wYgxiW5ABz549S7xXi&#x2B;v74eZdo0ZN6tevL9dKw9kfE3ioQAYOHMB94S37kYD69v2J158pU0Y2BZOOsRZJYsa7CZxjZL6NxLFjR1nmPWLESAGm1nHrRoBouKsDdMETAhl0uL4nT&#x2B;7MrRvlfhP2Bu4V8Cfo2LGzxv0lrep1DD&#x2B;KtWvXsRkc&#x2B;swjIEEHYYXv3L59B67vN8NC7kDR8/KlFxOAyKjDuA/3l3LlyjGJ5&#x2B;39mn76qR8bPfbo8T1L8StXriQ&#x2B;N5oVA/YErncoDEDAqAXIHTx69&#x2B;7F5AwUJDiXUCNAYbB9&#x2B;3Zav34DZc2ajYoVK0qLFy&#x2B;mp0/d6ejRw0wOYPzdvn2Xx2V4eBgVLVrMPNGR8fjx44d79&#x2B;49M3v27EunTp16FY4DFLtZ/riS&#x2B;KsB/E9O4m&#x2B;GSQCYYYYZ7ylyp0pBPUsX5bu4vbDltbcvoSogV94cnK2oXb8yHdh9ggmARw&#x2B;eUsu6P3J95YRZg6jK/8p9VMcFYBUAEkQA&#x2B;merEQG24F8JCCqRBEogWgnoG1EJ2AJ&#x2B;ve4EtuDeCBlhNLNvS0AAeGNCLrn3y3uqy7&#x2B;D1IbPSOeBq1ev8mT6t98G8kQf3RzwOj4/evRoJgfgEj9hwiQG9JDZQhGQJUtmql69Orf5&#x2B;uqrWpzxg4QYbu4HDuyjv/76i18fPXoky27hjo51Zs2albJnz87ZRrVzqPa3GbEfqG&#x2B;Xk0fotb5gwQJuhQcAhWwrssDIACPzj17tuLuh1/u337ZlII2SDwD9JUuWWluuxSQwFpC1L1y4MBsGOjs7R2sbqEbCYftylQruM97er2jixAlsSDdlisUsDhLyhAkdxPicEi/PJ5z4cX3a61uwaNEi9mHAMcfxwX3g4sXLAvD3Fee&#x2B;EZeswefB09OLWrduSX//PcuqoIjJdQpiEMRRv34/WV8LDAzi3z75eNyzZzcTDgMGDOS/x44dx/dDlB4MG/Y7n2cQACNHjhH/ZhavT2Njy2fPPJjMRBQpUsS80InbcT4Tx&#x2B;2OuN8fPnfunJeHh0cgxb3E396WfXEl8dcC96bE3wyTADDDDDP0Q2s6FBQYTE5JEou7fkSU5SLEpCY87A3Qy184F&#x2B;3YdJDf27BqJz2495hKlilCnb7pT/PXjKOqX33x0R0XfC8QAeg3jppxgA1IxaWuAUoSfdu6e7Vse0wBuBEvAq11ytdla2CnVeKgRl7IyQr&#x2B;MYk03kNfdHmmX76MnKxAhhZ10QDZ8qy6LaEh/QsDrzJlyrCZH8Ce1MoPwP/bb7&#x2B;l4cP/4HpfX18f8vB4zuetWrWqXNoBQqdbt27UoUMHNpPbv38/197i361bt1HevHlY3g/QL&#x2B;0L9lnJ7d3M&#x2B;L&#x2B;fAHEjJ&#x2B;F&#x2B;/LEnn6s1a1az2sPJKQmVKFGSCQA/vwAGYHv27BIA0Zfl3igZKVmy1FvvB7aJcbZ&#x2B;/Trx2Miv4d7wyy8/8/0C8n1bogsRFmYZV/AyAGiVAhlj7PvOnf/SuHF/ciu6ffv2ibHantatWx/vziM8FnC9IUP//fffa2a7AbxxvOrVq8/HEeaHIHl2795LBQrko7Nnz7APwObNmznjDiCNco5UqVzYFLFs2bK8nowZM8V4fzdu3MjlI/Jo3rzp/9m7DrCo0SY8ih0rZ&#x2B;/lsHdEsZ0dfxV7OXvvZ&#x2B;/17L03BO4UFAR7QQTB3lAQREFFERs2RFGKiArCnxlcLsQkm10WEPje51l2N8lmsyHle2feeQcsLKzoepEQEPjywwDQhIIaCCOjBhQ8wAw/&#x2B;hZgCQtizx4bmDdvLnTq1Dlx&#x2B;xgA1VkfAwMDn1pbW18/efLky6CgoM&#x2B;gWUs&#x2B;bch/clr4xYNyYz8lAQD&#x2B;MgBM4s/AAgAMDAxpgTNOl8HDHaWVOZLcAfIWyMsRr2yJ9wV0tMaSAMQDvydQoVIZ2O&#x2B;8DXq3/wt2bT8ATVs2gGw/Wg7GfIuB7Dmyp5t9gJlrVSAAMzg4EMRBKD8QICSHKpIgVtcv19pPzk1fjIDLmQKKbYdUFlu1jLB8QGzb&#x2B;WRe5eDPr&#x2B;nnm6PJyfvxNdY7o2M3OpsjgRIqLFTL4f8ApbT4fOzYEdi9exe1ZENXbfwMtnPbsWMn/X/Kli1H0m50&#x2B;l6&#x2B;fAXJxrHdWv369UjqjVlH3EYs98DB9&#x2B;zZs8HQsDIRfWyfhvuAv8/4/2OxOn8WBEg9JPwfEv4Xt2/7wIYNG6ne3tPTk3u9jjuOFpNkHtG9eze4ePEidXHAdn54vOgJOploQEyInNerZ8SRTkP6n7dr1w7Gj/&#x2B;LavIR2Gv&#x2B;y5docHG5TtNRkYDktXz58ont/jCAgevCspW2bdv9NwjjjkdHx5OkCsBj3Nx8O2zdug2WLl2a6Aif3oHnJgbh7OxsyWsBgzf//PMvTJkyJclyuA9U15DVq1fCokWLiGRjkACl&#x2B;9iu79u3r/T/xXMYnfPx2oH7GTsorFmzljLzmura8H/y9OlTUVUItuXLli17kqAEGkHa2u5NzPajJ8m8eQtIeYLr2bXrH3B1dSP1CfqN2Nruo/8tqkbQSwJbSWpaipARgS7&#x2B;L168eH7mzBmfLVu23PH3948EzST7ySX/qSnxj1NA9JWSfilSr63En5H&#x2B;TIisbBcwMDCIQT&#x2B;/PlhssYfYmFjwvuELL4OCfwxk84IeN8j6/Pm/PsVxP679ISGhULJMMcibTx&#x2B;mzhsBPt7&#x2B;ZMKEcL98C/p1mgRrFlmku32BgzfsoV2zZk3qt42yVSSlSBaFZF2M3Atfyy3Hz0ALiT3/&#x2B;&#x2B;TWwZ/HJ/Fiy0kFHITPKnKMpBj3BwZFsJ0iOptjlg4JlvB7xQi96vnKlctUxysmp1eVXOAjMDCQ1v3XXxM4onSKMv1IBBwcHGh5PA4HDuwPpqbtOALmTOQLySCSNHT3xqwgZlgxM4fbhtuOHQHGjBlLdbuq/yOSD6ESQUoZwdr&#x2B;pT4Sjv2E15jJR/Lv5eUFmzZtpGNDRf4RgwYN5gjkao6I/UulHtqSfwTWddvZ2VG9uep/X6JEKY7U2VGgCYF16Lt328Dw4cPh5ElHmubicpoy&#x2B;XjcPXz4gI6zOnVq0TO2lBQLdCEwsOXmdgZGjRqT7v9nqHpYtmwpZf0jIyM4wjybWi9i1j5v3jxJlrWwMKcODXi&#x2B;Y6AEAzt2dvZ0Xl64cJ6WQfUOmnGiPwL6O2CXju3bd3BE&#x2B;xps3Ljpxz5Ufl5iYAe/a9KkCXD0qLjaApVKfD6E5UToKWFtbU3bg/9blP6vWbOKAonoOTFy5Gi4dOki9/&#x2B;uTUoBNHRE1cjQoUOgbNlSmZr8I1H8&#x2B;PFjqL29vdOgQYM2Gxoa7hg7duwVjvyHYQwI4wK8R6zg9TeF06Se&#x2B;Y8Yhc/8x/cfD6nXYo843rPS1/z38SIBjHiJIAfIBCxAJuAgFmxQ/P9k5D99gikAGBgYRNHKtDH4vXCFnRvtYMeGvVB/z0mYsXAUzStSzADeh4TR68jIqEQyhGTst8IF6XWjpnXg7qsHifWu29fugdte9&#x2B;GO933IXyAvjJs2MN3tE5ScYyAAVQHoLB8cHExyXiQYYu3yhKSaT4KlSL7g5prkWaq1oBSJV72W&#x2B;065eaqABGblcHCNRF8l75fqkiCV8VdB9TlsxaYiZvzP4LpwOmbl0EEbTdGwjReqDHB&#x2B;//4DyMhNJc8fMGAgtQVE4oSkAYkBeg&#x2B;opLhiBoeoBFCX0WcE/9cCZpDx2EEFDgZ6MAMbFhbOkfxdFMj5j3R&#x2B;58jWcjh71o2ywp07d0nW906ePJmIJhI9VSBi3bq1VKMfE/ONSgvQKwSNJtGDomTJBFn49OnTORI/kur6OcJDwUPs9963bz/Z7ytUyIAeGQEeHtfJ4BDd&#x2B;ZH4072jSFHqusEH&#x2B;nNglw6s3586dSp3fu&#x2B;DQYOGQMOGxhRkxH09dOgwUlc0bdqcAgVYOoHeHdoCHfd79uxBZRb79tnDsmXLk8xHco8&#x2B;AxUqlCdzPgRK/VH1ge0GGzdunGgYGxYWQYomH587dI3E4Ci6/ata&#x2B;d29exceP35C7R0tLCxlr98Z9boTzV3Muf340MHBwYN7PHv9&#x2B;nU0KHfpV5L516aFH5P4s2w/CwAwMDAwCFG8ZBFYsn4qDBjeFcLDPyVOb966IdhbH4chY3qAj&#x2B;e9H7JLgNy5cv5XE07TvkHou48Q/jEC/O8&#x2B;gv7cerr2aQfdW42G6rUNoUXbRulyvyARKV68OAUCsPczBgOQsOJ0qbp/dQRe3XypeVKt&#x2B;/iDSSmzQrlggirTr5L4YxCAn/mWq4OXItf87y5SpDA8efIkyT5F4o8Bo/Pnz3Lvs5EkNzY2jgbj6PR95MgR8PLy4PZ9SRg8eDCRQczw4v9i6dLF5JSO61CRf7ntUhJQEQYmGNIO5cqVJxJpYtII8N&#x2B;CxB4z/Xzyj8D/Pxo59unTh0z6kgsk/1hj/uhRAFSpUpUk3Vg&#x2B;snbtOpg8eSItg50lsB7d2LgRGBomtAHE4xiPzTp16nBksQmRfww8JafbwK8I/J1IjGfPnskR827UiQNx4MB&#x2B;Cp5s376d3hcsWIjOIVRS8FvvYUDl9OnTcPy4I7XEGzFiJF1vMMiC5Lpo0aJU14&#x2B;oXbsOPXSB8ePH//AQ8aTtEV7KVqxYDqNGjaYSNwwq4e/EYI6xcUM4e/YMufnj/xQDFA4O9txxaUJKIzHTRgz&#x2B;WFvb0D0CgwpisLS0oABBly5dM8yxwR0X0dy98e2ZM2e8V69efSswMPATyMvzNSH/mkr84xSQfCbxZ6SfBQAYGBgYVKhcvWKS90NG9QC7f47CnAmrwefmPTD5oz5NL1ayMLx7&#x2B;4EyOapLzNPAl5BbPxeEvPkA7To1A6NGtSCPfh447XiJugSk54wHkg0ctKEqAAMBqAhAUqqSrys11FNqFijlkK/OLFCd6kC1bhUJV9X0YwBAFdRQQvLFtkf4W3HQjQQd&#x2B;68nTE4IDCCJQNMsdMLGOmEcfAcEBMCDB/eof7dq3p9/9qO2aLg8ynctLXeCk5MTtG3blpy61Y1ThPuCH5hQGshgSD1cuXKFaqmxPePChYvg3r27RDIxAywdLNCdxBqzt9ghYvjwhBZ/SPZ69OhJZpcYHECzyVKlSsLNm55kSInEErF06RKYNm0a9ZpXIaOR/wSi70AdFwICHsL//teBpmEd/Pz586k0o2fPXknOoZiYWCrT&#x2B;fr1G7n4f/&#x2B;eoBCLivrE7cOb0L17Vwo2GhgUovp/NPFs06aNzre7USNjePjQH1q2bAnm5juSnP/v3oVwv8kcGjQwTszov3nzBiZPnsRdE3NQW8Dz5y/SsngcqlN1qCBF/hGHDh2CFi1aZIQAQPxLDl5eXveXL1/u7uPjEyFo3acr8q&#x2B;rFn7CaQCaufgradcnl/mXCgSIkX6pIIEUuWcu/gwsAJBaFz62CxgyA6rXMYRDbjtheK&#x2B;ZkDdfHhg7OWEAVOn3svDA7zF8if6ShGRFhEVC1LcoKF&#x2B;pzI&#x2B;BMAYGXtBgMEc6MgVUFwjAbBUGAVARIAwEiEnRpciknLGf3LLqlhEzDlTVH&#x2B;MDpfP4rKrnFyPEUlJVdWQZB/WYSUO5L8r/8XtwVejgjhm4v/9eSAN&#x2B;zJJi7XRwcAj3&#x2B;gv06tWbpqFxGmZTcUCOrRkxc5g/fwEiZjgAR7ktrl&#x2B;qVl&#x2B;uraJYtl&#x2B;J0oEhhW&#x2B;o3L739vYmg0YEZvR1kdXXBA4O&#x2B;2DevPkcWXyYcI3jtmXDhvXc8awHvr5&#x2B;VJOePbseNG/&#x2B;BxH&#x2B;d&#x2B;/ec5&#x2B;xI/O4zODyjkR&#x2B;2LDh9H/BUgf8n2EpBBr3LVy4MMmyqvOzUqXfybwPM&#x2B;poEHj06FFyx8fz/Pr1G7TssmUJrT3//deKFBTJBXoQYGBCpSDAaw5m9VHSj8Scf20wMPgNRowYTiaiWPOPvwWvRXjNMjQ0pP9z/fr1tdoOVDk8ehQIHTp0SJx269YtUhIcPLifTFFxu3BfYRA2vYD7f37y8PC47ejo6GdpaRnIXaNjQHnWXhvyn1yJvxTZ11bir6mkn0n8GVgAIIORe3biMGQKNGlRH87dsoePoWEk50cYmdQCi8328OrFWwh&#x2B;9Q7QZ7R0ueLw4tkb7mKTLVFmqceRwfCwiCSmaxnigsr9LsxuoSQdM0YYCBBzuJfyCJCS6isNCsiRdpXTP39bMSOJg0xVXb/QLFAMUkRZajkE/n4c6ON3/fOPJfTrN5Ab8BpQ8CfB6O8RbN68CapUqcbtry3USu3161fQu/efVAaAy&#x2B;CgGA3UMLCiWjcGD0qUKJlYOqBy8JfK1otl/6WWkwsYMKQOcJ&#x2B;rpNppAewuMHjwUDKxQ/d5DEbcu3cPzp07S6aDqEhBQ0lsU4eKADw2MfPv5XUTHB2dSBKe0aFSRgwY0J/&#x2B;T506dYL79&#x2B;9xRN4dtm7dQp0Y/iOJX2g&#x2B;kt3GjRtxRHo65MqVg2rwnzx5Sm0&#x2B;a9WqTW76aB6Iqiobmz1JSgbEyX0k7NixPdGVXwzYVQHVBCjFV53/Ca0ZE8wl&#x2B;ec2Xk8GDx5GpQnly1ega1HFir&#x2B;Du/sN7npTIkm3E02AiqXOnc1g0aLFSaajfwAGllDBhNe4rl07k&#x2B;8J3kt&#x2B;dfj5&#x2B;d09f/68765du/y51xGguWRfCflPThAAQH32HySmKZX4x2lI&#x2B;kHNNEb6GVgAIB2Qf3bSMGRalCpTjB4qtDRtTCTMZuchCHjwFErlKgElShaBb1&#x2B;/Qb58&#x2B;om9sGnQFhEF8XEZ8/TBASL2t8fBIkrXcSCLWWskNPzsupzsXJOggJCgipF&#x2B;lbkeDtL5mX51wQOp1yo5v8rkkf/bVQZ9qvlY&#x2B;7pg/jww32kBFSpU&#x2B;lHLbcIN7m2gf/9&#x2B;8ODBA2rhheqJbt26Q716Cf3asVQA95tcoAG/Cx8q0q5JgEKJJ4PYM0PqIa3I//Pnz2Dz5s3g7/&#x2B;A/u/&#x2B;/veJPP7&#x2B;eyU4ePAwkX8hMAiwZMkSPFKojCazAFstOjqeoGAAXm8wIILmjCtXroA6depSp5Dbt29xpN&#x2B;Eum8gdu60gj17rKFVq9ZgZtY5yfrat2&#x2B;f2G71zz/7qv3&#x2B;hQsX0PfLBQCwIwS/zR&#x2B;2DMUAZK5ceWibsbNLUrIeBgULFqA6fwzo4jGA1/TkICTkLbWSFWb20cgUr0NRUZ/B3t4OXFxcf9ngOLddce/fv3975coVH&#x2B;76fcfV1TUkJibmu0Jir5T8x6kh/LqW&#x2B;Mtl8&#x2B;MUEH1dSfw1qetXFwRgpJ&#x2B;BBQBSKSAgd1Kyk4wh08Dpyi4Y0n06vA0OhaYtGkCu3LmgYuWyULiIATwJDIJyFRJcsuO&#x2B;x8kNMkT7wqfHQEDZsmVpAIm1wtj&#x2B;Cgmtqq5ejFCKmfrx94u6zLSw1R8Oovnyfn72SoogyxFd1TwcxGJgA/tx4&#x2B;9BEq6vn5cj8/7UlxuB2VIcQOPvfh6U8NtVrQOxjRvW37q7X4PFixeTgRj&#x2B;PsyAYUZPioCrC1RIEXh&#x2B;vb9YgIBl&#x2B;BlUSHCAzwcjRowir4qJEyeRCSBKw/G4lQOWt6TrwQ13DmCmHM9rJQEvVPYsX77sh&#x2B;9CwvmDknk07kMC3bt3T1J&#x2B;RUR8goCAR4mfq127NmzYsEl0nUjOp0yZqnibsZQgX77/6usxeIDbgtcjFcaNG091/dHRX8iIEH9j586dKfOeLVtWMDSsnLgsXtemTJkMNjZ76T1eO3UB9DxAD4Gk1&#x2B;uENrP4fdhZAI0mERgkxXvHr3JYcPvr/evXr9/s2LHjooODQxB3jf6mhrgrMevTtL4/ORJ/KXl/vBYPACbxZ2ABgExP/BkYGHioVssQDp3ZCRdOXweT5vUgR87s9KhSoyJcPXcTWrVrDHHxcTRNrGUz3prsd5&#x2B;As6evwZptc6BIUQPIqpe&#x2B;gwGYxUR/ADSTwjpZVSBArn2gWJZfjLgLCb/qs/idKjM/oWRVZfgnfC0lmRd7xvrYMWPGwNmz54iwIwE4c8aN6n/nzVtA9bwLFswDmz17qY83OnqbmXUigo890nGQPnLkKGrthcQfSZecj4C2rfqEXQiULMuQebF/vwOsXbuGO45vU2BKhYYNG2X43379&#x2B;nVqdzhz5gy4f/8BdTkRAz9Ai73tZ8yYARMnToBPn6Lg1CknuHbtGil5cN6QIUPI4A99OtAnRRs8fBhAgRisv5e6vqpuJqga6ty5E2X07ezsqfYf6/yxFAENHHfs2EZKowMHDlAtPqJePSNo2rQJvHr1Eo4fP0FlSrgeJOCqVqh8tZS2gZWE6/N/13MsCUDlAnazwBKGBg2MKPCkr58LSpcuk&#x2B;bHA3ePigoKCnphZ2d37d9//w3g9tsXUCbx15T8JzcIoM7NH9RMk3utjcSfkX4GFgDIJKQ/XsvPMTBkSGCWf&#x2B;i4Xkmmde/bHhbN3AymZn9AzLdYKPRbAdATyfIjBwt6/QbOOV&#x2B;FwS&#x2B;m0sBr3oq/oFmr9G&#x2B;ohQNV7BiAgQDMnHGDK3KzFxtcSnUMEJvPb9unyvTLSaeVkGghYRYLVOAAH0kDDqxR3uvs7EyGXdgFAomUj89t6Nf3Twp&#x2B;7NvnwA24H0HVqlVpcI6KAQwG4ENTYi&#x2B;WrZcKHogZ&#x2B;mkSVGBBgcwFzBCjyVtGBgbbhF0UcNrw4UOps8GQIUMT6&#x2B;6dnE6Cq6srtGjRkoz&#x2B;Xrx4ARcvXoDVq9fQuY8G79ipoUyZskRm9&#x2B;7dQyoILy9vmnbs2HH6Lk3OI7w2YFARr5Poo9K/fx/ufzJDMgCAgQVsz4jA3xAS8o46R2CQctWqlbBgwUI4e/Ys5MmjD7Nnz6blPD1vJpZpoAcBXi/R4&#x2B;H0aWfuuz/B33//DQYGBuTlggERO7t9P32vubk5lTBhi0MVLCzMqWUpqhuwJASB65gwARUIlj/UXwn3vYMHD4CHx40f18M47ntmUlnCjBmz6bvTCs&#x2B;fP396&#x2B;fLlO7t27fK7dOlSKGjWkk9X5D85Uv94UGbsp0Tir4T0AzCJPwMLALCAAAMDw8/o3u9/ZBDYy3QcDYLq1K8G2bKLX4Kyx&#x2B;tB/gL56GTDwdicCWth5t&#x2B;j4fPnaOgzuFOyszFpDczKoz8ADvJCQ0NpUM1XBChpEagi/ZjdR9Kvqu/n17YrMb2TI8NCwoxQdTZAmW&#x2B;DBg1h06YN4ObmSr9p&#x2B;3Zz6NWrBzf4vkr9s7EVGA7Mhw0bRr3S0eQLPQHwIbWNYmoEsW3jl4hIEXipdoTqAgus5j/zAo/VjApUH&#x2B;E1YsaM6dS9gA8kw6tWrQEzM7OEwSF3XUHyvWLFco6keoKt7V7uOpOHu169pzaICHx96pQL&#x2B;Pj4cI87MHjwIDKu69atW2LnBnUGfmJAV3w0Bu3Xrz/V7gcFvYD79&#x2B;8nWebo0SNksDpw4CAoXrwEbSu6/OP15vLlK2Bi0pDINQYnUHmE10cLCyuO4LuQA3/dunUT16UKlv7xRwto1MiE208faJ2Imzc96Dp97dpVaNq0GX3&#x2B;9es3gJefpUsXc98/MHE9rq5utG/z5MlLLf369RtA15NNmzZSIGTTps1UBoBBE9xO3KdPnjyB/fv3c/8PSwpKoNJh&#x2B;vTpqT6ujYyMjOCu294XLlwI2LBhw8MfrfuUSvY1If9KjPvU1fHLZf&#x2B;1de5PaYk/a93HwAIA6YTgxytcDtRE95gHAAMDEjaOTB09awHWOw/Cx/fhMGZqf9k6fzQIbNnWBPoP7wrNa/aG2RNXQ9SnKIiM&#x2B;ASjJvXLEOQMSTNmr7AuHutO0TAQAwE4&#x2B;JbK&#x2B;uM&#x2B;w8EsfhYH7fhaSsIvJLdKst9ytfA4D78LW5wVK1acpL1oipYzZ27YscMc8ujrw599/oSw8HAYMWIE1dXi8iinVbn3yxH7rKKKEOnWhppI&#x2B;jX1OmBgyEjgSB3kz5&#x2B;PiDKWIAmBJBiJ&#x2B;9y5s&#x2B;Hevftgb&#x2B;9Ayp5Jk6bQeY7lPTdv3uTmz0sMkmAd/&#x2B;TJkyhogCqfkyedkly7tMW8eXOgf/8EYo2BBLzGYX28CkjqBw0aSF4iGIxIMMyLJ&#x2B;PGGjVqUlASVQRfvnwlE0LsFjJ37nxo164d/UZ112QV&#x2B;Ufs3r2brst//TWBWkGOHDkcWrZsRSVOhQoVTPytCWUOvWHt2vXQh7sG4vUcSw1Q8YV&#x2B;CgkBmDBqH4ilUa9evSbzQwxqDx48mFvvaHqkov9NfExMTOwjDsePH/fcsWPHA&#x2B;53RssQfV2Rf21b&#x2B;AHoRuKviYEfk/gzsABAJg8GgJoTl514DAwKkC&#x2B;/PkyarTzDhkmIkqWKQZ68uWDWkrHcwKww/DVkIfQZZAYFDfIrJoLpIRCA9aY4iMZBI2aHhO0DVW37kPSjxB/nif12XewLqbp53AZn51M08MYaVRwEo8wXDbjy5MkDsTGx0H9Af2rNh2UA&#x2B;BvEgg9y2yvW2lDbz8oFAaS6BCjxCmBgSE9ARc7atauhefNm1M4uu4Tyyt5&#x2B;HxHekJD34OTkRI79eL3BbPu3bzEklccSHxXQrG/z5i2J7/G6pA2ioz&#x2B;TumDPHhsqP0DynC1bgsorX778dJ7mzZtg6IelCpMmTaBABHYLQQUVkuaSJUsR2cbtKVSoAHkP4DT0KFF1LNEUWKaFqiVT0/ZQpUoV6mqAUn00dEXVFZ9zHTp0CJo1a06eJoiVK5dz2zCMDGDR0BDbIuL6Vq5cScEL9JTYudOCrql47VQhpcn/dw4vXrx47ujo6GllZXXP39//049sf1wyyH9aSfylMvxM4s/AwAIAOgsEKCH6cj0/GRgYNKeiVCOOGSAsGahWsxK8jXwPkZFRkL9gXrDa4gD3fR9B245NoUvvdun&#x2B;1&#x2B;JgGx30sd0U9h7HgbDKyE/l4C/VHlApiRcuI0awpYg1&#x2B;hVcvHgR5s9fQO9xEBzDkf769etRlgzrbXGZxYuXUP1uSmXodWXmp6mhIANDegEqiVCaj27y6Ib//Xssd22pSORfjDYgOd24cQNcuXIVLC0twM3tNMTGxhCxxddr1qxLQv6TC2wN&#x2B;vLlC1IJoaKgYsVK1GoRAwCFChlQAJF/nVO1xcNWekWKFIUuXbrQtgUHv6VrDXoUVK5cBf799x&#x2B;6Z&#x2B;Bv6d37T62DEgiU/rdq1YY6BqCKqXXr1nSNa9fOlIIAXl5eicti&#x2B;cGdO7dh8uSJ5I2QsA2baR4GH9A/ISbmG9SrVx&#x2B;uXnWngIbQnDUlx7Bv3rx5/fDhw6dbtmxxd3FxCeZ&#x2B;T6xCoq8p&#x2B;U9OC7&#x2B;0kvjLkft4BVyASfwZWAAgAxD9LDInLoD6yJ/OTnIGhsxM/JPWcqv&#x2B;AGSFhMz3zeu&#x2B;sPpvc8jBDfD22RyHPoM6w9wl46BM&#x2B;RLpnsxhwAPVAJhh5w9g5YzvhKRfbD5fNSAmu1eXUcfaWF/fOyTnx0HtgwcPaECMAQE0usJtRaksSl5RgqsNQRea9qm2Weo3ahIUkAt2iH0XA0N6BJbodOnSmSOt36Bs2TKwa5c1d27mhDp16pAPQFzcrcRlMfmLBDc09APVraPjPsrT0ejP2noPlCpVAk6ccAJTU1OdbqO19W66fmzbtp0y4BgEwEAnokaNGhSwQGA7wW/fviYa7WEg4OnTJxwxb0kKI/QeQAUSbju2FMUA5L59dnT9RLl9coEdIdDjBAMM3bv3oOtDly5dyRxRtY2I/v0HgJfXTdi6dTv33b/Bnj22ifPOnTtLpolYToHAgEVqgCP5X&#x2B;7evXvfycnJZ9OmTQ/Cw8O/gWYt&#x2B;bQh/9q28APQzNhPSQCAvwwAk/gzMLAAgA4CBepOdJb9Z2DQEtFZoiEsPJLM4qTw9vV7&#x2B;PY1BhasnAjVaxtCv06TwOPKLahcrSLsd96W7veByuBPdd8XEnW5NnlSLvlytf18w0Ghi77qNRpYhYdHQO/evSg7hsRhzpy5YGRkRIR/zZq1tDxmv8S2R11GX06uL9xOJZ8XtlRU55GgJJDAwPCrw939OmWsly9fwRHl1mQyGh8fRzFUVBTxrwPu7ihND4XateuCra0tbN&#x2B;&#x2B;nc5tNCldtmw5tG3blgw8dQ3MhHfo0JGua7t27YaIiHAIC4ugeRgAVTn0f/6MwcaciWQeXffx9/Tp0xeWLFnCbVsF6iyCsLe357Z/GxQoUBCcnV0S15Ec4DowcBIQ8BBmzZpBJoH4naruJap9iSUCWK7Qo0c3WLlyFfe&#x2B;KrX5e/bsKUydOgVq1apJ5QApPjjlwO2foGPHjl07cuRI4LVr1z7EJcgnlEr2NSX/aSnxj1NA9JWSfilSr63En5F&#x2B;BhYASKcEXxu5v9QFg53EDAwaYMDA7tzIDz0D8kLc9ziI&#x2B;Rbz0zJI&#x2B;nPlzgnFShSGJi2MoHtfU3jz6h0UKfYbfI/9DnrZ9NL9flAiz&#x2B;eTXVWQQEm7O/57uY4B/OXQrHDlytXg6HicBsFoqmVk1IAycbiMsKWf2DZoS7KlShrUbbfYb5barxnBT4KBoUePHiTX19PLQtl1JLEJNfWqXvT/HeM3btyANm3aEjnF0h1U8iDBRuKPDvsphSZNmiReL7B8qGvXzmBl9S&#x2B;UK1eWzkHcLnTIP3ToIBw9ejzxc0iuMbjxv/91&#x2B;Enej7X2mInH36tN9wEVHj8OpPIJzPT/88&#x2B;/FIB49Ogh/PXXOHj&#x2B;PIg6EyR0Q8mW2E7xyJHD9DkPj5s0D5UW8&#x2B;fPgb17baFIkSLg5nY2RUn/u3fvQvz8/AL&#x2B;&#x2B;eefG87OzsGRkZExoN6oT1Pyry67/6tJ/OMkxuuaTJMKEkiReybxZ2ABgHRG&#x2B;DWZriRoEA&#x2B;sCwADg1aoVLEs/L16Mr3&#x2B;&#x2B;uUbFC5qALGxSSXlv1cpB8PG9wG7XcehnnEN&#x2B;Bz1hVoHbv53YbpvEygkrOpq/NURbLn3UgoCsWVxYGtq2o4jB21o8I2JJRX5l9o&#x2B;uenJDQ6oy/gLgwL8sgexMRYj/wzpGWiQ9/DhAzA2bgi//WYAEyb8Rd05sM98REQUkW4096tevUbiZ&#x2B;7fv0cZfmzfZ2xsDOvXr4PTp0/Dhg0bFX0nkvebNz3Jt6R&#x2B;fSPJ5bDUABVEKjx69Ihc9bGWHyXygYGBdE7u3WtD5QfYYvDNmxCYO3dOkg4AaMgndz1AI0BtoNo&#x2B;9Exo1qwpeSJcvHiJAilYVmBpaQkbN26BRYsWUmtavP5Vrlz5x2fjyGjRxcWV2vih/8KVK5fB19cXRowYCaNGjQJDQ0Od/7/DuI0NCAh4vG/fPs89e/Y8lZH4a0L&#x2B;U0riL0f2mcSfkX4GFgBIE/KfBcTr/0GC0IPMxQWAlQEwMOgMOXPlAJfrNvA9NkHCGgWfaPq7t6EQ/iECfG/5Q3uTwRDJDXC7/WmaoX67Eqm7MFDAJ8Gq91JlBOq&#x2B;V4yYoy8BQljjL5Vp1/b3ipUhqNs2JYEOueABCwAwpEcg4URPjqFDB3OktCoFANCQLirqMxFpjhxCq1Yt4PffDamsqmnT/8z8Pnz4CNOnT6XOHhg8wOAAlhBgAEEdPDw8YcCAvpTh3r3bWnK5NWtWU&#x2B;u&#x2B;gwcPJTreHzt2BEqXLkvlB5cuXaJrk5lZRwgODgErKyswMCgEz549IwKd0s74KNU/e/YM9OzZiyPxLtx&#x2B;HAZv3gSDhcVOCgAMHz6UWviNHTua2v1NmTIFLl48z&#x2B;3HZrwAQhxMnPgXBZ/REBBNXLElILb40yW4626sv7//g8uXL99bsmTJrZCQkC9qiLuuyb/csgBM4s9IPwMLAGSwIIHUeyWuonFsFzIwaI9CBglyTmwzN2rAQJL3586dC86fuQGlyhSHkRP&#x2B;hODX76Fle5MMlf1XSv6F84VZeylJv9J1qyPfUqZ66gIWmgQ&#x2B;lHYEUELiU6p9IgNDauP8&#x2B;XNw79596Nu3L5F&#x2B;7HuPWLx48Q81QAOSqbu6utF0LNtB530V6tSpTRl3DABMnjyFjOqw/l8JQkPfUS3&#x2B;oEEDiPBWq1b9p2Uwg29uvoMCD//8Y0Xfgdi3bx9l6zduXA8lS5aEP//sS10AJk2aTBlzbYBqBFyXEhw5cojbN42o/er69WuJ4GMAANsKLlq0mFQJbm5u8OVLNLd/79G6W7VqBUuWLKXPt2zZOsk1Fvf7jBnTKDCKpoVHjhyHjh076mwM&#x2B;p6Di4uL&#x2B;6lTpwIOHDjwSiFx15T866qFn5zBn5IMv5J2fXKZf6lAgBjplwoSyI35tSb9jPgz/DJjyox&#x2B;HP4Y1PFHdlkkHll/POvx3uuJPOv9CJzwn/GR/cf7bLzXic/cfj7IDjcGBl0Mhbg7P3fdCvsYAc8CX8Df0zfAu5CP0KlHa5i3fHxqtlZKUaCcFwedOLgUI/TCrJiw3l74XoyQi5F3deUB/OXkPAq0ydSLGQbKfUYqi6&#x2B;JEoCRf4a0Brb7RJKObTXFgKqbly9fQsWKCWZ8SDIjIyPpM2g616fPn9C2bTto0aI5R2jLU/35&#x2B;/chJDvHzy1fvhK6d&#x2B;8uum7Mft&#x2B;96weVKv3&#x2B;k0kd1ujj9VTd&#x2B;bFlyxZ49CgAtm/fQe&#x2B;RMOO2YenBlCmTYM6ceWBlZQGOjidh8uRJHDk&#x2B;Qr8Zy4cQdnb20Lx5c6rtV3UC0JBQUaABjQJxXxA7jIuTVA5ge8OSJUvA&#x2B;PF/UVvENWvWcNs5jQg&#x2B;1vmjogF9EI4dO8Htl0pkLojrbtCggeQ24P/k&#x2B;nV3am&#x2B;I/ihoAphccPsj2sfHx48j/N7cNjwLCQmJBuVZeyXkXxOTP23c/JMr8ddU0s8k/hmHt/0aw80M/G/LmsmPs3gtl1MXbWT1/wwMKXZ3AKqzPHHYDYb2mg4W9qvgr&#x2B;mD4MCek&#x2B;Bg7Zihb4RyGXgpUq&#x2B;6iakj/2LfrY4sa6skkCL&#x2B;cusTljYo/V455QAj/gxpCSTxaB7XvHkTsLZOKqHHDDRH&#x2B;Oi4R4L9xx/NYP/&#x2B;AzQPjfpQUo8kF03prl27AvPmzSEXenwdEvIWTp92g0OHjlDPeSnyj0CzPJSyC8n/kydPYfnyZWoHwOjSf&#x2B;CAQ6K0H4Hmd9gyFOXyGJjA34lt/N68eQ1Tp06F16/fcL/vAjg6OsHNm95E/hFKyX9YWDi8fPki8X1g4CPYvHkT5M2b70dAJZi8So4fPyb6eQyKILZt28pt&#x2B;0Ho3LkzeQ90796VuhMgiUc/BFQH5M2bF0aPHi1L/hGoPGvWrDmZEyaH/MdyCAwMDLCwsDhYvXr1ZU2bNrXfvHmzP3csROFsjMv8ePBfi72PEVn&#x2B;G2&#x2B;a2Lpifzy&#x2B;i0znP3/nLad6/s57LzVP6hEneB0neK3kfZxI4CFOJgAhDE7IjeVBmzF9PA/sasfwq4GVAIiT/SwixF9pZBJAPBrKwMCgQ5QtWxKecIPA549fweAxPaF524bQtsEA6DWwI5UHZKQggBL5vyaSeikiL&#x2B;ctIEbIlX6vXNBAmKVT2sFAGNjgr1&#x2B;qnl/MHJAFARjSCgsWzINLly5yhLEaSfNV8PLyAjMzM47AH&#x2B;Kuc&#x2B;VgzZqVYGBQGHbtsoK&#x2B;ff&#x2B;k2nR0yL9w4Ty8evUCLC19oVy58nDq1Cn6LJJubVvOrVixnCPwC&#x2B;Dvv&#x2B;dDsWLFZc8PbC3YoUMHbhteJp7HX79&#x2B;I1Lv6enJbctNjoSfIBl906bNYdq0aTS8Gj9&#x2B;PJQoUVKxXF94zi9cOB8KF/4NFi1akvidOXPmABXNwnKHc&#x2B;fOU0kEbse8efOJyKtQvnwF6nBw/PhR2LhxI20Tuv536mRGpomooED1QiqqyeKfceC21X/lypU3Hjx48Onr16&#x2B;xoCyrn5z6/l9B4i/l1K8rib8mdf1yrxWTfnZlY2ABgIxF/KU&#x2B;I9Z2RE/iIsbAwKAjtGrfGMaNGwjzp6yDBasmwOeoaHgSFgjR0V8yVABAjNgqzeLzP6caoCtVFYgRbeGzuvWo2yYxEq&#x2B;LWn&#x2B;pbVHtB2b4x/ArAOXqY8aMg&#x2B;rVk9bOL126hK5hmDkfPHgQnDjhBPr6&#x2B;tCrV0&#x2B;YMGEC2NntgdjYBN62Z48tPHv2nDpzVK1ajR7awt3dnTLp2P4OlQXlylVInPf8&#x2B;XN48MAfWrduk9h&#x2B;b9OmjTB27Dhy8w8JCaYM/6xZM7lrcBR3bR5HvgK4XfjctWs3WQd/pcCygYIFC5JCAUsXatas9eNc/u98Dgh4AP369YOrVy/DqlWrOcJfHkaPHpNkPcOGjQRPzxvQokVLIvqXL1&#x2B;FwoUL0zzc3tTAx48fP9y/f/&#x2B;Rra2tp42NzTOO9MeoIe7JIf/Jce9XZ/SnxNiPSfwZGFgAIE3JfUqsO05A/MUuhAwMDDoEErl15vNgTP950LvTX6CfKzcUyVICsulljMuamCxeTg0gRvL5be80IcrqAgNi/gJKgglyfgNiv11qTCX33eoCBoz8M6QVvn&#x2B;PAz29/85FlN67ubnCpEkTYPr0WdChw/9oOmbKT550gqJFi5LRHpr5nThxAiIiwqmW3tzckltPFjLdMzEx0dn2HTp0kKTsQUFBlFFXDV0wI967d09q1bdixUoYM2YshIeHwf37/hwZN4Bbt7yo/t3R0ZHOrdOnz4CDgwOpGnRohEdwdj4FLi7OUKZMWcrkowoCa&#x2B;4TzvGEZXJx9wKs20czwbJlS4OHx42fAgCTJv1F68ByAGzZhx0H/v57UYofA7GxsTH&#x2B;/v4PuX3ltW/fvkDudSQoy9prSv6TGwSQk8sryfrLvZbL/DPSz8DAAgApRtgBkmb7s4gEC5TW&#x2B;QsDAXoSF1AGBoYUwPY9S2H4&#x2B;D7gcfU2lCxVBPLmy5PhfqMSAzxN1qNpll1Oji8mpZeS8WsTJJAYeGncuUAYMGBgSE1s3bqVCPycOXMTpeXv3r2jjD4SbAsLc8qWY3Yd5ee//VaIaspz5sxNrfCqV68KpUuXAWvrPdCpUyedbdfffy&#x2B;ERo1MuHV2hL59&#x2B;4GT00lav7X1bvIYwHNmwYIFVFKAbQVtbKxh0KDBEBwcTGR879695FEQFhZGpoEODgfIRG/OnNlUQqBrVK1aFbZt20E1&#x2B;aiQ6NOnDxkKoi9MQtAC2xN6kCkgBk&#x2B;wy0Fc3H9qI9xGOztbuHjxEikXpk6dApUqVYQKFSqmJOmP5fbPRxcXl2sc8Q84fPjwa9BMsq&#x2B;0TZ8mLfySK/FXKutX4uivRM7PJP4MDCwAoLNAQBYNl1ciXxIGAVgJAANDCgJdnBs1q0uPjEj81WXNlbrl8&#x2B;X7wunqvleKgKsrBxCbJpThK5X/a&#x2B;pxILa9LPvPkFbYtm0LtdjjtyldunQxOdH//rshrF&#x2B;/BrZu3ULZd0tLC9i504JM8ZydT8ONG&#x2B;6UqUZiizX3usT27dtg7do1MHjwUGjUqCHUq1ePpuvr50msqT9//iz4&#x2B;z&#x2B;Efv36kmIBAxlFixajz9SrVxd69OgJ/fsPgAIF8sOwYcM5wvsVatSoSe7/ukatWrXJHPHs2TPw22&#x2B;/wYcPodz1BNvC6pMx4pUrV0mNgMoAPNfRF0HVAvHq1Sswd&#x2B;5c8Pa&#x2B;CYsXL4LKlStz2zgHTEwaU7BDpwPM&#x2B;Pi4yMjIiHv37j20sbHxsLa2fhoTEyNG9FOK/KtTAmiS/dfWuT&#x2B;lJf6sdR8DAwsA6CQgIPQBiJd5zb8oZlUQBGBgYGDQWTBAjhhLZdn5pFtYHiDnsi8XaFCavRcLGqhrJSgXTFBXHiDcRkb8GdISR44c48hrQr06Zsuxjv3cuXMccR7EkVlXePr0KcyePYtaAc6cOZuINJrrXb58ETw9PWDPHhs4fPiIZDmPNvjy5QtH1GuQQ//Jkye477CGjRs3JbC8uHg6x96/fwdRUVHkP4Cmfo0aNaJhEpLv1atXJ64LuwlwfBcePXpIbQdVgYRkEOifzllUTKC6YPToUdz29IL27f8HBgYGNK93795kYIjeCOjmv2jRYnjw4AHkyJEDGjduQsugq3&#x2B;3bt2gRYs/YO7chOAEkn/&#x2B;dTC5iI6O/vzo0aPAAwcOeG7btu1BZGRkjAzR14T8q6vv16aFH4BuJP6aGPgxiT8Dw68wpszoxzfvBsK/k2SReGTlPYs99NQ8skk8snP72YkdbgwMDEqB8laUtkqZ/ikh4nKfEyPG6pYR1t4LB81SxJ2/nHBdcutRWiYg1eZQLojAwJBWGDt2NFhYWEGZMqUhLOwjyddRLt&#x2B;rV2/o2LETfP36hUh53rz6RHYfP35Mmeu//poouU5sXYdGgapjHclytmzZoVChgqLkGjsJoKHexIkTOZKck0oBUGGAZP/q1WuU7Tc1NaVARNGiRUhpNWPGDDh92hWOHj1G3yW2Xsyk81UO2iAiIoL7rukUDNmyZStNw&#x2B;y&#x2B;re1eel&#x2B;pUgXo0qUL1K5dF86ccYNjx46TKmDnTnMoV64cmSvy2xKmNLjfHPf06dPHt27derRq1aobPj4&#x2B;EQqIvlKnfk3q&#x2B;5Mj9Vdn4sck/gypzdvSHBn5cGAKAJn/u8x0dSUAUjVUDAwMDFrdDJNzU1TqzC82TU6WL1WLr2SbpdrwyWX8k9N5gIEhLREeHk6E9tGjgMRpmG13d79GLe1ev34DK1euouDA0aNHYdy48bBkyVKO4J4jMi/XMg/LAwYM6EdEGM&#x2B;TCxcucIR&#x2B;AWzYsAk6dOiY5Jx78&#x2B;YNPWPpwfjx44j8Y5YfW&#x2B;nZ2OyFoUMH07K5cuVMNPDz9r4FPj63YOHCBWBq&#x2B;j/6HVLXhOSSf1/fO0T&#x2B;L1&#x2B;&#x2B;TCqJkSNHkXLixInj8PhxIHkLYPDh4MGDYGn5D7i6utLn0DARs/6picjIyHB3d/dbhw4d8t27d&#x2B;8zDST&#x2B;mpL/5LTwSyuJvxy5l2vnBzLBgRQh/Yz4M2RGsADAzxeULDIXJjn5v&#x2B;o18C7KWYF5ADAwMOiIuGtq0qeubl4XrfXULSdXhiD3ezX9TSzjz/ArA4krtpdD53o8PjHTjjL5oKDnsGrVSiL7L14EwadPUbBrl3Ui&#x2B;UYJe6lSpWTX7e3tBXnz5uPIsy99Hs352rfvAEZGDZIsd/XqVdi3z46c/BOCEmGkHEADQDTBa9LEBAYMGEjz&#x2B;vbtT6qEs2fPgrn5dvDy8oYyZcrA/PnzdSKXj4r6BPv3H4ARI0YkTnNzc6MASN68eWH3bhuYO3c2WFlZQpUqVeH0aRd49eoVPHwYAMeOHYOIiEhSMLRu3TpV/49fvnwhib&#x2B;dnd2N48ePPw8ICPgEmrXk04b8a9vCD0BZ1l&#x2B;TAAAAk/gzMLAAQAYk/cJpSiKb8YKLdlZgCgAGBgYdkH9tnPmF05UGEtQFCJQSfcEgS7QcQKxtobrt0UXQhIEhLYAZ9HXr1oO7&#x2B;3XK8N&#x2B;/fx/8/f3h27dvVEs/dux4Wm7Pnr0aZdFxPRhcMDZuSKUCaMbXtGlT&#x2B;Pr1K2XFEffu3aNa/2PHjlBZAcrjS5QoBr//Xglu3LgBnp5eRK5btGgJkydPps&#x2B;0b9&#x2B;ensuWLUPlCMbGxmBtbQP58&#x2B;eXPM8vX75ENfVoXqgOfn53YdSokdCuXVvuO8r9CAC4QO7cuWDWrDlQt249uj5YWVlx&#x2B;ygGtm3bSr8J6/nxt6YmuP/R1yAO3P/txokTJ564u7t/AM0k&#x2B;0pq&#x2B;H8Vib&#x2B;Sdn1KSb8UqWcSfwYGFgD4ZYMA/OlKWwKKBQLodVRU1Bt9ff0SbFczMDDoKhigjgArdc6XMxdUt5y2262puZ8mpJ&#x2B;Rf4ZfDU5OzlC4cGH49OkzfPz4gUg5mthhBrx16zaJywnJP7bYQ0KPbe/EgPXymOnfsGEjGfGhYgD72i9ZshiuXbtOy6xevQpsbe1IVv/hwwe4e/cudR6YPn0W&#x2B;PvfJ/O8wYMHU5tBISpXrgK7d1tL/i6U5mOGPjo6miPuM&#x2B;HChYvc1JxJAh/YZWD16rVUn4/Gg7ly5aLtwLZ9uM0qfP78BRo2bMRtzzJ48CAAHBzswcvLi9uu0jBhwsTUHRRyePv27Zs7d&#x2B;483LlzpydH/N&#x2B;AMpd&#x2B;JeRfybxfVeIfJ0H6NZkmFSRIEdLPiD8Dg8j4iJkAJr5Xadr4RoD4rMd7rwdJDQGFxoDZIKkZYOJrY2PjguPGjavXoUOHbsWLF6/JDj0GBgY5oDQXja2kyLhY9lwbg0CplnzqAgHqPADUGfgp9QxQ1ypQTvnA2v4x/GpIqNE/B4UK/abWKR9d7Js3b8qRbCdo0qSx7LJ37/pB8eIlSD5vatoWqlatBlZW/1B5gbn5Do7w/w4xMTGU/X/x4gXV&#x2B;yc4&#x2B;msPNCmtWLE8KQP8/PzAyekkBR34BnxDhgymgMOlS5dpW7DEoHr16tTuEBUAqhZ9&#x2B;NnNmzdz22pOBoRt2rSFtWvXpfr/5&#x2B;vXr9FeXl6&#x2B;HOH3sbCwCPzh4q&#x2B;0RV9qS/zlyD6T&#x2B;DPSn9552y9xvc6oyMwKgHhBYECdCgAkLpQgcaH9/uNzdKG/efNmBPe4VrBgQe&#x2B;NGzc2M&#x2B;VQqlSpWuxUZ2Bg0OSmqC7brbRkQAnxlvseIflX0rqP/1pYAiC80Yr9DqllmAKAIT2dx61bt00ywPz&#x2B;/Ttky5ZNNACQL1&#x2B;&#x2B;JDX3aNjn4uIMnTt3JZM8BJJpbIt38eIlqotHw0HMsJuatoNbt25BuXJlwcfHB7y8blErPJyP7fSSCwcHB8iePTsEBASQ8kDsN6C3Af6G&#x2B;/fvkZy/Z8&#x2B;e8Pz5Mzh06HCi3wACu574&#x2B;flC7tx54OpVd0mjwZRADIfXr1&#x2B;/sre3v&#x2B;Tq6hp06dKl92qIu67Jv1wwACDlJP5SRD&#x2B;tJP6M9DMwsABAipP/LGrmicn/xaRQWXjL8d9nFbthhIWFfR0&#x2B;fPhl7mZ53dLSskWrVq1alCtXrjY7FBkYGKQIQ3IN85QQfKG6QElrPf57/vJKjP6En1W3fcJsvtLyBgaGX3IQ8uN4dnQ8AUZGRqLyeyTX/FMDSXL37t3A29sb4uLiYciQoTTdzs6W5u3ZY8OR6&#x2B;fkK3D27Bki0ba2tlCtWjUi1sWKFaPldUH&#x2B;EagqwN/QoIExkXrcJiHKly9Pz9evu5Pkf968eeRV8PlzFFy8eCVxOSyHCAl5D0&#x2B;fPiGzwZRGLAd08ffw8PA1Nzf3OHXq1Nu4uLjvCoi7puRfV/X9cgZ/SjL8Smv5mcSfgYEFADJtQEBKuqQuUiqrAuC9/87doLMMGzbsYo4cOa5xN58/Wrdu3ZS7UdbOwkauDAwMaoIB/LGOJgZ/QmKvIiJKygnUEWxtlQbC&#x2B;VKyfSV&#x2B;A0zyz5AegK0AkTA3adKM6u&#x2B;PHz8hEyT47/3t2z4cma9ObfC2b98GrVq1pmko9f/69QssWDCfygBwfcHBb4j4V6xYKcV&#x2B;R4EC&#x2B;Wgbc&#x2B;TIDuXKlede/&#x2B;d3jJ4AZ864Qpcu3ei9gcFvZA6Iv6dSpYowcuRoMiFUwcDAAEqUKA5FihRN0X3Pkf4IX1/fezY2Njd37979jCP9saA8a6&#x2B;E/GvSwi8tJP6aSvqZxJ&#x2B;BgQUAMkUQQKorAPAurgBJ1QFxIO0xECcTDMBIfZaRI0dezpUr143169c3at&#x2B;&#x2B;fbNKlSrV4gaxWdm/hIGBEX4xmb0cyVURejG5vFzgQMm2KA0MaGpWmJTwaPdZBob0gt69e5HZnZGRMQQFvfhp/oYN6ykjnidP7iTnLBriLV68hIIH6J7ftWtnqq&#x2B;fOHEyeQTcuXOHm96OFAWpMmjitk1VwoAPfgBg3bq1FBRQAcsVKlSoAKdOOXPXJz0KYDg7O0OnTp0SlzE1NYWKFSvqfDu5bYvl9o2fu7t7wIoVK24FBwd/UUDslZJ/TST&#x2B;cnX&#x2B;AJpn/TWV&#x2B;MdpSPqlSD2T&#x2B;DMwsABAhg4CiD2D4CIYBz&#x2B;XCqimZeWTffjZfDBx2pcvX75NmDDheq5cuby4G5SRmZlZU&#x2B;5mWT179uw52b&#x2B;FgYFBHUEWq8NPrpO/0lZ/cnJ9de0BNSH8Uj4ALPvPkF6A8n2Oi0KJEiVI4q&#x2B;nlzTWz5FTMu378OEj9OjRg6Zhhj0w8BFHmrdTxv/t2xCoXbs2te6bNm0GLFu2jGrwe/XqrfPt/fjxI7x&#x2B;/RoqV65M24sq&#x2B;YCAR1C1alUoUCDBgwCz9mgsmC9fgUQ1kZ2dHRw8eIheo1mgre1eWLp0GZF/xPXr16Fx46TGhrNmzVbUQlApuO1&#x2B;yZH&#x2B;u3v37r198uTJYA2IfXLq&#x2B;38Fib8U0Zcz95MKBCSX9Mu9ZqSfgYEFANKM8AOIZ/7FLnB48dSDn1UAfAUAn&#x2B;R/FxB9vhKAPz0R2CJn&#x2B;vTpN2fNmuXTr1&#x2B;/sgsWLOheoUKFytzNPRc7XBkYMg/ECLyUrF5T8qtUwq9at5DQi32fNiaFSmr6lSgOVNvDggAMvzqwbh7Rvn17Ol4LFSqUZH5UVBTV/d&#x2B;&#x2B;fQs6dzaj2v6lS5fApUsXwNCwCjg6noQ6deqAi8tpCA&#x2B;PIFO/lMScObPB1fU09521ue8qT0S/UKGCYG29B8LCwsHExATq1q1LgQJsc4hGgF&#x2B;/fqXzcMGCeVCjRg24cOECPHv2DObOnZe4XmxLKAR2B0guPn/&#x2B;HOXj4&#x2B;NnY2Pj6eTk9Co4ODhaDXFPDvlPjnu/kuy/OmM/JvFnYGBgAQAtyH8WiWlC538pFYBcOYDwkcQDQCoAoPpOlNPZ2dk95x7b/vzzzzKLFy/uioGAnDlz5maHLQND5goEyJF0BN8lXGxZPjmWUwmoxlty7QDlyLoYMdc2WCG2PXJtB9lYkSGtgFl7PAZVJntyQFk/ImfOXESWsW0fH5UqVaLgwI0b1ylYgDL606ddoE2bNuDgsB&#x2B;ePn1KpB&#x2B;z76oMvK6BBP7x40DK/CPhR88BLy9vku/j75w6dRosXrwIjhw5DL6&#x2B;dxO3&#x2B;3//&#x2B;x/9Jj09PZL8nzt3Ds6ePcvN&#x2B;x0sLa2S/Faxa5a2iI6O/hwaGvqOGy9dtre3D/Dz84sAZVl7Tcl/coMA8SCf/Qc10&#x2B;Re60Liz0g/A0NmGVtm9HNNMNAUjjqFkvwsEo&#x2B;sgmc93nv&#x2B;Q&#x2B;/Hg/&#x2B;a/8imcLrocn369CmzcOFCM0NDwyosEMDAkLGBmcB3797RQFmdC78mXQA0cfaX&#x2B;h5N1iXVTUCqBECpQkATvwEGhpTEkCGDYOLESeSGL4WIiAhqzVe8eHFy58d&#x2B;90OGDIE//mgOjo6OULJkqcRlUdpvYtIQ/PzuQkxMLDx44A&#x2B;NGzcRbbOnS3z69Any5MkD06ZNpU4BjRo1BGPjRuTYv379enj58iWYmZnB1KmTITQ0DGbMmA7r1q1XEbck5&#x2B;LNm55w/Phxkvm3aNGSWgHqEuji//bt22A3NzdPKysrP09PzzCBi78uyL82LfySI/FXKutX6uivlOgziT/Dr8rb0hQZ&#x2B;dBkHgD/XbCkMv9i8&#x2B;PgvzZ/YrX/UsGE72q2QaoWix4HDx4M4h4WvXr1Kr1w4cKOVapUqcYCAQwMmeNGqCnZ17T1H/&#x2B;Gx1cWyLXoU&#x2B;f0r7RbgVSggD9P6vuZ7J8hLfH27Ts4f/48zJkzT3Q&#x2B;ZtOxrn3GjGnwv/91gB49etL0yMhwOm5z585Fzv18TJ8&#x2B;FapWrU4ZflxGV2375H/HW5g9exb888&#x2B;/sG&#x2B;fHQU02rY1hUuXLlJ3Aczeu7i4wps3b6Br125E6rt16y55fhsbN6SHrvHhw4f3Pj4&#x2B;9/fv33/733//fSpB9HVF/tVl99WRfCUGfwC/psSfte5jYMjAYAEA6dp/oexfyhNA6APALwtIzjZJPfQOHz78knv826FDh&#x2B;LLly/vVINDTtQTMjAwZMgggCYkX&#x2B;7zUuRZar3qCLyckZ&#x2B;STL46g0B1n2HknyGtER0dRQZ8Ylzm2rVrlD1v186U5PJ9&#x2B;vQlt/xx48aAlZUVGeLVqFGTJ4ePp9p&#x2B;Jycn2L//UIod2&#x2B;Hh4VCgQAF6jeULqEo4ceIEBAUFQUxMDJH9EyeOw/nz56jzQPPmzWHHjp20PJoX7tplnar7&#x2B;BuHu3fv3rt06ZL/2rVr7/Bc/LUh/5rU92vTwk8Tsi8n8Rcj8ppK/FldPwMDgygye6u5eAXzpaRS/Iu1OumYqv5fm0esyCMGn11cXN4YGRntNjU1XX2TA3fj/soOaQaGjEX&#x2B;xYi7VBBAXYBAXW2/VPBA7Du0admntOOAEkNApR0EGBhS6xxVITQ0lJ5Xr16VaPqHJN/aeheYmraDM2fOwrNnz4lwDx06lOaju3/Xrl1g8OBB0Lt3HzAz66T2u9&#x2B;&#x2B;DZadv3&#x2B;/PYwZM5pef/8eS8&#x2B;BgYFw&#x2B;PChxGXWrl1Dz1euXIKwsDDo2/dPKF26DLx8&#x2B;YpKEcaNGw9OTs4p0p5PDijnf/v27Rtra&#x2B;tjXbp0Wc&#x2B;NdfZMmzbtBkf&#x2B;o36Mg77xxkMxMtNiJN4Ll48VvOZP&#x2B;67hM/9zYssIH3Eir8XGj1LzpMah8TLTpMoUpMa/csEFtaRfBXbFYGD4NcAUAEkvdkKTP7HWf/zX/FIAoRpA9fk4wfqUBBz4F2c9kYs4f1rWy5cvh5iYmOxt1qxZYe4G2cjU1LRZ7ty587J/KQND&#x2B;icW6kiuunZ66mTyOE&#x2B;VgRQa70l9TsygT1MyrmmJAiP7DGmNL1&#x2B;iYcmSJTBixAiO2BsmEns&#x2B;3NxcyTwPSTzWzNva2oK/vz&#x2B;UKlUaDhw4QEaBbdq0A0NDQ9i6dVvi5/LmzUfEu107fVi5cpXo98fGxsL79&#x2B;8pY3/hwnkYPnwYXL3qzq27lBiBBmdnF275d9RC8M4dX/jjjz9g4MD&#x2B;MHTocFrG19cXjh49QqZ9Hh4e8OFDKISFfQRv79tw964v1KtXnwwAU/PcCwsLC/Xx8fHfvXs3uvi/5t5/A2VZe00z/8lp4afE4O9XkPjHS4wxAZjEn4Ehc48xM7kJIH&#x2B;alBkgwH/mf3LGgFklHnoyz2KmgerMBMXmJ5lmYmLy2/Tp0407dOjwB3fzzscOcwaG9IfPnz/TYJ9vAqi6pinJ9GvyGSXzhPPlDP7UkXhNFApKlmNg0BZ4DCPpvXr1GnTq1DGxT70YNm/eDDNnTocqVarAgAEDYO7c&#x2B;ShPh2rVqhDZNjSsTOZ91apVJwJ&#x2B;8eIFePXqNTn/37rlA5cuXeIIfjsoX76CTFAuHqRyBdeuXYWHDwM44j8cdu/eRcEFbLEntTxm8DE40KdPL5L6o4ngkydPoE2btkTsXVycqfXwy5evYd8&#x2B;e8iXTx9q165NnQdSE58&#x2B;fYoICAh4vG/fvhv29vbPfkj8NZHsa0P&#x2B;U0LiL2Xipy4AwF8muaRfirwziT9DeuRtaX5/YAGAzBUAAJDuCKAi&#x2B;yBB/rPwCHkWEcKeVSYAoC5AoGR&#x2B;4jwTExODSZMmGZmZmbXIly9ffnZZYWBIP8AuAOgazs/O8yE2XRddAJTM46sG5Mi60u4BUjd9uUADA4Mu0L17N8ibVx/8/R9QqzspIKHv1asnR6AfU4b//ftQOHjwEDetF0foy8CyZSvAz8&#x2B;PiPnnz9FE&#x2B;nfutIDHjx9Dz549KTiQXIwePQpq1KgBkydPoffR0V8gR47slMGXg6FhJfj48SO0atUK2rf/H0yY8Bd8/RoDY8eOoU4EUVGfqc1gagIl/k853Lhx4/6aNWtucvsuEuSN&#x2B;jQl/0pb&#x2B;CXHzV&#x2B;O/DMXfwYGFgD4ZZHZSgDEQutSzv9iF0q&#x2B;IaCYSSC/JOA7/CfV/65gu&#x2B;J5n9UT3Cj0IKn0X0/kO&#x2B;N4QQCazt1Y33GPM40aNfKaOHFi/c6dO7fInz9/QXZ5YWBInzdBXdwY1Tnty32vlPu&#x2B;NuRf3W&#x2B;SMh1kYEgOXF1doUWLFpArVy4ixUjQ58yZAwMGDCTJfunSpWk5NMqzsDDnSHNraNiwEZF&#x2B;lN5bW9vAuHFjIV&#x2B;&#x2B;vHDw4AEKAKCL/9ChQ0BfPy&#x2B;cOuUM7u7XoEuXzlCtWg2dbjtukyrwFhcXz21zP1i&#x2B;fAVUr149yXLo6B8V9QkqVqxE742NG8CZM&#x2B;dg715bwFMI2/3hZ1AJoC54oGtw&#x2B;/z9lStXfPbu3Xvb2dn5TXR0dGwyiL4cwdfEvf9XkfgrlfMziT8DAwMLAKRQcEDMC0DYBhAEBDwr74aQlUf8&#x2B;a&#x2B;VXMz5AYGsCki/nkwwIM7Dw&#x2B;M99zhnZGTkPWXKFAoEFChQoBD7lzMwZIzggDYtANURdXWBAW06Eoh9Xkn7P5b1Z9AWHMGkNnxInPfts4UFCxZAQMBjmleoUCE4f/4CKQCaNWsK5uY7KQCAx93UqVPAxsYG2rc3hRMnTpKcPnv2bGTWZ2j4OwwfPhKWLVtK61m9eg3s2rUL&#x2B;vbtR475&#x2B;EiRAVu2/8j6mjWryaX/4cOBPwUAli1bAn//vTjxfZMmzeDGDQ/InTsPxMR8o/Z95cuXT7X/QWRkZPizZ8&#x2B;CbG1tr504ceJFQEDAJ0gdif930D7LzyT&#x2B;jPQzMLAAQCYi/9IFeD8rAYTTlQYBxNYrFQDgqwGkSH8cJC0DiBeZFuft7R06aNCg8zVr1vSaO3cuegQ05QZAhdm/n4Hh1yb62rYC1JScixFwMT8B1XS5saBqvli5gJLAhFyggIFBKQ4ePAhNmzYlF3tbWzvInz9/kuOocOHCVFv/6NEjjmBnp2nYqg/Lb5YtWw5bt24GOztb&#x2B;PYtBszNzcHKypKI9M6dO2HJkoQAQMuWreiha2AbwY8fP4CZWefEc0CFKlUq03t&#x2B;vT62D7x//x48f/4cihYtmjj9xYsXsHjxUli6dAnNL1myFGzcuClF9/uXL18&#x2B;BwcHv92/f//VI0eOPPby8voI2rXkS059v1gwIB50L/GPU0D0lZJ&#x2B;KVKvrcSfkX4GBoafx1aZzAMAZMi9Ei8A4XsxU0AxY8As8LMnQBYBQc8C4j4BYvX9SuZLrSvxPTcg0l&#x2B;9enXT5s2b1y9evHhJdjowMPw6QBNAlQeAJnX&#x2B;mtT0KzEPlFqnpvNVgQAhkdfEJ4CBQROg8V2LFn9AsWJF4fLlqyTLR3Ls7e2TmE339vYi&#x2B;T5m&#x2B;FENULduPXBwcIAiRQrDH3&#x2B;04Ah2GWqhh2Z55cpVgIEDB5BfQEhICNjY7ElCtHWJffvsYPr0adz5Egdr166HIUOGwrRpU6mt4Pjxf0Fo6HtSIty//4BKE1DpUL9&#x2B;fW5bY6BgwYLcMhPAwKAgHD16FG7fvg0&#x2B;PneoZMDMzIyk/8WKFdf5NnPndhy3X95eu3btjqWlpbebm9s7DYh7WtT3yxn8KcnwK63lj5Mg/ZpMkwoSSJF7JvFnyCi8Lc3APAAyB6RUAFJtAYWvpcoCAP7L/vPTYFkFF/KsEhd&#x2B;oRpAWBrALz/Qk5gm&#x2B;v7JkycRffr0ceNen92xY0fjnj17NucGMyWysBE3A8MveSNMLmFXR8o1rc/XhLSLtRVkdf4MKQkk6dgGD&#x2B;v0ETlz5khyS8da&#x2B;fnz58PMmbNIzh8b&#x2B;52y5XPnzoZatWrD5MmToWPHjnD9&#x2B;nUizVOnTiMlQUoDPQQGDhwEI0eOgB49ekD27AnKBMz2o/kgKhKwA0Djxk2I/CNy5MgBs2fPou1buHABTJo0gdoGfv8eB6dPn6Zza&#x2B;9eO&#x2B;oEoGtER0d/vnr1queFCxcebdy48cFXdBjULGuvaX2/Nu79KSnx12XrPinyziT&#x2B;DAwMuhtfZkIFAIAyFYDUM/91VpHXUkoAOUWAkoc6pYDajL&#x2B;S9xs2bDDu379/q2LFirFAAANDGgIzemJdAMSy&#x2B;EICr4kaIDnZfU3b9kkFMITbz1z/GXSBz5&#x2B;joHr1ahyhvgElS5aE4cOHgZfXTbh16w4pAA4fPkRyfjQDXLBgHlSuXIWb70k18z4&#x2B;t6gkANvmoRonJRvpREZGwvbt26BLl67k8t&#x2B;yZQto164tzJ&#x2B;/kOa7ubmCsXFD8PW9A71794T37z9A&#x2B;fLlwMPjJhQpUiTJurB8YcOG9XDq1Clo3NgE&#x2B;vbtD3Xr1tX5NqOLP7dvnnDf42Vtbe1/586dcBFyri3510Ti/10hyVea9ddU4h&#x2B;nIemXIvVM4s/AAEwBwAIAaRMAkCL7YuSfT/Y1DQKoCwZkUUP4k0305d5zhENv&#x2B;fLldYcOHdoWSwNYIICBIW0CAEhMlEr&#x2B;k9MOUInBn5xZn7rvkroWJ8e8kIFBHT59ioRq1aoSUcYAwIgRw&#x2B;DmzZvg7X2bDP0WL14ENjbWZAZYoUIFOH/&#x2B;PNSpUxdcXE6T6z/K&#x2B;9EzICXw4UMoGBj8Rq&#x2B;bN28GV69eI8NBR8eT0LZta2obiG37XFycISgoCE6fdqW2f4sWLaRhwbRp06FSpUpS5JxKFvLkyaPz8TBK/Ll9eG/dunXunp6eH3&#x2B;4&#x2B;MelMPn/FST&#x2B;UkRfztxPKhCQXNIv95qRfgYWAGABALVgJQBq/vfwcykA/8iM45F0oQu/WDmAarmsEgGHeMF3iq1HD8Ql/1lBofRf3XuM7M&#x2B;bN897yZIld7jnWiNHjjQtiaMn&#x2B;cAJAwNDKt0YpaTz6mT8wuXEbm5ysn8ltftKAwZyr/nrYGBQh69fv9LxgjJ4FTCrjiQf2&#x2B;XxgTJ/nI7HVt68eaFUqdIwfvx46NOnD5FwExMTyJ07N9XapyRGjx4N&#x2B;/cfBF/f2xxRzw1Hjx6GESNGUJvC/PkLwPHjx8De3g6KFCkKs2fP4ZbRpzaD27btkDXVROB8XZL/0NDQd/fv3w/kSP9lDw&#x2B;PDyEhIdFqiHtyyH9y3PulyL6UvF8XrfuUvAdgEn8GBoZfaTyZSRUAAMpVAMJlhaaAAD8rAaTMAdUpAoQlAVIlAkpUAUKTQa0VATlz5tSbNWtWjTFjxrQvVapUGXbaMDCkPFQKAP5gX4yEK5HoyxnzqSP2SjL62iyrJADAwCAGb29vMDIySnyPknckzCYmjaFcuXLw8uVLOncsLa1g8GBsk1eDI9cjYdq0KRAWFg4nTzolBg6yZ8/BnWOpe6zdvesHDRoYwcGDh0kJ0KZNG9quHj26UeY&#x2B;IiKCghDt27eHFStWQunSqX/b/cbh4cOHD06fPu27devWu9w&#x2B;jQZlWXtNyb9cdl9J1l&#x2B;d1B/UTJN7rQuJPyP9DAy64W2pDlYCkPkCANoEAbIoeCgtDUgt3wAl7xM/mz17dr3Zs2fXGDVqVLuyZcuWZ5cpBobUCwDIEXM5HwAVhA78mnoBqCP4Sur&#x2B;5Qi/kvkMDA8ePIC&#x2B;ffvA7du&#x2B;9P7MmTMwZMggiIqKAjxksF0fEvsBAwaSkd7Zs2fA1nYvNG/enJv&#x2B;DebOnUuBgrREZGQER/a7g6FhFar3nz9/HoSFhUHOnDlBX18f&#x2B;vXrD927d4dq1aonUTWkBl69evXy/Pnz3ocOHfI/efJkMGgm2Vdaw69pC7/kSPyVyvqVOvorJfpM4s/AwAIAvywycwlAPCiTtKuWk&#x2B;oMAJC0I4Ac4ngEXtUVIJ73nEXwnBWSlgUIp8VB0pIA4UOqbEBdKUCWH9uXZF5MTEzc8uXLfbnH3YkTJxoOGTKkiZGRUX12uWJgSL0bo1Aar0RGr62hnjq1Ab&#x2B;LgHC6unXJlQiwsSuDFLAmPiAggGr5jY2NqV2eh4cnGfXZ2dnB4cOHYeTIkbB&#x2B;/To4ePAAR6Czk&#x2B;wfs&#x2B;gzZsyAkiVL6XybHj16BGXKlIFcuXIlmY6ZfE9PDzh27Bhw900oVMiApqOh4NSp02HPHhto1MiEjPxatWpN8v&#x2B;DBw&#x2B;RD0EqDnDjo6KiIj09Pe8cOXLkjq2t7bPIyMhvoHm9viYEP7NK/FnrPgYGhl9jPJmJFQAAylUA/NfqjAGzgHbdAvjT1D1LmQaqUweoKw3QuGyAG1BV7d27t3HDhg2NgHkEMDDoDKgAwKygEgWA8HrHJ&#x2B;fqyLw6ub7YuqS&#x2B;X912yb0XaxPIkDERHh4OPj4&#x2B;dIx36NBBcjk0s0NXe1UbPERg4CNo06Y1ZfhXrlxFxB&#x2B;J9o4d2&#x2B;HkSUdYtGgJtGzZkluvKdStWx9MTU3h3bt30LVrVyhevITibcQgQ2xsDJUPSAHb7FlaWnDf&#x2B;Tdw90HYvt0c9PT0aN7Onebg5&#x2B;dL31mzZi36ftU8xP79DnDhwkXu85Zw9eplOHHCkdoS7t1rm1rXl8/c971xcHC4&#x2B;u&#x2B;//z588uRJFChryZfc&#x2B;n5NgwC/msSf1fUzMKQdb0tVsBKAjH0g6SIIIBYMkHqvSXlAFgUBAF2VCSSrw8DUqVOr9OnThwIBWdU5FDEwMCgKACBRUlLLL0bsxYi1pm3&#x2B;NF1OyohQ3fqEn2fIuMCe9MuWLSGZfr9&#x2B;A2D69Ok0/f79&#x2B;/D06VPo1KlT4rLDhg3jiPgDjhyfJGk8BgTwecyYMXDjhjv3PI57vg7u7teIjP/zzy5o164dLYclAfny5dNqG/Hz3bp1pe/v3r2H5HJYWjB48BAYO3YMdRywsvqXavcR2Iavdu3apAwQAgMWRkb16HdhoODIkcO0vffu&#x2B;UPp0qVTbN9z&#x2B;ygmmIOzs/ONzZs33/H39/&#x2B;kgLgnh/wnV&#x2B;KvRM7PJP4MDCwAwAIAGoJ1AVDw/4ek0n&#x2B;l5QDxgiAA3/0/nkfShaUIWQXzpbwIhOUCcYLPypUGyHUN4PsFKC4b2LRpkz/3eDhhwgSPAQMGNDQ2NjbS46c7GBgYdHZTVOeYL9W&#x2B;T51PgNhnNblRy3UQUHJjZ&#x2B;Q/4&#x2B;Phwwckw587dx5UrVo1cfqWLZupXr9u3TrkzG9hYcER5GPw8WM4HDt2lGrhy5YtB9myZYMPH96T7H7y5ImQM2cOaNSoEezb55CY4ccYtLbkX3WeeHndhNGjxyQJCjx58pj7/uxQvnx5mnbhwnnYu3cvDBo0iN67ubmR4gDBD2So8PHjB269t2DVquXUnaB69eowZMhQcv1v1KghJDTb0T3evXsXcvv2bX9ra2svBweHF6A8a68p&#x2B;Vdi3Ke0nl&#x2B;K6Ktr3ZfSEn&#x2B;xjH2qkH5G/BkYGFgAIGUIvrZBALlAAP99nCAo8J0XFPgOSdsFCmv&#x2B;syh81kUgQOtWgtu3b3/IPR6NHj36xrBhwxo1aNDAKBuO2BgYGFIkECA0A5RbXlWvz5f0S2XepdoFJpfEy5UTMGR8TJw4CczMzCA4&#x2B;G2SVnVv3wZDUNALcHZ2hm7dusO2bVs4suwNixcvhsuXL1NmfcmSxRASEgIzZ86imv6YmBgYOnQo1KlTh9z8dQnhMero6Ajjxo2BihUrwunTbhRg&#x2B;PDhAwUxPD09Ye/ePbSNqgCA2HHv6uoGS5cugWfPnoKl5T80nbtH0kPXwHa&#x2B;t27dus3tO/9Vq1b5vn///itoJtnXhvxr4t6vpJ5ficRfjujHAWvdx8DAwPDzWI2VACQh6Josl0Xis2IlAfz3mpQFyHkGpHQHgWS1DkwYP2XNOmjQoPKjRo1qXLt27er50PmIgYFBEVTtwPjkXKymX9MWfkql/cJl1C3HDyRo4hnAAgCZDx06tIcXL17C4cNHElUAgYGB0LlzJ6hXrx6MGjWaSH/t2nVg1aoVJKOvXLkq7NtnS63xli1bAcWLF0&#x2B;x7UPfgfLly8DOnVYUrEDUrl2TbqHPnz8De/v9lOHHVn6hoe8hMjKSOnb4&#x2B;d2jrL4UsOwByf/btyHQuHHjJN4GukJQUNCzM2fOeFtZWfn5&#x2B;PiEx8TEfNeC6MvV8KeWxF&#x2B;K4DOJPwMD422pAuYBkHkOpCxaLJdF4rNyBoHCaVkVBAXSUyDgp7aDDRo0MNi0aZNp7dq1a&#x2B;RHvSMDA4PaAAB6AAhJv7Zt&#x2B;VTZf7nsu5I6fbnvkPMG4G&#x2B;Dtl0JGNI/njx5Ag0bNqCWfCYmJrBnzx7ImzcfcPcFcHCwh4sXL8GIESOga1cziIiIhIEDB5L8f8uWrRQ0KFeunM63Cc02X79&#x2B;lWj4hwGAChXKgbm5BQUAsEb/zZs31FYQAwGFCxeBsmXLgofHDWrph237pk&#x2B;fmaSkIRUHqPHv3r17&#x2B;&#x2B;jRo6fm5ubXnZ2dX3O/R6mLvy7q&#x2B;5UGAdJK4q9Uzs8k/gwMLACQaQIATJr984VcaWtAFWHny&#x2B;/5xD5eYn3x8HMdfxz8XGIgfMh5Bei6NCALiJsDatw6UPXey8vrffPmzfcbGRkV2rBhQ7u6devWKFCgQCF2yDEwaHdTFGbcheUA/GlSngBKs/FSN2S5Vn5iyzAwXLt2Fdq0aUtS&#x2B;TFjRsHu3buJ1KMB4IYN68HW1g5q1apJBn9o7IfO&#x2B;Cj3z5pVLwn5x5p8JO4GBgY/fQcSeMy280sM5ICBB3d3d9izZy&#x2B;cOeMG7dqZkpxf9Xk06hs8eCiYm2&#x2B;nVn5BQc/h8eNA6NChI/Tv3w86deoMqW15Ex4e/jEoKOiFhYXF5cOHD78ICQn5Aqkj8de2hV88KDf2UxIA4C8DwCT&#x2B;DAwMDMrHlEwBIP4xLZfVZVkAQOooAuTIv9RrtRl/de9r1apVYPPmze2MjIxqsUAAA8PPUJUAqJP1a1oCoHov1jJQHaHXpuWf8Pt0cH1mSMdYsmQJTJ48mSP8T6BPn95gaFiZOgPg8YctAffv3w/v3r2HkJC3ZLC3Y4c5qQYqVKiQZD3W1rvh2LFjcPz4Cfoskn70BMiVKxd07doFli5dCnXq1FW0TWfPnoXKlavA3bu&#x2B;1E7Q0dEJTEwaQc&#x2B;evcDX9w5cvnyJ25533PpjwcPDg7L&#x2B;GHioV69&#x2B;qu477jfGPnv27Kmrq&#x2B;utTZs2&#x2B;QYGBn4C7VryJae&#x2B;P7Uk/nEKiL5S0i9F6rWV&#x2B;DPSz8Dwa/G2FAFTAGQ&#x2B;xGsQCBCqAfivxToF8DP8Ut0CpN6nlCJAqAQQUwnoCaZnFXxOI&#x2B;NAPz&#x2B;/j23atDlcuXJl123btrVt1KhRvQIFChRkhx4DA8gSeil3fiXmfFLZeHXzhM9KZfxSSgBG/DPpjZU7BjB7PmjQALh50wv69&#x2B;9PzveYzUcn/d69&#x2B;5Dcf8iQIeTC/&#x2B;FDKJib7/iJ/CPs7GyhSZOmiecCGvQ1a/YHlC9fjlrwrVixUvF2tW3blp6PHTsCL1&#x2B;&#x2B;pO3BWv5FixaSQ7&#x2B;VlRXcvXuXug00bNgw1XdbaGjoe47033Bzcwu0t7cPEtT164r866q&#x2B;X87gT5cS/zgJ0q/JNKkggRS5ZxJ/BgaGjDG&#x2B;ZAoA9atIxvJy/gAAqa8IyAI/&#x2B;wCIKQPEFAFZIKncXyzLr7VxYOnSpfNwgyzTZs2aGeXLl495BDBkeqgUAHy3fuE1jR8QUGoQKDVfiuwr/Yw2yzNkDmBm/uDBA&#x2B;R2P2PGdMr4d&#x2B;/eHSwsrKBQoUJJjgkk358&#x2B;fYLbt29zx3UctGjR8qf1PX78mCP7TaB27drg6noG7ty5DR07dgBjY2Po2rUrTJ8&#x2B;HS5fvgo1a9YUPa9QJYDA8wt9NtBkEIHf2aWLGQQGPiFTwqNHj0KTJo2hdes2qb7PuH3w6eHDh48OHDjgaWtr&#x2B;yQ4OPiLDNnXhvxr08IvNSX&#x2B;umzdJ0XemcSfgSHj8TadgSkAMjc0UQMIl4&#x2B;XIP5ppQjIKlhHVpHl4kTIv1SLQGGWX0wdoOj9y5cvP3Xs2PF40aJFT&#x2B;/atattq1atGuvr6&#x2B;djhx9DZr4JKnXsF/MBUELS&#x2B;VCVAPzKN2OG9InQ0FDK6tvY2MDWrdvB3/8&#x2B;tG//P9G6eTwO0RDwjz/&#x2B;kFwfqgTQKBDN9xCvXr2CnDlzkrEg3obi4vBcSEr6nz17Bk5OJ6mN4Nq16xIJf8WK/6kLSpQoQWoD7FyLCgA5R/8UCpR8e/LkyeNjx455WVpa3ue2&#x2B;bMaoq8J&#x2B;ddE4v9dIclXmvXXVOIfpyHplyL1TOLPwMDAwAIALBAA0qUA/Ey/EtNAKfm/RsRf&#x2B;J4bnEV17tzZqXTp0ufmzJlTr1&#x2B;/fm0NDAwKs8OPIdNdcBSMH5W08FO3vOpZ9X1KDQKFpQhKAgVypQYMGRf6&#x2B;nlgy5Yt5KKPEJP0awLM2GNNvo&#x2B;PD3kIGBoaQnh4GMyaNQv09NAPIDZx2Q8fPsDy5ctIWYBBBSwzUOHlyxeJJB9VCp6eHtCnT9&#x2B;fOmWkNLCu/9atWw9Xrlx53dfXN0KhxD&#x2B;55D&#x2B;tJP5K2vXJmftJBQKSS/rlXjPSz8DAkKHASgCSsepkLJ&#x2B;apQHCcgCxcgG5UgBt2gjKlQnoabJs2bJl80ycOLHm0KFD2xfG3ksMDJkE6GKupASA/1pKCaC01Z/S0gHhskJSr6QUgIFBWyBZRxWAvn5uaNOmHbRs2YICDM&#x2B;ePQd392vQrl1bjszfhBo1akJkZCRl/StVqvTTerDGv2DBglChQkWws9sHly9fBCcn51Sp8&#x2B;e2K&#x2B;LmzZt3nJ2d75mbmz&#x2B;Kjo6OAeVZe03Jvy4k/lJkX4mxH5P4MzAwpDVvAy3O7Qy7n5kCIBnHhYaBgLRSBAiVAfysvvC7pEoBNG0jqNQcULZ1IL4PCgqKnDlzpueOHTvujhkzptqIESPaFylSpDg7/BjYTVKZw786Is/vAKD0M5oEExj5Z9A1MKtfunRJIvienjfAxcUJZsyYncBO4&#x2B;KSDNzy5ctHD7GB3efP0bB&#x2B;/XpqN6ivr8&#x2B;tY2aKkn908X/8&#x2B;PGTQ4cOXT9w4ECgn59fBCjL2mta85&#x2B;cIACA&#x2B;uw/qJkm91oXEn9G&#x2B;hkYGBiSM4ZkCgDdfVUylk8LRYAw4w&#x2B;gvn2gMPuvTgmgxBxQI&#x2B;PA8uXL58FAwJAhQ9qWKFGiFDuFGTIqUAGAZmgqCGXJ2mbypZ7FXPq1bfPHyD&#x2B;DLvDixQsyCcybNy&#x2B;9f//&#x2B;Pfj7&#x2B;0Pz5s3Jrb906dKwY8dW2LhxM0fiY7jXO6FIkcLwv//9D4KD35IvgBywpd&#x2B;cObOgevUaMGrUaKhbt67Of0McB267Q65cueJjbm7uzT2HCiT&#x2B;uiD/qS3xl8vmx6kh&#x2B;kpIvxLyr4T0yxF/RvoZGDI3b1NyzrMAADuQ0kUgAASEXtNAQBY1AQCxQIA2QQBtygSSvC9ZsmTuqVOn1uzXr1&#x2B;LUqVKlWWXTIaMGABA&#x2B;TISf7ksv9h1TpXRl1IDKCH32nQNUL2WKwlgYFCK9u1NoWfPnjB69Bh6v2DBfPD2vgUuLi6JAYEpUyZzJH4umJl1JBk/3lbWrVsDJ06cVDS4E3bQ0BVCQ0Pf3blz54GlpaWHq6vr2/Dw8K&#x2B;QPLM&#x2B;dQZ&#x2B;30F7ab9c9v9Xl/hrQvoZ8WdgYLyNBQBYACDDBwLEHiBC&#x2B;LUNBEh5BYi1ERS&#x2B;TnbrQHxvYGCQ8&#x2B;&#x2B;//67XrVu3JuXKlSvPLp0MGQXfvn1LVAAkt4Zf29Z9/BaDciaBLPvPkFL371KlioOf331SAnTo0B4ePgyAq1evQbFixWDmzBkQHf0ZfHxuQ8GCBeD0aTfqMID&#x2B;AJUq/Z7q2xvNbUxgYOBjR0fHW&#x2B;vWrbvLkf5voKwln7Zt/bQNAqhz8wdIXYk/q&#x2B;tnYGBgAQAWAMhQB1JKBwKkAgPqygEyVCBAX18/GzfgatS6devav//&#x2B;e2U9sf5SDAzpCKoSABX5FsvqKw0OqGsZqKk6QGoZuekMDFLH&#x2B;Z07t6FevfqQPXv2JPNmzJgOGzZshJMnT4KZmRkcPnwIxo4dA1euXIPChQtDw4bG8PHjB6hTpw4cPXoMfvst9RvGIFF88eLF80uXLt3ZvXu338WLF98rIO7JIf/aSvvlpP7xCqYBMIk/AwMDCwCwAAA7kFI9EKAuQJASgQBQGABQ5xWgJzFfLiig6Xt6zJw5E80CW/7OQU9PjxldMqRbYqQqAeBLlJUSb23c/ZND8tW1DWRgEMPhw4dhwIB&#x2B;8ObNW3rdr18/iIgIh/&#x2B;zdy9QdpX13YDfmRBCBCIgckkxKCKoGBABuSi3QAW1Kl&#x2B;0tRWUyodVKQottSDaoqVdraY2UChxCdIsoBAiWgMY5Q7KJZCEQCAkQO4kIReSkAsZSDIz3zn5GNbhsC/v3ufMZGbyPGvNmjlnzlzZOcPvt//7ff/oj/YJGzZsCKed9tktW/OdffbZWx7/gQ8cWHncr8Iee7wzXHHFFWHkyJHh4IMP6dGt&#x2B;6pBsfLvs&#x2B;3ee&#x2B;&#x2B;ddOedd866/PLLnwvxZ&#x2B;2Lhv&#x2B;YhfvyruPPW7E/b&#x2B;u&#x2B;7h7xTzpj3yOhX/AHuU0B4EDq9oOopfg3tDWKgPpSIK0ISJoCiCkCasN/2SIgd/2Ac889932Vl5Pe&#x2B;973vm&#x2B;7Ck&#x2B;r9NUCoDZwx4Ty2HBff71&#x2B;3loDRQoA4Z8Yd999V5g&#x2B;fXo47rjjwhFHfDT84Q9/COPH3xwuuuiicMcdd4a///u/23Ld/7Bh&#x2B;4b58&#x2B;eFo446Mjz66OSw777DQvFeveF/k68&#x2B;//zzs3/5y18&#x2B;Nnbs2Ofnz5&#x2B;/IRQb2S8T/stu4RdC&#x2B;RH/rKDfEWzdBygAFAAOpHIHUcEyIKYIyAr9Se/rrUVAXrgvNC3wta99bb&#x2B;/&#x2B;7u/O2W//fbbXxFAXywAtvyje/11WtBPCuRlr&#x2B;VPKgbyAr5r/2nEVVddFS688DvhH//xkvDDH/4g7L333mHJksXhM5/5XBg37uYtj/nCF0aG6gL6EyZM6LHva3PFwoULF/zud7&#x2B;bWvken5oxY8a6kkE/6xr&#x2B;nhrxTwv4RvwBuW0bKgCEoa17YHUWKAI6a4J72tu1f2BbMj5PS93b9eG/I&#x2B;Xt&#x2B;s/bWRPWO2u&#x2B;n46aj22te1xr3X0Dah5X&#x2B;zED6t5uzXhc5u2rr7569tixY&#x2B;edccYZ&#x2B;1544YWnVouAgfUXm0Iv/kNY9A9i2uPrV&#x2B;fPC/SxXzdvFwCo196&#x2B;ecuCfh/84Ae33D788MO3bOW3adOmUF3Cpfry3e9&#x2B;L3zrW98O//3fPw/jxo3bMh0wZ868Hvn&#x2B;li1b9uLMmTPnjho16g933XXXste37uvpEf&#x2B;iW/b11Ih/Vrg34g/Q2///0gRA72mRetFEQFfgr31f/dn/tEUD8xYKjF00MGtxwNLrBVQMOOOMM4ZddNFFp1bXCBg4cOD2ngbojWIuAai9nTTK34x1AdJCfcxlBpDmiSeeCL/97cRKyL/49UKgPbztbTuEu&#x2B;66Z8sCf9VV/t/xjndsmQL49re/He6//74tr//xH3/Qbd/Txo0bX33yySefnjBhwrSf//zns5cuXfpq6JkR/7Jb&#x2B;HWG&#x2B;IX9YgqA2seEYMQf2EZzW2x2UwA4kJp2ECkCooqA3DUA8m6ffvrpwy6&#x2B;&#x2B;OJT3ve&#x2B;9x2gCKC3qW4DWC0A8sJ/ffiuHfVPWhit/r76sf&#x2B;kxxQtDCDN4sWLw803jwuDBu0Q9t57rzBy5Oe33L9gwYLwx398Upg06bGw2267veljqtMCL7zwQnjXu4aFZm/wsnnz5k2V72nRr3/960duv/32eXfffffyUG5Lvkau7&#x2B;&#x2B;pEf&#x2B;OiKAfG/rTQn3ZEX&#x2B;hH1AAKAC23QJgKxQBScE/6XZrNxYBSWsFFHkpWwS0fOELX9jna1/72hEnnnjiMQMHDhzk6ZfeoH4CIOlsfu1TRP0aAWmhvfZjs87qp5UFaYsGKgCI8fd//50watS/h//7f88KHR0d4etf/0Z48sknw7/&#x2B;67&#x2B;Eb37znMr7L&#x2B;z276G9vX3zqorp06c/O3bs2Mk33HDDwlBuS76eur4/a4G/Zo74d6SE/iL3pZUEaeHeiD&#x2B;gAFAAKAD6aBHQklAGxBYBWQsEdncR8MbLyJEj9zn77LMPGzFixMcGVU9PQS8rALrCd14hkDX6n1QO1H/u2rfTnk&#x2B;t&#x2B;k8Zv/71/4YVK14K8&#x2B;fPD6NH/yRUnmvDyy&#x2B;v3bLA3y9&#x2B;8ctu/TO8vuLpp5&#x2B;eef311z921VVXzckI&#x2B;mXDf5kt/Iz4O9sPKAAUAAqAflEEhBIFQJEioCUrzIcGdhD4zGc&#x2B;M/Sb3/zmR0eMGHF05X9OB3s6ZmsVAGvXrn1j5DnpEoDY4B&#x2B;7BkDa&#x2B;7IeI/xTxp133rFlGqA61v&#x2B;pT30yfOUrZ4Ydd9yp6V&#x2B;nveKZigceeGDGj370oycWLVrUFrLP8hcJ/0VG/NsjQ37sWX8j/oDcpgBQAPT3AqAHioD6QqBMEVA/AdCMIiAr/LeEYosDRk8HnHLKKXudd955R1YvDdhhhx0UAfR4AZC0CGCXrG0Bs15njfHnFQB5RQAU&#x2B;Zu4evXqsNNOO4btt2/&#x2B;lVcrVqxYfv/990/55S9/OeMXv/jFko6OjvaI4N5o&#x2B;N9aI/4x2/VlnflPKwKSQn9aSZAW7m3dBygAFAAKgF5QBNQH/mYVAWkv3V0E1C8ImFYElFo4cMSIEXucf/75R5588skfGzx48Ns8PdPTBUDtc1n9An9FJwBir&#x2B;OP2THAdn/0Jm1tba/MmDFj1jXXXPNwJfi/8NJLL70a4s/aFw3/zRjxTwv7ZUf8i470G/EH5DYFgAOpLx5ELcV/yJZeXAS0JAT7MkVAWtgvvV7A8ccf/86/&#x2B;Zu/&#x2B;ehRRx118J577rm3p2m2VgFQ&#x2B;/xWH867CoL6x&#x2B;YtEpi2jaBF/&#x2B;jNXn311bbZs2fPuemmmyZVQv/8559/fn1HdXXBYiP7MeG/kRIghPyz/yHlvtgR/46CoT/k3Cf0AwoABYADqbcfRP2oCAghe6vAtBKgNaIIiLlMIPP2XnvtNfjKK688/uMf//ihigC6uwCoDfb1IT9vJ4DaM/5J70sK&#x2B;WmP6c1/pNm2VIPivHnz5k6bNu3Z0aNHT3nooYdWhfLX62ddw9&#x2B;TI/5ZZ/M7IoJ&#x2B;s0b8i1zXn1cCCP2AAkABoADooZ&#x2B;5PxQBaRMCWZMBMbsHNK0I2GWXXbb/6U9/evwJJ5xw2J577jnU0zbNLgCSFgGMHfOvLwCSioSuYiCpTEgb9zf6z9ayZs2a1VOmTHl6woQJ06&#x2B;44orZodiWfGVG/NtD&#x2B;dH&#x2B;rLP/nQXCvxF/QAGgAFAAKAD6XRGQtW1g1poBrQ0WAaXWBKh/38CBAweMHTv2hJNOOumjJgJoZgFQOwFQfZ123X99gI9ZLyCrRIh9G7rbpoq5c&#x2B;fOvvnmmyeNHz9&#x2B;7owZM9aGuC35iob/RkuAvNX8Q859WW&#x2B;XGfEX&#x2B;gG5TQGgANhWD6J&#x2B;UASEkL9IYNkioClbB3bdHjt27PGf/OQnj95jjz328jROswqAvJX&#x2B;k4J90uUCWWf70y4TyNsxAJptc8XatWtfvu222/5QCf4zf/vb3y6PCPrdEf4bGfXvDHEL&#x2B;8WM&#x2B;MeE/hCM&#x2B;ANymwJAAaAA6ONFQN7aAHmXCLQWLAAa3jqw6/bPf/7zYz/72c9&#x2B;fPfdd9/T0zllC4DqJQC1I/tdgb4&#x2B;pCeF/vrnwLSSoP5pIalk6I1/mOlfKn8jO9asWfPyI4888sTVV189deLEiS9W/g1sjgz6RcN/zMJ9edfxZ539L7tyfzNH/Lfa1n2CP6AAUAA4kHrZQbSVi4BQF&#x2B;iLFgGx2wg2swgovV7AT3/602M&#x2B;//nPn7h7RcLvDAoVAPUBP22Ev/5Mf9aIf/1OAV0flzQRAM3W1ta24Zlnnqme5Z9&#x2B;ySWXPNXR0dFeMOiXCf9lt/ALofyIf1bQ7wiu6wdQACgAFADbSBFQ9KVoEdAaUQK05IT90gsFVm8PGjRou69//ev7X3DBBZ8aNmzYuz29U7YASAv/WSP8eYsGJn3OtM8BzTJ79uznp0yZ8uy///u/T546deqaJgT9mGv3u2PEPy3gG/EHUAAoABQAvfZ31N1FQFoxkHc5QEgI/H22CBgyZMh2X/7yl9/zt3/7t5/ab7/93utpniyvvvrqG7sAZI3ux5QDWaE&#x2B;bccABQDNVh3xf&#x2B;ihhx7/xS9&#x2B;Mf2mm25auJVG/Itu2ddTI/5Z4d6IP6AAkN0UAAoARUAotjZAzCUCA1Le38wioHXIkCEDTz/99GoRcMr&#x2B;&#x2B;&#x2B;9/gKd70gqA6iKA9SP6aaE/tgDI2&#x2B;4vaas/JQBlbdiwYf2cOXPmXX/99Q9PnDhx0eur&#x2B;BfZkq/siH/ZLfw6Q/zCfjEFQO1jQjDiD6AAUAAoAPppEZBXEDRaBNSXAs0uAmrDf30RUGRNgNTH7rjjjgPPOuus/b7xjW&#x2B;M&#x2B;GCFp31qde0CkBTo88b3a7f/q788oD7QJ10&#x2B;UL1dnTzoet6qnxaoLQcg4dh9dcWKFctuuummP4wfP372lClTVodiq/I34/r&#x2B;nhrx74gI&#x2B;rGhPy3Ulx3xF/oBuU0BoABwEHVrGRBTBGSF/qT3NasISLocoJEioCU0aevAgQMHDjjvvPMO/MpXvvKx4cOHH&#x2B;zpn6quSwCqwTxp&#x2B;760hQGT7ksqB9IuJUjbTrC3/6Fmq/&#x2B;N66yG/qlTpz5z&#x2B;eWXT7rrrrtW1Czo19HE8N&#x2B;s6/t7asS/IyX0F7kvrSRIC/dG/AG5TQGgAHAQ9ZsiIC38N6sISFsXIOl9Tb9M4Hvf&#x2B;95BX/jCF4788Ic/fIg/AwqA2kUAyy70l7dWQMx1/0oA0mzYsOGVSuiffscddzw9ZsyY51atWrUxxC3UFxv&#x2B;y2zhZ8Tf2X5AblMAKAAcRP28CEgK/WmLBuYtFJhWBBTZOrChIuD73//&#x2B;h0499dQPHX744YcOGjRoB38SFAC14T3vOv20&#x2B;4osCJj2HJr2FKAI2HZs3LjxtaVLl7546623PnrTTTfNevjhh1eF7PH8IuG/6Ih/R0TIT1vgLyvgG/EHUAAoABxIDqJtvAiILQFiLxPIvf25z31u6EUXXXTioYceOnzQoEGD/WlQAJTdBjAt7Hd9zq6Pr18vQBHAluTb0dG&#x2B;smLq1KkzrrjiikkTJ05cFhnci4b/7hjxTwr7sQVA2TP/aUVAUuhPKwnSwr2t&#x2B;wC5TXZTACgA&#x2B;n0RkBT8k263dmMRkHU5QHcWAS2f&#x2B;MQn9rz00ks/cfDBBx&#x2B;0ww47vM2fiG2jAOhaBDBtpf&#x2B;0a/ljg3/aVEDtOgFlCgCLBPYfL7/88qrp06fPvPbaayf/&#x2B;te/XrxmzZrXQvxZ&#x2B;zLhv9ER/7SwX3bEv&#x2B;hIvxF/AAWAAsCB1L8Pom2kCMhaILDoS&#x2B;GtA7teTjjhhD1&#x2B;/OMfn/KhD33og4MHD97Rn4r&#x2B;XQBUJwDyFutLOutf/zp2bYCYSwBiyoCuEqC3/TEnzuaKSuh/atKkSc&#x2B;NHj16&#x2B;uzZs9eH4iP7MeG/kRIghPyz/yHlvtgR/46CoT/k3Cf0AygAFAAKAEXAVigCWnLKgGYVAS2hsTUBUt937LHH7j5q1KhTDzrooA/stNNOO/uT0T8LgDVr1rwR8OsvBShypj9rC8CYVf9jxv2TzvwL/33LsmXLXrz77rsn33zzzc/cdtttSwsE&#x2B;9jw35ET&#x2B;Js94p91Nr8jIug3a8S/yHX9eSWA0A/IbbKbAkABsE0VAfWFQJkioD70h1B8EiBm0cABOW83vHBgtQj40Y9&#x2B;dMrw4cOrRcAQfzr6VwFQOwFQJLzHPCbpev&#x2B;YM/tlygFlQO&#x2B;1bt26NbNmzXr&#x2B;sssu&#x2B;/3999&#x2B;/fMmSJRtygnvMYn1Fr&#x2B;9vZMQ/bby/ka37jPgDKAAUAA4kB1EPFwH1gb9ZRUDaS28pAkqtF3DMMce848c//nF1jYAP7rzzzm/3J6R/FAC1EwBpwT1m9D8p5Ced7U/aFrDr7diz&#x2B;7Wfv36XAmsD9A7r169fN3/&#x2B;/AXXXHPNH&#x2B;68887FM2fOXBfiRvyLhv9GS4C81fxDzn1Zb5cZ8Rf6ARQACgAHkoOoG4qAEJInAXpLEdAS3jr&#x2B;H1sEtESE/dLrBRx22GG7nnfeeYd&#x2B;7nOfO2HIkCG7&#x2B;FPStwuAl19&#x2B;&#x2B;U2j/9XX9Sv01xcBtUE&#x2B;dj2AtOfMRq7/zwr&#x2B;yoCe197evvnFF19c8sADD0y77LLLpk2ZMuXlUGxLvmaF/0ZG/TtD3MJ&#x2B;MSP&#x2B;MaE/BCP&#x2B;AAoABYADyUGkCKh7X9JWgWklQGtPFAHDhw9/&#x2B;3e&#x2B;853DPvvZzx7/9re/fVdHXt8vAJJW&#x2B;a8P2knvy1oTIG0KIOt5NPbMfuzlAkqA7lU5hlY/9NBDj//mN795ZsyYMXNCsZH9IuE/ZuG&#x2B;vOv4s87&#x2B;l125v7tH/Hsk9Av&#x2B;gAJAdlMAKAAUAVu/CEibEMiaDEgL/4nb/4XyWwdueXn/&#x2B;9&#x2B;/80UXXXT4aaedVi0CdnPk9d0CoD6wx5zVz5oOSLq/9nWZbQDrS4G0AiHt40wFNEd7xRNPPDH9vvvue/ryyy&#x2B;fsWjRoraMoN&#x2B;s8F92C78QmjPiX2QBPyP&#x2B;AHKbAsCB5CBSBGQWAVnbBmatGdAaym8jWHpNgPr3HXDAATtdeOGFHxk5cuSIXXbZRRHQxwqApDBfXwDUrwuQdH9tOK//fF331Z/djwn9SWsGpD0m7fMK/43pqFi&#x2B;fPnSO&#x2B;6449Gf/exn0ydNmvRy5a72nKBfZFu/nhzxTzvDb8QfQG6T3RQACgBFQK8oAkLIXySwbBHQlK0Du4qA888//5A///M/P3nXXXd9hyOv7xQAaSv6x04C1If0oqv/x4T8mLIgK/ArAooHxZUrV6549NFHp//Hf/zHo48//vjqyjGzMTLoFw3/jWzht7VG/LPCfdZ2fiGjHOiW0C/4AygAFAAKAEVA3ygC8tYGyLtEoFlFQKHLBLqKgFNOOeWw/fbb770JvzO2sra2ti27ACRd418f7utLgbTCIOt10RBftDiI&#x2B;Xy99X8Cepv169evnTdv3vxrr732oeuuu27uqlWrNoZiW/KVCf9lt/ALodjCfjEFQO1jQjDiDyC3yW4KAAWAIqCBIiDUBfqiRUDsNoJJRUBrwZeG1gvYcccdB/7TP/3ToaeddtpRioDeVwBkrQFQP65fWwbkbRlYZgKgyO200iGtGKj/3iwWmOy5ikceeeSZUaNGTZ0xY8baUGxkv2j435oj/h0RQT829KeF&#x2B;rIj/kI/gAJAAeBAUgAoAhoqAlojSoCkgN&#x2B;s9QIGDBw4cMCll1566J/&#x2B;6Z8eowjoXQVA3pn/rAX&#x2B;si4PSHt&#x2B;THt/0S0BYy4VyPrnnTU1sC156aWXVjz44IPTbr311hk33njjC6&#x2B;99trmkL9QX9Hwn3d2v7eN&#x2B;HekhP4i96WVBGnh3og/gAJAAeBAchD1oyIgrRjIuxwgJAT&#x2B;nioCYkqBwrf/&#x2B;Z//&#x2B;ZC/&#x2B;Iu/OO49FZVfe6ujr/cUANXnkQEDBiRu/9dVCtReq582HVB0hf&#x2B;ilwLkBfgi1/7HFgb9ybp169YuWLBg4f/8z/88PG7cuHnz58/fEOJX6W/29f2xZ/mN&#x2B;Av9AAoABYADSQGgCAjxawP0liKg9fUi4MOnn376ccOGDXtPa&#x2B;28OD1WAKxevTpxrL9WtRBIu9Y&#x2B;bUqg9nXSx8Vel18k&#x2B;BedICh6X1&#x2B;3cePGVxctWrR4/PjxD91www3PR4z4NzP8523lF4IRf6EfQAGgAHAgOYj6eBGQVxA0WgTUlwJlioCYRQOTxv/LrAmQ&#x2B;L4f/OAHB5955pknvOtd73r3gGraZKsVALHj/WlbBcaG6qKL9sVOE5TdQSB2QqCvqQbFJUuWLH7kkUeeGjNmzNR77733pcjgXjT8N2sLv6wF/mLO8Mds15d15j&#x2B;tCEgK/WklQVq4N&#x2B;IPILcpABxIDqJttAjICv1J72tWEZA0BdBIERC7JkBUSXDhhRd&#x2B;8K/&#x2B;6q9O3rdiwIAB2zn6eqYAqB7iXQsB1obg&#x2B;pH&#x2B;tKKg632NjP4XOXtfJKzHlgW1b8cUCL3dhg0bXnn00Uen3XPPPbMuu&#x2B;yyWa&#x2B;88srGEH/Wvkz4b3TEPy3slx3xLzrSb8QfQAEguykAFAA0VAZ0ZxGQFv6bVQSkXQ7QEoovDlho4cDqYoEjRozY49/&#x2B;7d8&#x2B;fcghhwy3RkD3FgCrVq16I7ynndVPCvRp5UBWsC4SyIuWAlmfM&#x2B;bxecVF1mN7i46OjvZ58&#x2B;bNnTBhwmNjx46d9dRTT62NCPZlwn8jJUAI5c/6x474dxQM/SHnPqEfQG6T3RQACgBFQK8sApJCf9qigXnrAxQtAhqeAKi9PWjQoO1OOOGEd/7Lv/zLqR/5yEc&#x2B;rAjo3gKgNvDnvZ1UEsSE76SPjw33eWP&#x2B;RXcTKFMm9NYSYMmSJYumT5/&#x2B;/A9/&#x2B;MPfV0P/K6&#x2B;8siky2DdyfX9vGPFPC/rNGvEvcl1/Xgkg9APIbQoAB5KDSBHQJ4uAvPCfFO7LrBew5XbFgE996lN7XnzxxSOOOuqoIxQBzbNhw4Y3XQIQwlsXAOy6r/6sfloxkBfYk4J61wRB3lh/3nX7edMEXc&#x2B;RRS9RSCobap9vt8bfgOXLly979tln54wZM&#x2B;aRu&#x2B;66a9lLL730ak5wbyT8523hV2bEP228v5Gt&#x2B;4z4A6AAUAAoAOhXRUBS8E&#x2B;63dqNRUDsFEBDlwIk3f7iF7&#x2B;4zznnnHPMsccee7QioHHVCYCVK1eGrnUXs671ry0CskJ57PuKvj82yGddw582NVB0TYHYywWarbqKfyX0z77jjjueuPzyy59etGhRW4g7a180/DdaAnSG7LP/Iee&#x2B;rLeN&#x2B;AOgAFAAOJAUAIqAHioCshYILPpSpgjY8rVOP/30fc8&#x2B;&#x2B;&#x2B;yPVosAiwWWV50AKHIJQFfwrb/eP6YISJoASAvYsYVCo7fTSoS8RQB7cqeAyvfSsXz58qUTJkx4qPIye&#x2B;LEictCsZH92G36imzhV2TUPynsx471x6zoHzPOb8QfAAWAAkABwDZfBLQklAHdUQQkjf83vHVg9eXMM898z5e//OXDjjvuuKMGDhy4vSOveAHQdQlA7XNZ0gJ/9SG&#x2B;/mPSAn6RkiAmnMe8v&#x2B;z6AkUXIEz6PM1YG6AaFNva2jY89thj08aNGzftxhtvnL9u3bpNofj1&#x2B;kUCftbZ/bzr&#x2B;LPO/pddub&#x2B;nRvxt3QegAJDdFAAKAHp9EVBfCJQpAuqDfyhRAOQVAbXhv2gREF0SfOlLXxr2Z3/2ZwefeOKJRw4ZMuTtjrz4AqB6CUDWLgBdhUBtEZAW4OtH82OutS9ypr3RM/x5pUHt99/IZQFl/yZU/nusX7Ro0ZJf/epXj1ZH/JcuXfpqRtAvEv67Ywu/EJoz4l9kAT/X9QOgAFAAOJAUAP26CKgP/M0qAtJemlUEZE0B5JUCpdcLOPDAA4eMHj16xNFHH33oLrvssqsjL78AqF4C0BXya8Nv1tu1z31FV&#x2B;TP&#x2B;xy1b5fZSjCmYOh6rkxaeDDmGv&#x2B;sdQaK/m14feu&#x2B;&#x2B;Q8//PBTP/jBDx6bO3fuhoigH7tSf9Et/Mqu5p&#x2B;3iJ8RfwDkNgWAA8lBpAgoWAb0pyKgJSLsl14v4IADDtj5iiuuOPmII444eNddd32HIy&#x2B;9AKhOANSO9cduA1gkiDfrrH6RUJ5WGqRNKmQVAVlrAyR9X1nfR5eXXnppxdSpU2dcd911j48bN&#x2B;6FahEQGfSLhv9GtvDbWiP&#x2B;WeE&#x2B;azu/kFEOdEvoF/wB5DbZTQHgIGJbKgJCyN4qMG9dgG4tAt797nfveNVVV1WLgOG77777Ho68txYAlSD6pksA0hb6y1v9v&#x2B;gEQOylAzEBO68IKFI45H29Ij9jvc0V06ZNe&#x2B;Kuu&#x2B;56unJczlqyZElbKLYlX5nwX3YLvxDizvoXKQBqHxOCEX8AFAAKAAeSg0gR0OeKgLQJgQEhbq2AtAUE8y4TKFIEvO3KK6886cgjjzx4991339ORl1wAJIX92mJgywGQsANAVsAv8rgiwTp214Ha&#x2B;7vWMSgyvp&#x2B;3FkDa2f6ut9vb2zcvXbp08W9/&#x2B;9vJN99886x77713RSg2sh9zDX9vGfGP2a6v7NZ9IRjxB0ABoABwICkAFAH9pgjIOutfak2A&#x2B;o8dOnTo4KuuuurEo48&#x2B;&#x2B;sN77LHHXgqA/18ApK3sn3Z/bODOCtdpY/dJEwF5hUHMDgRpnyfvev&#x2B;s7zmtHKjc175y5cqXfv/73z9&#x2B;zTXXPHHfffct37RpU3vIX6U/JvzHvK&#x2B;3jvh3pIT&#x2B;IvellQTdEvoFfwC5TXZTACgAUASkbxsYQv7aAGWLgKZsHVi9vdtuuw26&#x2B;uqrTzz22GM/8s53vnObLQJeeeWVN9YAqH0uq1/tP&#x2B;usfv3Z9TLBvEyx0MzR/6zdAGI&#x2B;vub3uXbu3LnzKqH/weuvv37e61v39dYR/6ywb8TfH1QAuU12UwAoAFAERJUBMUVA1paBjRQBhaYDdt5554Hf&#x2B;973DjnzzDNP3muvvYZuiwVA1yUAXc9laZMA9eE6b5X&#x2B;vODeHYv/JZ3Vj922MO1nyPv67RWV0P/8fffdN33MmDFPzZgxY21OcC9SCMSE/6wyIITuG/FPC/pba8Rf6AdAAaAAUACgCGigCKgN8WWKgNjdA5KKgNaCLw2tFzB48ODtLrnkkg9/5StfOWnvvff&#x2B;o22pAFixYsWbFgGsLwKKhOnYhQKLntmPeV/W1y36eZIeX/v9Vt7uWLt27ap777138u9&#x2B;97tnx44dOz8yuBcN/826vj9rgb&#x2B;YM/yx1/Ib8QdAbpPdFAAOIvpBEVB7Zr&#x2B;7ioDWBkuAhtcLqBYBF1988fCzzjrrE0MrEn5n/b4AqB3lT7t2P&#x2B;t5sGhxkBSwYwL9lnbq9QX9sr63spcNJIT&#x2B;ztdee61t5syZs2655ZYpP/vZz55bt27dxhB/1j4m/BfZwm9rjPgXHek34g&#x2B;A3KYAcCA5iOjjRUDSS0gI/N1ZBNSe6U866196x4Dq7R133HHg&#x2B;eeff&#x2B;A555zzyaFDh75rWykAkoJ&#x2B;bCgveza/zKUEaQsIpn0/sTsCJF1CsGnTpo1z5syZfeutt06&#x2B;9tprZy1YsGBDRLDvjhH/rOv8Qyh&#x2B;1r/oiH9HwdCfFuqN&#x2B;AOgAFAAOJAcRPSyIiCtGMi7HCCvCAiRBUBvKAJaq4sFnn322ft/61vf&#x2B;uQ&#x2B;&#x2B;&#x2B;yzb387jtavX/9GAZC0vV&#x2B;Rrfpirs3PCu5lR/2zioCiWxHWfK7OhQsXzp8&#x2B;ffpzV1555eTf//73L4X4s/qNhP/eMOKfFvSzFvdLKwIaDf1Zbwv9ACgAFAAKABQBJYqAvIKg0SKgvhQoUwRkLRqY9P6G1gSo/zy77777oK9&#x2B;9av7n3HGGcd86EMfOqgSlgf0h&#x2B;OnOgGwbNmyMGDAgMzgX6QIyAvsRR5f9munTRHkXWpQ&#x2B;X2sf&#x2B;KJJ6bfdtttT15zzTWz29raNuUE90bCfyOr98ec/c9b2M&#x2B;IPwAKANlNAaAAQBEQVQQkFQLNKgKSpgCK7B5QtgjILQmqwf&#x2B;cc87Z/6tf/erHDjnkkIMHdCXnPqprAiB29f&#x2B;8UiDtjHpeQC9SBMQWDHkf03Xf5s2bNy1atGj&#x2B;DTfc8Iff/OY385966qk1Ie6sfdHwn3V2P&#x2B;asf2fIPvsfcu7LersZI/5CPwBym&#x2B;ymAHAQ0cvLgJgiICnsxxQBaeG/p4qAIosDFl448K//&#x2B;q/3P&#x2B;ussz5&#x2B;yCGHDB8wYMB2/aEAyAv0WcG66Oh90bH9Igv85ZUFldDfvmrVquWTJ0&#x2B;efvXVV0958MEHV7722mubQ/zIfuw1/EW38GtkxD92rD92Rf/YoG/EHwC5TXZTADiIUASkFgFJoT9t0cC89QGSwn5WEdDQBEDS7W984xvvPfvssz9&#x2B;8MEHDx9Y0dcKgOolAPXbAMYE&#x2B;yIBvNFt/spu/1d/e&#x2B;XKlctnzZr17HXXXTflf//3fxdVQn/SiH&#x2B;zwn/siH9ayI9Z4C&#x2B;E3jnib&#x2B;s&#x2B;AOQ2BYADyUGEIqDHioAi2wg2ul7AlrfPOuus95xzzjnHDR8&#x2B;/KDtt99&#x2B;UF8pAJYvXx4V/mvDfMzK/M263j9pMcEipcCmTZtefeaZZ2Y88MADz1x66aXTKrfbM4J&#x2B;0ZX6s67vL3qdfzNH/JOCfNERf9f1AyC3yW4KAAUAioDcIiAp&#x2B;Pd0ERA7BdDwpQD1t7/0pS&#x2B;964ILLhhRXSywtxcBtRMAWSG6yKh9WmAvGvBjv5&#x2B;Ur9/54osvLqqE/snjx4&#x2B;fef/996&#x2B;ICO6NhP9GR/yzxvmLrtxvxB8AFAAKAAUA9MoioDb8N6sIiF0XoMh0QOEdBEaOHLnPxRdffPJBBx30gR122GFwby0Ali5d&#x2B;pYCIC/Yd91O2D4v9XX1MdWv0/U8FXNGP&#x2B;1QTfk&#x2B;O9va2l555JFHptx6663Tb7nllgUbNmyIHfEvGv4b2cIv5ux/bxjxTzpj3yOhX/AHQAGgAHAgKQDYNouAloQyoDuKgKTx/4a2Dgyv7xqw//777/Rf//VfnzjuuOOO6m0TAevWrXvTBEBW&#x2B;I8I4KmPySsIil46UPsxGzdubFu4cOG822&#x2B;//bHrrrvu2crbG0Kxkf0y4b/I6v1lr&#x2B;ePLQBqH9No6E8L70b8AZDbZDcFgAIARUCPFwGhRAGQVwTUhv&#x2B;iRUBUSVAtAg488MCdR40adfzJJ5/88UGDBvWKiYBqAZA3ARAT&#x2B;LOmA2KLgqxSoP59mysWL148/8EHH3zy8ssvf3zBggUbOjo62ksE/axr&#x2B;I34pwd5I/4AyG2ymwLAQYQiILEIqC8EYouAtJdmFQFZUwB5pUDphQMPO&#x2B;ywXb///e8fc&#x2B;qppx63tS8N6CoA0s7O14b5rueXvGmB2AX7YtYMqP/YlStXLp05c&#x2B;bz11577aQ777xzSc2Cfkb848f5jfgDoACQ3RQACgBouAioD/x9vQhoiQj7pdcLOOaYY95x3nnnHf6Zz3zmhMGDB&#x2B;&#x2B;4tQqAF1988Y1r8/Ou408L82mPSQv5MSP/XbcrIb9tRsXEiROn3XLLLXOWLFnSFnpmxD929f7YsJ92ht&#x2B;IPwAoABQADiQHEX2qCAgheRKgtxQBLSF9q8C8dQFqi4C0XQJKFwHHH3/8O7/5zW8e&#x2B;ulPf/r4nXbaaeetUQDEhPjYcJ/2nJhVKtQ&#x2B;5vXQv3HNmjXLbr/99ofvvvvuOffcc8&#x2B;yUG5Lvkau7&#x2B;&#x2B;pEf&#x2B;OiKAfG/rTQn3ZEX&#x2B;hHwC5TXZTACgAUAT0ySIghOytAlsKhP&#x2B;Y6YCiEwG7nXvuuYf9yZ/8yfE777zzkJ74b7t27do3CoC88B&#x2B;z/V/a82LM46vX8L/yyisvV8L&#x2B;wxMnTpxZeVkSym3J11PX92ct8Bdzhj/2Wv6OlNBf5L60kiAt3BvxB0Buk90UAAoAFAF9vghImxCILQKyzvq3hAa3Dqy&#x2B;fcQRR&#x2B;x67rnnfvjkk08&#x2B;YujQoft0dwGwZMmSQrsApF2zX7vFX9LHphQEnZXQv2727NnP3nLLLY/eeOON8zZu3Lg5I/iXCf9Fru/fGiP&#x2B;zdy6Ly28G/EHAAWAAkABAP26CEjbNjCE/LUBeqoISH3sbrvtNuiKK6742HHHHfeRffbZ510Jv7OmFQB5i//lXd&#x2B;f9JyYNQHQ3t6&#x2B;ed68ec9Onjx51pgxYx6fP3/&#x2B;&#x2B;pB9lr9I&#x2B;C8y4t8eGfJjz/oXHfHvKBj600K9EX8AUAAoABQAoAhooAjI2jIwrwgoHfzrP75aBIwePfpjJ5xwwqHDhg3bt5lFQLUAWLx4cdS2fTFrAdS&#x2B;r37Rv&#x2B;qEwOrVq1dUQv/jEyZMmF4d8a/buq&#x2B;7wn9vGPFPC/pZi/ulFQGNhv6st4V&#x2B;AOQ22U0BoACAflUExFwSEFMEtBZ8KbNw4BtrC&#x2B;yyyy7b/&#x2B;QnPzn6pJNO&#x2B;si&#x2B;&#x2B;&#x2B;67XzP&#x2B;261Zs2ZLAdB1CUBtWM/bzq/&#x2B;P3vtZQS12tra1s6dO3f2&#x2B;PHjH7rzzjsXL1u2bEOIP2tfNPw3Y8Q/LezHLOxnxB8A5DYFgALAQYQioJuLgBDefGa/J4qAMiVA4QmA&#x2B;pchQ4YMHDVq1FGnnHLK4fvuu&#x2B;97Gy0AFi1a9KYCoL4ISHuOy7pEYOPGjW2VzztvwoQJD99zzz0LZ86cuSYUH9mPCf&#x2B;NlAAh5J/9Dzn3Zb3djBF/oR8AFAAKAAeSAgBFQE4RkPQSEgJ/2SIgba2ApG0E03YJKHqZwJs&#x2B;36BBg7b7yU9&#x2B;cuSnP/3pI9/97neXKgJefvnlNy4BqC8Akl4nPe91va48/3QsX7584ZNPPvnMjTfeOO2hhx5aHuKuyS8S/nt6xD/rbH7eiH9M6I8J/zGhPyv4C/0AoABQACgAoM8XAWnFQN7lAH2hCMh73JsmEv7zP//zyNNOO&#x2B;1jQ4cOHTZgwIDtYn/h1QmAF154IXMXgLxLANra2tZVQv/Ue&#x2B;&#x2B;99&#x2B;nrrrvu&#x2B;Y6OjiLb7ZUZ8W8P5Uf7s87&#x2B;9/YRf1v3AYACQAHgQFIAsE0UAXkFQXcUASGyAIhZNDDp/UVKgZaEt9/yOb/97W/vf9555326ukZATBFQnQCoXgKQdMa/drS//nV7e/vGxYsXV0f8H7j//vsXzpgxY01k8C4a/hstAfJW8w&#x2B;hZ0f8XdcPAHKbAsCB5CBCEdANRUBSIZBXBNSXAmlFQNIUQJHdA7LezioFsnYheOPrn3POOftfcMEF1SJg/6wioFoAVCcA0lbyr33d0dGxce3ataunTp362E033fT4pEmTVtSd7Y8J/c0I/42M&#x2B;ndG3BeCEX8AkNtkNwWAAgC2ShkQUwQkhf2&#x2B;XgSknfVvzflab3xfZ5111r7f/e53P7fffvt9oDVhmf5qAbBw4cK3rOBfG/7Xr1&#x2B;/4tlnn50&#x2B;bty4SRMnTlwcsve6z3td9JKAvDKgyNn/mK37unvEP&#x2B;mMfY&#x2B;EfsEfABQACgAFACgCksN/UuhPWysgb32AtLP1WcE&#x2B;97r/lBLgLQXFgAEDWr/4xS/&#x2B;0SWXXPJ/DjjggINrf1&#x2B;rV69&#x2B;SwFQ/U&#x2B;yefPmV&#x2B;fMmTNt8uTJT48ePXraxo0b20P2YnidEYG8Wav3x17PHzPinxX0O4Kt&#x2B;wBAbpPdFAAKAFAENKEIiAn/MSP/qeG/5ntv2WGHHQaMHDly6D/8wz&#x2B;c9v73v/&#x2B;wrgJgwYIFbxQAK1aseG7GjBlP3HzzzY8//PDDKxKCal4JkFQGFD2r34wR/45QbOV&#x2B;I/4AoACQ3RQACgBQBGy1IiDmEoK81/Xfe8vAgQNbzzzzzH3/8i//8uj3ve99J86dO7ftueeee&#x2B;TWW2999O677160Zs2azXXhszOiBIgZyW&#x2B;kBNhaI/5Z4d6IPwDIbbKbAgBoxj&#x2B;rHioCkoJ/0u3WbiwCYoJ&#x2B;VnGQdva/JaHESPsdhIhwmvfSaAlQZsQ/7Qz/NjPiX7YsAAAUAN1lO/95gZKhpqXgY9Perg1s9eG/9v7ax9bebq8J1O0Jn6O15nN13e6su6/2dcfrj&#x2B;moe2xtwO8oGf7rC4qQUASEjCKgM&#x2B;N1UoAuWwIUeVzREf&#x2B;OiKAfG/qzfhexoT&#x2B;2EBD6AYA&#x2B;zwQA0PA/s5KP7cmJgLTpgNYCr9PuK/I56r9&#x2B;1s8SEzTrg2t9oE5bbK/ILgE9PeLfkRL6i9yX9vtJC&#x2B;oNj/gL/gDQf7gEQAEAbL0iICQE46JFQP3ofSNFQEwxkHbJQdL30ZLy8yX9PtLG2susBRAaDPtG/IV&#x2B;AFAA9DEuAQCa9lxZoAhIuhwgKfjXB7aWUPzSgPqX&#x2B;ksN8i4JCAmBP&#x2B;uSgfaQvep/1gRAUtmR9fvLC85ZoTx2jN&#x2B;Iv9APACgAAJpWBKSVAc0oAjobLAJCSuDPOttfWwrUn/VvD/ETADG/t9gJgM6cIJ83zp93hj9mu76sM/9pP0tS6E8rCbJ&#x2B;R0I/AKAA8CsAekERUP/43lgEJL2uP/vfUhP6W1O&#x2B;XlrwL7MLQFaALlMCFDnDX2brvpjbWeHeiD8AgAIAUAR0axHQWvexnQkfVx/8OzKCf&#x2B;zZ/5bIgJsXqpPG8mMCfu1Z/ZgR/46CoT/k3Cf0AwAoAABFQLcXATHbBiatE9AR4rb7a637eYrsABAignRaMM8K9XnTAnlBv1kj/kWu688rAYR&#x2B;AAAFAKAIyCwCWhLCfmvK16i/ryO8dQqgfiKgo&#x2B;5niF0HIG1UPi1gd&#x2B;dLCEb8AQAUAAD9rAjImwDI&#x2B;/gQ3joFUGT8Py8EFwniseG&#x2B;0RF/oR8AQAEA0KuKgK6PbU0I8vXBvTWiFEgrADpC8sJ/LSk/R2yIjR23byTox4T&#x2B;EIz4AwD0Wi2dnf37/4taWlr8V4Y&#x2B;9s&#x2B;2gcenraKfNWafdV/eGfzWnI9pyQn8ad9XXqkRUsJ0XhiPCfPdPeLfU6Ff8AcAyv0PRD/OyCYAgF73nFuwCCg7EVB/O&#x2B;2&#x2B;tOv2k876ZxUDeYVDmfKjM&#x2B;J10UsCuiP0h2DEHwBAAQCwlYqApI9vSbkvKeB3ZgT8zj5WAMTeDsGIPwCAAgCgDxQBWffXh/7OkL5gYHuIG&#x2B;9Puh0iXjdaACQF&#x2B;DKhv8h9aeVAd4V&#x2B;wR8AQAEA9PMiIDYoJxUBaW93huxV9/N2Dgglwn/W/T1dAoRgxB8AQAEA0IvLgGYVAbUBtyWjBMgK/p0Jb6eF/EbP/JcpAbLCftZ9IRjxBwBQAABsI0VA2haCISf4h5B8zX/S/aHEz5J0f95Z&#x2B;phyIOmxWZ&#x2B;/O0K/4A8A0GS2AQT61T/5ko9tyfgcWeP7aQG/yONjvofYoB0T&#x2B;EMotkWfEX8AYJvSnzOyAgBQBMQXAWkBPib0533OIt97Z0bgDwUCf5n3xX5NoR8AUAD0Mi4BAPrl83aJMB1zaUDtx7TUPbYzI9Snva8z5O9KUPRnjjkj31mwLAg5n9uIPwBAH2ACANgmnutKPjbvzHyzzvDH3tcZeV&#x2B;ZQqBo6C8b4IV&#x2B;AKBXcwmAAgDYtouAZpQBeZ&#x2B;jzJNVkevx094v9AMAbCMFgEsAgG3q&#x2B;bxA2O6sC&#x2B;dZlwfUB&#x2B;qWiK/V2Q0FQGyQj5kksHUfAIACAGCbKgJCSvgPGQE&#x2B;bb2AtK/byDoARc/gd2foF/wBABQAAP2qCIgJ7S0RQbslIzS3FAzWnQW//5jyQOgHAFAAAGzTRUDRMqBMqO9s0s/UHYFf6AcAUAAAbHNFQFIYLjvS31Ly6xV5THcUCwAAKAAAtqkiICskx5QCRRcO7KmwLvQDACgAALaJIqCRMqBIiG6JfGxnD//sAAAoAACUAf0odAv9AAAKAAAygnJLP/gZAABQAADQYJhu6YXfEwAACgAAhHEAAPqbVr8CAAAAUAAAAAAACgAAAABAAQAAAAD0Cv1&#x2B;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&#x2B;VvvkU&#x2B;sAAAAASUVORK5CYII=" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>